<SEC-DOCUMENT>0001104659-24-058318.txt : 20240508
<SEC-HEADER>0001104659-24-058318.hdr.sgml : 20240508
<ACCEPTANCE-DATETIME>20240507215205
ACCESSION NUMBER:		0001104659-24-058318
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20240621
FILED AS OF DATE:		20240508
DATE AS OF CHANGE:		20240507

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50626
		FILM NUMBER:		24924023

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>tm242764-1_def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<html>
  <head>
    <title>tm242764-1_def14a - none - 5.9531516s</title>
  </head>
  <body style="margin-left:auto;margin-right:auto;width:595.31pt;">
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;min-height:706pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">UNITED STATES</font>
          <br >
          <font style="letter-spacing:-0.2pt;">SECURITIES AND EXCHANGE COMMISSION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">WASHINGTON, D.C. 20549</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:18.5pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">SCHEDULE 14A</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Proxy Statement Pursuant to Section&#160;14(a) of</font>
          <br >
          <font style="letter-spacing:0.2pt;">the Securities Exchange Act of 1934 (Amendment No.&#8199;&#8199;) </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Filed by the Registrant &#9746; </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Filed by a Party other than the Registrant &#9744; </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Check the appropriate box: </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Preliminary Proxy Statement </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Confidential, for Use of the Commission Only (as permitted by Rule&#160;14a-6(e)(2))</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9746;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Definitive Proxy Statement </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Definitive Additional Materials </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Soliciting Material under Under Rule&#160;14a-12 </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">CYCLACEL PHARMACEUTICALS, INC. </font>
        </div>
        <div style="margin-top:1.167pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Name of Registrant as Specified In Its Charter) </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8199;</font>
        </div>
        <div style="margin-top:2.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:2pt; text-align:center; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Payment of Filing Fee (Check the appropriate box): </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9746;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">No fee required. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Fee paid previously with preliminary materials. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Fee computed on table in exhibit required by Item&#160;25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cyclacel Pharmaceuticals, Inc.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">200 Connell Drive, Suite 1500</font>
          <br >
          <font style="letter-spacing:-0.2pt;">Berkeley Heights, New Jersey 07922</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:3pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">May&#160;7, 2024</font>&#8203;</div>
        <div style="margin-top:3pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To Our Stockholders: </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You are cordially invited to attend the 2024 Annual Meeting of Stockholders of Cyclacel Pharmaceuticals, Inc. (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;) to be held at 11:00&#160;a.m., E.D.T., on June&#160;21, 2024. We have decided to hold this year&#8217;s annual meeting via live audio webcast on the internet. We believe hosting a virtual annual meeting enables greater stockholder attendance and participation from any location around the world, improves meeting efficiency and our ability to communicate effectively with our stockholders, and reduces the cost and environmental impact of our annual meeting. You will be able to attend the annual meeting, vote and submit your questions during the annual meeting by visiting www.virtualshareholdermeeting.com/CYCC2024. You will not be able to attend the annual meeting in person. </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The attached Notice of Annual Meeting and proxy statement describe the business we will conduct at the annual meeting and provide information about us that the holders of our common stock (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Common Stock</font><font style="letter-spacing:0.2pt;">&#8221;) should consider when voting. </font>
        </div>
        <div style="margin-left:20pt; margin-top:3pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the annual meeting, we will ask our holders of Common Stock to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">re-elect each of Dr.&#160;Christopher Henney, Paul McBarron, and Dr.&#160;Robert Spiegel, nominees for Class&#160;3 directors, to our Board of Directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">ratify the appointment of RSM US LLP as our independent registered public accounting firm for our fiscal year ending December&#160;31, 2024; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">approve a proposed amendment to the Company&#8217;s 2018 Equity Incentive Plan to increase the number of shares of Common Stock available for the grant of awards by 160,000 shares; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">approve by an advisory vote the compensation of our named executive officers, as disclosed in this proxy statement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:3pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Board of Directors recommends the approval of each of these proposals. </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Such other business will be transacted as may properly come before the annual meeting and at any adjournments or postponements thereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under Securities and Exchange Commission rules that allow companies to furnish proxy materials to stockholders over the Internet, we have elected to deliver our proxy materials to the majority of our stockholders over the Internet. This delivery process allows us to provide stockholders with the information they need, while at the same time conserving natural resources and lowering the cost of delivery. On or about May&#160;10, 2024, we will commence mailing to our stockholders a Notice of Internet Availability of Proxy Materials (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Notice</font><font style="letter-spacing:0.2pt;">&#8221;) containing instructions on how to access our proxy statement for our 2024 Annual Meeting of Stockholders and our 2023 annual report to stockholders. The Notice also provides instructions on how to vote online or by telephone, how to access the virtual annual meeting and how to receive a paper copy of the proxy materials by mail. </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We hope you will be able to attend the annual meeting. Whether you plan to attend the annual meeting or not, it is important that you cast your vote either at the meeting or by proxy. You may vote over the Internet as well as by telephone or by mail. Therefore, when you have finished reading the proxy statement, you are urged to vote in accordance with the instructions set forth in this proxy statement. We encourage you to vote by proxy so that your shares will be represented and voted at the annual meeting, whether or not you can attend. </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Thank you for your ongoing support of Cyclacel Pharmaceuticals, Inc. We look forward to seeing you at the annual meeting. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sincerely, </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">/s/ Spiro Rombotis </font>
        </div>
        <div style="margin-right:264pt; margin-top:2.5pt; width:192pt;">
          <div style="margin-left: 0pt; width: 192pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Spiro Rombotis</font> <br ><font style="letter-spacing:0.2pt;">President and Chief Executive Officer</font></div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cyclacel Pharmaceuticals, Inc.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">200 Connell Drive, Suite 1500</font>
          <br >
          <font style="letter-spacing:-0.2pt;">Berkeley Heights, New Jersey 07922</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">May&#160;7, 2024</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:60pt;">
              <font style="letter-spacing:-0.2pt;">Time:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:384pt;">
              <div style="font-style:normal;font-weight:normal;">
                <font style="letter-spacing:0.2pt;">11&#160;a.m. E.D.T </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:-0.2pt;">Date:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <div style="font-style:normal;font-weight:normal;">
                <font style="letter-spacing:0.2pt;">June&#160;21, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:60pt;">
              <div style="font-style:italic;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Access:</font>
                <br >
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:384pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">This year&#8217;s annual meeting will be a virtual meeting via live audio webcast on the Internet. You will be able to attend the annual meeting, vote and submit your questions during the meeting by visiting www.virtualshareholdermeeting.com/CYCC2024 and entering the 16-digit control number included in the Notice of Internet Availability or proxy card that you receive. For further information about the virtual annual meeting, please see the Questions and Answers about the Meeting beginning on page 2 of the accompanying proxy statement. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <div style="line-height:12pt;font-style:italic;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Purposes:</font>
                <br >
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">For the holders of our common stock (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Common Stock</font><font style="letter-spacing:0.2pt;">&#8221;): </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:384pt;white-space:normal;">
              <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">1.</font>
                <br >
              </div>
              <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">To re-elect each of Dr.&#160;Christopher Henney, Paul McBarron, and Dr.&#160;Robert Spiegel, nominees for Class&#160;3 directors, to our Board of Directors; </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
              <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2.</font>
                <br >
              </div>
              <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">To ratify the appointment of RSM US LLP as our independent registered public accounting firm for our fiscal year ending December&#160;31, 2024; </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
              <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">3.</font>
                <br >
              </div>
              <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">To approve a proposed amendment to the Company&#8217;s 2018 Equity Incentive Plan to increase the number of shares of Common Stock available for the grant of awards by 160,000 shares; and </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
              <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">4.</font>
                <br >
              </div>
              <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">To approve by an advisory vote the compensation of our named executive officers, as disclosed in this proxy statement.</font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">WHO MAY VOTE?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You may vote if you were the record holder of our Common Stock at the close of business on May&#160;3, 2024. A list of stockholders of record will be available at the annual meeting and during the ten days prior to the annual meeting at the office of our Secretary at the above address. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All stockholders are cordially invited to attend the annual meeting. </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Whether you plan to attend the annual meeting or not, we urge you to vote by following the instructions in the Notice of Internet Availability of Proxy Materials that you previously received and submit your proxy by the Internet, telephone or mail in order to ensure the presence of a quorum</font><font style="letter-spacing:0.2pt;">. You may change or revoke your proxy at any time before it is voted at the meeting. If you participate in and vote your shares at the annual meeting, your proxy will not be used. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">By order of the Board of Directors </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">/s/ Paul McBarron</font>
        </div>
        <div style="margin-right:264pt; margin-top:2.5pt; width:192pt;">
          <div style="margin-left: 0pt; width: 192pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Paul McBarron</font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Secretary</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:266pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:325pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:427.96pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tINRT"><font style="letter-spacing:0.2pt;">IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE SHAREHOLDER MEETING TO BE HELD ON JUNE 21, 2024 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tINRT">1</a></font> <a href="#tINRT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tIMP"><font style="letter-spacing:0.2pt;">IMPORTANT INFORMATION ABOUT THE ANNUAL MEETING AND VOTING </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tIMP">2</a></font> <a href="#tIMP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSOOC"><font style="letter-spacing:0.2pt;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSOOC">8</a></font> <a href="#tSOOC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tMACG"><font style="letter-spacing:0.2pt;">MANAGEMENT AND CORPORATE GOVERNANCE </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMACG">10</a></font> <a href="#tMACG"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tEADC"><font style="letter-spacing:0.2pt;">EXECUTIVE AND DIRECTOR COMPENSATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tEADC">17</a></font> <a href="#tEADC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tECPI"><font style="letter-spacing:0.2pt;">EQUITY COMPENSATION PLAN INFORMATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tECPI">20</a></font> <a href="#tECPI"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPVP"><font style="letter-spacing:0.2pt;">PAY VERSUS PERFORMANCE </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPVP">25</a></font> <a href="#tPVP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tROAC"><font style="letter-spacing:0.2pt;">REPORT OF AUDIT COMMITTEE </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tROAC">28</a></font> <a href="#tROAC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCRAR"><font style="letter-spacing:0.2pt;">CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCRAR">29</a></font> <a href="#tCRAR"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPRO"><font style="letter-spacing:0.2pt;">PROPOSALS TO BE VOTED UPON BY HOLDERS OF COMMON STOCK </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPRO">30</a></font> <a href="#tPRO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tP1OC"><font style="letter-spacing:0.2pt;">PROPOSAL 1: ELECTION OF CLASS 3 DIRECTORS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tP1OC">30</a></font> <a href="#tP1OC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:427.96pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tP2OA"><font style="letter-spacing:0.2pt;">PROPOSAL 2: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tP2OA">31</a></font> <a href="#tP2OA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:427.96pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tPRO1"><font style="letter-spacing:0.2pt;">PROPOSAL 3: AMENDMENT TO 2018 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR THE GRANT OF AWARDS BY 160,000 SHARES </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPRO1">33</a></font> <a href="#tPRO1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:427.96pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tPR4"><font style="letter-spacing:0.2pt;">PROPOSAL 4: ADVISORY VOTE ON APPROVAL OF EXECUTIVE COMPENSATION AS DISCLOSED IN THIS PROXY STATEMENT </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPR4">39</a></font> <a href="#tPR4"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCOCA"><font style="letter-spacing:0.2pt;">CODE OF CONDUCT AND ETHICS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCOCA">41</a></font> <a href="#tCOCA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tOTMA"><font style="letter-spacing:0.2pt;">OTHER MATTERS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tOTMA">41</a></font> <a href="#tOTMA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSPAN"><font style="letter-spacing:0.2pt;">STOCKHOLDER PROPOSALS AND NOMINATIONS FOR DIRECTOR </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSPAN">41</a></font> <a href="#tSPAN"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tAPA"><font style="letter-spacing:0.2pt;">APPENDIX A: 2018 EQUITY INCENTIVE PLAN, AS AMENDED </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAPA">A-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">i</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tINRT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:160pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cyclacel Pharmaceuticals, Inc.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">200 Connell Drive, Suite 1500</font>
          <br >
          <font style="letter-spacing:-0.2pt;">Berkeley Heights, New Jersey 07922</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROXY STATEMENT FOR CYCLACEL PHARMACEUTICALS, INC.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">2024 ANNUAL MEETING OF STOCKHOLDERS</font>
          <br >
          <font style="letter-spacing:-0.2pt;">TO BE HELD ON JUNE 21, 2024</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This proxy statement, along with the accompanying notice of the 2024 annual meeting of stockholders, contains information about the 2024 annual meeting of stockholders of Cyclacel Pharmaceuticals, Inc., including any adjournments or postponements of the annual meeting. This year&#8217;s annual meeting will be held via live audio webcast on the internet. You will be able to participate, vote and submit your questions during the annual meeting by visiting www.virtualshareholdermeeting.com/CYCC2024. You will not be able to attend the annual meeting physically. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In this proxy statement, we refer to Cyclacel Pharmaceuticals, Inc. as &#8220;Cyclacel,&#8221; &#8220;the Company,&#8221; &#8220;we&#8221; and &#8220;us.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This proxy statement relates to the solicitation of proxies by our Board of Directors for use at the annual meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">On or about May&#160;10, 2024, we intend to begin sending to our stockholders the Important Notice Regarding the Availability of Proxy Materials containing instructions on how to access our proxy statement for our 2024 annual meeting of stockholders and our 2023 annual report to stockholders.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE SHAREHOLDER MEETING TO BE HELD ON JUNE 21, 2024</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">This proxy statement, the notice of 2024 annual meeting of stockholders, our form of proxy card and our 2023 annual report to stockholders are available for viewing, printing and downloading at www.proxyvote.com. To view these materials, please have your 16-digit control number(s) available that appears on your Internet Availability Notice or proxy card. On this website, you can also elect to receive future distributions of our proxy statements and annual reports to stockholders by electronic delivery.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Additionally, you can find a copy of our Annual Report on Form 10-K, which includes our financial statements, for the fiscal year ended December&#160;31, 2023 on the website of the Securities and Exchange Commission, or the SEC, at www.sec.gov, or in the &#8220;SEC Filings&#8221; section of the &#8220;Investors&#8221; section of our website at www.cyclacel.com. You may also obtain a printed copy of our Annual Report on Form 10-K, including our financial statements, free of charge, from us by sending a written request to: Cyclacel Pharmaceuticals, Inc., 200 Connell Drive, Suite 1500, Berkeley Heights, New Jersey 07922, attention: Secretary, Annual Meeting. Exhibits will be provided upon written request and payment of an appropriate processing fee. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tIMP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IMPORTANT INFORMATION ABOUT THE ANNUAL MEETING AND VOTING</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Why is the Company Soliciting My Proxy?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Board of Directors of Cyclacel is soliciting your proxy to vote at the 2024 annual meeting of stockholders, and any adjournments or postponements of the meeting, which we refer to as the annual meeting, to be held at 11:00&#160;a.m., E.D.T., on June&#160;21, 2024. This year&#8217;s annual meeting will be held via live audio webcast on the internet. You will be able to participate, vote and submit your questions during the annual meeting by visiting www.virtualshareholdermeeting.com/CYCC2024. If you encounter any difficulties accessing the virtual meeting during check-in or the meeting, please call the technical support number that will be posted on the virtual shareholder meeting log-in page. We believe that a virtual meeting will provide expanded stockholder access and participation and improved communications. You will not be able to attend the annual meeting physically. The proxy statement, along with the accompanying Notice of Annual Meeting of Stockholders, summarizes the purposes of the meeting and the information you need to know to vote at the annual meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have made available to you on the Internet or have sent you this proxy statement, the 2024 notice of annual meeting of stockholders, the proxy card or cards and a copy of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2023 because you owned shares of our common stock (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Common Stock</font><font style="letter-spacing:0.2pt;">&#8221;) on the record date. We intend to commence distribution of the Important Notice Regarding the Availability of Proxy Materials, which we refer to throughout this proxy statement as the Internet Availability Notice, and, if applicable, proxy materials to stockholders on or about May&#160;10, 2024. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Why Did I Receive a Notice in the Mail Regarding the Internet Availability of Proxy Materials Instead of a Full Set of Proxy Materials?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As permitted by the rules of the U.S. Securities and Exchange Commission, or the SEC, we may furnish our proxy materials to our stockholders by providing access to such documents on the Internet, rather than mailing printed copies of these materials to each stockholder. Most stockholders will not receive printed copies of the proxy materials unless they request them. We believe that this process should expedite stockholders&#8217; receipt of proxy materials, lower the costs of the annual meeting and help to conserve natural resources. If you received the Internet Availability Notice by mail or electronically, you will not receive a printed or email copy of the proxy materials, unless you request one by following the instructions included in the Internet Availability Notice. Instead, the Internet Availability Notice instructs you as to how you may access and review all of the proxy materials and submit your proxy on the Internet. If you requested a paper copy of the proxy materials, you may authorize the voting of your shares by following the instructions on the proxy card, in addition to the other methods of voting described in this proxy statement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Why Are You Holding a Virtual Annual Meeting?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This year&#8217;s annual meeting will be held in a virtual meeting format only. We have designed our virtual format to enhance, rather than constrain, stockholder access, participation and communication. For example, the virtual format allows stockholders to communicate with us in advance of, and during, the annual meeting so they can ask questions of our board of directors or management, as time permits. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How do I access the Virtual Annual Meeting?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The live webcast of the Annual Meeting will begin promptly at 11:00&#160;a.m. E.D.T. Online access to the audio webcast will open 15 minutes prior to the start of the Annual Meeting to allow time for you to log-in and test your device&#8217;s audio system. The virtual Annual Meeting is running the most updated version of the applicable software and plugins. You should ensure you have a strong internet connection wherever you intend to participate in the Annual Meeting. You should also allow plenty of time to log in and ensure that you can hear streaming audio prior to the start of the Annual Meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Log-in Instructions. To be admitted to the virtual Annual Meeting, you will need to log-in at www.virtualshareholdermeeting.com/CYCC2024 using the 16-digit control number found on the proxy card or voting instruction card previously mailed or made available to stockholders entitled to vote at the Annual Meeting. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Who May Vote?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Only stockholders who owned our Common Stock at the close of business on May&#160;3, 2024 will be entitled to vote at the annual meeting. On this record date, there were 1,463,259 shares of our Common Stock outstanding and entitled to vote on the proposals submitted to our holders of Common Stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If on May&#160;3, 2024 your shares of our common stock were registered directly in your name with our transfer agent, Equiniti Trust Company, LLC, then you are a stockholder of record. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If on May&#160;3, 2024 your shares were held, not in your name, but rather in an account at a brokerage firm, bank, dealer or other similar organization, then you are the beneficial owner of shares held in &#8220;street name&#8221; and the Internet Availability Notice or if applicable, our proxy materials are being forwarded to you by that organization. The organization holding your account is considered to be the stockholder of record for purposes of voting at the annual meeting. As a beneficial owner, you have the right to direct your broker or other agent regarding how to vote the shares in your account. You are also invited to attend the annual meeting. However, since you are not the stockholder of record, you may not vote your shares at the annual meeting unless you request and obtain a valid proxy from your broker or other agent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You do not need to attend the annual meeting to vote your shares. Shares represented by valid proxies, received in time for the annual meeting and not revoked prior to the annual meeting, will be voted at the annual meeting. For instructions on how to change or revoke your proxy, see &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">May I Change or Revoke My Proxy?</font><font style="letter-spacing:0.2pt;">&#8221; below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the ten-day period immediately prior to the annual meeting, the list of the stockholders of record entitled to vote at the annual meeting will be available for inspection at our offices at 200 Connell Drive, Suite 1500, Berkeley Heights, New Jersey 07922, by stockholders for such purposes as are set forth in the General Corporation Law of the State of Delaware. Such list will also be available for inspection at the annual meeting. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What Proposals Can I Vote on as a Holder of Preferred Stock?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The holders of Preferred Stock are not entitled to vote on any current proposals. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the terms of the Certificate, holders of the Preferred Stock are entitled to receive, when, as and if declared by the Board of Directors, out of the funds of the Company legally available therefor, cash dividends payable in equal quarterly installments on each of February&#160;1, May&#160;1, August&#160;1, and November&#160;1. The Certificate further provides that, if the Company is in arrears in an aggregate amount equal to at least six quarterly dividends (whether or not consecutive), the number of members of the Company&#8217;s Board of Directors will be increased by two, effective as of the time of election of such directors, and the holders of Preferred Stock, voting separately as a class, will have the right to vote and elect such two additional directors. This right accrued to the holders of our Preferred Stock as of August&#160;2, 2010. The Company is still in arrears in an aggregate amount in excess of six quarterly dividends on the Preferred Stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In light of the arrearage on the dividends, the holders of Preferred Stock have a continuing right to elect two directors on the Company&#8217;s Board of Directors. Since the Company&#8217;s 2022 annual meeting, Dr Kenneth M. Ferguson has served as a Class&#160;1 director and since the Company&#8217;s 2023 annual meeting, Dr.&#160;Samuel L. Barker has served as a Class&#160;2 director. They will serve as directors until the earlier of (a)&#160;the 2025 and 2026 annual meetings, respectively, and the time that their successors are duly elected and qualified, and (b)&#160;such time as all accrued and unpaid dividends on the Preferred Stock have been declared and paid or set apart for payment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How Many Votes Do I Have?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each share of our Common Stock that you own entitles you to one vote with respect to each of the proposals to be voted on by holders of Common Stock presented in the proxy statement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How Do I Vote?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Whether you plan to attend the annual meeting or not, we urge you to vote by proxy. All shares represented by valid proxies that we receive through this solicitation, and that are not revoked, will be voted </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">in accordance with your instructions on the proxy card or as instructed via the Internet or telephone. You may specify whether your shares should be voted for or withheld for each nominee for director, and whether your shares should be voted for, against or abstain with respect to each of the other proposals. If you properly submit a proxy without giving specific voting instructions, your shares will be voted in accordance with our board of directors&#8217; recommendations as noted below. Voting by proxy will not affect your right to attend the annual meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">If your shares are registered directly in your name through our transfer agent, Equiniti Trust Company LLC, or you have stock certificates registered in your name, you may vote: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">BY INTERNET OR BY TELEPHONE. FOLLOW THE INSTRUCTIONS ON YOUR NOTICE TO VOTE OVER THE INTERNET. IF YOU RECEIVED A PROXY CARD IN THE MAIL, THE PROXY CARD WILL HAVE INSTRUCTIONS FOR VOTING OVER THE INTERNET OR BY TELEPHONE.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">BY MAIL. IF YOU RECEIVED ONE OR MORE PROXY CARDS BY MAIL, YOU CAN VOTE BY MAIL BY COMPLETING, SIGNING, DATING AND RETURNING THE ENCLOSED PROXY CARD IN THE ENCLOSED POSTAGE PREPAID ENVELOPE. YOUR PROXY WILL BE VOTED IN ACCORDANCE WITH YOUR INSTRUCTIONS. IF YOU SIGN THE PROXY CARD BUT DO NOT SPECIFY HOW YOU WANT YOUR SHARES VOTED, THEY WILL BE VOTED AS RECOMMENDED BY OUR BOARD OF DIRECTORS.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AT THE MEETING. YOU MAY VOTE YOUR SHARES ELECTRONICALLY AT THE VIRTUAL ANNUAL MEETING. YOU WILL NEED THE 16-DIGIT CONTROL NUMBER ON YOUR NOTICE OR PROXY CARD IN ORDER TO VOTE AT THE MEETING. EVEN IF YOU PLAN TO ATTEND THE ANNUAL MEETING VIRTUALLY, WE ENCOURAGE YOU TO VOTE IN ADVANCE SO THAT YOUR VOTE WILL BE COUNTED IN THE EVENT YOU LATER DECIDE NOT TO ATTEND.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">If your shares are held in &#8220;street name&#8221; by a bank, broker or other nominee, please see the materials you received from your bank, broker or other nominee for voting instructions. To participate and vote during the annual meeting, you will need the 16-digit control number included on your Notice or your voting instruction form. If you do not have your 16-digit control number, you may gain access to and vote at the meeting by logging in to website of your bank, broker or other nominee and selecting the stockholder communications mailbox to access the meeting. Even if you plan to attend the annual meeting virtually, we encourage you to vote in advance so that your vote will be counted in the event you later decide not to attend. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Telephone and Internet voting facilities for all stockholders of record will be available 24-hours a day and will close at 11:59&#160;p.m., E.D.T., on June&#160;20, 2024.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How Does the Board of Directors Recommend that I Vote on the Proposals?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Board of Directors recommends that you, as a holder of Common Stock, vote as follows: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; the re-election of each of Dr.&#160;Christopher Henney, Paul McBarron, and Dr.&#160;Robert Spiegel, nominees for Class&#160;3 directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.49pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.49pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; the ratification of the appointment of RSM US LLP as our independent registered public accounting firm for our fiscal year ending December&#160;31, 2024; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; the approval of the amendment to our 2018 Equity Incentive Plan to increase the number of shares of Common Stock available for the grant of awards by 160,000 shares; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; the compensation of our named executive officers, as disclosed in this proxy statement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">If any other matter is properly presented at the annual meeting, your proxy provides that your shares will be voted by the proxy holder listed in the proxy in accordance with the proxy holder&#8217;s best judgment. At the time this proxy statement was first made available, we knew of no matters that needed to be acted on at the annual meeting, other than those described in this proxy statement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">May I Change or Revoke My Proxy?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If you submit a proxy, you may change or revoke it at any time before the annual meeting. You may change or revoke your proxy in any one of the following ways: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">By submitting a new proxy card with a date later than your previously delivered proxy and submitting it as instructed above or by providing written notice of revocation to us before the annual meeting at 200 Connell Drive, Suite 1500, Berkeley Heights, New Jersey 07922, Attention: Paul McBarron, Executive Vice President&#8201;&#8212;&#8201;Finance, Chief Financial Officer, Chief Operating Officer and Secretary; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">By submitting a later proxy by Internet or by telephone as instructed above; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">By attending the annual meeting and voting at the meeting. Attending the annual meeting will not, in and of itself, change or revoke a previously submitted proxy unless you specifically request it or vote at the annual meeting. Your most current vote, whether by telephone, Internet or proxy card is the one that will be counted. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What if I Receive More Than One Internet Availability Notice or Proxy Card?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You may receive more than one Internet Availability Notice or proxy card if you hold shares of our Common Stock in more than one account, which may be in registered form or held in street name. Please vote in the manner described above under &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">How Do I Vote?</font><font style="letter-spacing:0.2pt;">&#8221; for each account to ensure that all of your shares are voted. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Will My Shares be Voted if I Do Not Vote?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If your shares are registered in your name or if you have stock certificates, they will not be counted if you do not vote as described above under &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">How Do I Vote?</font><font style="letter-spacing:0.2pt;">&#8221;. If your shares are held in street name and you do not provide voting instructions to the bank, broker or other nominee that holds your shares as described above, the bank, broker or other nominee that holds your shares has the authority to vote your unvoted shares only on the ratification of the appointment of our independent registered public accounting firm (Proposal 2 of this proxy statement) without receiving instructions from you. Therefore, we encourage you to provide voting instructions to your bank, broker or other nominee. This ensures your shares will be voted at the annual meeting and in the manner you desire. A &#8220;broker non-vote&#8221; will occur if your broker, bank or other nominee cannot vote your shares on a particular matter because it has not received instructions from you and does not have discretionary voting authority on that matter or because your broker, bank or other nominee chooses not to vote on a matter for which it does have discretionary voting authority. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Your bank, broker or other nominee does not have the ability to vote your uninstructed shares in the election of directors. Therefore, if you hold your shares in street name, it is critical that you cast your vote if you want your vote to be counted for the election of directors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What Vote Is Required to Approve Each Proposal and How Are Votes Counted?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:222pt;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Proposal 1: Elect Dr.&#160;Christopher Henney, Paul McBarron, and Dr.&#160;Robert Spiegel as Class&#160;3 Directors</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">The three nominees for director who receive the most votes (also known as a &#8220;plurality&#8221; of the votes cast) will be elected. You may vote FOR all of the nominees, WITHHOLD your vote from all of the nominees or WITHHOLD your vote from any one of the nominees. Votes that are withheld will not be included in the vote tally for the election of directors. Brokerage firms do not have authority to vote customers&#8217; unvoted shares held by the firms in street name for the election of directors. As a result, any shares not voted by a customer will be treated as a broker non-vote. Such broker non-votes will have no effect on the results of this vote. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:222pt;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Proposal 2: Ratify Appointment of Our Independent Registered Public Accounting Firm</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">The affirmative vote of a majority of the votes cast for this proposal at the annual meeting is required to ratify the appointment of our independent registered public accounting firm. Abstentions will have no effect on this proposal. Brokerage firms have authority to vote customers&#8217; unvoted shares held by the firms in street name on this proposal. If a broker does not exercise this authority, such broker non-votes will have no effect on the results of this vote. We are not required to obtain the approval of our holders of Common Stock to appoint our independent registered public accounting firm. However, if our holders of Common Stock do not ratify the appointment of RSM US LLP as our independent registered public accounting firm for the year ending December&#160;31, 2024, the Audit Committee of our Board of Directors will reconsider its selection. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:222pt;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Proposal 3: Approval of a Proposed Amendment to our 2018 Equity Incentive Plan to increase the number of shares of Common Stock available for the grant of awards by 160,000 shares</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">The affirmative vote of a majority of the votes cast for this proposal is required to approve the amendment to the 2018 Equity Incentive Plan. Abstentions will have no effect on this proposal. Brokerage firms do not have authority to vote customers&#8217; unvoted shares held by the firms in street name on this proposal. As a result, any shares not voted by a customer will be treated as a broker non-vote. Such broker non-votes will have no effect on the results of this vote. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:222pt;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Proposal 4: Approve an Advisory Vote on the Compensation of our Named Executive Officers</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">The affirmative vote of a majority of the votes cast for this proposal at the annual meeting is required to approve, on an advisory basis, the compensation of our named executive officers, as described in this proxy statement. Abstentions will have no effect on this proposal. Brokerage firms do not have authority to vote customers&#8217; unvoted shares held by the firms in street name on this proposal. As a result, any shares not voted by a customer will be treated as a broker non-vote. Such broker non-votes will have no effect on the results of this vote.</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:20.99pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Is Voting Confidential?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will keep all of the proxies, ballots and voting tabulations private. We only let our Inspector of Election, a representative of Broadridge Financial Solutions, Inc., examine these documents. Management will not know how you voted on a specific proposal unless it is necessary to meet legal requirements. Broadridge Financial Solutions, Inc., however, will forward to management any written comments you make, on the proxy card or elsewhere. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Where Can I Find the Voting Results of the Annual Meeting?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The preliminary voting results will be announced at the annual meeting, and we will publish preliminary, or final, results, if available, in a Current Report on Form 8-K within four business days of the annual meeting. If final results are unavailable at the time we file the Form 8-K, then we will file an amended report on Form 8-K to disclose the final voting results within four business days after the final voting results are known. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:30pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What Are the Costs of Soliciting these Proxies?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will pay all of the costs of soliciting these proxies. Our directors and employees may solicit proxies in person or by telephone, fax or email. We will pay these employees and directors no additional compensation for these services. We will ask banks, brokers and other institutions, nominees and fiduciaries to forward these proxy materials to their principals and to obtain authority to execute proxies. We will then reimburse them for their expenses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have engaged Alliance Advisors, LLC to act as our proxy solicitor in connection with the proposals to be acted upon at our annual meeting. Pursuant to our agreement, Alliance Advisors, LLC will, among other things, provide advice regarding proxy solicitation issues and solicit proxies from our stockholders on our behalf in connection with the annual meeting. For these services, we will pay a fee of approximately $20,000 plus expenses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What Constitutes a Quorum for the Annual Meeting?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The presence, at the meeting or by proxy, of the holders of a majority of the voting power of all outstanding shares of our Common Stock entitled to vote at the annual meeting is necessary to constitute a quorum at the annual meeting. Votes of stockholders of record who are present at the annual meeting or by proxy, abstentions, and broker non-votes are counted for purposes of determining whether a quorum exists. Broker non-votes will be counted for purposes of determining whether a quorum exists with respect to all of the Proposals. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Attending the Annual Meeting</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This year, the annual meeting will be held in a virtual meeting format only. To attend the annual meeting, go to </font><font style="font-weight:bold;letter-spacing:-0.2pt;">www.virtualshareholdermeeting.com/CYCC2024</font><font style="letter-spacing:0.2pt;"> shortly before the meeting time, and follow the instructions. You need not attend the annual meeting in order to vote. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Householding of Annual Disclosure Documents</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Some brokers or other nominee record holders may be sending you a single set of our proxy materials if multiple of our stockholders live in your household. This practice, which has been approved by the SEC, is called &#8220;householding.&#8221; Once you receive notice from your broker or other nominee record holder that it will be &#8220;householding&#8221; our proxy materials, the practice will continue until you are otherwise notified or until you notify them that you no longer want to participate in the practice. Stockholders who participate in householding will continue to have access to and utilize separate proxy voting instructions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will promptly deliver a separate copy of our Internet Availability Notice. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1)&#160;visit www.ProxyVote.com, (2)&#160;call 1-800-579-1639 or (3)&#160;send an email to sendmaterial@proxyvote.com. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Electronic Delivery of Company Stockholder Communications</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Most stockholders can elect to view or receive copies of future proxy materials over the Internet instead of receiving paper copies in the mail. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You can choose this option and save us the cost of producing and mailing these documents by: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">following the instructions provided on your Internet Availability Notice or proxy card; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">following the instructions provided when you vote over the Internet; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">going to </font><font style="font-style:italic;letter-spacing:0.2pt;">www.proxyvote.com</font><font style="letter-spacing:0.2pt;"> and following the instructions provided. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSOOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth certain information with respect to the beneficial ownership of our Common Stock and our 6% Convertible Exchangeable Preferred Stock (the &#8220;Preferred Stock&#8221;) as of May&#160;3, 2024 for (a)&#160;each of our named executive officers, (b)&#160;each of our directors and director nominees, (c)&#160;all of our current directors and executive officers as a group, and (d)&#160;each stockholder known by us to own beneficially more than 5% of our Common Stock or Preferred Stock, relying solely upon the amounts and&#160;percentages disclosed in their public filings. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to the securities. We deem shares of Common Stock that may be acquired by an individual or group within 60&#160;days of May&#160;3, 2024 pursuant to the exercise of options or warrants to be outstanding for the purpose of computing the&#160;percentage ownership of such individual or group but do not deem them to be outstanding for the purpose of computing the&#160;percentage ownership of any other person shown in the table. Except as indicated in footnotes to this table, we believe that the stockholders named in this table have sole voting and investment power with respect to all shares of stock shown to be beneficially owned by them based on information provided to us by these stockholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Percentage of ownership of Common Stock is based on 1,463,259 shares of Common Stock outstanding as of May&#160;3, 2024. Percentage of ownership of Preferred Stock is based on 335,273 shares of Preferred Stock outstanding as of May&#160;3, 2024. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The address for each of the directors, director nominees and named executive officers is c/o&#160;Cyclacel Pharmaceuticals, Inc., 200 Connell Drive, Suite 1500, Berkeley Heights, New Jersey 07922. Addresses of other beneficial owners are noted in the table. </font>
        </div>
        <table style="width:456pt;height:275.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:199.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name of Beneficial Owners </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Common Stock</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Beneficially</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Owned </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Common Stock</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Owned </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Preferred Stock</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Beneficially</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Owned </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Preferred Stock</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Owned </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:199.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dr.&#160;Samuel L. Barker</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">8,398 </td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:199.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dr.&#160;Kenneth M. Ferguson</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">7,407</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:199.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dr.&#160;Christopher Henney</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">8,332</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:199.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Paul McBarron</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">16,611</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.14<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:199.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Spiro Rombotis</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(5)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">30,658</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.10<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,600</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:199.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dr.&#160;Robert Spiegel</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(6)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">8,316</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:199.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dr.&#160;Brian Schwartz</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(7)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">29,297</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.00<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:199.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Karin Walker</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(8)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">8,463 </td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:199.38pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Executive officers and directors as a group (8&#160;persons)</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(9)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">117,482 </td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">8.03<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,600</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:199.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">5% or more stockholders</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:199.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Armistice Capital, LLC</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(10)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">145,000</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">9.91<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:199.38pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Entities affiliated with Lind Global Fund&#160;II LP</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(11)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">102,250</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6.99<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:199.38pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Entities affiliated with Altium Growth Fund, LP</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(12)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">82,032</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">5.61<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:16.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:23.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.4pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Represents beneficial ownership of less than 1% of the outstanding shares of our Common Stock or of our Preferred Stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes options to purchase 2,829 shares of Common Stock that are exercisable within 60&#160;days of May&#160;3, 2024 and 1,414 Restricted Stock Units that will vest within 60&#160;days of May&#160;3, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes options to purchase 3,004 shares of Common Stock that are exercisable within 60&#160;days of May&#160;3, 2024 and 528 Restricted Stock Units that will vest within 60&#160;days of May&#160;3, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:280pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes options to purchase 2,829 shares of Common Stock that are exercisable within 60&#160;days of May&#160;3, 2024 and 1,414 Restricted Stock Units that will vest within 60&#160;days of May&#160;3, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes options to purchase 370 shares of Common Stock that are exercisable within 60&#160;days of May&#160;3, 2024 </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes options to purchase 704 shares of Common Stock that are exercisable within 60&#160;days of May&#160;3, 2024. Does not include 46 shares of Common Stock beneficially owned by Kalliopi Rombotis, Mr.&#160;Rombotis&#8217; mother. Mr.&#160;Rombotis disclaims beneficial ownership of the foregoing shares. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes options to purchase 2,829 shares of Common Stock that are exercisable within 60&#160;days of May&#160;3, 2024 and 1,414 Restricted Stock Units that will vest within 60&#160;days of May&#160;3, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes options to purchase 7,005 shares of Common Stock that are exercisable within 60&#160;days of May&#160;3, 2024 and 5,585 Restricted Stock Units that will vest within 60&#160;days of May&#160;3, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(8)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes options to purchase 2,838 shares of Common Stock that are exercisable within 60&#160;days of May&#160;3, 2024 and 1,418 Restricted Stock Units that will vest within 60&#160;days of May&#160;3, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(9)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">See footnotes 1 through and including 8. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(10)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Based solely on Securities Purchase Agreement dated April&#160;30, 2024 between the Company and Armistice Capital, LLC, as filed within the Company&#8217;s Current Report on Form 8-K filed with the SEC on May&#160;2, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(11)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Based solely on Schedule&#160;13G/A filed with the SEC on January&#160;4, 2024 by Lind Global Fund&#160;II, LP. Lind Global Partners II LLC, the general partner of Lind Global Fund&#160;II LP, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Fund&#160;II LP. Jeff Easton, the managing member of Lind Global Partners II LLC, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Fund&#160;II LP. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(12)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Based solely on Schedule&#160;13G/A filed with the SEC on January&#160;10, 2024 by Altium Growth Fund, LP. Altium Capital Management, LP is the investment adviser of, and may be deemed to beneficially own securities, owned by the Altium Growth Fund, LP (the &#8220;Fund&#8221;). Altium Growth GP, LLC is the general partner of, and may be deemed to beneficially own securities, owned by the Fund.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMACG">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MANAGEMENT AND CORPORATE GOVERNANCE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Board of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our charter provides that our business is to be managed by or under the direction of our Board of Directors. Our Board of Directors is divided into three classes for purposes of election. One class is elected at each annual meeting of stockholders to serve for a three-year term. Our Board of Directors currently consists of three classes, as set forth below. We also have two directors who are elected by holders of our 6% Convertible Exchangeable Preferred Stock (the &#8220;Preferred Stock&#8221;), </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;6, 2024, our Board of Directors accepted the recommendation of the Nominating and Corporate Governance Committee and voted to nominate Dr Christopher Henney, Paul McBarron and Dr.&#160;Robert Spiegel for election at the annual meeting for a term of three&#160;years to serve until the 2027 annual meeting of stockholders, or until their respective successors have been elected and qualified. Set forth below, as of December&#160;31, 2023, are the names of the persons nominated as directors for election at the annual meeting as well as the directors whose terms do not expire this year, their ages, their offices in the Company, if any, their principal occupations or employment for at least the past five&#160;years, the length of their tenure as directors and the names of other public companies in which such persons hold or have held directorships during the past five&#160;years. Additionally, information about the specific experience, qualifications, attributes or skills that led to our Board of Directors&#8217; conclusion at the time of filing of this proxy statement that each person listed below should serve as a director is set forth below: </font>
        </div>
        <table style="width:456pt;height:140.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:110.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:36pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Age </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:285.58pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Position </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:110.42pt;">
              <font style="letter-spacing:0.2pt;">Spiro Rombotis </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">65 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:285.58pt;">
              <font style="letter-spacing:0.2pt;">President and Chief Executive Officer; Class&#160;2 Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:110.42pt;">
              <font style="letter-spacing:0.2pt;">Paul McBarron </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">63 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:285.58pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Executive Vice President&#8201;&#8212;&#8201;Finance, Chief Financial Officer, Chief Operating Officer and Secretary; Class&#160;3 Director Nominee </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:110.42pt;">
              <font style="letter-spacing:0.2pt;">Dr.&#160;Christopher Henney </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">83 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:285.58pt;">
              <font style="letter-spacing:0.2pt;">Chairman; Class&#160;3 Director Nominee </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:110.42pt;">
              <font style="letter-spacing:0.2pt;">Dr.&#160;Robert Spiegel </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">74 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:285.58pt;">
              <font style="letter-spacing:0.2pt;">Vice Chairman; Class&#160;3 Director Nominee </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:110.42pt;">
              <font style="letter-spacing:0.2pt;">Dr.&#160;Samuel L. Barker </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">81 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:285.58pt;">
              <font style="letter-spacing:0.2pt;">Class&#160;2 Director on behalf of our holders of Preferred Stock </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:110.42pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dr.&#160;Kenneth M. Ferguson </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">68 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:285.58pt;">
              <font style="letter-spacing:0.2pt;">Class&#160;1 Director on behalf of our holders of Preferred Stock </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:110.42pt;">
              <font style="letter-spacing:0.2pt;">Dr.&#160;Brian Schwartz </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">62 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:285.58pt;">
              <font style="letter-spacing:0.2pt;">Class&#160;2 Director; Interim Chief Medical Officer </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:110.42pt;">
              <font style="letter-spacing:0.2pt;">Karin L. Walker </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">60 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:285.58pt;">
              <font style="letter-spacing:0.2pt;">Class&#160;1 Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.8pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Board Diversity Matrix</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(as of May&#160;3, 2024)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This table provides information on the diversity of our current Board of Directors: </font>
        </div>
        <table style="width:456pt;height:99pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 2.5pt 0pt; width:378.64pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total Number of Directors </font><font style="font-weight:normal;font-size:8pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.2pt;">8</font><font style="font-size:8pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:378.64pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Male </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Female </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:378.64pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Part&#160;I: Gender Identity</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:378.64pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Directors </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:378.64pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Part&#160;II: Demographic Background</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:378.64pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">White </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">6</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:9.385pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:378.64pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Did not Disclose Demographic Background </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Continuing Class&#160;1 Director (Term to Expire in 2025)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Karin L. Walker</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Ms.&#160;Walker has served as a director of the Company since November&#160;2020 and has over 30&#160;years of extensive finance experience in biopharmaceuticals, including in public biotechnology companies and technology companies. Ms.&#160;Walker currently serves as the Chief Accounting Officer of Prothena Corporation plc, a late-stage clinical biotechnology company with expertise in protein dysregulation and a pipeline of investigational therapeutics focused on neurodegenerative and rare peripheral amyloid diseases, and has held this position since 2013. Prior to joining Prothena, she was Vice President, Finance </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">and Chief Accounting Officer of Affymax, Inc., a position she held from 2012 to 2013. From 2009 to 2012, Ms.&#160;Walker was Vice President, Finance and Corporate Controller at Amyris Inc. From 2006 to 2009, she was Vice President, Finance and Corporate Controller for CV Therapeutics, Inc. Ms.&#160;Walker also held senior financial leadership positions at Knight Ridder Digital, Accellion, Niku Corporation, Financial Engines, Inc. and NeoMagic Corporation. Ms.&#160;Walker also served as a director and Audit Committee Chair for LifeSci Acquisition Corp. (a publicly-traded special purpose acquisition company) in 2020. Ms.&#160;Walker earned her B.S. in business from the California State Polytechnic University, San Luis Obispo, and is a certified public accountant (CPA). We believe that Ms.&#160;Walker&#8217;s qualifications to serve on the Board of Directors include experience in the biotechnology and pharmaceutical industry and her many&#160;years&#8217; experience in finance. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Class&#160;2 Directors (Terms to expire in 2026)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Spiro Rombotis</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Mr.&#160;Rombotis joined Cyclacel as its first CEO in 1997 and has over 38&#160;years at three public biotechs and two pharmas. He participated in in-licensing, clinical development, regulatory approval, partnering and commercial launch of several drugs, mainly in inflammation and hematology/oncology, including Abelcet</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">, Evacet/Myocet</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">, ProHance</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">, Remicade</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> and Reopro</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">. Major functional roles included international operations and business development as Vice President at Liposome (subsequently acquired by Elan) and previously Vice President in the pharmaceuticals division of Bristol-Myers Squibb. He began his career in the early &#8216;80s, after training at Novartis, as one of the first employees of Centocor (subsequently acquired by Johnson &amp; Johnson). He holds an MBA and MPH (Hospital &amp; Health Services Management) with honors, Kellogg School of Management, Northwestern University and a BA, Williams College (1981 James A. Garfield Scholar). He serves on the Board of Trustees of BioNJ, the NJ biotech association. We believe Mr.&#160;Rombotis&#8217; qualifications to serve on the Board of Directors include his role as President and Chief Executive Officer of our Company, his extensive knowledge and experience in the biotechnology and life sciences industry and his leadership, strategic guidance and operational vision. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Brian Schwartz, M.D</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Dr.&#160;Schwartz has served as a director of the company since December&#160;2020 and as our interim Chief Medical Officer since January&#160;2024. Dr.&#160;Schwartz has wide-ranging experience as a drug development expert in pharmaceutical and biotechnology industries primarily in oncology, hematology, and rare diseases. From June&#160;2008 to 2020, he served as Senior Vice President, Head of Research &amp; Development and Chief Medical Officer of ArQule Inc., which was acquired for $2.7&#160;billion by Merck &amp; Co. in 2020. Prior to ArQule, Dr.&#160;Schwartz was Chief Medical Officer at Ziopharm, having previously held several senior leadership roles at Bayer and LEO Pharma. He is a current Board Member of Enlivex Pharmaceuticals and also served as a director of LifeSci Acquisition Corp., Mereo Biopharma and Infinity. In addition, he serves as an advisor and independent consultant for numerous biotech and investment companies. He received his medical degree from the University of Pretoria, South Africa, completed a fellowship at the University of Toronto, Canada and practiced medicine prior to his career in the biopharmaceutical industry. We believe Dr.&#160;Schwartz&#8217;s qualifications to serve on the Board of Directors include his extensive knowledge and experience in the biotechnology and life science industry. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Continuing Preferred Stock Class&#160;1 Director (Term to Expire in 2025)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Dr.&#160;Kenneth M. Ferguson</font><font style="font-style:italic;letter-spacing:0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Dr.&#160;Ferguson has worked in the biopharmaceutical industry for 30&#160;years, and has led Research and Development operations in a number of publicly funded biotechnology companies. Dr.&#160;Ferguson is currently an operating partner at Accelerator Life Science Partners. He served at ICOS Corporation, at various times in its history, as President, Vice President of Therapeutic Development and Senior Director of Research. He was co-team leader of ICOS&#8217; joint venture with Eli Lilly and Company that resulted in the launch of Cialis</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">/Adcirca</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> for the treatment of erectile dysfunction, benign prostatic hyperplasia and pulmonary arterial hypertension. Subsequently, Dr.&#160;Ferguson was Vice President of Development and Chief Development Officer at Omeros Corporation and was involved in the approval and the launch of its first product for use in cataract surgery. Dr.&#160;Ferguson has also served as President and CEO of privately held Imvaxyn Corporation, a company dedicated to the exploration of new vaccine technology and was Chief Scientific Officer of EMulate Therapeutics. Dr.&#160;Ferguson graduated in biological sciences from Cornell University, obtained his PhD in pharmacology from the University of Texas Health Sciences Center Dallas, and completed his postdoctoral studies at Cold Spring Harbor Laboratory in New York. We believe Dr.&#160;Ferguson&#8217;s qualifications to serve on the Board of Directors include his extensive </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">knowledge and business experience in the biotechnology industry, including as an executive in public companies, where he developed specific expertise in research and development of pharmaceutical products. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Continuing Preferred Stock Class&#160;2 Director (Term to Expire in 2026)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Samuel L. Barker</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Dr.&#160;Barker has served as a director of the Company since September&#160;2014. In 2001, Dr.&#160;Barker co-founded Clearview Projects, Inc., a provider of partnering and transaction services to biopharmaceutical companies, where he was active until September&#160;2010, having served as its President and Chief Executive Officer from 2003 to 2004. Dr.&#160;Barker served in a series of leadership positions at Bristol-Myers Squibb Company until his retirement in 1999. His positions at Bristol-Myers Squibb included service as Executive Vice President, Worldwide Franchise Management and Strategy during 1998; President, United States Pharmaceuticals from 1992 to 1998; and President, Bristol-Myers Squibb Intercontinental Commercial Operations from 1989 to 1991. Prior to 1989, Dr.&#160;Barker held executive positions in research and development, manufacturing, business development and served as President of U.S. commercial operations at Squibb Pharmaceuticals. Dr.&#160;Barker has served as a director of Lexicon Pharmaceuticals, Inc. since 2001 and as Chairman from 2005 to 2012. Dr.&#160;Barker also served as a director of Cadence Pharmaceuticals, Inc. from 2006 to 2014 and AtheroGenics, Inc. from 2005 to 2009. Dr.&#160;Barker received his B.S. from Henderson State College, his M.S. from the University of Arkansas and his Ph.D. from Purdue University. We believe that Dr.&#160;Barker&#8217;s qualifications to serve on the Board of Directors include his extensive experience in senior leadership positions in the global pharmaceutical industry, where he developed specific expertise in the identification, development, commercialization and partnering of pharmaceutical products. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Nominees for Class&#160;3 Directors (Term to Expire in 2027; if re-elected)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Christopher S. Henney, Ph.D. D.Sc</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Dr.&#160;Henney has served as a director of the Company since March&#160;2006. Dr.&#160;Henney became Chairman of the Board of Directors of the Company in October&#160;2020. Dr.&#160;Henney had served as a director of Xcyte Therapies Inc., acquired by the Company in 2006, since March&#160;2005, and continued on as Vice Chairman of the Company. Previously, Dr.&#160;Henney co-founded three major publicly held U.S. biotechnology companies, Immunex, ICOS and Dendreon, and held a seat on the board of directors and executive positions at each company. From 1995 to January&#160;2003, Dr.&#160;Henney was Chairman and Chief Executive Officer of Dendreon Corporation. During part of 2016, he was also interim President and Chief Executive Officer of Cascadian Therapeutics Inc. and a board member of Anthera Pharmaceuticals, Inc., both biotechnology companies. Dr.&#160;Henney was a director of Prothena Corporation plc from 2013 until May&#160;2022. Dr.&#160;Henney received a Ph.D. in experimental pathology from the University of Birmingham and a D.Sc. from the same university for contributions to the field of immunology. In 2012, Dr.&#160;Henney was inducted into the Biotechnology Hall of Fame. We believe Dr.&#160;Henney&#8217;s qualifications to serve on the Board of Directors include his extensive knowledge and business experience in the biotechnology industry, including a diversified background as an executive in public companies and as a board member of many public companies, giving him a breadth of knowledge and valuable understanding of our business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Paul McBarron</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Mr.&#160;McBarron has served as a director of the Company since March&#160;2006. Mr.&#160;McBarron joined Cyclacel in January&#160;2002 and has over 30&#160;years of experience with pharmaceutical and biotechnology companies. He has served as a financial executive at Sterling Drug, Sanofi-Winthrop and SmithKline Beecham and, from 1996 to 2001, as a senior member of the finance team at Shire Pharmaceuticals plc, where he held the positions of Director of Corporate Finance and Group Financial Controller. He joined Shire when it was an emerging public company. He qualified as a chartered accountant with Ernst &amp; Young and served on the Scottish Lifesciences Association Board. We believe Mr.&#160;McBarron&#8217;s qualifications to serve on the Board of Directors include his role as Executive Vice President, Finance and Chief Operating Officer of our Company, his experience in the biotechnology and pharmaceutical industry and his expertise in financial areas and operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Robert J. Spiegel, M.D</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Dr.&#160;Spiegel has served as a director of the Company since September&#160;2018. Dr.&#160;Spiegel has over 30&#160;years of extensive R&amp;D and operational experience in biopharmaceuticals, including large pharmaceutical and biotechnology companies, and academic startups as well as an advisor to venture capital and private equity funds. Dr.&#160;Spiegel has also served as a director of Athenex, Inc., a global biopharmaceutical company, since August&#160;2020, of Geron Corp., a late-stage clinical biopharmaceutical </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">company, since May&#160;2010, and of Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, since December&#160;2017. Dr.&#160;Spiegel was an Assistant Professor and Director of the Developmental Therapeutics Program at New York University Medical Center and then spent 25&#160;years at Schering-Plough (subsequently acquired by Merck &amp; Co.), where he joined as the first Director for Oncology Clinical Research. He subsequently held a series of senior executive positions, including Senior Vice President for Worldwide Clinical Research and Chief Medical Officer. During his time at Schering-Plough he led teams that took numerous drug candidates through clinical development and was involved with over 30 New Drug Application approvals by the U.S. FDA. For the last seven&#160;years, he has been a consultant to the biotech industry and has served on the Scientific Advisory Board and Board of Directors of multiple biotech companies. Dr.&#160;Spiegel received his B.A. from Yale University and his M.D. from the University of Pennsylvania. He completed his specialty training at the National Cancer Institute, National Institute of Health (NIH). We believe Dr.&#160;Spiegel&#8217;s qualifications to serve on the Board of Directors include his extensive knowledge and business experience in the biotechnology industry, including a diversified background as an executive in public companies and as a board member of several public companies, giving him a breadth of knowledge and valuable understanding of our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Director Independence</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Board of Directors has reviewed the materiality of any relationship that each of our directors has with the Company, either directly or indirectly. Based upon this review, our Board of Directors has determined that each of the following directors is an &#8220;independent director&#8221; as such term is defined by rules of The Nasdaq Stock Market, Inc., or Nasdaq: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Christopher S. Henney, Ph.D., D.Sc. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Robert J. Spiegel, M.D. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Samuel L. Barker, Ph.D. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Kenneth M. Ferguson, Ph.D. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Karin L. Walker </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Board of Directors has established three standing committees: (1)&#160;the Compensation and Organization Development Committee, (2)&#160;the Audit Committee, and (3)&#160;the Nominating and Corporate Governance Committee. The Board of Directors has also determined that each member of these committees meets the independence requirements applicable to each such committee as prescribed by Nasdaq and the SEC. Dr.&#160;Schwartz will not be considered an independent director while serving as interim Chief Medical Officer. Following his appointment on January&#160;25, 2024, Dr Schwartz resigned from the Nominating and Corporate Governance Committee. In September&#160;2018, the Board of Directors also reconstituted the Science and Technology Committee. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Committees of the Board of Directors and Meetings</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Meeting Attendance</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;During fiscal 2023, there were 11 meetings of our Board of Directors, and the Compensation and Organization Development Committee, the Audit Committee, the Nominating and Corporate Governance Committee and the Science and Technology Committee met collectively a total of 15 times. No director attended fewer than 55% of the total number of meetings of the Board of Directors or of the committees of the Board of Directors on which they served during fiscal 2023. We have adopted a policy encouraging our directors to attend annual meetings of stockholders. Five of our then directors attended our annual stockholders&#8217; meeting held on June&#160;13, 2023. Each of the committees of the Board of Directors is described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Audit Committee</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our Audit Committee met six times during fiscal 2023. The Audit Committee during such period had four members: Karin L. Walker (Chair), Dr.&#160;Christopher Henney, Dr.&#160;Samuel L. Barker and Dr.&#160;Robert J. Spiegel. Karin L. Walker was appointed as Chairman of the Audit Committee on February&#160;18, 2021. All members of the Audit Committee satisfy the current independence standards promulgated by Nasdaq and the SEC, as such standards apply specifically to members of audit committees. The Board of Directors has determined that Karin L. Walker is an &#8220;audit committee financial expert,&#8221; as the SEC has defined that term in Item&#160;407 of Regulation&#160;S-K. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Audit Committee&#8217;s role and responsibilities are set forth in the Audit Committee&#8217;s written charter and include the authority to retain and terminate the services of our independent registered public accounting firm. In addition, the Audit Committee reviews annual financial statements, considers matters relating to accounting policy and internal controls and reviews the scope of annual audits. For additional information, please see the report of the Audit Committee set forth elsewhere in this proxy statement. A copy of the Audit Committee&#8217;s written charter is publicly available on our website at </font><font style="font-style:italic;letter-spacing:0.2pt;">www.cyclacel.com</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Compensation and Organization Development Committee</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our Compensation and Organization Development Committee met three times during fiscal 2023. The Compensation and Organization Development Committee is composed entirely of directors who are not our current or former employees, all of whom qualify as independent under the definition promulgated by Nasdaq and the SEC. The Compensation and Organization Development Committee currently has three members: Dr.&#160;Samuel L. Barker (Chairman), Dr.&#160;Christopher S. Henney and Dr.&#160;Kenneth M. Ferguson. Our Compensation and Organization Development Committee&#8217;s role and responsibilities are set forth in its written charter and include reviewing, approving and making recommendations regarding our compensation policies, practices and procedures to ensure that legal and fiduciary responsibilities of the Board of Directors are carried out and that such policies, practices and procedures contribute to our success. The Compensation and Organization Development Committee also administers our 2020 Inducement Equity Incentive Plan, our 2018 Equity Incentive Plan, our 2015 Equity Incentive Plan and our Amended and Restated 2006 Equity Incentive Plan, as amended. Our Compensation and Organization Development Committee is responsible for the determination of the compensation of our chief executive officer, and shall conduct its decision making process with respect to that issue without the chief executive officer present. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A copy of the Compensation and Organization Development Committee&#8217;s written charter is publicly available on our website at www.cyclacel.com. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Nominating and Corporate Governance Committee</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our Nominating and Corporate Governance Committee met once during fiscal 202</font><font style="font-style:italic;letter-spacing:0.2pt;">3</font><font style="letter-spacing:0.2pt;">. The Nominating and Corporate Governance Committee consists of Dr.&#160;Christopher S. Henney (Chairman), Karin L. Walker and Dr.&#160;Robert J. Spiegel, all of whom qualify as independent under the definition promulgated by Nasdaq and the SEC. Dr.&#160;Brian Schwartz resigned from the Nominating and Corporate Governance Committee when appointed interim Chief Medical Officer on January&#160;25, 2024. The functions of the Nominating and Corporate Governance Committee are set forth in the Nominating and Corporate Governance Committee&#8217;s charter and include evaluating and making recommendations to the full Board of Directors as to the size and composition of the Board of Directors and its committees, evaluating and making recommendations as to potential candidates, and evaluating the performance of the Board of Directors. Generally, our Nominating and Corporate Governance Committee considers candidates recommended by stockholders as well as from other sources such as other directors or officers, third party search firms or other appropriate sources. Once identified, the Nominating and Corporate Governance Committee will evaluate a candidate&#8217;s qualifications in accordance with its guiding principles as set forth in the Nominating and Corporate Governance Committee&#8217;s written charter. Additionally, the Nominating Committee will consider issues of diversity among its members in identifying and considering nominees for director, and strive where appropriate to achieve a diverse balance of backgrounds, perspectives, experience, age, gender, ethnicity and country of citizenship on our board of directors and its committees. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If a stockholder wishes to nominate a candidate for director who is not to be included in our proxy statement, it must follow the procedures described in our By-Laws and in &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Stockholder Proposals and Nominations for Director</font><font style="letter-spacing:0.2pt;">&#8221; at the end of this proxy statement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, under our current corporate governance policies, the Nominating and Corporate Governance Committee may consider candidates recommended by stockholders as well as from other sources, such as other directors or officers, third party search firms or other appropriate sources. For all potential candidates, the Nominating and Corporate Governance Committee may consider all factors it deems relevant, such as a candidate&#8217;s personal integrity and sound judgment, business and professional skills and experience, independence, knowledge of the industry in which we operate, possible conflicts of interest, diversity, the extent to which the candidate would fill a present need on the Board of Directors and concern for the long-term interests of the stockholders. In general, persons recommended by stockholders will be considered on the same basis as candidates from other sources. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A copy of the Nominating and Corporate Governance Committee&#8217;s written charter is publicly available on our website at </font><font style="font-style:italic;letter-spacing:0.2pt;">www.cyclacel.com</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Science and Technology Committee</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Science and Technology Committee, which met four times during fiscal 2023, consists of Dr.&#160;Robert J. Spiegel (Chairman), Dr.&#160;Samuel L. Barker, Dr.&#160;Kenneth M. Ferguson and Dr.&#160;Brian Schwartz. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The responsibilities of the Science and Technology Committee are set forth in the Science and Technology Committee&#8217;s charter and include providing oversight on behalf of the Board of Directors of our overall strategic direction and investment in research and development (&#8220;R&amp;D&#8221;) and technological and scientific initiatives. The Science and Technology Committee also assists the Board of Directors and our management in evaluating risks and potential commercial value of technical profiles regarding our R&amp;D programs and technology, as they might impact our business performance, growth and competitive position. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Board Leadership Structure</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Dr.&#160;Christopher Henney serves as the Chairman of our Board of Directors and Mr.&#160;Rombotis serves as our President and Chief Executive Officer. Dr.&#160;Christopher Henney is an independent director under the definition promulgated by Nasdaq and the SEC, and we believe that it is preferable for one of our independent directors to serve as Chairman of the Board of Directors. We also believe that this structure is the most effective structure for us and our stockholders at this time because a separate chairman (i)&#160;can provide the Chief Executive Officer with guidance and feedback on his performance, (ii)&#160;provides a more effective channel for the Board of Directors to express views on management, and (iii)&#160;allows the Chairman to focus on stockholder interests and corporate governance while providing Mr.&#160;Rombotis with the ability to focus his attention on managing our day-to-day operations. As Dr.&#160;Henney has significant senior level pharmaceutical industry experience, he is particularly well-suited to serve as Chairman. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We recognize that different board leadership structures may be appropriate for companies in different situations. We will continue to re-examine our corporate governance policies and leadership structures on an ongoing basis to ensure that they continue to meet the Company&#8217;s needs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Role in Risk Oversight</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Management is responsible for managing the risks that we face. The Board of Directors is responsible for overseeing management&#8217;s approach to risk management that is designed to support the achievement of organizational objectives, including strategic objectives and risks associated with our clinical trials, to improve long-term organizational performance and enhance stockholder value. The involvement of the full Board of Directors in reviewing our strategic objectives and plans, including with respect to our clinical trials, is a key part of the Board of Directors&#8217; assessment of management&#8217;s approach and tolerance to risk. A fundamental part of risk management is not only understanding the risks a company faces and what steps management is taking to manage those risks, but also understanding what level of risk is appropriate for us. In setting our business strategy, our Board of Directors assesses the various risks being mitigated by management and determines what constitutes an appropriate level of risk for us. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While the Board of Directors has ultimate oversight responsibility for overseeing management&#8217;s risk management process, various committees of the Board of Directors assist it in fulfilling that responsibility. Notably, the Audit Committee assists the Board of Directors in its oversight of risk management in the areas of financial reporting, internal controls and compliance with legal and regulatory requirements, the Nominating and Corporate Governance Committee reviews legal and regulatory compliance risks and the Compensation and Organization Development Committee assists the Board of Directors in its oversight of the evaluation and management of risks related to our compensation policies and practices. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Policy Prohibiting Hedging</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our Insider Trading Policy provides that no employee, officer or director may acquire, sell or trade in any interest or position relating to the future price of Company securities, such as a put option, a call option or a short sale (including a short sale &#8220;against the box&#8221;), or engage in hedging transactions (including &#8220;cashless collars&#8221;). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:408pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stockholder Communications to the Board of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Generally, stockholders who have questions or concerns should contact our Investor Relations department at (908) 517-7330 or e-mail at </font><font style="font-style:italic;letter-spacing:0.2pt;">ir@cyclacel.com</font><font style="letter-spacing:0.2pt;">. However, stockholders wishing to submit written communications directly to the Board of Directors should send their communications to our Secretary, Paul McBarron, Cyclacel Pharmaceuticals, Inc., 200 Connell Drive, Suite 1500, Berkeley Heights, New Jersey 07922. All stockholder communications will be considered by the independent members of our Board of Directors. Items that are unrelated to the duties and responsibilities of the Board may be excluded, such as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">junk mail and mass mailings; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">resumes and other forms of job inquiries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">surveys; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">solicitations or advertisements. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, any material that is unduly hostile, threatening, or illegal in nature may be excluded, provided that any communication that is filtered out will be made available to any independent director upon request. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tEADC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXECUTIVE AND DIRECTOR COMPENSATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Summary Compensation Table</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table shows the compensation paid or accrued during the last two fiscal&#160;years ended December&#160;31, 2022 and 2023 to (1)&#160;our President and Chief Executive Officer, (2)&#160;our Executive Vice President, Finance, Chief Financial Officer and Chief Operating Officer, and (3)&#160;our former Senior Vice President and Chief Medical Officer. </font>
        </div>
        <table style="width:456pt;height:152.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:190.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name and Principal Position </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Salary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Bonus</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">All Other</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Compensation</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:190.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Spiro Rombotis </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2023</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">560,131</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">48,581</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,337</td>
            <td style="padding:0pt;padding-left:9.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">661,049</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:190.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">President and Chief Executive Officer </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">546,470</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">169,406</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">47,675</td>
            <td style="padding:0pt;padding-left:9.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">763,551</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:190.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Paul McBarron</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2023</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">304,214</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">31,003</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">17,398</td>
            <td style="padding:0pt;padding-left:9.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">352,615</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:190.84pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Executive Vice President, Finance, Chief </font>
                <br >
                <font style="letter-spacing:0.2pt;">Financial Officer, Chief Operating Officer, </font>
                <br >
                <font style="letter-spacing:0.2pt;">Secretary </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">279,568</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">93,655</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.81pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">21,452</td>
            <td style="padding:0pt;padding-left:9.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">394,675</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:190.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Mark Kirschbaum, MD </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2023</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">396,760</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">31,003</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,855</td>
            <td style="padding:0pt;padding-left:9.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">480,618</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:190.84pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Former Senior Vice President and Chief Medical Officer</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(4)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">381,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">97,644</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.81pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">44,699</td>
            <td style="padding:0pt;padding-left:9.81pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">523,843</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.2pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">These amounts represent the aggregate grant date fair value for option awards computed in accordance with FASB ASC Topic 718. A discussion of the assumptions used in determining grant date fair value may be found in our Financial Statements included in our Annual Report on Form 10-K for the year ended December&#160;31, 2023. No Options were granted during the year ended December&#160;31, 2022 to Spiro Rombotis, Paul McBarron, or Mark Kirschbaum. Options were granted during the year ended December&#160;31, 2023 to Spiro Rombotis, Paul McBarron, and Mark Kirschbaum in the amounts of 7,333 shares, 4,680 shares, and 4,680 shares, respectively. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of the following for all executive officers: Payments for private medical and health insurance, life insurance and permanent health insurance; and matching contributions made under the Company&#8217;s U.S. 401(k) Plan and U.K. Group Personal Pension Plan. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Mr.&#160;McBarron&#8217;s compensation was translated from British pound sterling to the U.S. dollar using the exchange rates of 1.35104 as of December&#160;31, 2022 and 1.24361 as of December&#160;31, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:3.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Dr.&#160;Kirschbaum was terminated as Chief Medical Officer on January&#160;25, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Narrative Disclosure to Summary Compensation Table</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Compensation and Organization Development Committee of our Board of Directors makes decisions regarding the compensation of our President and Chief Executive Officer. The Compensation and Organization Development Committee is composed entirely of independent directors and meets in executive sessions to discuss and formulate its recommendation for the Chief Executive Officer&#8217;s base salary and bonus. The Compensation and Organization Development Committee does not rely solely on any predetermined formula or a limited set of criteria in evaluating the Chief Executive Officer&#8217;s performance for the year but does consider the achievement of preset goals as part of its deliberations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The evaluation is based on the Chief Executive Officer&#8217;s success in achieving his performance goals, which include financial, strategic and leadership objectives. The Chief Executive Officer also provides the Compensation and Organization Development Committee with a self-review of his performance as part of the Company&#8217;s review process. The Compensation and Organization Development Committee also approves the annual compensation (including base salary, bonus, and stock-based compensation) for our other named executive officers based on: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the executive&#8217;s scope of responsibilities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">an informed market assessment of competitive practices for similar roles within peer group companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">evaluations of performance for the year, as assessed by the Chief Executive Officer, supported by the Company&#8217;s performance review process and the executive&#8217;s self-assessment; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">recommendations by our Chief Executive Officer for each named executive officer with respect to base salary, cash bonus, and stock-based compensation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Compensation and Organization Development Committee is authorized to engage and retain independent consultants and other experts to assist in fulfilling its responsibilities, and the Committee engages periodically an external consultant to provide independent verification of market position and ensure the appropriateness of executive compensation. During the year ended December&#160;31, 2023, our Compensation and Organization Development Committee retained Radford, part of the Aon Rewards Solutions practice, or Radford, an independent, executive compensation consulting firm, to review and provide recommendations concerning our non-employee director and executive director compensation programs. Radford performed services solely on behalf of the Compensation and Organization Development Committee and has no relationship with the Company or management beyond the performance of such services (except that Aon plc provides directors &amp; officers insurance services to the Company). The Compensation and Organization Development Committee has assessed the independence of Radford pursuant to SEC rules and the corporate governance rules of The Nasdaq Stock Market and has concluded that no conflict of interest exists that would prevent Radford from independently representing the Compensation and Organization Development Committee. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the most recent year ended December&#160;31, 2023, the Board of Directors and the Compensation and Organization Development Committee reviewed the annual compensation for our executive officers. The Compensation and Organization Development Committee determined to provide increases in base salary for 2023 to Spiro Rombotis, Paul McBarron and Mark Kirschbaum, raising annual salaries to $560,131, &#163;244,622 (or $304,214) and $396,760, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We granted 3,840, 2,080, and 2,080 restricted stock&#160;units to Spiro Rombotis, Paul McBarron and Mark Kirschbaum, respectively, during the year ended December&#160;31, 2023. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Spiro Rombotis, President and Chief Executive Officer</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;On April&#160;28, 2023, we entered into a two-year employment agreement with Mr.&#160;Spiro Rombotis, effective January&#160;1, 2023. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Mr.&#160;Rombotis&#8217; current annual base salary is $560,131, which may be increased in the future in accordance with the terms of his employment agreement. Mr.&#160;Rombotis was paid an annual base salary of $560,131 for the year ending December&#160;31, 2023 and $546,470 for the year ending December&#160;31, 2022. Mr.&#160;Rombotis is also eligible for a yearly incentive cash bonus, based on a&#160;percentage of his then current base salary, if he meets certain corporate and individual performance criteria set by the Compensation and Organization Development Committee at the beginning of each year of employment. The agreement also provides for reimbursement of reasonable and necessary expenses incurred by Mr.&#160;Rombotis in connection with his performance of his services. Mr.&#160;Rombotis is also entitled to certain employment benefits in accordance with the Company&#8217;s benefit policies in effect from time to time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, Mr.&#160;Rombotis also agreed to certain confidentiality and assignment of inventions obligations and will be subject to certain non-competition obligations for a period of one year following termination of his employment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For further information on terms regarding termination and change-in-control of the Company, see &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Potential Payments upon Termination or Change-in-Control</font><font style="letter-spacing:0.2pt;">&#8221; below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Paul McBarron, Executive Vice President&#8201;&#8212;&#8201;Finance, Chief Financial Officer, Chief Operating Officer and Secretary</font><font style="letter-spacing:0.2pt;">. On April&#160;28, 2023, we entered into a two-year employment agreement with Mr.&#160;Paul McBarron, effective January&#160;1, 2023. Mr.&#160;McBarron&#8217;s current annual base salary is &#163;244,622, or $304,214, which may be increased in the future in accordance with the terms of his employment agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Mr.&#160;McBarron was paid an annual base salary of &#163;244,622, or $304,214 for the year ending December&#160;31, 2023 and &#163;226,133, or $279,568, for the year ending December&#160;31, 2022, respectively. Mr.&#160;McBarron is also eligible for a yearly incentive cash bonus based on a&#160;percentage of his then current base salary, if he meets certain corporate and individual performance criteria set by the Compensation and Organization </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:372pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Development Committee at the beginning of each year of employment. The agreement also provides for reimbursement of reasonable and necessary expenses incurred by Mr.&#160;McBarron in connection with the performance of his services. Mr.&#160;McBarron is also entitled to certain employment benefits in accordance with the Company&#8217;s benefit policies in effect from time to time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, Mr.&#160;McBarron also agreed to certain confidentiality and assignment of inventions obligations and will be subject to certain non-competition obligations for a period of one year following termination of his employment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For further information on terms regarding termination and change-in-control of the Company, see &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Potential Payments upon Termination or Change-in-Control</font><font style="letter-spacing:0.2pt;">&#8221; below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Mark Kirschbaum, Former Senior Vice President and Chief Medical Officer</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;On October&#160;17, 2020, we entered into an employment agreement with Dr.&#160;Mark Kirschbaum, effective October&#160;23, 2020. We terminated Dr.&#160;Kirschbaum&#8217;s employment on January&#160;25, 2024. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prior to his termination, Dr.&#160;Kirschbaum&#8217; annual base salary was $396,760. Dr.&#160;Kirschbaum was paid an annual base salary of $396,760 for the year ending December&#160;31, 2023 and $381,500 for the year ending December&#160;31, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, Dr.&#160;Kirschbaum also agreed to certain confidentiality and assignment of inventions obligations and will be subject to certain non-competition obligations for a period of one year following termination of his employment. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tECPI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EQUITY COMPENSATION PLAN INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Outstanding Equity Awards at 2023 Fiscal Year-End</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table shows grants of stock options outstanding on the last day of the fiscal year ended December&#160;31, 2023, to each of the executive officers named in the Summary Compensation Table. As applicable, the figures described in this section have been adjusted to give effect to the reverse stock split completed on December&#160;15, 2023. </font>
        </div>
        <table style="width:456pt;height:329.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:242.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exercisable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unexercisable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price</font><font style=" position:relative; bottom:3.25pt;line-height:6pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Expiration</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:242.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Spiro Rombotis </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">22<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(2</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">3,096.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">02/18/2025</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:242.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">121<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(3</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">2,120.40</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/07/2025</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:242.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">104<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(4</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">522.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/29/2027</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:242.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">95<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(4</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">468.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">02/22/2028</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:242.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">1,693<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(5</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">213.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">01/04/2029</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:242.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">11,666<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(6</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">64.80</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/11/2030</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:242.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">8,444<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(8</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4,222</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">51.75</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/13/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:242.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">0<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(9</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">7,333</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8.70</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">06/27/2033</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:242.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Paul McBarron </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">14<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(2</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">3,096</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">02/18/2025</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:242.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">72<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(3</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">2,120.40</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/07/2025</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:242.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">86<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(4</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">522.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/29/2027</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:242.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">79<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(4</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">468.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">02/22/2028</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:242.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">900<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(5</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">213.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">01/04/2029</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:242.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">8,000<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(6</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">64.80</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/11/2030</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:242.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">4,444<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(8</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,222</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">51.75</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/13/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:242.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">0<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(9</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4,680</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8.70</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">06/27/2033</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:242.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Mark Kirschbaum</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(10)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">8,000<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(7</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">56.55</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">10/23/2030</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:242.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">4,444<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(8</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,222</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">51.75</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/13/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:242.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">0<font style=" position:relative; bottom:4.25pt;font-size:6.5pt;">(9</font><font style="position:absolute;padding-top:0pt;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">)</font> </font></td>
            <td style="padding:0pt;padding-left:2.175pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4,680</td>
            <td style="padding:0pt;padding-left:11.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8.70</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">06/27/2033</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The option exercise price is the closing price of our Common Stock on The Nasdaq Capital Market on the date the option was granted. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">These options were granted on February&#160;18, 2015, and vest ratably on a monthly basis over 36&#160;months. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">These options were granted on December&#160;7, 2015, and vest ratably on a monthly basis over 36&#160;months. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:3.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Certain performance criteria were deemed to have been met in 2018 and 2019, and as such, performance-based options granted in 2017 and 2018 vested. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:3.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">These options were granted on January&#160;4, 2019 and included part of the 2018 bonus award, and vest ratably on a monthly basis over 36&#160;months. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">These options were granted on December&#160;11, 2020, and vest ratably on a monthly basis over 36&#160;months. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:3.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">These options were granted on October&#160;23, 2020 and vest over 36&#160;months as to one third (1/3) of the shares on the first anniversary of the Grant Date and as to one thirty-sixth (1/36) of the total number shares monthly thereafter. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(8)</font>
          <br >
        </div>
        <div style=" margin-top:3.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">These options were granted on December&#160;13, 2021, and vest ratably on a monthly basis over 36&#160;months. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(9)</font>
          <br >
        </div>
        <div style=" margin-top:3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">These options were granted on June&#160;27, 2023, and vest on achievement of certain performance criteria. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(10)</font>
          <br >
        </div>
        <div style=" margin-top:3.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">We terminated Dr.&#160;Kirschbaum&#8217;s employment on January&#160;25, 2024. These options have ceased vesting as of January&#160;25, 2024, and have not been exercised as of February&#160;6, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Potential Payments Upon Termination or Change-in-Control</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have entered into agreements that require us to make payments and/or provide benefits to certain of our executive officers in the event of a termination of employment or change-in-control. Our 2006 Equity Incentive Plan, or 2006 Plan, our 2015 Equity Incentive Plan, or 2015 Plan, our 2018 Equity Incentive Plan, or 2018 Plan, and our 2020 Inducement Equity Incentive Plan, or 2020 Plan (and collectively with the 2006 Plan, 2015 Plan, and 2018 Plan the &#8220;Plans&#8221;) provide for payments to named executive officers in connection with a termination or a change-in-control of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following summarizes the potential payments to certain of our executive officers with whom we have entered into an employment agreement that includes a payment upon termination and/or a change-in-control, as further described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Spiro Rombotis, President and Chief Executive Officer</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Mr.&#160;Rombotis&#8217;s employment agreement provides for certain severance arrangements. In the event that Mr.&#160;Rombotis&#8217;s employment is terminated &#8220;without cause,&#8221; other than termination in connection with a &#8220;change of control&#8221; &#8203;(each as defined in the employment agreement), we will be required to pay Mr.&#160;Rombotis (i)&#160;all accrued but unpaid compensation up to the time of such termination; (ii)&#160;for a period of twelve&#160;months following such termination, severance payments in the form of his base salary as in effect immediately prior to such termination, or Severance Payments, including form of continuation coverage of his medical care and life insurance on the same terms as applicable to other executive employees, unless Mr.&#160;Rombotis obtains substitute coverage; and (iii)&#160;a period of six&#160;months in which to exercise all vested options held by Mr.&#160;Rombotis. In the event that Mr.&#160;Rombotis&#8217;s employment is terminated within six&#160;months following a &#8220;change-in-control&#8221; event, Mr.&#160;Rombotis will be entitled to (i)&#160;all accrued but unpaid compensation up to the time of such termination; (ii)&#160;Severance Payments for a period of 24&#160;months; (iii)&#160;out-of-pocket expenses reasonably incurred by Mr.&#160;Rombotis in connection with his and his family&#8217;s relocation to London; and (iv)&#160;eighteen&#160;months&#8217; accelerated vesting of any options held by him. In the event of termination due to his death or disability, we will pay Mr.&#160;Rombotis (or his estate, as the case may be) (i)&#160;all accrued but unpaid compensation up to the time of such termination and (ii)&#160;Severance Payments for a period of twelve&#160;months. He (or his estate, as the case may be) would also be entitled to a period of twelve&#160;months in which all of his vested options can be exercised. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Paul McBarron, Executive Vice President&#8201;&#8212;&#8201;Finance, Chief Financial Officer, Chief Operating Officer and Secretary</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Mr.&#160;McBarron&#8217;s employment agreement provides for certain severance arrangements. In the event that Mr.&#160;McBarron&#8217;s employment is terminated &#8220;without cause,&#8221; other than termination in connection with a &#8220;change of control&#8221; &#8203;(each as defined in his employment agreement), we will be required to pay Mr.&#160;McBarron (i)&#160;all accrued but unpaid compensation up to the time of such termination; (ii)&#160;Severance Payments for a period of twelve&#160;months following such termination; and (iii)&#160;a period of six&#160;months in which to exercise all vested options held by Mr.&#160;McBarron. In the event that Mr.&#160;McBarron&#8217;s employment is terminated within six&#160;months following a &#8220;change-in-control&#8221; event, Mr.&#160;McBarron will be entitled (i)&#160;all accrued but unpaid compensation up to the time of such termination; (ii)&#160;Severance Payments for a period of twelve&#160;months; and (iii)&#160;eighteen&#160;months&#8217; accelerated vesting of any options held by him. In the event of termination due to his death or disability, we will pay Mr.&#160;McBarron (or his estate, as the case may be) all accrued but unpaid compensation up to the time of such termination and Severance Payments for a period of twelve&#160;months. He (or his estate, as the case may be) would also be entitled to a period of twelve&#160;months in which all of his vested options can be exercised. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Potential payments to each named executive officer under our Plans in connection with a termination or a change-in-control of the Company</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following summarizes the potential payments to each named executive officer under the Plans in connection with a termination or a change-in-control of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Termination For Cause</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If an award recipient&#8217;s service relationship with the Company terminates for &#8220;cause&#8221; &#8203;(as defined in the Plans), then any unexercised award shall terminate immediately upon his or her termination of service. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Termination Without Cause</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If an award recipient&#8217;s service relationship with the Company terminates for any reason other than for &#8220;cause&#8221; &#8203;(excluding death or disability), then the recipient generally may exercise </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the award, to the extent vested, within 30&#160;days (in our 2006 Plan) or three&#160;months (in our 2015 Plan, 2018 Plan, and 2020 Plan), of such termination to the extent that the award is vested on the date of termination (but in no event later than the expiration of the term of the award as set forth in the award agreement). If the recipient dies within three&#160;months following such a termination, the award generally may be exercised, to the extent vested, within 180&#160;days&#8217; or one year (as per the 2006 Plan, 2015 Plan, 2018 Plan, and 2020 Plan, respectively) of the recipient&#8217;s death. If an award recipient&#8217;s service relationship with the Company terminates due to his or her death, the award recipient&#8217;s personal representative, estate, or the person who acquires the right to exercise the award by bequest or inheritance, as the case may be, generally may exercise the award, to the extent the award was vested on the date of termination, within one year from the date of the recipient&#8217;s death. Pursuant to the 2006 Plan, if an award recipient&#8217;s service relationship with the Company terminates due to his or her disability, the recipient, the recipient&#8217;s personal representative, estate, or the person who acquires the right to exercise the award by bequest or inheritance, as the case may be, generally may exercise the award, to the extent exercisable on the date of termination, within one year from the date of the recipient&#8217;s termination, or if the recipient dies during such one-year period, within the later of one year from the date of the recipient&#8217;s termination and 180&#160;days from the recipient&#8217;s death. In no event may an award be exercised later than the expiration of the term of the award as set forth in the award agreement. Pursuant to the 2015 Plan, 2018 Plan, and 2020 Plan, with regard to options outstanding on the date of an individual&#8217;s termination due to disability, he or she may exercise any option to the extent that the option is exercisable but has not been exercised on the date of termination. Such an individual is also entitled to any additional vesting rights that would have accrued on the next vesting date had he or she not become disabled. Exercise may only occur during the one-year period after the date of termination. With regard to stock grants and stock-based awards outstanding on the date of an individual&#8217;s termination due to disability, to the extent the forfeiture provisions or the Company&#8217;s rights of repurchase have not lapsed, they shall be exercisable; provided, however, that in the event such forfeiture provisions or rights of repurchase lapse periodically, they shall lapse to the extent of a pro&#160;rata portion of the shares subject to such stock grant or stock-based award through the date of disability as would have lapsed had the individual not become disabled. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Change-in-Control</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Pursuant to the terms of the Plans, in the event of a change-in-control (as defined in the Plans), all outstanding awards granted under the Plans will be either: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">assumed by the successor corporation or a parent or subsidiary of the successor corporation; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">substituted with an equivalent award by the successor corporation or a parent or subsidiary of the successor corporation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">However, in the event that the successor corporation refuses to assume or substitute an award: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">awards consisting of options, stock appreciation rights and rights to purchase restricted stock will become fully vested and immediately exercisable, including awards that would not otherwise have become vested or exercisable; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">all other awards will become fully earned and eligible to receive a payout. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the purposes of the Plans, a participant&#8217;s award will be considered assumed if, following the change-in-control, the assumed award confers, for each share of the Company&#8217;s Common Stock subject to the award immediately prior to the change-in-control, the right to receive the consideration (whether stock, cash, or other securities or property) received in the change-in-control for each share of Common Stock held on the effective date of the transaction; provided, however, that if the consideration received in the change-in-control is not solely common stock of the successor corporation or its parent, the committee administering the plan may, with the consent of the successor corporation, provide for the consideration per share to be received upon the exercise of the award, to be solely common stock of the successor corporation or its parent equal in fair market value to the per share consideration received by holders of the Company&#8217;s Common Stock in the change-in-control. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the Plans, a change-in-control is the occurrence of one of the following events: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a person, partnership, joint venture, corporation or other entity, or two or more of any of the foregoing acting as a group (or any &#8220;person&#8221; within the meaning of Sections&#160;13(d)(3) and 14(d) of the Exchange Act), other than the Company, a Subsidiary, or an employee benefit plan (or related </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">trust) of the Company or a Subsidiary, become(s) the &#8220;beneficial owner&#8221; &#8203;(as defined in Rule&#160;13d-3 under the Exchange Act) of 30% or more of the then-outstanding voting stock of the Company; </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">during any period of two consecutive&#160;years, individuals who at the beginning of such period constitute the Board of Directors (together with any new director whose election by the Board of Directors or whose nomination for election by the Company&#8217;s stockholders, was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of such period or whose election or nomination for election was previously so approved) cease for any reason to constitute a majority of the directors then in office; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">all or substantially all of the business of the Company is disposed of pursuant to a merger, consolidation or other transaction in which the Company is not the surviving corporation or the Company combines with another Company and is the surviving corporation (unless the stockholders of the Company immediately following such merger, consolidation, combination, or other transaction beneficially own, directly or indirectly, more than 50% of the aggregate voting stock or other ownership interests of (x)&#160;the entity or entities, if any, that succeed to the business of the Company or (y)&#160;the combined company); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Company is a party to a merger, consolidation, sale of assets or other reorganization, or a proxy contest, as a consequence of which the Board of Directors in office immediately prior to such transaction or event constitutes less than a majority of the Board of Directors thereafter; or the stockholders of the Company approve a sale of all or substantially all of the assets of the Company or a liquidation or dissolution of the Company. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Director Compensation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table shows the total compensation paid or accrued during the fiscal year ended December&#160;31, 2023 to each of our non-employee directors. Directors who are employed by us are not compensated for their service on our Board of Directors. As applicable, the figures described in this section have been adjusted to give effect to the reverse stock split completed on December&#160;15, 2023. </font>
        </div>
        <table style="width:456pt;height:116.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:255.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fees Earned or</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Paid in Cash</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Stock</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)(3)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:255.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Christopher S. Henney, Ph.D. D.Sc </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">105,500</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">18,991</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">12,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">136,991</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:255.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Robert J. Spiegel, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">84,500</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">18,991</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">12,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">115,991</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:255.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Samuel L. Barker, Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">66,500</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">18,991</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">12,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">97,991</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:255.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Kenneth M. Ferguson, Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">54,000</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">18,991</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">12,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">85,491</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:255.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Brian Schwartz, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">53,000</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">18,991</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">12,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">84,491</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:255.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Karin L. Walker </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">64,000</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">18,991</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">12,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">95,491</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.4pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">These amounts represent the aggregate grant date fair value of options and restricted stock&#160;units granted to each director during the year ended December&#160;31, 2023 computed in accordance with FASB ASC Topic 718. A discussion of the assumptions used in determining grant date fair value may be found in Note 11 to our financial statements included on our Form 10-K for the fiscal year ended December&#160;31, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The fair value of the options granted on June&#160;30, 2023 was $6.71 per share. Each non-employee director held an aggregate of 2,829 stock options as of December&#160;31, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The fair value of RSUs granted on June&#160;30, 2023 was $8.84 per share. Each non-employee director held an aggregate of 1,415 RSUs as of December&#160;31, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Director Compensation Program</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of our Director Compensation Program, the non-employee members of our Board of Directors are paid a fixed annual fee, payable on a quarterly basis, in arrears, on the first day of each quarter, as follows: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;height:40pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:371.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Chairman of the Board </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">85,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:371.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Vice Chairman of the Board </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">65,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:371.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other Non-Management Board Members </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">45,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Chair of each of the various committees of the Board of Directors will also receive the following fixed annual fee, payable on a quarterly basis, in arrears, on the first day of each quarter, as follows: </font>
        </div>
        <table style="width:416pt;height:55pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:371.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Audit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">15,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:371.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Compensation and Organization Development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">10,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:371.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nominating and Corporate Governance </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:371.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Science and Technology </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The non-Chair members of each of the various committees of the Board of Directors will also receive the following fixed annual member fee, payable on a quarterly basis, in arrears, on the first day of each quarter, as follows: </font>
        </div>
        <table style="width:416pt;height:55pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:376.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Audit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">7,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:376.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Compensation and Organization Development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:376.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nominating and Corporate Governance </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:376.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Science and Technology </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, the non-employee members of our Board of Directors are entitled to receive stock options and / or restricted stock options (RSUs) on their initial appointment to the Board and on an annual basis on the date of the Company&#8217;s annual meeting, such options and RSUs to vest fully on the first anniversary of the date of the grant. The non-employee directors are also reimbursed for customary business expenses in connection with attending Board of Directors and committee meetings. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Equity Compensation Plan&#160;Information</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table provides certain aggregate information with respect to all of our equity compensation plans in effect as of December&#160;31, 2023. As applicable, the figures described in this section have been adjusted to give effect to the reverse stock split completed on December&#160;15, 2023. </font>
        </div>
        <table style="width:456pt;height:142pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:286.45pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(a) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(b) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(c) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:286.45pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Plan&#160;Category </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Securities to be</font>
                <br >
                <font style="letter-spacing:-0.16pt;">issued upon</font>
                <br >
                <font style="letter-spacing:-0.16pt;">exercise of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">outstanding</font>
                <br >
                <font style="letter-spacing:-0.16pt;">options,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">warrants and</font>
                <br >
                <font style="letter-spacing:-0.16pt;">rights </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">exercise price</font>
                <br >
                <font style="letter-spacing:-0.16pt;">of outstanding</font>
                <br >
                <font style="letter-spacing:-0.16pt;">options,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">warrants,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">and rights </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">remaining</font>
                <br >
                <font style="letter-spacing:-0.16pt;">available for</font>
                <br >
                <font style="letter-spacing:-0.16pt;">future issuance</font>
                <br >
                <font style="letter-spacing:-0.16pt;">under equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">compensation</font>
                <br >
                <font style="letter-spacing:-0.16pt;">plans (excluding</font>
                <br >
                <font style="letter-spacing:-0.16pt;">securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">reflected in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">column (a)) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:286.45pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total equity compensation plans approved by security holders</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">137,446</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">59.11</td>
            <td style="padding:0pt;padding-left:10.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.69pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">22,466</td>
            <td style="padding:0pt;padding-left:12.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:286.45pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Equity compensation plans not approved by security holders</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">8,000</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">56.55</td>
            <td style="padding:0pt;padding-left:10.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.69pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">5,333</td>
            <td style="padding:0pt;padding-left:12.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of our 2018 Plan, our 2015 Plan, and our 2006 Plan. The Plans provide for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock&#160;units and performance&#160;units. There were no shares available for issuance, as of the date hereof, under the 2006 Plan or the 2015 Plan. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of our 2020 Plan. The 2020 Plan provides for the grant of nonqualified stock options, stock appreciation rights, restricted stock, restricted stock&#160;units and performance&#160;units.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPVP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:28.71pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PAY VERSUS PERFORMANCE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PAY VERSUS PERFORMANCE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">As required by SEC rules, we are providing the following information about the relationship between executive compensation and certain financial performance of our Company. The disclosure included in this section is prescribed by SEC rules and does not necessarily align with how the Company or the compensation committee view the link between the Company&#8217;s performance and the compensation of our named executive officers (our &#8220;NEOs&#8221;). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Pay Versus Performance Table</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The table below presents information on the compensation of our chief executive officer (our Principal Executive Officer, or &#8220;PEO&#8221;) and our other NEOs in comparison to certain performance metrics for the fiscal&#160;years listed below. The metrics are not those that the compensation committee uses when setting executive compensation. The use of the term &#8220;compensation actually paid&#8221; &#8203;(&#8220;CAP&#8221;) is required by the SEC&#8217;s rules. Neither CAP nor the total amount reported in the Summary Compensation Table reflect the amount of compensation actually paid, earned or received during the applicable year. Per SEC rules, CAP was calculated by adjusting the Summary Compensation Table Total values for the applicable year as described in the footnotes to the table. </font>
        </div>
        <table style="width:456pt;height:98.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:86.05pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Summary </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Compensation </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Table Total for </font>
                <br >
                <font style="letter-spacing:-0.16pt;">PEO</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Compensation </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Actually Paid </font>
                <br >
                <font style="letter-spacing:-0.16pt;">to PEO</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)(3)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Summary </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Compensation </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Table Total for </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Non-PEO </font>
                <br >
                <font style="letter-spacing:-0.16pt;">NEOs</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Compensation </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Actually Paid </font>
                <br >
                <font style="letter-spacing:-0.16pt;">to Non-PEO </font>
                <br >
                <font style="letter-spacing:-0.16pt;">NEOs</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)(3)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Value of initial </font>
                <br >
                <font style="letter-spacing:-0.16pt;">fixed $100 </font>
                <br >
                <font style="letter-spacing:-0.16pt;">investment </font>
                <br >
                <font style="letter-spacing:-0.16pt;">based on total </font>
                <br >
                <font style="letter-spacing:-0.16pt;">shareholder </font>
                <br >
                <font style="letter-spacing:-0.16pt;">return (TSR)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Net Loss </font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(5)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:86.05pt;text-align:left;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">2023</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.155pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">661,049</td>
            <td style="padding:0pt;padding-left:2.155pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">65,807</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.155pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">833,233</td>
            <td style="padding:0pt;padding-left:2.155pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">172,676</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.425pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4.58</td>
            <td style="padding:0pt;padding-left:11.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(22,555<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:8.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:86.05pt;text-align:left;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">2022</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.155pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">763,551</td>
            <td style="padding:0pt;padding-left:2.155pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(77,717<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.155pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">918,518</td>
            <td style="padding:0pt;padding-left:2.155pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(36,348<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.425pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8.54</td>
            <td style="padding:0pt;padding-left:11.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(21,198<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:8.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:86.05pt;text-align:left;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.155pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,339,226</td>
            <td style="padding:0pt;padding-left:2.155pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,183,476</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.155pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,502,436</td>
            <td style="padding:0pt;padding-left:2.155pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,350,036</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.425pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">49.81</td>
            <td style="padding:0pt;padding-left:11.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(18,887<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:8.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13.7pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">For each year shown, the CEO was Spiro Rombotis and the other NEOs were Paul McBarron and Mark Kirschbaum, MD. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:5.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:5.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Amounts in this column represent the &#8220;Total&#8221; column set forth in the Summary Compensation Table (&#8220;SCT&#8221;) in the &#8220;Executive and Director Compensation&#8221; section. See the footnotes to the SCT for further detail regarding the amounts in these columns. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The dollar amounts reported in these columns represent the amounts of &#8220;compensation actually paid.&#8221; The Amounts are computed in accordance with SEC rules by deducting and adding the following amounts from the &#8220;Total&#8221; column of the SCT (pursuant to SEC rules, fair value at each measurement date is computed in a manner consistent with the fair value methodology used to account for share-based payments in our financial statements under GAAP): </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Cumulative Total Shareholder Return (&#8220;TSR&#8221;) measures the cumulative value of $100 invested on the last trading day before the earliest fiscal year in the table, or December&#160;31, 2020, including the reinvestment of dividends, through and including the end of the applicable fiscal year for which TSR is calculated, or December&#160;31, 2021, December&#160;31, 2022 and December&#160;31, 2023. We did not pay dividends in the periods presented. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:5.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:5.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The dollar amounts reported represent the amount of net loss reflected in the Company&#8217;s audited financial statements for the applicable year. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:73.5pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:238.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:183.02pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fiscal Year 2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fiscal Year 2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fiscal Year 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:183.02pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">PEO </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">NON-</font>
                <br >
                <font style="letter-spacing:-0.16pt;">PEO </font>
                <br >
                <font style="letter-spacing:-0.16pt;">NEO&#8217;s </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">PEO </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">NON-</font>
                <br >
                <font style="letter-spacing:-0.16pt;">PEO </font>
                <br >
                <font style="letter-spacing:-0.16pt;">NEO&#8217;s </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">PEO </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">NON-</font>
                <br >
                <font style="letter-spacing:-0.16pt;">PEO </font>
                <br >
                <font style="letter-spacing:-0.16pt;">NEO&#8217;s </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:183.02pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">SCT Total Compensation</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">661,049</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">833,233</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">763,551</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">918,518</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1,339,226</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1,502,436</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:183.02pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Subtract Reported SCT Stock Option Award Value ($) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(100,421<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(118,167<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">(499,700<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">(526,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:183.02pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="font-style:italic;letter-spacing:0.2pt;">Add</font><font style="letter-spacing:0.2pt;"> Year-end Fair Value of Unvested </font>
                <br >
                <font style="letter-spacing:0.2pt;">Awards Granted in the Applicable Fiscal </font>
                <br >
                <font style="letter-spacing:0.2pt;">Year ($) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">21,961</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">26,051</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">499,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">526,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:183.02pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="font-style:italic;letter-spacing:0.2pt;">Add</font><font style="letter-spacing:0.2pt;"> Change in Fair Value of Awards </font>
                <br >
                <font style="letter-spacing:0.2pt;">Granted in Prior Years Outstanding and </font>
                <br >
                <font style="letter-spacing:0.2pt;">Unvested as of the Applicable Fiscal </font>
                <br >
                <font style="letter-spacing:0.2pt;">Year End ($) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(164,307<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(172,971<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(494,733<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(545,667<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">(103,834<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">(99,067<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:183.02pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="font-style:italic;letter-spacing:0.2pt;">Add</font><font style="letter-spacing:0.2pt;"> Change in Fair Value of Awards Granted in Prior Years that Vested during the Applicable Year as of the Vesting Date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(352,475<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(395,470<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(346,535<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(409,198<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:33.75pt; text-align:right; white-space:nowrap;">(51,916<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:33.75pt; text-align:right; white-space:nowrap;">(53,333<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:183.02pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total Compensation Actually Paid</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">65,807</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">172,676</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(77,717<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(36,347<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:33.75pt; text-align:right; white-space:nowrap;">1,183,476</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:33.75pt; text-align:right; white-space:nowrap;">1,350,036</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Company Total Shareholder Return (&#8220;TSR&#8221;)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs, and the Company&#8217;s cumulative TSR over the three most recently completed fiscal years. </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="bc_paidvstsr-4c.jpg" alt="[MISSING IMAGE: bc_paidvstsr-4c.jpg]" height="272" width="604" >
        </div>
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:321pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Net Income (Loss)</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs, and our Net Income (Loss) during the three most recently completed fiscal years.</font>
        </div>
        <div style="position:relative;margin-top:10pt; width:456pt;">
          <img src="bc_paidvsnetloss-4c.jpg" alt="[MISSING IMAGE: bc_paidvsnetloss-4c.jpg]" height="317" width="624" >
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tROAC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:136pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">REPORT OF AUDIT COMMITTEE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Audit Committee of the Board of Directors, which consists entirely of directors who meet the independence and experience requirements of The Nasdaq Capital Market, has furnished the following report: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Audit Committee assists the Board of Directors in overseeing and monitoring the integrity of our financial reporting process, compliance with legal and regulatory requirements and the quality of internal and external audit processes. The Audit Committee&#8217;s role and responsibilities are set forth in our charter adopted by the Board of Directors. The Audit Committee reviews and reassesses our charter annually and recommends any changes to the Board of Directors for approval. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In fiscal 2023, the Audit Committee met with management to consider the adequacy of the Company&#8217;s internal controls and the objectivity of its financial reporting. The Audit Committee discussed these matters with the Company&#8217;s independent registered public accounting firm and with appropriate Company financial personnel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Audit Committee is responsible for overseeing our overall financial reporting process, and for the appointment, retention, and oversight of the work of RSM US LLP, or RSM. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Audit Committee reviewed and discussed the audited financial statements for the fiscal year ended December&#160;31, 2023 with management and RSM, our independent registered public accounting firm. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Audit Committee discussed with RSM the matters required to be discussed in accordance with </font><font style="font-style:italic;letter-spacing:0.2pt;">Auditing Standard No. 18&#8201;&#8212;&#8201;Communications with Audit Committees</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Audit Committee received written disclosures and the letter from RSM regarding its independence as required by applicable requirements of the Public Company Accounting Oversight Board regarding RSM&#8217;s communications with the Audit Committee and the Audit Committee further discussed with RSM their independence. The Audit Committee also considered the status of pending litigation, taxation matters and other areas of oversight relating to the financial reporting and audit process that the Audit Committee determined appropriate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Based on the Audit Committee&#8217;s review of the audited consolidated financial statements and discussions with management and RSM, the Audit Committee recommended to the Board of Directors that the audited financial statements be included in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2023 for filing with the SEC. </font>
        </div>
        <div style="margin-left:240pt; margin-top:12pt; width:216pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Members of the Audit Committee</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:240pt; margin-top:8pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Karin L. Walker (Chair)</font>
          <br >
          <font style="letter-spacing:0.2pt;">Dr.&#160;Samuel L. Barker</font>
          <br >
          <font style="letter-spacing:0.2pt;">Dr.&#160;Christopher S. Henney</font>
          <br >
          <font style="letter-spacing:0.2pt;">Dr.&#160;Robert J. Spiegel </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCRAR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:444pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our Audit Committee reviews and approves in advance all related-party transactions. Except as described below, there have been no transactions during our last two fiscal&#160;years with our directors and officers and beneficial owners of more than 5% of our voting securities and their affiliates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;21, 2023, in an insider private placement, we entered into an Insider Securities Purchase Agreement pursuant to which we agreed to sell in a private placement (i)&#160;6,070 shares of common stock and warrants to purchase 6,070 shares of common stock, on the same terms as the unregistered warrants&#160;issued to certain institutional investors (the &#8220;Purchasers&#8221; and such warrants, the &#8220;Private Warrants&#8221;), to Spiro Rombotis, our Chief Executive Officer, and (ii)&#160;1,886 shares of common stock and warrants to purchase 1,886 shares of common stock on the same terms as the Private Warrants issued to the Purchasers in the Offerings to Paul McBarron, our Executive Vice President-Finance, Chief Financial Officer and Chief Operating Officer. Each such share of common stock and accompanying warrant was sold at a purchase price of $3.315, which was the same purchase price for the shares of common stock sold in a concurrent registered direct offering. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPRO">&#8203;</a><a name="tP1OC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:210pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROPOSALS TO BE VOTED UPON BY HOLDERS OF COMMON STOCK </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROPOSAL 1:</font>
          <br >
          <font style="letter-spacing:-0.2pt;">ELECTION OF CLASS 3 DIRECTORS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Background</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws, as amended, the number of directors is fixed from time to time by the Board of Directors. We have a staggered Board of Directors comprised of three classes, and each director serves until the annual meeting in which his or her term expires. Each of Dr Christopher Henney, Paul McBarron, and Dr.&#160;Robert Spiegel is a Class&#160;3 director, the term of which class expires at the 2024 annual meeting, and, if elected, would serve until our 2027 annual meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Board of Directors has nominated Dr.&#160;Christopher Henney, Paul McBarron, and Dr.&#160;Robert Spiegel for re-election at the 2024 annual meeting to serve as Class&#160;3 directors until the 2027 annual meeting of stockholders and until their respective successors have been elected and qualified. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless authority to vote for either of these nominees is withheld, proxies solicited by the Board of Directors will be voted FOR the re-election as director of each of Dr.&#160;Christopher Henney, Paul McBarron, and Dr.&#160;Robert Spiegel. In the event that either nominee shall become unable or unwilling to serve, proxies solicited by the Board of Directors will be voted for the election of such other person as the Board of Directors may recommend in his place. The Board of Directors has no reason to believe that either nominee will be unable or unwilling to serve. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Required Vote</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A plurality of the votes cast at the annual meeting by the holders of our Common Stock is required to elect the nominees as director. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE BOARD OF DIRECTORS RECOMMENDS THE RE-ELECTION BY HOLDERS OF COMMON STOCK OF EACH OF DR. CHRISTOPHER HENNEY, PAUL MCBARRON, AND DR. ROBERT SPIEGEL AS CLASS 3 DIRECTORS, AND PROXIES SOLICITED BY THE BOARD OF DIRECTORS WILL BE VOTED IN FAVOR THEREOF UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tP2OA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROPOSAL 2:</font>
          <br >
          <font style="letter-spacing:-0.2pt;">RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC</font>
          <br >
          <font style="letter-spacing:-0.2pt;">ACCOUNTING FIRM</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Audit Committee has appointed RSM US LLP, or RSM, as our independent registered public accounting firm, to audit our consolidated financial statements for the fiscal year ended December&#160;31, 2024. The Board of Directors proposes that our holders of Common Stock ratify this appointment. We expect that representatives of RSM will be present at the annual meeting via conference call, will be able to make a statement if they so desire, and will be available to respond to appropriate questions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table presents fees for professional audit services rendered by RSM for the audit of Cyclacel&#8217;s annual financial statements for the&#160;years ended December&#160;31, 2022 and 2023, and fees billed for other services rendered by them during those periods. </font>
        </div>
        <table style="width:416pt;height:54pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:316.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:316.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Audit fees</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">331,916</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">335,430</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:316.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Tax fees</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">27,300</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">31,164</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:316.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">359,216</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">366,594</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.2pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Audit fees represent fees for the audit of the Company&#8217;s annual consolidated financial statements, review of the Company&#8217;s interim financial statements included in quarterly reports on Form 10-Q, services that an independent auditor would customarily provide in connection with subsidiary audits, other regulatory filings and similar engagements for each fiscal year shown, such as attest services, comfort letters, consents and assistance with review of reports filed with the SEC. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Tax fees represent tax compliance and return preparation and tax planning and advice. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Policy on Audit Committee Pre-Approval of Audit and Permissible Non-audit Services of Independent&#160;Auditors </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Consistent with SEC policies regarding auditor independence, the Audit Committee has responsibility for appointing, setting compensation, and overseeing the work of our independent registered public accounting firm. In recognition of this responsibility, the Audit Committee has established a policy to pre-approve all audit and permissible non-audit services provided by our independent registered public accounting firm. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Prior to engagement of the independent auditor for the next year&#8217;s audit, management will submit an aggregate of services expected to be rendered during that year for each of four categories of services to the Audit Committee for approval. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Audit</font><font style="letter-spacing:0.2pt;"> services include audit work performed in the preparation of financial statements, as well as work that generally only the independent registered public accounting firm can reasonably be expected to provide, including comfort letters, statutory audits and attest services and consultation regarding financial accounting and/or reporting standards. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Audit-Related</font><font style="letter-spacing:0.2pt;"> services are for assurance and related services that are traditionally performed by the independent registered public accounting firm, including due diligence related to mergers and acquisitions, employee benefit plan audits and special procedures required to meet certain regulatory requirements. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Tax</font><font style="letter-spacing:0.2pt;"> services include all services performed by the independent registered public accounting firm&#8217;s tax personnel except those services specifically related to the audit of the financial statements, and includes fees in the areas of tax compliance, tax planning and tax advice. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Other Fees</font><font style="letter-spacing:0.2pt;"> are those associated with services not captured in the other categories. The Company generally does not request such services from our independent registered public accounting firm. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Prior to engagement, the Audit Committee pre-approves these services by category of service. The fees are budgeted and the Audit Committee requires our independent registered public accounting firm and management to report actual fees versus the budget periodically throughout the year by category of service. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:368pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the year, circumstances may arise when it may become necessary to engage our independent registered public accounting firm for additional services not contemplated in the original pre-approval. In those instances, the Audit Committee requires specific pre-approval before engaging the independent registered public accounting firm. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Audit Committee may delegate pre-approval authority to one or more of its members. The member to whom such authority is delegated must report, for informational purposes only, any pre-approval decisions to the Audit Committee at its next scheduled meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event the stockholders do not ratify the appointment of RSM as our independent registered public accounting firm, the Audit Committee will reconsider its appointment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Required Vote</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The affirmative vote of a majority of the votes cast at the annual meeting is required to ratify the appointment of the independent registered public accounting firm. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE BOARD OF DIRECTORS RECOMMENDS A VOTE TO RATIFY THE APPOINTMENT OF RSM US, LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, AND PROXIES SOLICITED BY THE BOARD OF DIRECTORS WILL BE VOTED IN FAVOR OF SUCH RATIFICATION UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPRO1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROPOSAL 3: </font>
          <br >
          <font style="letter-spacing:-0.2pt;">AMENDMENT TO 2018 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR THE GRANT OF AWARDS BY 160,000 SHARES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are requesting that you vote to approve an amendment to the Cyclacel Pharmaceuticals, Inc. 2018&#160;Equity Incentive Plan (the &#8220;2018 Plan&#8221;). On May&#160;3, 2024, the Board of Directors adopted a resolution approving, subject to approval by our stockholders, an amendment of the 2018 Equity Incentive Plan to increase the number of shares of Common Stock available for grant under the 2018 Plan by adding 160,000&#160;shares. The 2018 Plan was previously approved by our stockholders at the 2018 annual meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of May&#160;23, 2024, the equity overhang, represented by all awards outstanding plus those available for future grant under the 2018 Plan, was 9.3%. The equity overhang from all awards outstanding and shares available for issuance would be 12.3%, assuming approval of this Proposal. Equity overhang was calculated in each instance above as all shares issuable upon exercise of outstanding options plus shares available for future grant divided by (a)&#160;common shares outstanding plus (b)&#160;shares in the numerator. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Key Considerations for Requesting Additional Shares</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In determining the number of shares to be authorized under the 2018 Plan, as proposed to be amended, the Board considered the following principal factors: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Number of Shares Available for Grant under Existing Plan: As of May&#160;3, 2024, 13,842 shares remained available for issuance under the 2018 Plan. Except for 13,333 shares that remained available under our 2020 Inducement Equity Incentive Plan, there were no shares available to grant under prior incentive plans. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Number of Outstanding Awards Under All Plans: As of May&#160;3, 2024, there were 135,950 outstanding stock options, which had a weighted average exercise price of $46.78 and a weighted average remaining contractual life of 7.16&#160;years, and there were 44,918 RSU awards outstanding. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Board of Directors, the Compensation Development Committee and management all believe that the proposed amendment of the 2018 Plan is in the best interests of, and will provide long-term advantages to, us and our stockholders and recommends approval by our stockholders. The Board of Directors&#160;believes that the number of shares of common stock currently available for issuance under the 2018 Plan is insufficient in view of our compensation structure and strategy. The Board of Directors has concluded that our ability to attract, retain and motivate top quality employees is material to our success and would be enhanced by our continued ability to make grants under the 2018 Plan. The Board of Directors has directed that the&#160;proposal to approve the amendment of the 2018 Plan be submitted to the stockholders for approval at the 2024 annual meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a brief summary of the 2018 Plan, as amended by this Proposal, and is qualified in all respects by the specific language of the full text of the amended and restated 2018 Plan, a copy of which is attached as Appendix&#160;A to the Proxy Statement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Material Features of the 2018 Plan</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Eligibility</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The 2018 Plan allows us, under the direction of our Compensation and Organization Development Committee, to make grants of stock options, restricted and unrestricted stock awards and other stock-based awards to employees, consultants and directors who, in the opinion of the Compensation and Organization Development Committee, are in a position to make a significant contribution to our long-term success. The purpose of these awards is to attract and retain key individuals, further align employee and stockholder interests, and to closely link compensation with Company performance. The 2018 Plan provides an essential component of the total compensation package, reflecting the importance that we place on aligning the interests of key individuals with those of our stockholders. All employees, directors and consultants of the Company and its affiliates are eligible to participate in the 2018 Plan. As of May&#160;23, 2024, there were approximately 21 individuals eligible to participate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Shares Available for Issuance</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;As of May&#160;3, 2024, 13,842 shares of our common stock were available for future awards under the 2018 Plan. In addition, if any awards granted under the 2018 Plan lapse or are </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">canceled, the shares subject to those awards will again become available for awards under the 2018 Plan. As of May&#160;3, 2024, 135,950 shares were subject to outstanding awards under the 2018 Plan. Generally, shares of common stock reserved for awards under the 2018 Plan that lapse or are canceled will be added back to the share reserve available for future awards. However, shares of common stock tendered in payment for an award or shares of common stock withheld for taxes will not be available again for grant. The 2018 Plan provides that no non-employee director participant may receive awards for more than an aggregate grant date fair value of $100,000 in any fiscal year. If our stockholders approve this proposal, an additional 160,000 shares of our common stock would be available for future awards under the 2018 Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Stock Options</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Stock options granted under the 2018 Plan may either be incentive stock options, which are intended to satisfy the requirements of Section&#160;422 of the Internal Revenue Code of 1986, as amended, or the Code, or non-qualified stock options, which are not intended to meet those requirements. Incentive Stock Options may be granted to employees of the Company and its affiliates. Non-qualified options may be granted to employees, directors and consultants of the Company and its affiliates. The exercise price of a stock option may not be less than 100% of the fair market value of our common stock on the date of grant. If an incentive stock option is granted to an individual who owns more than 10% of the combined voting power of all classes of our capital stock, the exercise price may not be less than 110% of the fair market value of our common stock on the date of grant and the term of the incentive stock option may not be longer than five&#160;years. Non-qualified options may not have a term longer than ten&#160;years. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Award agreements for stock options include rules for exercise of the stock options after termination of service. Options may not be exercised unless they are vested, and no option may be exercised after the end of the term set forth in the award agreement. Generally, stock options will be exercisable for three&#160;months after termination of service for any reason other than death or total and permanent disability, and for 12&#160;months after termination of service on account of death or total and permanent disability but will not be exercisable if the termination of service was due to cause. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Restricted Stock</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Restricted stock is common stock that is subject to restrictions, including a prohibition against transfer and a substantial risk of forfeiture, until the end of a &#8220;restricted period&#8221; during which the grantee must satisfy certain vesting conditions. If the grantee does not satisfy the vesting conditions by the end of the restricted period, the restricted stock is forfeited. During the restricted period, the holder of restricted stock has the rights and privileges of a regular stockholder, except that the restrictions set forth in the applicable award agreement apply. For example, the holder of restricted stock may vote and receive dividends on the restricted shares; but he or she may not sell the shares until the restrictions are lifted. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Restricted Stock Units</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Restricted stock&#160;units are phantom shares that vest in accordance with terms and conditions established by the Board of Directors or the Compensation and Organization Development Committee and when the applicable restrictions lapse, the grantee shall be entitled to receive a payout in cash, shares or a combination thereof based on the number of restricted stock&#160;units as specified in the award agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Other Stock-Based Awards</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The 2018 Plan also authorizes the grant of other types of stock-based compensation including, but not limited to phantom stock awards, stock appreciation rights and stock unit awards. Our Compensation and Organization Development Committee may award such stock-based awards subject to such conditions and restrictions as it may determine however each stock appreciation right shall have an exercise price which shall not be less than the fair market value of our common stock on the date of grant and shall terminate no more than ten&#160;years from the date of grant. These conditions and restrictions may include continued employment with us through a specified restricted period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Plan&#160;Administration</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In accordance with the terms of the 2018 Plan, our Board of Directors has authorized our Compensation and Organization Development Committee to administer the 2018 Plan. The Compensation and Organization Development Committee may delegate part of its authority and powers under the 2018 Plan to one or more of our directors and/or officers, but only the Compensation and Organization Development Committee can make awards to participants who are directors or executive officers of the Company. In accordance with the provisions of the 2018 Plan, our Compensation and Organization Development Committee determines the terms of awards, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">which employees, directors and consultants will be granted awards; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number of shares subject to each award; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the vesting provisions of each award; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the termination or cancellation provisions applicable to awards; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">all other terms and conditions upon which each award may be granted in accordance with the 2018 Plan. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, our Compensation and Organization Development Committee may, in its discretion, amend any term or condition of an outstanding award provided (i)&#160;such term or condition as amended is permitted by the 2018 Plan, and (ii)&#160;any such amendment shall be made only with the consent of the participant to whom such award was made, if the amendment is adverse to the participant; and provided, further, that, without the prior approval of our stockholders, options will not be repriced, replaced or regranted through cancellation or by lowering the exercise price of a previously granted award and will not be exchanged for another type of award or cash. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Stock Dividends and Stock Splits</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If our common stock shall be subdivided or combined into a greater or smaller number of shares or if we issue any shares of common stock as a stock dividend, the number of shares of our common stock deliverable upon exercise of an option or upon vesting of an award shall be appropriately increased or decreased proportionately, and appropriate adjustments shall be made in the purchase price per share to reflect such subdivision, combination or stock dividend. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Corporate Transactions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Upon a merger or other reorganization event, our Board of Directors, may, in its sole discretion, take any one or more of the following actions pursuant to the 2018 Plan, as to some or all outstanding awards: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">provide that all outstanding options shall be assumed or substituted by the successor corporation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">upon written notice to a participant provide that the participant&#8217;s unexercised options will terminate immediately prior to the consummation of such transaction unless exercised by the participant; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in the event of a merger pursuant to which holders of our common stock will receive a cash payment for each share surrendered in the merger, make or provide for a cash payment to the participants equal to the difference between the merger price times the number of shares of our common stock subject to such outstanding options, and the aggregate exercise price of all such outstanding options, in exchange for the termination of such options; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">provide that outstanding awards shall be assumed or substituted by the successor corporation, become realizable or deliverable, or restrictions applicable to an award will lapse, in whole or in part, prior to or upon the merger or reorganization event; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">with respect to stock grants and in lieu of any of the foregoing, the Board of Directors or an authorized committee may provide that, upon consummation of the transaction, each outstanding stock grant shall be terminated in exchange for payment of an amount equal to the consideration payable upon consummation of such transaction to a holder of the number of shares of common stock comprising such award (to the extent such stock grant is no longer subject to any forfeiture or repurchase rights then in effect or, at the discretion of the Board of Directors or an authorized committee, all forfeiture and repurchase rights being waived upon such transaction). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">However, in the event that the successor corporation refuses to assume or substitute an award: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">awards consisting of options, SARs and rights to purchase restricted stock will become fully vested and immediately exercisable, including awards that would not otherwise have become vested or exercisable; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">all other awards will become fully earned and eligible to receive a payout. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Amendment and Termination</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The 2018 Plan may be amended by our stockholders. It may also be amended by our Board of Directors, provided that any amendment approved by our Board of Directors which is of a scope that requires stockholder approval as required by the rules of The Nasdaq Stock Market, in order to ensure favorable federal income tax treatment for any incentive stock options under Code </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;422, or for any other reason is subject to obtaining such stockholder approval. However, no such action may adversely affect any rights under any outstanding award without the holder&#8217;s consent. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Duration of Plan</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The 2018 Plan will expire by its terms on March&#160;29, 2028. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Federal Income Tax Considerations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The material federal income tax consequences of the issuance and exercise of stock options and other awards under the 2018 Plan, based on the current provisions of the Code and regulations, are as follows. Changes to these laws could alter the tax consequences described below. This summary assumes that all awards granted under the 2018 Plan are exempt from or comply with, the rules under Section&#160;409A of the Code related to nonqualified deferred compensation. </font>
        </div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:120pt;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Incentive Stock Option:</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:324pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Incentive stock options are intended to qualify for treatment under Section&#160;422 of the Code. An incentive stock option does not result in taxable income to the optionee or deduction to us at the time it is granted or exercised, provided that no disposition is made by the optionee of the shares acquired pursuant to the option within two&#160;years after the date of grant of the option nor within one year after the date of issuance of shares to the optionee (referred to as the &#8220;ISO holding period&#8221;). However, the difference between the fair market value of the shares on the date of exercise and the option price will be an item of tax preference includible in &#8220;alternative minimum taxable income&#8221; of the optionee. Upon disposition of the shares after the expiration of the ISO holding period, the optionee will generally recognize long term capital gain or loss based on the difference between the disposition proceeds and the option price paid for the shares. If the shares are disposed of prior to the expiration of the ISO holding period, the optionee generally will recognize taxable compensation, and we will have a corresponding deduction, in the year of the disposition, equal to the excess of the fair market value of the shares on the date of exercise of the option over the option price. Any additional gain realized on the disposition will normally constitute capital gain. If the amount realized upon such a disqualifying disposition is less than fair market value of the shares on the date of exercise, the amount of compensation income will be limited to the excess of the amount realized over the optionee&#8217;s adjusted basis in the shares. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 2.833pt 0pt; width:120pt;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Non-Qualified Options:</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 2.833pt 0pt; width:324pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">Options otherwise qualifying as incentive stock options, to the extent the aggregate fair market value of shares with respect to which such options are first exercisable by an individual in any calendar year exceeds $100,000, and options designated as non-qualified options will be treated as options that are not incentive stock options. </font>
              </div>
              <div style="margin-top:6pt;">
                <font style="letter-spacing:0.2pt;">A non-qualified option ordinarily will not result in income to the optionee or deduction to us at the time of grant. The optionee will recognize compensation income at the time of exercise of such non-qualified option in an amount equal to the excess of the then value of the shares over the option price per share. Such compensation income of optionees may be subject to withholding taxes, and a deduction may then be allowable to us in an amount equal to the optionee&#8217;s compensation income.</font>
              </div>
              <div style="margin-top:6pt;">
                <font style="letter-spacing:0.2pt;">An optionee&#8217;s initial basis in shares so acquired will be the amount paid on exercise of the non-qualified option plus the amount of any corresponding compensation income. Any gain or loss as a result of a subsequent disposition of the shares so acquired will be capital gain or loss. </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 7.833pt 0pt; width:120pt;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Stock Grants:</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 7.833pt 0pt; width:324pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">With respect to stock grants under the 2018 Plan that result in the issuance of shares that are either not restricted as to transferability or not subject to a </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:120pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.833pt 0pt; width:324pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">substantial risk of forfeiture, the grantee must generally recognize ordinary income equal to the fair market value of shares received. We generally will be entitled to a deduction in an amount equal to the ordinary income recognized by the grantee. </font>
              </div>
              <div style="margin-top:3pt;">
                <font style="letter-spacing:0.2pt;">With respect to stock grants involving the issuance of shares that are restricted as to transferability and subject to a substantial risk of forfeiture, the grantee must generally recognize ordinary income equal to the fair market value of the shares received at the first time the shares become transferable or are not subject to a substantial risk of forfeiture, whichever occurs earlier. A grantee may elect to be taxed at the time of receipt of shares rather than upon lapse of restrictions on transferability or substantial risk of forfeiture, but if the grantee subsequently forfeits such shares, the grantee would not be entitled to any tax deduction, including as a capital loss, for the value of the shares on which he previously paid tax. If such election is desired, the grantee must file such election with the Internal Revenue Service within 30&#160;days of the receipt of the shares. We generally will be entitled to a deduction in an amount equal to the ordinary income recognized by the grantee. </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1pt 0pt; width:120pt;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Stock Units:</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1pt 0pt; width:324pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">The grantee recognizes no income until the issuance of the shares. At that time, the grantee must generally recognize ordinary income equal to the fair market value of the shares received. We generally will be entitled to a deduction in an amount equal to the ordinary income recognized by the grantee.</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:19.7pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Plan&#160;Benefits</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Since the adoption of the 2018 Plan through May&#160;3, 2024, we have granted the following stock options and restricted stock&#160;units under the 2018 Plan to the individuals and groups listed below. In all cases, the securities underlying such equity awards were shares of our common stock. </font>
        </div>
        <table style="width:416pt;height:197.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:372.42pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name and Position </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:372.42pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Named Executive Officers: </font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:372.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Spiro Rombotis </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">37,198</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:372.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Paul McBarron </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">22,326</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:372.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">All current executive officers as a group </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">59,524</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:372.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">All current directors who are not executive officers as a group </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">75,863</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:372.42pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Each nominee for election as a director: </font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:372.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dr.&#160;Christopher Henney </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,316</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:372.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Paul McBarron </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">22,326</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:372.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dr.&#160;Robert Spiegel </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,316</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:372.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Each associate of any executive officers, current directors or director nominees </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:372.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Each other person who received or is to receive 5% of awards </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:372.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">All employees, including all current officers who are not executive officers, as a group </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">33,512</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.7pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">New Plan&#160;Benefits</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Other than the annual grant of stock options or restricted stock&#160;units, or any initial grant of restricted stock&#160;units to our non-employee directors, the amounts of future grants under the 2018 Plan are not determinable as awards under the 2018 Plan and will be granted at the sole discretion of the Compensation and Organization Development Committee, or other delegated persons and we cannot determine at this time either the persons who will receive awards under the 2018 Plan or the amount or types of any such awards. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:468pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;3, 2024, the closing market price per share of our common stock was $2.00, as reported by the Nasdaq Stock Market. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Required Vote</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The Board of Directors has recommended adopting the amendment to the 2018 Plan. The affirmative vote of a majority of the votes cast at the annual meeting is required to approve the amendment to the 2018 Plan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Recommendation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">THE BOARD OF DIRECTORS RECOMMENDS APPROVAL OF THE AMENDMENT TO THE 2018 PLAN. PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR OF THE AMENDMENT UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPR4">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROPOSAL 4: </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADVISORY VOTE ON APPROVAL OF EXECUTIVE COMPENSATION AS DISCLOSED IN</font>
          <br >
          <font style="letter-spacing:-0.2pt;">THIS PROXY STATEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Dodd-Frank Wall Street Reform and Consumer Protection of 2010 (or &#8220;the Dodd-Frank Act&#8221;) enables our stockholders to vote to approve on an advisory and non-binding basis, the compensation of our named executive officers as described in the Executive Officer and Director Compensation section of this proxy statement, the compensation tables and related material contained in this proxy statement. This &#8220;say-on-pay&#8221; proposal gives our stockholders the opportunity to express their views on our overall compensation decisions and policies. The Dodd-Frank Act also requires an advisory vote on executive compensation at least once every three&#160;years. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Stockholders are urged to read the Executive and Director Compensation section of this proxy statement, which discusses how our compensation policies and procedures implement our compensation philosophy. The Compensation and Organization Development Committee and the Board of Directors believe that these policies and procedures are effective in implementing our compensation philosophy and in achieving its goals. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">As more fully described in the Executive and Director Compensation section of this proxy statement, existing employment contracts provide for the bulk of the compensation of our executives. A significant portion, however, is discretionary and determined by the Compensation and Organization Development Committee on an annual basis. Historically (but subject to change in the future), much of the additional or bonus compensation and equity awards have been based on specific numeric and weighted criteria for these officers. On an annual basis, the Committee reviews and approves the objectives for each officer&#8217;s goals and the following year analyzes to what extent the objectives have been achieved. The Committee then determines the resulting additional compensation and equity grants. In so doing, the Committee considers the interest of the stockholders, current market practices, the clinical goals of the Company, the need to motivate its officers, and other criteria. The Committee has also considered the extensive experience of our executives in the biotech industry as well as their related and relevant activities prior to their entry into the biotech industry. These considerations inform the Committee&#8217;s assessment of the type of compensation program and incentives that are appropriate and necessary to attract, motivate and retain the named executives who are crucial to the Company&#8217;s long-term success. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Because your vote is advisory, it will not be binding on our Compensation and Organization Development Committee or our Board of Directors, nor will it directly affect or otherwise limit any compensation or award arrangements that have already been granted to any of the named executive officers. However, the Compensation and Organization Development Committee and the Board will review the voting results and take them into consideration when making future decisions regarding executive compensation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In accordance with the rules adopted by the SEC, the following resolution, commonly known as a &#8220;say-on-pay&#8221; vote, is being submitted for a stockholder vote at the 2024 annual meeting: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;RESOLVED, that the compensation paid to the named executive officers of Cyclacel Pharmaceuticals, Inc., as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Executive Officer and Director Compensation section of the proxy statement for the 2024 annual meeting, the compensation tables and the related material disclosed in the proxy statement, is hereby APPROVED.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Required Vote</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The affirmative vote of a majority of the votes cast at the annual meeting is required to approve, on an advisory basis, this resolution. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">39</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:560pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Recommendation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">THE BOARD OF DIRECTORS RECOMMENDS A VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AND PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR OF SUCH APPROVAL UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">40</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCOCA">&#8203;</a><a name="tOTMA">&#8203;</a><a name="tSPAN">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:144pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CODE OF CONDUCT AND ETHICS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have adopted a code of conduct and ethics that applies to all of our employees, including our chief executive officer and chief financial and accounting officers. The text of the code of conduct and ethics is posted on our website at www.cyclacel.com, is filed as an exhibit to our Annual Report on Form 10-K, and will be made available to stockholders without charge, upon request, in writing to the Corporate Secretary at 200 Connell Drive, Suite 1500, Berkeley Heights, New Jersey 07922, Attention: Paul McBarron, Executive Vice President&#8201;&#8212;&#8201;Finance, Chief Financial Officer, Chief Operating Officer and Secretary. Disclosure regarding any amendments to, or waivers from, provisions of the code of conduct and ethics that apply to our directors, principal executive and financial officers will be included in a Current Report on Form 8-K within four business days following the date of the amendment or waiver, unless website posting of such amendments or waivers is then permitted by the rules of The Nasdaq Stock Market. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">OTHER MATTERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Board of Directors knows of no other business which will be presented to the annual meeting. If any other business is properly brought before the annual meeting, proxies will be voted in accordance with the judgment of the persons voting the proxies. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">STOCKHOLDER PROPOSALS AND NOMINATIONS FOR DIRECTOR</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To be considered for inclusion in the proxy statement relating to our 2025 Annual Meeting of Stockholders, we must receive stockholder proposals (other than for director nominations) by no later than December&#160;15, 2024. To be considered for presentation at the 2025 Annual Meeting of Stockholders, although not included in the proxy statement, proposals (including director nominations) must be received no earlier than February&#160;13, 2025 and no later than March&#160;15, 2025. In addition to satisfying the foregoing advance notice requirements, to comply with the universal proxy rules under the Exchange Act, stockholders who intend to solicit proxies in support of director nominees other than the Company&#8217;s nominees must follow the requirements set forth in Rule&#160;14a-19 as promulgated under the Exchange Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Proposals that are not received in a timely manner will not be presented or voted on at the 2025 Annual Meeting of Stockholders. If a proposal is received on time, the proxies that management solicits for the meeting may still exercise discretionary voting authority on the proposal under circumstances consistent with the proxy rules of the SEC. All stockholder proposals should be marked for the attention of Secretary, Cyclacel Pharmaceuticals, Inc., 200 Connell Drive, Suite 1500, Berkeley Heights, New Jersey 07922. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2023, as amended (other than exhibits thereto), filed with the SEC, which provides additional information about us, is available on the Internet at www.cyclacel.com and is available in paper form to beneficial owners of our stock without charge upon written request to 200 Connell Drive, Suite 1500, Berkeley Heights, New Jersey 07922, Attention: Paul McBarron, Executive Vice President&#8201;&#8212;&#8201;Finance, Chief Financial Officer, Chief Operating Officer and Secretary.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">41</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tAPA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Appendix&#160;A</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2018 EQUITY INCENTIVE PLAN, AS AMENDED </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Effective June&#160;21, 2024</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">DEFINITIONS.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless otherwise specified or unless the context otherwise requires, the following terms, as used in this Cyclacel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, have the following meanings: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Administrator means the Board of Directors, unless it has delegated power to act on its behalf to the Committee, in which case the Administrator means the Committee. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Affiliate means a corporation, which, for purposes of Section&#160;424 of the Code, is a parent or subsidiary of the Company, direct or indirect. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Agreement means a written or electronic document setting forth the terms of a Stock Right delivered pursuant to the Plan in such form as the Administrator shall approve. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Board of Directors means the Board of Directors of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Cause means, with respect to a Participant (a)&#160;dishonesty with respect to the Company or any Affiliate, (b)&#160;insubordination, substantial malfeasance or non-feasance of duty, (c)&#160;unauthorized disclosure of confidential information, (d)&#160;breach by a Participant of any provision of any employment, consulting, advisory, nondisclosure, non-competition or similar agreement between the Participant and the Company or any Affiliate, and (e)&#160;conduct substantially prejudicial to the business of the Company or any Affiliate; provided, however, that any provision in an agreement between a Participant and the Company or an Affiliate, which contains a conflicting definition of Cause for termination and which is in effect at the time of such termination, shall supersede this definition with respect to that Participant. The determination of the Administrator as to the existence of Cause will be conclusive on the Participant and the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Change of Control means the occurrence of any of the following events: (a)&#160;any person, partnership, joint venture, corporation or other entity, or two or more of any of the foregoing acting as a group (or any &#8220;person&#8221; within the meaning of Sections&#160;13(d) and 14(d) of the Exchange Act), other than the Company, an Affiliate, or an employee benefit plan (or related trust) of the Company or an Affiliate, become(s) the &#8220;beneficial owner&#8221; &#8203;(as defined in Rule&#160;13d-3 under the Exchange Act) of 30% or more of the then-outstanding voting stock of the Company; (b)&#160;during any period of two consecutive&#160;years, individuals who at the beginning of such period constitute the Board of Directors (together with any new director whose election by the Board of Directors or whose nomination for election by the Company&#8217;s stockholders, was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of such period or whose election or nomination for election was previously so approved) cease for any reason to constitute a majority of the directors then in office; (c)&#160;all or substantially all of the business of the Company is disposed of pursuant to a merger, consolidation or other transaction in which the Company is not the surviving corporation or the Company combines with another company and is the surviving corporation (unless the stockholders of the Company immediately following such merger, consolidation, combination, or other transaction beneficially own, directly or indirectly, more than 50% of the aggregate voting stock or other ownership interests of (x)&#160;the entity or entities, if any, that succeed to the business of the Company or (y)&#160;the combined company); (d)&#160;the Company is a party to a merger, consolidation, sale of assets or other reorganization, or a proxy contest, as a consequence of which the Board of Directors in office immediately prior to such transaction or event constitutes less than a majority of the Board of Directors thereafter; or (e)&#160;the stockholders of the Company approve a sale of all or substantially all of the assets of the Company or a liquidation or dissolution of the Company; provided, that if any payment or benefit payable hereunder upon or following a Change of Control would be required to comply with the limitations of Section&#160;409A(a)(2)(A)(v) of the Code in order to avoid an additional tax under Section&#160;409A of the Code, such payment or benefit shall be made only if such Change of Control constitutes a change in ownership or control of the Company, or a change in ownership of the Company&#8217;s assets in accordance with Section&#160;409A of the Code. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Code means the United States Internal Revenue Code of 1986, as amended including any successor statute, regulation and guidance thereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Committee means the committee of the Board of Directors to which the Board of Directors has delegated power to act under or pursuant to the provisions of the Plan. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Common Stock means shares of the Company&#8217;s common stock, $0.001 par value per share. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Company means Cyclacel Pharmaceuticals, Inc., a Delaware corporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Consultant means any natural person who is an advisor or consultant who provides bona fide services to the Company or its Affiliates, provided that such services are not in connection with the offer or sale of securities in a capital raising transaction, and do not directly or indirectly promote or maintain a market for the Company&#8217;s or its Affiliates&#8217; securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Corporate Transaction means a merger, consolidation, or sale of all or substantially all of the Company&#8217;s assets or the acquisition of all of the outstanding voting stock of the Company in a single transaction or a series of related transactions by a single entity other than a transaction to merely change the state of incorporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Disability or Disabled means permanent and total disability as defined in Section&#160;22(e)(3) of the Code. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Employee means any employee of the Company or of an Affiliate (including, without limitation, an employee who is also serving as an officer or director of the Company or of an Affiliate), designated by the Administrator to be eligible to be granted one or more Stock Rights under the Plan. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Exchange Act means the United States Securities Exchange Act of 1934, as amended. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Fair Market Value of a Share of Common Stock means: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the Common Stock is listed on a national securities exchange or traded in the over-the-counter market and sales prices are regularly reported for the Common Stock, the closing or, if not applicable, the last price of the Common Stock on the composite tape or other comparable reporting system for the trading day on the applicable date and if such applicable date is not a trading day, the last market trading day prior to such date; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the Common Stock is not traded on a national securities exchange but is traded on the over-the-counter market, if sales prices are not regularly reported for the Common Stock for the trading day referred to in clause (1), and if bid and asked prices for the Common Stock are regularly reported, the mean between the bid and the asked price for the Common Stock at the close of trading in the over-the-counter market for the trading day on which Common Stock was traded on the applicable date and if such applicable date is not a trading day, the last market trading day prior to such date; and </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the Common Stock is neither listed on a national securities exchange nor traded in the over-the-counter market, such value as the Administrator, in good faith, shall determine in compliance with applicable laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ISO means an option intended to qualify as an incentive stock option under Section&#160;422 of the Code. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Non-Qualified Option means an option which is not intended to qualify as an ISO. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Option means an ISO or Non-Qualified Option granted under the Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Participant means an Employee, director or Consultant of the Company or an Affiliate to whom one or more Stock Rights are granted under the Plan. As used herein, &#8220;Participant&#8221; shall include &#8220;Participant&#8217;s Survivors&#8221; where the context requires. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Performance-Based Award means a Stock Grant or Stock-Based Award which vests based on the attainment of written Performance Goals as set forth in Paragraph 9 hereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Performance Goals means performance goals determined by the Committee in its sole discretion and set forth in an Agreement. The satisfaction of Performance Goals shall be subject to certification by the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Committee. The Committee has the authority to take appropriate action with respect to the Performance Goals (including, without limitation, making adjustments to the Performance Goals or determining the satisfaction of the Performance Goals in connection with a Corporate Transaction) provided that any such action does not otherwise violate the terms of the Plan. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Plan means this Cyclacel Pharmaceuticals, Inc. 2018 Equity Incentive Plan. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Securities Act means the United States Securities Act of 1933, as amended. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Shares means shares of the Common Stock as to which Stock Rights have been or may be granted under the Plan or any shares of capital stock into which the Shares are changed or for which they are exchanged within the provisions of Paragraph 3 of the Plan. The Shares issued under the Plan may be authorized and unissued shares or shares held by the Company in its treasury, or both. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stock-Based Award means a grant by the Company under the Plan of an equity award or an equity based award, which is not an Option or a Stock Grant. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stock Grant means a grant by the Company of Shares under the Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stock Right means a right to Shares or the value of Shares of the Company granted pursuant to the Plan-an ISO, a Non-Qualified Option, a Stock Grant or a Stock-Based Award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Survivor means a deceased Participant&#8217;s legal representatives and/or any person or persons who acquired the Participant&#8217;s rights to a Stock Right by will or by the laws of descent and distribution. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">PURPOSES OF THE PLAN.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Plan is intended to encourage ownership of Shares by Employees and directors of and certain Consultants to the Company and its Affiliates in order to attract and retain such people, to induce them to work for the benefit of the Company or of an Affiliate and to provide additional incentive for them to promote the success of the Company or of an Affiliate. The Plan provides for the granting of ISOs, Non-Qualified Options, Stock Grants and Stock-Based Awards. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">SHARES SUBJECT TO THE PLAN.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The number of Shares which may be issued from time to time pursuant to this Plan shall be the sum of: (i)&#160;3,035,000 shares of Common Stock and (ii)&#160;any shares of Common Stock that are represented by awards granted under the Company&#8217;s 2015 Equity Incentive Plan and the Company&#8217;s Amended and Restated 2006 Equity Incentive Plan that are forfeited, expire or are cancelled without delivery of shares of Common Stock or which result in the forfeiture of shares of Common Stock back to the Company on or after May&#160;31, 2018, or the equivalent of such number of Shares after the Administrator, in its sole discretion, has interpreted the effect of any stock split, stock dividend, combination, recapitalization or similar transaction in accordance with Paragraph 25 of this Plan; provided, however, that no more than 35,494 Shares shall be added to the Plan pursuant to subsection&#160;(ii). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If an Option ceases to be &#8220;outstanding&#8221;, in whole or in part (other than by exercise), or if the Company shall reacquire (at not more than its original issuance price) any Shares issued pursuant to a Stock Grant or Stock-Based Award, or if any Stock Right expires or is forfeited, cancelled, or otherwise terminated or results in any Shares not being issued, the unissued or reacquired Shares which were subject to such Stock Right shall again be available for issuance from time to time pursuant to this Plan. Notwithstanding the foregoing, if a Stock Right is exercised, in whole or in part, by tender or withholding of Shares or if the Company or an Affiliate&#8217;s tax withholding obligation is satisfied by the tender or withholding of Shares, the number of Shares deemed to have been issued under the Plan for purposes of the limitation set forth in Paragraph 3(a) above shall be the number of Shares that were subject to the Stock Right or portion thereof, and not the net number of Shares actually issued. In addition, Shares repurchased by the Company with the proceeds of the option exercise price may not be reissued under the Plan. However, in the case of ISOs, the foregoing provisions shall be subject to any limitations under the Code. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">ADMINISTRATION OF THE PLAN.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Administrator of the Plan will be the Board of Directors, except to the extent the Board of Directors delegates its authority to the Committee, in which case the Committee shall be the Administrator. Subject to the provisions of the Plan, the Administrator is authorized to: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Interpret the provisions of the Plan and all Stock Rights and to make all rules and determinations which it deems necessary or advisable for the administration of the Plan; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Determine which Employees, directors and Consultants shall be granted Stock Rights; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Determine the number of Shares for which a Stock Right or Stock Rights shall be granted, provided however that in no event shall Stock Rights to be granted to any non-employee director under the Plan in any calendar year exceed an aggregate grant date fair value of $100,000 except that the foregoing limitation shall not apply to (i)&#160;awards made pursuant to an election by a non-employee director to receive an award in lieu of cash for all or a portion of cash fees to be received for service on the Board or any Committee thereof and (ii)&#160;in connection with a non-employee director initially joining the Board of Directors; </font>
        </div>
        <div style="text-indent:40pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Specify the terms and conditions upon which a Stock Right or Stock Rights may be granted; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Amend any term or condition of any outstanding Stock Right, other than reducing the exercise price or purchase price or extending the expiration date of an Option, provided that (i)&#160;such term or condition as amended is not prohibited by the Plan; (ii)&#160;any such amendment shall not impair the rights of a Participant under any Stock Right previously granted without such Participant&#8217;s consent or in the event of death of the Participant the Participant&#8217;s Survivors; and (iii)&#160;any such amendment shall be made only after the Administrator determines whether such amendment would cause any adverse tax consequences to the Participant, including, but not limited to, the annual vesting limitation contained in Section&#160;422(d) of the Code and described in Paragraph 6(b)(iv) below with respect to ISOs and pursuant to Section&#160;409A of the Code; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Determine and make any adjustments in the Performance Goals included in any Performance-Based Awards; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Adopt any sub-plans applicable to residents of any specified jurisdiction as it deems necessary or appropriate in order to comply with or take advantage of any tax or other laws applicable to the Company, any Affiliate or to Participants or to otherwise facilitate the administration of the Plan, which sub-plans may include additional restrictions or conditions applicable to Stock Rights or Shares issuable pursuant to a Stock Right; </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">provided, however, that all such interpretations, rules, determinations, terms and conditions shall be made and prescribed in the context of potential tax consequences under Section&#160;409A of the Code and preserving the tax status under Section&#160;422 of the Code of those Options which are designated as ISOs. Subject to the foregoing, the interpretation and construction by the Administrator of any provisions of the Plan or of any Stock Right granted under it shall be final, unless otherwise determined by the Board of Directors, if the Administrator is the Committee. In addition, if the Administrator is the Committee, the Board of Directors may take any action under the Plan that would otherwise be the responsibility of the Committee. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To the extent permitted under applicable law, the Board of Directors or the Committee may allocate all or any portion of its responsibilities and powers to any one or more of its members and may delegate all or any portion of its responsibilities and powers to any other person selected by it. The Board of Directors or the Committee may revoke any such allocation or delegation at any time. Notwithstanding the foregoing, only the Board of Directors or the Committee shall be authorized to grant a Stock Right to any director of the Company or to any &#8220;officer&#8221; of the Company as defined by Rule&#160;16a-1 under the Exchange Act. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">ELIGIBILITY FOR PARTICIPATION.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Administrator will, in its sole discretion, name the Participants in the Plan; provided, however, that each Participant must be an Employee, director or Consultant of the Company or of an Affiliate at the time a Stock Right is granted. Notwithstanding the foregoing, the Administrator may authorize the grant </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of a Stock Right to a person not then an Employee, director or Consultant of the Company or of an Affiliate; provided, however, that the actual grant of such Stock Right shall be conditioned upon such person&#160;becoming eligible to become a Participant at or prior to the time of the execution of the Agreement evidencing such Stock Right. ISOs may be granted only to Employees who are deemed to be residents of the United States for&#160;tax purposes. Non-Qualified Options, Stock Grants and Stock-Based Awards may be granted to any Employee, director or Consultant of the Company or an Affiliate. The granting of any Stock Right to any individual shall neither entitle that individual to, nor disqualify him or her from, participation in any other grant of Stock Rights or any grant under any other benefit plan established by the Company or any&#160;Affiliate for Employees, directors or Consultants. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">TERMS AND CONDITIONS OF OPTIONS.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each Option shall be set forth in an Option Agreement, duly executed by the Company and, to the extent required by law or requested by the Company, by the Participant. The Administrator may provide that Options be granted subject to such terms and conditions, consistent with the terms and conditions specifically required under this Plan, as the Administrator may deem appropriate including, without limitation, subsequent approval by the shareholders of the Company of this Plan or any amendments thereto. The Option Agreements shall be subject to at least the following terms and conditions: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Non-Qualified Options: Each Option intended to be a Non-Qualified Option shall be subject to the terms and conditions which the Administrator determines to be appropriate and in the best interest of the Company, subject to the following minimum standards for any such Non-Qualified Option: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Exercise Price: Each Option Agreement shall state the exercise price (per share) of the Shares covered by each Option, which exercise price shall be determined by the Administrator and shall be at least equal to the Fair Market Value per share of the Common Stock on the date of grant of the Option. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Number of Shares: Each Option Agreement shall state the number of Shares to which it pertains. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;Vesting: Each Option Agreement shall state the date or dates on which it first is exercisable and the date after which it may no longer be exercised, and may provide that the Option rights accrue or become exercisable in installments over a period of&#160;months or&#160;years, or upon the occurrence of certain performance conditions or the attainment of stated goals or events. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;Additional Conditions: Exercise of any Option may be conditioned upon the Participant&#8217;s execution of a shareholders agreement in a form satisfactory to the Administrator providing for certain protections for the Company and its other shareholders, including requirements that: </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A.&nbsp;&nbsp;&nbsp;The Participant&#8217;s or the Participant&#8217;s Survivors&#8217; right to sell or transfer the Shares may be restricted; and </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B.&nbsp;&nbsp;&nbsp;The Participant or the Participant&#8217;s Survivors may be required to execute letters of investment intent and must also acknowledge that the Shares will bear legends noting any applicable restrictions. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;Term of Option: Each Option shall terminate not more than ten&#160;years from the date of the grant or at such earlier time as the Option Agreement may provide. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;ISOs: Each Option intended to be an ISO shall be issued only to an Employee who is deemed to be a resident of the United States for tax purposes, and shall be subject to the following terms and conditions, with such additional restrictions or changes as the Administrator determines are appropriate but not in conflict with Section&#160;422 of the Code and relevant regulations and rulings of the Internal Revenue Service: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Minimum Standards: The ISO shall meet the minimum standards required of Non-Qualified Options, as described in Paragraph 6(a) above, except clause (i)&#160;and (v)&#160;thereunder. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; text-indent:20pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Exercise Price: Immediately before the ISO is granted, if the Participant owns, directly or by reason of the applicable attribution rules in Section&#160;424(d) of the Code: </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A.&nbsp;&nbsp;&nbsp;10% or less of the total combined voting power of all classes of stock of the Company or an Affiliate, the exercise price per share of the Shares covered by each ISO shall not be less than 100% of the Fair Market Value per share of the Common Stock on the date of grant of the Option; or </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">B.&nbsp;&nbsp;&nbsp;More than 10% of the total combined voting power of all classes of stock of the Company or an Affiliate, the exercise price per share of the Shares covered by each ISO shall not be less than 110% of the Fair Market Value per share of the Common Stock on the date of grant of the Option. </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;Term of Option: For Participants who own: </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A.&nbsp;&nbsp;&nbsp;10% or less of the total combined voting power of all classes of stock of the Company or an Affiliate, each ISO shall terminate not more than ten&#160;years from the date of the grant or at such earlier time as the Option Agreement may provide; or </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">B.&nbsp;&nbsp;&nbsp;More than 10% of the total combined voting power of all classes of stock of the Company or an Affiliate, each ISO shall terminate not more than five&#160;years from the date of the grant or at such earlier time as the Option Agreement may provide. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;Limitation on Yearly Exercise: The Option Agreements shall restrict the amount of ISOs which may become exercisable in any calendar year (under this or any other ISO plan of the Company or an Affiliate) so that the aggregate Fair Market Value (determined on the date each ISO is granted) of the stock with respect to which ISOs are exercisable for the first time by the Participant in any calendar year does not exceed $100,000. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">TERMS AND CONDITIONS OF STOCK GRANTS.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each Stock Grant to a Participant shall state the principal terms in an Agreement duly executed by the Company and, to the extent required by law or requested by the Company, by the Participant. The Agreement shall be in a form approved by the Administrator and shall contain terms and conditions which the Administrator determines to be appropriate and in the best interest of the Company, subject to the following minimum standards: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Each Agreement shall state the purchase price per share, if any, of the Shares covered by each Stock Grant, which purchase price shall be determined by the Administrator but shall not be less than the minimum consideration required by the Delaware General Corporation Law, if any, on the date of the grant of the Stock Grant; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Each Agreement shall state the number of Shares to which the Stock Grant pertains; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Each Agreement shall include the terms of any right of the Company to restrict or reacquire the Shares subject to the Stock Grant, including the time period or attainment of Performance Goals or such other performance criteria upon which such rights shall accrue and the purchase price therefor, if any; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Dividends (other than stock dividends to be issued pursuant to Section&#160;25 of the Plan) may accrue but shall not be paid prior to the time, and may be paid only to the extent that the restrictions or rights to reacquire the Shares subject to the Stock Grant lapse. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">TERMS AND CONDITIONS OF OTHER STOCK-BASED AWARDS.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Administrator shall have the right to grant other Stock-Based Awards based upon the Common Stock having such terms and conditions as the Administrator may determine, including, without limitation, the grant of Shares based upon certain conditions, the grant of securities convertible into Shares and the grant of stock appreciation rights, phantom stock awards or stock&#160;units. The principal terms of each Stock-Based Award shall be set forth in an Agreement, duly executed by the Company and, to the extent required by law or requested by the Company, by the Participant. The Agreement shall be in a form approved by the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Administrator and shall contain terms and conditions which the Administrator determines to be appropriate and in the best interest of the Company. Each Agreement shall include the terms of any right of the Company including the right to terminate the Stock-Based Award without the issuance of Shares, the terms of any vesting conditions, Performance Goals or events upon which Shares shall be issued, provided that dividends (other than stock dividends to be issued pursuant to Section&#160;25 of the Plan) or dividend equivalents may accrue but shall not be paid prior to and may be paid only to the extent that the Shares subject to the Stock-Based Award vest. Under no circumstances may the Agreement covering stock appreciation rights (a)&#160;have an exercise or base price (per share) that is less than the Fair Market Value per share of Common Stock on the date of grant or (b)&#160;expire more than ten&#160;years following the date of grant. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company intends that the Plan and any Stock-Based Awards granted hereunder be exempt from the application of Section&#160;409A of the Code or meet the requirements of paragraphs (2), (3)&#160;and (4)&#160;of subsection (a)&#160;of Section&#160;409A of the Code, to the extent applicable, and be operated in accordance with Section&#160;409A so that any compensation deferred under any Stock-Based Award (and applicable investment earnings) shall not be included in income under Section&#160;409A of the Code. Any ambiguities in the Plan shall be construed to effect the intent as described in this Paragraph 8. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">PERFORMANCE-BASED AWARDS.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Committee shall determine whether, with respect to a performance period, the applicable Performance Goals have been met with respect to a given Participant and, if they have, to so certify and ascertain the amount of the applicable Performance-Based Award. No Performance-Based Awards will be issued for such performance period until such certification is made by the Committee. The number of Shares issued in respect of a Performance-Based Award determined by the Committee for a performance period shall be paid to the Participant at such time as determined by the Committee in its sole discretion after the end of such performance period, and any dividends (other than stock dividends to be issued pursuant to Section&#160;25 of the Plan) or dividend equivalents that accrue shall only be paid in respect of the number of Shares earned in respect of such Performance-Based Award. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EXERCISE OF OPTIONS AND ISSUE OF SHARES.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">An Option (or any part or installment thereof) shall be exercised by giving written notice to the Company or its designee (in a form acceptable to the Administrator, which may include electronic notice), together with provision for payment of the aggregate exercise price in accordance with this Paragraph for the Shares as to which the Option is being exercised, and upon compliance with any other condition(s) set forth in the Option Agreement. Such notice shall be signed by the person exercising the Option (which signature may be provided electronically in a form acceptable to the Administrator), shall state the number of Shares with respect to which the Option is being exercised and shall contain any representation required by the Plan or the Option Agreement. Payment of the exercise price for the Shares as to which such Option is being exercised shall be made (a)&#160;in United States dollars in cash or by check; or (b)&#160;at the discretion of the Administrator, through delivery of shares of Common Stock held for at least six&#160;months (if required to avoid negative accounting treatment) having a Fair Market Value equal as of the date of the exercise to the aggregate cash exercise price for the number of Shares as to which the Option is being exercised; or (c)&#160;at the discretion of the Administrator, by having the Company retain from the Shares otherwise issuable upon exercise of the Option, a number of Shares having a Fair Market Value equal as of the date of exercise to the aggregate exercise price for the number of Shares as to which the Option is being exercised; or (d)&#160;at the discretion of the Administrator, in accordance with a cashless exercise program established with a securities brokerage firm, and approved by the Administrator; or (e)&#160;at the discretion of the Administrator, by any combination of (a), (b), (c)&#160;and (d)&#160;above or (f)&#160;at the discretion of the </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Administrator, by payment of such other lawful consideration as the Administrator may determine. Notwithstanding the foregoing, the Administrator shall accept only such payment on exercise of an ISO as is permitted by Section&#160;422 of the Code. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company shall then reasonably promptly deliver the Shares as to which such Option was exercised to the Participant (or to the Participant&#8217;s Survivors, as the case may be). In determining what constitutes &#8220;reasonably promptly,&#8221; it is expressly understood that the issuance and delivery of the Shares may be delayed by the Company in order to comply with any law or regulation (including, without limitation, state&#160;securities </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">or &#8220;blue sky&#8221; laws) which requires the Company to take any action with respect to the Shares prior to their issuance. The Shares shall, upon delivery, be fully paid, non-assessable Shares. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">PAYMENT IN CONNECTION WITH THE ISSUANCE OF STOCK GRANTS AND STOCK-BASED AWARDS AND ISSUE OF SHARES.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any Stock Grant or Stock-Based Award requiring payment of a purchase price for the Shares as to which such Stock Grant or Stock-Based Award is being granted shall be made (a)&#160;in United States dollars in cash or by check; or (b)&#160;at the discretion of the Administrator, through delivery of shares of Common Stock held for at least six&#160;months (if required to avoid negative accounting treatment) and having a Fair Market Value equal as of the date of payment to the purchase price of the Stock Grant or Stock-Based Award; or (c)&#160;at the discretion of the Administrator, by any combination of (a)&#160;and (b)&#160;above; or (d)&#160;at the discretion of the Administrator, by payment of such other lawful consideration as the Administrator may determine. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company shall when required by the applicable Agreement, reasonably promptly deliver the Shares as to which such Stock Grant or Stock-Based Award was made to the Participant (or to the Participant&#8217;s Survivors, as the case may be), subject to any escrow provision set forth in the applicable Agreement. In determining what constitutes &#8220;reasonably promptly,&#8221; it is expressly understood that the issuance and delivery of the Shares may be delayed by the Company in order to comply with any law or regulation (including, without limitation, state securities or &#8220;blue sky&#8221; laws) which requires the Company to take any action with respect to the Shares prior to their issuance. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">12.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">RIGHTS AS A SHAREHOLDER.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No Participant to whom a Stock Right has been granted shall have rights as a shareholder with respect to any Shares covered by such Stock Right except after due exercise of an Option or issuance of Shares as set forth in any Agreement, tender of the aggregate exercise or purchase price, if any, for the Shares being purchased and registration of the Shares in the Company&#8217;s share register in the name of the Participant. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">13.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">ASSIGNABILITY AND TRANSFERABILITY OF STOCK RIGHTS.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">By its terms, a Stock Right granted to a Participant shall not be transferable by the Participant other than (i)&#160;by will or by the laws of descent and distribution, or (ii)&#160;as approved by the Administrator in its discretion and set forth in the applicable Agreement provided that no Stock Right may be transferred by a Participant for value. Notwithstanding the foregoing, an ISO transferred except in compliance with clause (i)&#160;above shall no longer qualify as an ISO. The designation of a beneficiary of a Stock Right by a Participant, with the prior approval of the Administrator and in such form as the Administrator shall prescribe, shall not be deemed a transfer prohibited by this Paragraph. Except as provided above during the Participant&#8217;s lifetime a Stock Right shall only be exercisable by or issued to such Participant (or his or her legal representative) and shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be subject to execution, attachment or similar process. Any attempted transfer, assignment, pledge, hypothecation or other disposition of any Stock Right or of any rights granted thereunder contrary to the provisions of this Plan, or the levy of any attachment or similar process upon a Stock Right, shall be null and void. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">14.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EFFECT ON OPTIONS OF TERMINATION OF SERVICE OTHER THAN FOR CAUSE OR DEATH OR DISABILITY.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in a Participant&#8217;s Option Agreement, in the event of a termination of service (whether as an Employee, director or Consultant) with the Company or an Affiliate before the Participant has exercised an Option, the following rules apply: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;A Participant who ceases to be an Employee, director or Consultant of the Company or of an Affiliate (for any reason other than termination for Cause, Disability, or death for which events there are special rules in Paragraphs 15, 16, and 17, respectively), may exercise any Option granted to him or her to the extent that the Option is exercisable on the date of such termination of service, but only within such term as the Administrator has designated in a Participant&#8217;s Option Agreement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Except as provided in Subparagraph (c)&#160;below, or Paragraph 16 or 17, in no event may an Option intended to be an ISO, be exercised later than three&#160;months after the Participant&#8217;s termination of employment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;The provisions of this Paragraph, and not the provisions of Paragraph 16 or 17, shall apply to a Participant who subsequently becomes Disabled or dies after the termination of employment, director status or consultancy; provided, however, in the case of a Participant&#8217;s Disability or death within three&#160;months after the termination of employment, director status or consultancy, the Participant or the Participant&#8217;s Survivors may exercise the Option within one year after the date of the Participant&#8217;s termination of service, but in no event after the date of expiration of the term of the Option. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Notwithstanding anything herein to the contrary, if subsequent to a Participant&#8217;s termination of employment, termination of director status or termination of consultancy, but prior to the exercise of an Option, the Administrator determines that, either prior or subsequent to the Participant&#8217;s termination, the Participant engaged in conduct which would constitute Cause, then such Participant shall forthwith cease to have any right to exercise any Option. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;A Participant to whom an Option has been granted under the Plan who is absent from the Company or an Affiliate because of temporary disability (any disability other than a Disability as defined in Paragraph 1 hereof), or who is on leave of absence for any purpose, shall not, during the period of any such absence, be deemed, by virtue of such absence alone, to have terminated such Participant&#8217;s employment, director status or consultancy with the Company or with an Affiliate, except as the Administrator may otherwise expressly provide; provided, however, that, for ISOs, any leave of absence granted by the Administrator of greater than three&#160;months, unless pursuant to a contract or statute that guarantees the right to reemployment, shall cause such ISO to become a Non-Qualified Option on the date that is six&#160;months following the commencement of such leave of absence. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Except as required by law or as set forth in a Participant&#8217;s Option Agreement, Options granted under the Plan shall not be affected by any change of a Participant&#8217;s status within or among the Company and any Affiliates, so long as the Participant continues to be an Employee, director or Consultant of the Company or any Affiliate. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">15.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EFFECT ON OPTIONS OF TERMINATION OF SERVICE FOR CAUSE.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in a Participant&#8217;s Option Agreement, the following rules apply if the Participant&#8217;s service (whether as an Employee, director or Consultant) with the Company or an Affiliate is terminated for Cause prior to the time that all his or her outstanding Options have been exercised: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;All outstanding and unexercised Options as of the time the Participant is notified his or her service is terminated for Cause will immediately be forfeited. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Cause is not limited to events which have occurred prior to a Participant&#8217;s termination of service, nor is it necessary that the Administrator&#8217;s finding of Cause occur prior to termination. If the Administrator determines, subsequent to a Participant&#8217;s termination of service but prior to the exercise of an Option, that either prior or subsequent to the Participant&#8217;s termination the Participant engaged in conduct which would constitute Cause, then the right to exercise any Option is forfeited. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">16. </font><font style="font-weight:bold;letter-spacing:-0.2pt;">EFFECT ON OPTIONS OF TERMINATION OF SERVICE FOR DISABILITY.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in a Participant&#8217;s Option Agreement: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;A Participant who ceases to be an Employee, director or Consultant of the Company or of an Affiliate by reason of Disability may exercise any Option granted to such Participant to the extent that the Option has become exercisable but has not been exercised on the date of the Participant&#8217;s termination of service due to Disability; and in the event rights to exercise the Option accrue periodically, to the extent of a pro&#160;rata portion through the date of the Participant&#8217;s termination of service due to Disability of any additional vesting rights that would have accrued on the next vesting date had the Participant not become Disabled. The proration shall be based upon the number of days accrued in the current vesting period prior to the date of the Participant&#8217;s termination of service due to Disability. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;A Disabled Participant may exercise the Option only within the period ending one year after the date of the Participant&#8217;s termination of service due to Disability, notwithstanding that the Participant might have been able to exercise the Option as to some or all of the Shares on a later date if the Participant had not been terminated due to Disability and had continued to be an Employee, director or Consultant or, if earlier, within the originally prescribed term of the Option. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;The Administrator shall make the determination both of whether Disability has occurred and the date of its occurrence (unless a procedure for such determination is set forth in another agreement between the Company and such Participant, in which case such procedure shall be used for such determination). If requested, the Participant shall be examined by a physician selected or approved by the Administrator, the cost of which examination shall be paid for by the Company. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">17. </font><font style="font-weight:bold;letter-spacing:-0.2pt;">EFFECT ON OPTIONS OF DEATH WHILE AN EMPLOYEE, DIRECTOR OR CONSULTANT.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in a Participant&#8217;s Option Agreement: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;In the event of the death of a Participant while the Participant is an Employee, director or Consultant of the Company or of an Affiliate, such Option may be exercised by the Participant&#8217;s Survivors to the extent that the Option has become exercisable but has not been exercised on the date of death; and in the event rights to exercise the Option accrue periodically, to the extent of a pro&#160;rata portion through the date of death of any additional vesting rights that would have accrued on the next vesting date had the Participant not died. The proration shall be based upon the number of days accrued in the current vesting period prior to the Participant&#8217;s date of death. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If the Participant&#8217;s Survivors wish to exercise the Option, they must take all necessary steps to exercise the Option within one year after the date of death of such Participant, notwithstanding that the decedent might have been able to exercise the Option as to some or all of the Shares on a later date if he or she had not died and had continued to be an Employee, director or Consultant or, if earlier, within the originally prescribed term of the Option. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">18.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EFFECT OF TERMINATION OF SERVICE ON UNACCEPTED STOCK GRANTS AND STOCK-BASED AWARDS.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event of a termination of service (whether as an Employee, director or Consultant) with the Company or an Affiliate for any reason before the Participant has accepted a Stock Grant or a Stock-Based Award and paid the purchase price, if required, such grant shall terminate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For purposes of this Paragraph 18 and Paragraph 19 below, a Participant to whom a Stock Grant or a Stock-Based Award has been issued under the Plan who is absent from work with the Company or with an Affiliate because of temporary disability (any disability other than a Disability as defined in Paragraph 1 hereof), or who is on leave of absence for any purpose, shall not, during the period of any such absence, be deemed, by virtue of such absence alone, to have terminated such Participant&#8217;s employment, director status or consultancy with the Company or with an Affiliate, except as the Administrator may otherwise expressly provide. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, for purposes of this Paragraph 18 and Paragraph 19 below, any change of employment or other service within or among the Company and any Affiliates shall not be treated as a termination of employment, director status or consultancy so long as the Participant continues to be an Employee, director or Consultant of the Company or any Affiliate. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">19.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EFFECT ON STOCK GRANTS AND STOCK-BASED AWARDS OF TERMINATION OF SERVICE OTHER THAN FOR CAUSE, DEATH OR DISABILITY.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in a Participant&#8217;s Agreement, in the event of a termination of service for any reason (whether as an Employee, director or Consultant), other than termination for Cause, death or Disability for which there are special rules in Paragraphs 20, 21, and 22 below, before all forfeiture provisions or Company rights of repurchase shall have lapsed, then the Company shall have the right to cancel or repurchase that number of Shares subject to a Stock Grant or Stock-Based Award as to which the Company&#8217;s forfeiture or repurchase rights have not lapsed. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">20.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EFFECT ON STOCK GRANTS AND STOCK-BASED AWARDS OF TERMINATION OF SERVICE FOR CAUSE.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in a Participant&#8217;s Agreement, the following rules apply if the Participant&#8217;s service (whether as an Employee, director or Consultant) with the Company or an Affiliate is terminated for Cause: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;All Shares subject to any Stock Grant or Stock-Based Award that remain subject to forfeiture provisions or as to which the Company shall have a repurchase right shall be immediately forfeited to the Company as of the time the Participant is notified his or her service is terminated for Cause. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Cause is not limited to events which have occurred prior to a Participant&#8217;s termination of service, nor is it necessary that the Administrator&#8217;s finding of Cause occur prior to termination. If the Administrator determines, subsequent to a Participant&#8217;s termination of service, that either prior or subsequent to the Participant&#8217;s termination the Participant engaged in conduct which would constitute Cause, then all Shares subject to any Stock Grant or Stock-Based Award that remained subject to forfeiture provisions or as to which the Company had a repurchase right on the date of termination shall be immediately forfeited to the Company. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">21.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EFFECT ON STOCK GRANTS AND STOCK-BASED AWARDS OF TERMINATION OF SERVICE FOR DISABILITY.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in a Participant&#8217;s Agreement, the following rules apply if a Participant ceases to be an Employee, director or Consultant of the Company or of an Affiliate by reason of Disability: to the extent the forfeiture provisions or the Company&#8217;s rights of repurchase have not lapsed on the date of Disability, they shall be exercisable; provided, however, that in the event such forfeiture provisions or rights of repurchase lapse periodically, such provisions or rights shall lapse to the extent of a pro&#160;rata portion of the Shares subject to such Stock Grant or Stock-Based Award through the date of Disability as would have lapsed had the Participant not become Disabled. The proration shall be based upon the number of days accrued prior to the date of Disability. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Administrator shall make the determination both as to whether Disability has occurred and the date of its occurrence (unless a procedure for such determination is set forth in another agreement between the Company and such Participant, in which case such procedure shall be used for such determination). If requested, the Participant shall be examined by a physician selected or approved by the Administrator, the cost of which examination shall be paid for by the Company. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">22.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EFFECT ON STOCK GRANTS AND STOCK-BASED AWARDS OF DEATH WHILE AN EMPLOYEE, DIRECTOR OR CONSULTANT.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in a Participant&#8217;s Agreement, the following rules apply in the event of the death of a Participant while the Participant is an Employee, director or Consultant of the Company or of an Affiliate: to the extent the forfeiture provisions or the Company&#8217;s rights of repurchase have not lapsed on the date of death, they shall be exercisable; provided, however, that in the event such forfeiture provisions or rights of repurchase lapse periodically, such provisions or rights shall lapse to the extent of a pro&#160;rata portion of the Shares subject to such Stock Grant or Stock-Based Award through the date of death as would have lapsed had the Participant not died. The proration shall be based upon the number of days accrued prior to the Participant&#8217;s date of death. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">23.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">PURCHASE FOR INVESTMENT.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless the offering and sale of the Shares shall have been effectively registered under the Securities Act, the Company shall be under no obligation to issue Shares under the Plan unless and until the following conditions have been fulfilled: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The person who receives a Stock Right shall warrant to the Company, prior to the receipt of Shares, that such person is acquiring such Shares for his or her own account, for investment, and not with a view to, or for sale in connection with, the distribution of any such Shares, in which event the person acquiring such Shares shall be bound by the provisions of the following legend (or a legend in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">substantially similar form) which shall be endorsed upon the certificate evidencing the Shares issued pursuant to such exercise or such grant of a Stock Right: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;The shares represented by this certificate have been taken for investment and they may not be sold or otherwise transferred by any person, including a pledgee, unless (1)&#160;either (a)&#160;a Registration Statement with respect to such shares shall be effective under the Securities Act of 1933, as amended, or (b)&#160;the Company shall have received an opinion of counsel satisfactory to it that an exemption from registration under such Act is then available, and (2)&#160;there shall have been compliance with all applicable state securities laws.&#8221; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;At the discretion of the Administrator, the Company shall have received an opinion of its counsel that the Shares may be issued in compliance with the Securities Act without registration thereunder. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">24.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">DISSOLUTION OR LIQUIDATION OF THE COMPANY.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon the dissolution or liquidation of the Company, all Options granted under this Plan which as of such date shall not have been exercised and all Stock Grants and Stock-Based Awards which have not been accepted, to the extent required under the applicable Agreement, will terminate and become null and void; provided, however, that if the rights of a Participant or a Participant&#8217;s Survivors have not otherwise terminated and expired, the Participant or the Participant&#8217;s Survivors will have the right immediately prior to such dissolution or liquidation to exercise or accept any Stock Right to the extent that the Stock Right is exercisable or subject to acceptance as of the date immediately prior to such dissolution or liquidation. Upon the dissolution or liquidation of the Company, any outstanding Stock-Based Awards shall immediately terminate unless otherwise determined by the Administrator or specifically provided in the applicable Agreement. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">25.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">ADJUSTMENTS.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon the occurrence of any of the following events, a Participant&#8217;s rights with respect to any Stock Right granted to him or her hereunder shall be adjusted as hereinafter provided, unless otherwise specifically provided in a Participant&#8217;s Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Stock Dividends and Stock Splits. If (i)&#160;the shares of Common Stock shall be subdivided or combined into a greater or smaller number of shares or if the Company shall issue any shares of Common Stock as a stock dividend on its outstanding Common Stock, or (ii)&#160;additional shares or new or different shares or other securities of the Company or other non-cash assets are distributed with respect to such shares of Common Stock, each Stock Right and the number of shares of Common Stock deliverable thereunder shall be appropriately increased or decreased proportionately, and appropriate adjustments shall be made including, in the exercise, base or purchase price per share and in the Performance Goals applicable to outstanding Performance-Based Awards to reflect such events. The number of Shares subject to the limitations in Paragraph 3(a) and 4(c) shall also be proportionately adjusted upon the occurrence of such events. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Corporate Transactions. If the Company is to be consolidated with or acquired by another entity in a Corporate Transaction, the Administrator or the board of directors of any entity assuming the obligations of the Company hereunder (the &#8220;Successor Board&#8221;), shall, as to outstanding Options, either: (i)&#160;make appropriate provision for the continuation of such Options by substituting on an equitable basis for the Shares then subject to such Options either the consideration payable with respect to the outstanding shares of Common Stock in connection with the Corporate Transaction or securities of any successor or acquiring entity; or (ii)&#160;upon written notice to the Participants, provide that such Options must be exercised (either (A)&#160;to the extent then exercisable or (B)&#160;at the discretion of the Administrator, any such Options being made partially or fully exercisable for purposes of this Subparagraph), within a specified number of days of the date of such notice, at the end of which period such Options which have not been exercised shall terminate; or (iii)&#160;terminate such Options in exchange for payment of an amount equal to the consideration payable upon consummation of such Corporate Transaction to a holder of the number of shares of Common Stock into which such Option would have been exercisable (either (A)&#160;to the extent then exercisable or, (B)&#160;at the discretion of the Administrator, any such Options being made partially or fully exercisable for purposes of this Subparagraph) less </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the aggregate exercise price thereof. For purposes of determining the payments to be made pursuant to Subclause (iii)&#160;above, in the case of a Corporate Transaction the consideration for which, in whole or in part, is other than cash, the consideration other than cash shall be valued at the fair value thereof as determined in good faith by the Board of Directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">With respect to outstanding Stock Grants, the Administrator or the Successor Board, shall make appropriate provision for the continuation of such Stock Grants on the same terms and conditions by substituting on an equitable basis for the Shares then subject to such Stock Grants either the consideration payable with respect to the outstanding Shares of Common Stock in connection with the Corporate Transaction or securities of any successor or acquiring entity. In lieu of the foregoing, in connection with any Corporate Transaction, the Administrator may provide that, upon consummation of the Corporate Transaction, each outstanding Stock Grant shall be terminated in exchange for payment of an amount equal to the consideration payable upon consummation of such Corporate Transaction to a holder of the number of shares of Common Stock comprising such Stock Grant (to the extent such Stock Grant is no longer subject to any forfeiture or repurchase rights then in effect or, at the discretion of the Administrator, all forfeiture and repurchase rights being waived upon such Corporate Transaction). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In taking any of the actions permitted under this Paragraph 25(b), the Administrator shall not be obligated by the Plan to treat all Stock Rights, all Stock Rights held by a Participant, or all Stock Rights of the same type, identically. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Recapitalization or Reorganization. In the event of a recapitalization or reorganization of the Company other than a Corporate Transaction pursuant to which securities of the Company or of another corporation are issued with respect to the outstanding shares of Common Stock, a Participant upon exercising an Option or accepting a Stock Grant after the recapitalization or reorganization shall be entitled to receive for the price paid upon such exercise or acceptance if any, the number of replacement securities which would have been received if such Option had been exercised or Stock Grant accepted prior to such recapitalization or reorganization. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Adjustments to Stock-Based Awards. Upon the happening of any of the events described in Subparagraphs (a), (b)&#160;or (c)&#160;above, any outstanding Stock-Based Award shall be appropriately adjusted to reflect the events described in such Subparagraphs. The Administrator or the Successor Board shall determine the specific adjustments to be made under this Paragraph 25, including, but not limited to the effect of any, Corporate Transaction and, subject to Paragraph 4, its determination shall be conclusive. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Modification of Options. Notwithstanding the foregoing, any adjustments made pursuant to Subparagraph (a), (b)&#160;or (c)&#160;above with respect to Options shall be made only after the Administrator determines whether such adjustments would (i)&#160;constitute a &#8220;modification&#8221; of any ISOs (as that term is defined in Section&#160;424(h) of the Code) or (ii)&#160;cause any adverse tax consequences for the holders of Options, including, but not limited to, pursuant to Section&#160;409A of the Code. If the Administrator determines that such adjustments made with respect to Options would constitute a modification or other adverse tax consequence, it may in its discretion refrain from making such adjustments, unless the holder of an Option specifically agrees in writing that such adjustment be made and such writing indicates that the holder has full knowledge of the consequences of such &#8220;modification&#8221; on his or her income tax treatment with respect to the Option. This paragraph shall not apply to the acceleration of the vesting of any ISO that would cause any portion of the ISO to violate the annual vesting limitation contained in Section&#160;422(d) of the Code, as described in Paragraph 6(b)(iv). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Change of Control. In the event that the successor corporation refuses to assume or substitute the Stock Right as set forth in this Paragraph 25, the Participant shall fully vest and become exercisable or earned, if applicable, in each outstanding Stock Right as to which it would not otherwise be vested, exercisable or earned. If a Stock Right becomes fully vested and exercisable or earned, as applicable in lieu of assumption or substitution in the event of a Corporate Transaction or Change of Control, the Administrator shall notify each Participant in writing or electronically that (i)&#160;the Stock Right shall be fully vested and exercisable for a period determined by the Administrator, and all outstanding Stock Rights shall terminate upon the expiration of such period and (ii)&#160;any Stock Rights to which shares or other payment shall be due shall be paid out immediately prior to the Corporate Transaction or Change of Control as if fully vested or earned. For the purposes of this paragraph, the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stock Right shall be considered assumed if, following the Corporate Transaction or Change of Control, the assumed Stock Right confers the right to purchase or receive, for each Share subject to a Stock Right immediately prior to the Corporate Transaction or Change of Control, the consideration (whether stock, cash, or other securities or property) received in the Corporate Transaction or Change of Control by holders of Common Stock for each share of Common Stock they hold on the effective date of the transaction (and if holders are offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Common Stock); provided, however, that if such consideration received in the Corporate Transaction or Change of Control is not solely common stock of the successor corporation or its parent, the Administrator may, with the consent of the successor corporation, provide for the consideration to be received upon the exercise (or payout or vesting, as applicable) of the Stock Right, for each Share subject to the Stock Right, to be solely common stock of the successor corporation or its parent equal in Fair Market Value to the per share consideration received by holders of Common Stock in the Corporate Transaction or Change of Control. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">26.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">ISSUANCES OF SECURITIES.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as expressly provided herein, no issuance by the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares subject to Stock Rights. Except as expressly provided herein, no adjustments shall be made for dividends paid in cash or in property (including without limitation, securities) of the Company prior to any issuance of Shares pursuant to a Stock Right. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">27.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FRACTIONAL SHARES.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No fractional shares shall be issued under the Plan and the person exercising a Stock Right shall receive from the Company cash in lieu of such fractional shares equal to the Fair Market Value thereof. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">28.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">WITHHOLDING.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event that any federal, state, or local income taxes, employment taxes, Federal Insurance Contributions Act withholdings or other amounts are required by applicable law or governmental regulation to be withheld from the Participant&#8217;s salary, wages or other remuneration in connection with the issuance of a Stock Right or Shares under the Plan or for any other reason required by law, the Company may withhold from the Participant&#8217;s compensation, if any, or may require that the Participant advance in cash to the Company, or to any Affiliate of the Company which employs or employed the Participant, the statutory minimum amount of such withholdings unless a different withholding arrangement, including the use of shares of the Company&#8217;s Common Stock or a promissory note, is authorized by the Administrator (and permitted by law). For purposes hereof, the fair market value of the shares withheld for purposes of payroll withholding shall be determined in the manner set forth under the definition of Fair Market Value provided in Paragraph 1 above, as of the most recent practicable date prior to the date of exercise. If the Fair Market Value of the shares withheld is less than the amount of payroll withholdings required, the Participant may be required to advance the difference in cash to the Company or the Affiliate employer. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">29.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">NOTICE TO COMPANY OF DISQUALIFYING DISPOSITION.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each Employee who receives an ISO must agree to notify the Company in writing immediately after the Employee makes a Disqualifying Disposition of any Shares acquired pursuant to the exercise of an ISO. A Disqualifying Disposition is defined in Section&#160;424(c) of the Code and includes any disposition (including any sale or gift) of such Shares before the later of (a)&#160;two&#160;years after the date the Employee was granted the ISO, or (b)&#160;one year after the date the Employee acquired Shares by exercising the ISO, except as otherwise provided in Section&#160;424(c) of the Code. If the Employee has died before such Shares are sold, these holding period requirements do not apply and no Disqualifying Disposition can occur thereafter. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">30.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">TERMINATION OF THE PLAN.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Plan will terminate on March&#160;29, 2028, the date which is ten&#160;years from the earlier of the date of its adoption by the Board of Directors and the date of its approval by the shareholders of the Company. The Plan may be terminated at an earlier date by vote of the shareholders or the Board of Directors of the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Company; provided, however, that any such earlier termination shall not affect any Agreements executed prior to the effective date of such termination. Termination of the Plan shall not affect any Stock Rights theretofore granted. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">31.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">AMENDMENT OF THE PLAN AND AGREEMENTS.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Plan may be amended by the shareholders of the Company. The Plan may also be amended by the Administrator; provided that any amendment approved by the Administrator which the Administrator determines is of a scope that requires shareholder approval shall be subject to obtaining such shareholder approval including, without limitation, to the extent necessary to qualify any or all outstanding Stock Rights granted under the Plan or Stock Rights to be granted under the Plan for favorable federal income tax treatment as may be afforded ISOs under Section&#160;422 of the Code and to the extent necessary to qualify the Shares issuable under the Plan for listing on any national securities exchange or quotation in any national automated quotation system of securities dealers. Other than as set forth in Paragraph 25 of the Plan, the Administrator may not without shareholder approval reduce the exercise price of an Option or cancel any outstanding Option in exchange for a replacement option having a lower exercise price, any Stock Grant, any other Stock-Based Award or for cash. In addition, the Administrator not take any other action that is considered a direct or indirect &#8220;repricing&#8221; for purposes of the shareholder approval rules of the applicable securities exchange or inter-dealer quotation system on which the Shares are listed, including any other action that is treated as a repricing under generally accepted accounting principles. Any modification or amendment of the Plan shall not, without the consent of a Participant, adversely affect his or her rights under a Stock Right previously granted to him or her, unless such amendment is required by applicable law or necessary to preserve the economic value of such Stock Right. With the consent of the Participant affected, the Administrator may amend outstanding Agreements in a manner which may be adverse to the Participant but which is not inconsistent with the Plan. In the discretion of the Administrator, outstanding Agreements may be amended by the Administrator in a manner which is not adverse to the Participant. Nothing in this Paragraph 31 shall limit the Administrator&#8217;s authority to take any action permitted pursuant to Paragraph 25. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">32.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EMPLOYMENT OR OTHER RELATIONSHIP.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Nothing in this Plan or any Agreement shall be deemed to prevent the Company or an Affiliate from terminating the employment, consultancy or director status of a Participant, nor to prevent a Participant from terminating his or her own employment, consultancy or director status or to give any Participant a right to be retained in employment or other service by the Company or any Affiliate for any period of time. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">33.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">SECTION 409A.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If a Participant is a &#8220;specified employee&#8221; as defined in Section&#160;409A of the Code (and as applied according to procedures of the Company and its Affiliates) as of his separation from service, to the extent any payment under this Plan or pursuant to the grant of a Stock-Based Award constitutes deferred compensation (after taking into account any applicable exemptions from Section&#160;409A of the Code), and to the extent required by Section&#160;409A of the Code, no payments due under this Plan or pursuant to a Stock-Based Award may be made until the earlier of: (i)&#160;the first day of the seventh month following the Participant&#8217;s separation from service, or (ii)&#160;the Participant&#8217;s date of death; provided, however, that any payments delayed during this six-month period shall be paid in the aggregate in a lump sum, without interest, on the first day of the seventh month following the Participant&#8217;s separation from service. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Administrator shall administer the Plan with a view toward ensuring that Stock Rights under the Plan that are subject to Section&#160;409A of the Code comply with the requirements thereof and that Options under the Plan be exempt from the requirements of Section&#160;409A of the Code, but neither the Administrator nor any member of the Board, nor the Company nor any of its Affiliates, nor any other person acting hereunder on behalf of the Company, the Administrator or the Board shall be liable to a Participant or any Survivor by reason of the acceleration of any income, or the imposition of any additional tax or penalty, with respect to a Stock Right, whether by reason of a failure to satisfy the requirements of Section&#160;409A of the Code or otherwise. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:408pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">34.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">INDEMNITY.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Neither the Board nor the Administrator, nor any members of either, nor any employees of the Company or any parent, subsidiary, or other Affiliate, shall be liable for any act, omission, interpretation, construction or determination made in good faith in connection with their responsibilities with respect to this Plan, and the Company hereby agrees to indemnify the members of the Board, the members of the Committee, and the employees of the Company and its parent or subsidiaries in respect of any claim, loss, damage, or expense (including reasonable counsel fees) arising from any such act, omission, interpretation, construction or determination to the full extent permitted by law. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">35.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">CLAWBACK.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding anything to the contrary contained in this Plan, the Company may recover from a Participant any compensation received from any Stock Right (whether or not settled) or cause a Participant to forfeit any Stock Right (whether or not vested) in the event that the Company&#8217;s Clawback Policy as then in effect is triggered. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">36.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">GOVERNING LAW.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This Plan shall be construed and enforced in accordance with the law of the State of Delaware.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.31pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="position:relative;padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:-8pt;margin-left:0pt;width:595.31pt;">
        <div style="position:relative;z-index:-1;text-align:center; width:595.31pt;">
          <img src="px_24cyclacelpxy1pg01-bw.jpg" alt="[MISSING IMAGE: px_24cyclacelpxy1pg01-bw.jpg]" height="1003" width="775" >
        </div>
        <div style="margin-top:5pt; width:595.31pt; line-height:1pt;color:#FFFFFF;font-family:Times New Roman, Times, serif ;font-size:1pt;">
          <font style="letter-spacing:0.02pt;">Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY V50259-P11821 ! ! ! For All Withhold All For All Except For Against Abstain ! ! ! ! ! ! To withhold authority to vote for any individual nominee(s), mark &quot;For All Except&quot; and write the number(s) of the nominee(s) on the line below. CYCLACEL PHARMACEUTICALS, INC. 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS, NJ 07922 CYCLACEL PHARMACEUTICALS, INC. 2. Ratify the appointment of RSM US LLP as the Company&#39;s independent registered public accounting firm for the fiscal year ending December 31, 2024. NOTE: The Company will transact any other business that may properly be presented before the annual meeting or at any adjournment or postponement thereof. 1. Election of Class 3 Directors Nominees: The Board of Directors recommends you vote FOR the following: The Board of Directors recommends you vote FOR proposals 2, 3 and 4: 4. Approve by an advisory vote the compensation of the Company&#39;s named executive officers, as disclosed in the Company&#39;s proxy statement. 3. Approve a proposed amendment to the Company&#8217;s 2018 Equity Incentive Plan to increase the number of shares of common stock available for the grant of awards by 160,000 shares. Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. 01) Dr. Christopher Henney 02) Paul McBarron 03) Dr. Robert Spiegel ! ! ! VOTE BY INTERNET Before The Meeting - Go to www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. During The Meeting - Go to www.virtualshareholdermeeting.com/CYCC2024 You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions. VOTE BY PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. SCAN TO VIEW MATERIALS &amp; VOTE w</font>
        </div>
      </div>
      <hr >
    </div>
    <div style=" width:595.31pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="position:relative;padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:-8pt;margin-left:0pt;width:595.31pt;">
        <div style="position:relative;z-index:-1;margin-top:8pt; text-align:center; width:595.31pt;">
          <img src="px_24cyclacelpxy1pg02-bw.jpg" alt="[MISSING IMAGE: px_24cyclacelpxy1pg02-bw.jpg]" height="1003" width="775" >
        </div>
        <div style="margin-top:5pt; width:595.31pt; line-height:1pt;color:#FFFFFF;font-family:Times New Roman, Times, serif ;font-size:1pt;">
          <font style="letter-spacing:0.02pt;">V50260-P11821 Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice and Proxy Statement and Form 10-K are available at www.proxyvote.com. CYCLACEL PHARMACEUTICALS, INC. This proxy is solicited by the Board of Directors Annual Meeting of Stockholders June 21, 2024 The stockholder(s) hereby appoint(s) each of Spiro Rombotis and Paul McBarron, severally and not jointly, as proxies, each with the power to appoint his substitute, and hereby authorize(s) each of them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of Common Stock of Cyclacel Pharmaceuticals, Inc. that the stockholder(s) is/are entitled to vote at the Annual Meeting of Stockholders to be held at 11:00 A.M. Eastern Time on June 21, 2024, via live audio webcast at www.virtualshareholdermeeting.com/CYCC2024 and any adjournment or postponement thereof. THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED AS DIRECTED BY THE STOCKHOLDER(S). IF NO SUCH DIRECTIONS ARE MADE, THIS PROXY WILL BE VOTED FOR THE ELECTION OF THE NOMINEES LISTED ON THE REVERSE SIDE FOR THE BOARD OF DIRECTORS AND FOR PROPOSALS 2, 3 AND 4. IF ANY OTHER MATTERS PROPERLY COME BEFORE THE MEETING, THE PERSONS NAMED IN THIS PROXY WILL VOTE IN THEIR DISCRETION. PLEASE MARK, SIGN, DATE AND RETURN THIS PROXY CARD PROMPTLY USING THE ENCLOSED REPLY ENVELOPE. Continued and to be signed on reverse side</font>
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>bc_paidvsnetloss-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_paidvsnetloss-4c.jpg
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M Q$!_\0 S  !  (# 0$!              0& P4' @@! 0$!  (# 0$
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M .2U?#)\_6 <EJ^&3Y^L Y+5\,GS]8!R6KX9/GZP#DM7PR?/U@'):OAD^?K
M.2U?#)\_6 <EJ^&3Y^L Y+5\,GS]8!R6KX9/GZP#DM7PR?/U@'):OAD^?K .
M2U?#)\_6 <EJ^&3Y^L Y+5\,GS]8!R6KX9/GZP#DM7PR?/U@'):OAD^?K .2
MU?#)\_6 <EJ^&3Y^L Y+5\,GS]8!R6KX9/GZP#DM7PR?/U@'):OAD^?K .2U
M?#)\_6 B2:N W-A-(823;JG"<26/I$E!F6.WX11+I?JN-]'\)B">
M
M
M                               "!,^L*[Z3OZLP"E^JXWT?PF G@
M
M
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MX^3$@$NGO*C4,(K&DFM3X)K6UWAA1+1O&E&E:<2\I&6!@%9>TUT4LZJ<S,*
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MX1.&@OZ64L3)/QF6 #=5]A!M83%C626ID"2@G(\EA9.-.(/H-*DF9&0"2
M                                "!,^L*[Z3OZLP"E^JXWT?PF G@
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M.B;;3-WIF#9:00VU0O)4<9AILF":5G,W$&V1$2%$O-F+X1%6
M                        $"9]85WTG?U9@%+]5QOH_A,!/
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M5@WMZ,<=@(:S\.[&VU!$UKI"XY%J^&R<13SC)2(LJ.9XDV^WBDSP,]AD?X,
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M:PA-2+&I6MRMDN)Q6PMU.19H/R&9; &R
M     :RQT]26\^NL[."U*GU#BGJQ]U.93#JRRFM'P'@72 V8
M
M      @3/K"N^D[^K, I?JN-]'\)@)X
M
M
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M@R4E23Z#(RV&0#V
M
M         /Q:TMI4M:B2A)&I2E'@1$6TS,S :ZAOJS4M8W;U#N^@N+=;2O#
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MZ19%V\,6&ZNTUMIR"DFZ6KN".NCIV-L)EQ67W&FR_HH):E*));"S;!)'1!%
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M3K.QDY=])EO89UJ)!)2DL")*4I+!*2(A%;T
M
M                             5[657=V-.ZO3=D_77L,ER(!LFUNWWTM
MJ)#3Z7DK2;:E&6/1ATX@(VD](N4TB1?7,]ZVU79,,,SY[^[2E#;&*DL,MM)2
MA#:5+4K86)F>)F*-EJ.JL[F!W*LMETZU&9/O-L,R#6TI)I-&#Q&18XXXEM$&
MMTMI*RTQIYS3Q7STQAIA,6J?<CL-N1$(;-"<,A%O#(\%>G\ HRUM'^Q.B44F
MGF'+"161%HB-J6A#TF49&HUK6K!)*<<,U+5\9F TY:!MI=+IEV?J"0WKK3[*
MB_:%M#;IN+DH),A#C2TY7&U8%@1D1^BD]AABCT?A?6OT4^NGV,N1=V4UJVDZ
MA(T-S$V,8T&PZV24Y$):)"4H;RY<NS;B88C/7^'S:WK.=JNS>U%96L%50\\\
MVW&:;KW,36RVTR1$G.H\RU8F9X%T8 ,%/X</PYM2]=:AF7D#3V)T,&2VRVEE
M>[-E#CRVTDIYQ#9FE"E=&)GACM#$7L10       $"9]85WTG?U9@%+]5QOH_
MA,!/
M
M                                           ! F?6%=])W]68!2_5
M<;Z/X3 3P
M
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M*6@G48I-*VU&E:%I41*2I)E@I*B(R ;(
M
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MO.VJ75$Q&:6T1^@I3AI,R^,LI@/&_NN$9[4_9 -_=<(SVI^R ;^ZX1GM3]D
MW]UPC/:G[(!O[KA&>U/V0#?W7",]J?L@&_NN$9[4_9 -_=<(SVI^R ;^ZX1G
MM3]D W]UPC/:G[(!O[KA&>U/V0#?W7",]J?L@&_NN$9[4_9 -_=<(SVI^R ;
M^ZX1GM3]D W]UPC/:G[(!O[KA&>U/V0#?W7",]J?L@&_NN$9[4_9 -_=<(SV
MI^R ;^ZX1GM3]D W]UPC/:G[(!O[KA&>U/V0#?W7",]J?L@&_NN$9[4_9 -_
M=<(SVI^R ;^ZX1GM3]D W]UPC/:G[(!O[KA&>U/V0#?W7",]J?L@&_NN$9[4
M_9 -_=<(SVI^R ;^ZX1GM3]D W]UPC/:G[(!O[KA&>U/V0#?W7",]J?L@&_N
MN$9[4_9 -_=<(SVI^R ;^ZX1GM3]D W]UPC/:G[(!O[KA&>U/V0#?W7",]J?
ML@&_NN$9[4_9 -_=<(SVI^R ;^ZX1GM3]D W]UPC/:G[(!O[KA&>U/V0#?W7
M",]J?L@&_NN$9[4_9 -_=<(SVI^R ;^ZX1GM3]D W]UPC/:G[(!O[KA&>U/V
M0#?W7",]J?L@&_NN$9[4_9 -_=<(SVI^R ;^ZX1GM3]D W]UPC/:G[(!O[KA
M&>U/V0#?W7",]J?L@&_NN$9[4_9 -_=<(SVI^R ;^ZX1GM3]D W]UPC/:G[(
M!O[KA&>U/V0#?W7",]J?L@&_NN$9[4_9 -_=<(SVI^R ;^ZX1GM3]D W]UPC
M/:G[(!O[KA&>U/V0#?W7",]J?L@&_NN$9[4_9 -_=<(SVI^R ;^ZX1GM3]D
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MN1R:FV'VZP
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M7Q)VOX:78!WFL@
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M; N=%"LZ^L9C7-D=M9$:E/SC:1')9J49X);;V)2DCRD6)GATF9B*V(
M                             *#XV_PJU1_E"_6H'6S/VY_K=9G4O;;>
M_P 3XC&OO5P      ?77\M7\-2_W&9^4D9O)>YYWFOB3M?PTNP#O-9
M
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M&OO5P      ?77\M7\-2_P!QF?E)&;R7N>=YKXD[7\-+L [S60
M
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M)3C]TC 3                        0)GUA7?2=_5F 4OU7&^C^$P$\
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MLOOST8XW+AEV.     &-[^S5\BOR3&'UUV&[T>.&Q>&OVN7Z?RU(H\@?HH
M    'UU_+5_#4O\ <9GY21F\E[GG>:^).U_#2[ .\UD
M
M                          ! F?6%=])W]68!2_5<;Z/X3 3P   <]\0-
M2:'@VU%%O-31J2\JYC5G'0[Z9FTI*V5H=+H0AU"U)SJ,L#V^05&(O#NS>OV9
M3-^A6B>:%J1NJ3'2I\YRCWF5,DEX;@W#WN&3'R8X!B.CB*
M              ^1/YA/XFR/\A#_ +P;OJCL\;\M4UE]^>C'&Y<,NQP
MQO?V:OD5^28P^NNPW>CQPV+PU^UR_3^6I%'D#]%       ^NOY:OX:E_N,S\
MI(S>2]SSO-?$G:_AI=@'>:R
M
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MWFL@
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M4UC?-6U?>,,L:@H9RZZP**:CCNX(2ZT\T2_2)*VUI/*HSP/$L05:Q
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M2]SSO-?$G:_AI=@'>:R
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M?0 U%A4:CM5VGB%%II1$5_4V<&G<1N[!^NJ&N[N+)I6TEK)QU;;:L%&1%Y3
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M;\<>TACE=]]=?RU?PU+_ '&9^4D9O)>YYWFOB3M?PTNP#O-9
M
M          !BE18\Z,]#F-)?B2$*:?9<+,A;:RRJ2HCZ2,CP,![;;0RVAII)
M(:;(DH0DL")*2P(B+X@'H  1K"OAVL&16V+)2(,I"F9+"L<JVUE@I)X8;#+8
M8#.VVAI"6FDDAI!$E"$D1)2DBP(B(N@B >@     !P*A7X554BS9\58\5K7R
MYTI5C*OF3<)]M3RS85&<=2ILV=T:"02#V=!EB*C:Z8>T/*\2*I[PH:2F 4>7
M^U;]:VMJK4R;9%&2O8EI3Q.X&G)Z67-CL =H$4  $"9]85WTG?U9@%+]5QOH
M_A,!/   !2/$B59H9H:N#9NTL6YM68$^UC$G?M-K;<6A#:EDHD*=<0ALEX;,
M?A,6$<WK+"56:FK84C65I.O&-2NU,K34F6DW'8)FLV7S;)!*-*6LCRU?,46)
M;#%'?Q\J                            ^1/YA/XFR/\ (0_[P;OJCL\;
M\M4UE]^>C'&Y<,NQP     QO?V:OD5^28P^NNPW>CQPV+PU^UR_3^6I%'D#]
M%   SPYDNO?*3!>4P^72I/0HO@41[%%\H^*Z*:XPJC&'7S.6M9FCD7:8JI\N
MYO3N+K6ZNKK1KE]ZTVRMST34HLT9S'9MQ^:?R_?&(NY.NW/*MSC_ 'CUO/<]
MX=S&4J^ME*IJB-'OT_\ :/ZF$2XT0M!')I%9T'Z7<UJQ/#_IK/I^17WQRV<_
MCL7.'UN[JWQ3$^QFHPGGQ'_ZIW-^.!]%_P MS;C7AP;;S:FG4V4PE-K(TJ(R
M4GI(QM^1F)MXQI=#Q#737FN53,3$TT[,;,.O#OM;
M
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M"S_Z:]A*^3I^(;3D]:6LQL>[5HGBTN&FY$K@,NY
M
M               ' K1B%=W]I9>'>G]2*;.2ZW8VM)9MU%?*F-*-#JD(>4:7
M%$HC2MQ""Q,NDQ](WOAW'HJW5FXO:BZK]<RH[I0)FHI16)O14&E3R(KZ%*;(
MR]%2T$E*L/A(21V 10  0)GUA7?2=_5F 4OU7&^C^$P$\   %4URI+C%37%=
MSZ*396"(D656I:6XMTVG7-VO>H<(D&2#,SPZ2(6!6Y>DZ^AMJ"SUAJFXOBYD
MPQ30I:F2C)L726EIQ;<=MO,:=N!JQ))[01T\10  5W7EA?56D+>PTPP<F\CL
M&N(TEO?*QS$2E);Q+.I*<RDH_I&6 "L>&[=2LK*TTMJY[429I*?L8,W<DXFQ
M4E"2=<2AMMUDS2@D&VI.&!;"V"HJ.EM3WUA<T,5G4$Z7KU4U2-::9DI:3"A0
MV\W>#2V2"W9(,V]PM#BC7B6..)X4;9V5JS4M)JK7-;J&37.T\FP;T]6,):."
MIFI-2?\ N4*0I3IOJ;5F/,64C++T""=7V-UXDW+S$>XET%-7U59,R5BFT/NS
MK9E4C%;CB%^@T@DD2"+TC/: LGAI?66H-+(>NG$O7$"5+K)TA"20EUV"^MG>
M92V)SDDE&1;",PE5'>GZON])ZA\2Z^_DPY%:]8/4E.V37+SAU+JT&V^A2#4X
MIXFEFI><C3F++A@"-O%EW7B+?VL>-=S*"GJ(=><9NM-M+KDVQC%+-QU;B%YD
M-H6A*6\"(]IF U=)JC4^N&]*:;=LUUDN1&LY&I+"O2AI]TZB64 DLFM*R:WK
MA[Q1D6.&PL %MT#8VZ;+4^D[F8NR=T[,91#L7B23[L.9'3(:)W(24FM&*D&H
MB+,1$?2 NXB@#$J3&0HT+>0E1=*341&7G ?G?(GOV_73U@'?(GOV_73U@'?(
MGOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@/DC^8%QMSQ+D*;42T]P
MB%F29&7_ .)\ W?5'9XWY:IK+[\]&.-S 9=C@    !C>_LU?(K\DQA]==AN]
M'CAL7AK]KE^G\M2*/('Z*      !]9_RZ'"<\,3C3#:4VY/F$ME[*:5)-1=*
M5=)#-92F*K<Q,8QB\U\2=K^&E-U3X7U[N>;I:4TR[CF.N=<(FS/_ *:S/%!_
M$>SY!A<YJ2)]JSL3S=SS3N-1JM:&IT]XD7NFG^4ZB:<F1FL$J)S9+:27XJCV
M.)^4_NCI9;6E[+5?3O1,Q&GWH]?];+YIN33L2ZW5:DI+J*F9736W&C^<DU$E
M:#_%4E6!D8VZQF+=^GE43C#LQ5$[2?WR)[]OUT]8["G?(GOV_73U@'?(GOV_
M73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'
M?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV
M_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@
M'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GO
MV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U
M@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(G
MOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73
MU@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(
MGOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_7
M3U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@'?(GOV_73U@/U
M,F,M1(0\A2CZ$DHC,_. R@                .8PJ7Q*T2EZHTFW57FF2D/
MOP&9SSL*;%3)<4\II2T(<0XE*EJRJP)6'2*CWIR)JC5>IX6I=2SJA$;3O>$1
M*FD?5,4F5*;-E:Y+RLN!I0:B2A*?+B8#I8B@  @3/K"N^D[^K, I?JN-]'\)
M@)X   .8>)6CM&6-Q0V5K6.S+RSL8\!"6'5-[YI+3RE)=-2L$MMHS.&:"SF:
M221[181[E:/\/=!WFG;*)IE!O39Y5[%B3KCIPY$AM1-+R/+5\\RW>9.U.(#I
M@B@  U]TY<M5SKE Q'DVB#2;4>8XMEE9$HLZ36A*S29IQRGE/;T@.:T-5>:Z
MN6?$0H3.E$N54R!$-E9O3Y#DLTDAV29(;3E9-&9I.T\3QQ(5$.OT/JMRNTKI
MYVAA5+^G)D:4_JEB63SKI1E$;ZFD9"=-<LL2<)U6&"CQS; $]_3.O:NOU+HZ
MB@PWJ?4$J:_!NW).[[BS:F:GDN1\IJ6ILU+-O(K!6S'#: FMZ<U3HB]?GZ2K
MV;RIL*V! >B/24PGF)%6A3+3N92%)4A;:L%$7I$:=F(#]T^FWT.6F-&--LV=
MU<RIUEJ-]!K0W':<4M]YY&P_1)UQMELEX9OO@-6YI+7<&AO/#RJAQ7*&XD3>
MYZ@7)R'%@V;BG'D+C9#4MQ&\<2C*K*?HXX;0&UY#JS1NH;.PTE61[JJN8L)H
MX[\HH;D657,]V0I1J2HEM+;)&.7TB-/1M 0(6@]3Z/1I:WI4L7=O4QI\2[AF
MYW-,DK5\I;JV'%DHBW;Y>B2^E'P& M.B:&V@2+W4.H$M,W6HI:)+L-A9O-QH
M\=E+##.\,DYU$E.*U$1%B>S8"K<( ".N#"<6;CD=M2U;5*4DC,_N@//+J_A6
MO43U '+J_A6O43U '+J_A6O43U '+J_A6O43U '+J_A6O43U '+J_A6O43U
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M]1/4 <NK^%:]1/4 <NK^%:]1/4 <NK^%:]1/4 <NK^%:]1/4 <NK^%:]1/4
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M9)]@
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M::"_'_[56$5EG=MOQR4SB:FE&18EL =>$4
M !\B?S"?Q-D?Y"'_ '@W?5'9XWY:IK+[\]&.-RX9=C@    !C>_LU?(K\DQA
M]==AN]'CAL7AK]KE^G\M2*/('Z*      !]=?RU?PU+_ '&9^4D9O)>YYWFO
MB3M?PTNP#O-9    8)D*'8QG(<YA$B*Z6"VG$DI)E\ACCN6Z:Z>35&,2DQBY
M/J?PFD15G8Z3<4LD'O"@K6:74&6W%ES'S*V_&-5SFI9I]NQ/FW?-+@JM:&'3
MGBG9U#W*]6,N/H:/(N0:<LMHRV8.(/#-\O3\HX\KKBNU/(OQ,X;O^Z-^-U*;
MLQL2ZU76=?;Q43:R0B3%7\UQL\2Q^ RZ2/XC&VVKU%VGE43C#L1.*6.50
M
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M)9C(O+AT@!N(2I*%*(EKQR),RQ/#IP+RX "W&VB)3BR01F1$:C(BQ/H+: ]
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MVZ 1D98ET#/N8
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MG\M2*/('Z*      !]=?RU?PU+_<9GY21F\E[GG>:^).U_#2[ .\UD
M    $*TJ:VZB*A6D9$F,K^@LN@_A2?21_&0X;UFB[3R:XQA)B)VW)-1>&%Q1
MOE:Z4>=D-LGG0TA668U]!189R\_RC4LUJBY9GEV)F</Y1O:77JMS&S"9I?Q:
M<:4FOU6@_1/)S!M!DI)EL_/-D6)8>4TE]P<V3UW,>S?_ )>N%INZ75HDN+.C
MMRX3R'XSI9FW6U$I)E\1D-JHKIKCE4SC$NQ$LP^P
M                                                           !
M2=:5.HD7-)K#3$1JTGTZ)4634ONE'-^+-)O,;+JB-*'4*:299MBBQ+'H%&I@
MKU3J?6U!;ZBJ&=,0*=$Q<"'(ELR;";)D,[I>5+6Q+;:#-2MIF9X>0@1TP10
M 0)GUA7?2=_5F 4OU7&^C^$P$\   '.=;Z@TU94<NLU1IZUDQ56R:F'&8CF4
MI^6VV;[<F&:7$JREE,T.)41XD*BN:4A:?9U/6S']/ZTG6+2S9KYVHD.2(L$W
M$FDW"S.94>CZ.?*:L ':1%                            ?(G\PG\39'
M^0A_W@W?5'9XWY:IK+[\]&.-RX9=C@    !C>_LU?(K\DQA]==AN]'CAL7AK
M]KE^G\M2*/('Z*      !]=?RU?PU+_<9GY21F\E[GG>:^).U_#2[ .\UD
M           5?5&@Z/4Z3>>1W6SPP1.8(B7\1++H67R_?&,SFKK68V9V*M,?
MULOBJB*G+'H>M?#&8<AA9JK5J+,Z@C<A._ 3B>E"OCV?*8U:JWFM758Q[O\
MQG?T.OA50Z/I7Q(IM19(DHRK[96!%'=5Z#A_]->PC^B>T;'D]:VK_LS[-6C3
MO2YZ;D2N@S+D
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MIM!V7T
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M)K,RVEDQV;0$BGNJG4$!NTI)C4ZO=,R0^RK,G,D\%)/RDHCV&1[2 3P
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M9;#&S1,3&,.=[%
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M9'4 =[L_L[],CJ .]V?V=^F1U '>[/[._3(Z@#O=G]G?ID=0!WNS^SOTR.H
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M5&BT%I2WCV%$>H=05<QG3$5V/25E09GF6ZWNER'UN*S*42,4I2E)$6)F$CK
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MH8C9Z=TW5Z7@J@5:%Y7G5R94A]Q3TB1(=/%;KKBS-2EJPVF?R%L$&V
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MQ$Q.TV0["@
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MR!^B@      ?77\M7\-2_P!QF?E)&;R7N>=YKXD[7\-+L [S60
M             &DU#I2DU,R3=I'Q>26#4IOT'T?167D^(\2'2S62M9B,*XV=
M.Z^:J8JVW-+3P@N(+G>M/3DR5)VH2X9QY!?(M/HGYAK5[4=RB>5:JQ]$\+@F
MU,;2"UK7Q!T@XF/=M./,%T)L$&>)='HOHZ?NF8X(UAG,K.%R,8_R_P"R<NJG
M;7.G\7=/3LK=HVY6/'TJ66]9]=!8E]U(S-C7=FO8KQHGACA<D78G;7F'.A6#
M)2($AN2P?0XRLEIV_&1F,Y1<IKC&F8F/(Y8G%('(H
M                                              I$CP?\,Y3SLB1I
MJ(MYYQ;SJC)99G'%&I2L"5AB9GB+BF"72>&6@M-V;=Q144:#9LI6AJ2T2LZ4
MN%E418J/I(,56P0  ! F?6%=])W]68!2_5<;Z/X3 3P   5;6]'9VD:NM*-^
M.Q=T,LK&&4W'NKI$TMEUITTXF@E-N*P61'E/ Q10-)4FKKU^!7V9U,.AJ[AW
M4$GE\WF$I^0M]U]IDLJ4I;;0MSTE'Z2LI;"Q,5':!\J
M           ^1/YA/XFR/\A#_O!N^J.SQORU367WYZ,<;EPR['     #&]_9
MJ^17Y)C#ZZ[#=Z/'#8O#7[7+]/Y:D4>0/T4      #ZZ_EJ_AJ7^XS/RDC-Y
M+W/.\U\2=K^&EV =YK(                          /#S+,AM3+[:76E%
M@IM9$I)E\9'L$JIBJ,)%,N?"W2UIF<C-*K9*MN\BG@C'X3;5BG[V PU_4^7N
M;,1R)\GJ<4VXE1IOAGK#3KQS-/2N\DG$R7%6<>1@7PH,\JO6,8.YJG,V)Y5J
M<=[8G@<4VZHVGJ#XHZKHGBA:BA]Y-!X*2^@XLG O@/#*KU1;>N,Q9GDW:<=_
M8DB[,;:]4WB?I6V-+3SYUTI6!;J661.)^0G"Q2?WR&<L:WR]W8F>3/E]>TYH
MN1*XMN-O(2ZTM+C:BQ2M)DI)E\1D,Q$Q,8PY'H4
M                                               0)GUA7?2=_5F
M4OU7&^C^$P$\   ',_&MRL9HZ9V_6IS32+:/SFM;WF>9'R.?FR)LC-9(5E=4
MWLS)29=.!'825"LM1>#E7?Z9LM"I;J)T6<E=E90H<F*R5:AM6^9>2EHMYO<4
MI0G*>"O2Q+#;1W73^H:C5%8W<4<CO5<ZI:$/&AQK%3:C2HLKB4JV&7P#Y5M
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M+WNU;.B=B7-%<2L@R+[
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MSS$ \;JZXECLE>T ;JZXECLE>T ;JZXECLE>T ;JZXECLE>T ;JZXECLE>T
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M[0[3Z-U=<2QV2O: -U=<2QV2O: -U=<2QV2O: -U=<2QV2O: -U=<2QV2O:
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M?=9#2'6B-/S3)*B,BP\@#+"@PJR*W!KHS42$R65F.PA+32"Z<$I21$0"0
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MKE[WYWY>P:L[):Z,*J.%D     !UK^7#^)B?]NE?E-CNY/[C7/$79/BCC?8
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M=U)4\XZJQ9L&EDZJ1G49+5O"2ZE7]$RV;-@#L0B@       ($SZPKOI._JS
M*7ZKC?1_"8">   "EW3%'XB+L]-QY,N)9:;E1W47$,MVJ)8[LW$;IQ1&E:DH
M7^=09&65>4^D45][3\BMU3IA>O\ 5<Z^2N4LJ&,4-F%7ILFF5*;5(-CYSN3/
MNLQY<Q'LQP!'5!%                            ?(G\PG\39'^0A_P!X
M-WU1V>-^6J:R^_/1CC<N&78X     8WO[-7R*_),8?778;O1XX;%X:_:Y?I_
M+4BCR!^B@      ?77\M7\-2_P!QF?E)&;R7N>=YKXD[7\-+L [S60
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MT[55$3#2#J,J     .M?RX?Q,3_MTK\IL=W)_<:YXB[)\4<;[ &<>9
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M:S<62E-H4>!-I21J/,?1@ Z"(H       "!,^L*[Z3OZLP"E^JXWT?PF G@
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MQEI1[U/IM^LG'SC?<CKK)YW[-R)GF[57\9V6/N6*Z/>A!S)/:1E@,RX#$OA
M,2^$ Q+X0$+$L>GR)_)(>.ZW[;>Z<OT9X;_59;_^5)B7PC%-A,2^$ Q+X0#$
MOA ,2^$!UG^7 R_>:G_;I7Y38[N3^XUOQ%V/XHXWV",X\R
M                  0)GUA7?2=_5F 4OU7&^C^$P$\
M 5_6<RDB4$@M25[MG123*//CM1E34I:<QQ6XV@E*R)PQ4HB/+T@.?Z%8D2K:
MUC: L+.+X>OUJ#@S9Z%O-1[-;IY3@%.2:U-$UM42L6\<,!4=,HJ^UKHJV;>W
M<N9"G#6B2ZPS'4E!D1$C*PE*3(C(SQ,L=HBMH   "$[7FZXISO<AO,>.1"R)
M)?(6 #QRL^.E=H7L@'*SXZ5VA>R <K/CI7:%[(!RL^.E=H7L@'*SXZ5VA>R
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MT./7PFB9A1&D,1V4_-0TTDDH26/D(BP 9P
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M&E&2TXK+%)I46&)'A\ V?(9^G-4S,1A,;;GHKY2S#)/L
M                       ! F?6%=])W]68!2_5<;Z/X3 3P
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M L<R\J=OWBMEI;4$75>G:W4<-M;,:R82^AEW#>(-72E6&)8D9&6P0;<
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MJZZ:[,@\NM*N<_5640G"?;3)BY<QMN$2<R#)1&1X$?D/H$%E
M                          $"9]85WTG?U9@%+]5QOH_A,!/
M #$L<,=I]                               J?B#K>-H6E1/6UWB?,=*
M)7,JSI9-]9&9*><2E6[:01&I:L.CH(SP(6!S1]NJL_#F[5IRQ/4^J69T/4&H
MWHK+B5R7VY+;JT--J21Y$MLFAELL?121=)[:BRNZCI];ZZTM-TV^<ZKT\U/L
M;:>VAQ++!2(Y,,M*4I)?G%&I2C;^<1)VB#44VOM+ZTUE!O+FR1$AP'E1])T3
MC;Q2')+^+)S))&W@E:DGD8;Q]%*C4KTE8)#8^(.L-,Q-::0:DV*&UT=E(>MB
M-#A]W;<KWTI4LTI,L#4M*2^,P'5&'VI+#4EA1+8>0EQI9="D++$C^Z1B*R
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M=!$; 7G2#VG7=-UR=)K2YIZ.T4:"I!*).[8_-X>F1'L-.TSZ1%;L
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M(E1UH2MY:S,DF[@\:TI>46+A;3QZ0DAT@10                 Z>@
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M2,C ?I$1%@6PBZ"   !C>99DM*8D-I=966"VW$DI*B^ R/$C 9
M    ! F?6%=])W]68!2_5<;Z/X3 3P
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M_-+Y/(+BBZB*
M                @3/K"N^D[^K, I?JN-]'\)@)X
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M/R ,!:ABGJA>E-TYWY$!-F;V!;K=+>4QEQQQS8IQZ.@!MP
M                          $"9]85WTG?U9@%+]5QOH_A,!/
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M:J(-%XN6-97SGY49K3["RC2I"I2XF>8O\V2W#4X25$6<DK4?Q;!!U$10
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MHVCCKD)S*>6V:]X9+6LU*7Z6W%1F8#>@
M            ($SZPKOI._JS *7ZKC?1_"8">
M                              K%!KRAU'J"[TS!-YNVHG-W*;?;W:7"
M(\JELGB>="5>BH_(?R@-CIW4,'4]<JSKDNICID28AD^DD+WD-Y;"SP(SV&I!
MY3^ !*M+2!2UDJXLWB8K832Y$E_ U$AILLRE8)(S/ B\A )+3J'VD/-'F:<2
M2T*Z,4J+$CV@-;2:@@WYV10DN)Y7.>K).]22<7XY)-1HP,\4^D6!@-KCY/*
M8D7W>@ Q+'#R_
M                                                   @3/K"N^D[
M^K, I?JN-]'\)@)X
M#D=[1>*[]S.>@S'C@K=4<7<2TL-DT?S2)!J29&1;#^,:GF<MK"J[5--4X8[&
M%6&QO.O537BU_P"SGC#Q<O\ ^H(]L=?JNLN=/\WSR:S]G/&'BY?_ -01[8=5
MUESI_F<FL_9SQAXN7_\ 4$>V'5=9<Z?YG)K/V<\8>+E__4$>V'5=9<Z?YG)K
M631%1XBP;HWM12G%5.Z63C;\A,DU+/#)D(C4:3+RG\ R.K[&=HNXW9]G#=G%
MR415$[*JM0I<4K[7=0A3MII75=HY)8;VJD5#Y,E-8P\IDDM\@OQT%\(V1RM.
MQ8KFZ%TPQ =:>TW>ZFM2E+?D+AQ9#+DB6]&:>>;)2D(=42?1P](\$'TBC:7.
MDW8.A_$!N<B BI;B)GUU%7RWIB($QEEPU/%G2V;9+]%9(PRXD9^4!U;1=915
M6GHC&GFVFH+J4OK2PLW$&ZZA*E'B:E=/RB2JN>'=E71I&KX\B8PS(7J:PRM.
M.(2L\Q-$6"3,CVGT!** [&T[8Z!U-K6\GN-^(4.58X3N\.-S8,^*^XB'&8;)
M194X):2ELDX.$K';F%&UU<P=?8HUQJJ-&OJ^/$K6[.M[TJ/84\G$E*<C-I42
M5;Q2R4I&*7#P]$U%L 2K*/#H-=%J6Y8CZ@K[2WC1:^S9E+3954I:4,HC&P2L
MJV27BI1(,E%F,UI,BQ$'8Q%
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M;Y*1L2K.:<<2\A]) /V57Z&G6C=W-@P9%NSE-N<['0MXC1\T\YIQQ3_1^#R
M/U,#0R+<[]$&"F[49J.P*.@G\QE@:L^7',9;,W3@ VW.JOB4^?J$#G57Q*?/
MU '.JOB4^?J .=5?$I\_4 <ZJ^)3Y^H YU5\2GS]0!SJKXE/GZ@#G57Q*?/U
M '.JOB4^?J .=5?$I\_4 <ZJ^)3Y^H YU5\2GS]0!SJKXE/GZ@#G57Q*?/U
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$A%'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>bc_paidvstsr-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_paidvstsr-4c.jpg
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M Q$!_\0 SP !  (" P$!              0&!0<! @,("0$! 0 # 0$! 0
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M(823;JG"<26OM$E!F6O'X11+I?JN-]'\)B">
M
M
M          ($SZPKOI._LS *7ZKC?1_"8">
M
M
M         ($SZPKOI._LS *7ZKC?1_"8">
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MCF-L(4X_:)>2<=M"/G&I>NB=->.H"@8CYZ8O9-VJLJN*NH7'L'X]6GMS3[Q
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M$?0(K-                          "!,^L*[Z3O[,P"E^JXWT?PF G@
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MA6PE;4*6G4$2K/RCIIGEK#\N(DMZ,Q6):776/!3S<IA9N)=,N!'JHU:EPZ>
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M6VEA=P8#3%O;&@[&:E/ZU[LBVHW*/CH1=! ,F
M                                                           (
M$SZPKOI._LS *7ZKC?1_"8">
M
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M)<;42VUD2D+2>I&1\2,C+I(P'8
M
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MKN3 .;(\+*[DP#FR/"RNY, YLCPLKN3 .;(\+*[DP#FR/"RNY, YLCPLKN3
M.;(\+*[DP#FR/"RNY, YLCPLKN3 .;(\+*[DP#FR/"RNY, YLCPLKN3 .;(\
M+*[DP#FR/"RNY, YLCPLKN3 .;(\+*[DP#FR/"RNY, YLCPLKN3 .;(\+*[D
MP#FR/"RNY, YLCPLKN3 .;(\+*[DP#FR/"RNY, YLCPLKN3 .;(\+*[DP#FR
M/"RNY, YLCPLKN3 .;(\+*[DP#FR/"RNY, YLCPLKN3 .;(\+*[DP#FR/"RN
MY, YLCPLKN3 .;(\+*[DP#FR/"RNY, YLCPLKN3 .;(\+*[DP#FR/"RNY, Y
MLCPLKN3 .;(\+*[DP#FR/"RNY, YLCPLKN3 .;(\+*[DP#FR/"RNY, YLCPL
MKN3 .;(\+*[DP#FR/"RNY, YLCPLKN3 .;(\+*[DP#FR/"RNY, YLCPLKN3
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M+59+6RI)\$LMRFMY_(DU$9_T!@+. Z/-]JTXUO4WO2:>T0>BT[BTU2?'0R]
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M*2T2DB(09X
M
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M-*36WN).XBU(!LVCHX&.5C-15DXFOCFKL&WG7'S0E:C5L);JE*VEKHDC/@7
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M-JD^\,+8(B>W;=-Y<?FF,UJ_3<T-=G=V7LI$3<P_%HPG'0N(SM6
M
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M'HHU*+56I:)+XP%KJVV6(#$5B6N:B,DF#E/.$^ZM37LF;BRZ5ZE[7QB*F
M                                 Q>2_P#3EQ_]E)_9*&.Y[D\CZ,MX
MM/:C^+\](G_"L?[-']4AS<OVNOWIY7J(\     #Z$_E6_P"/RG_9P_ONC9Y'
M3+B_JGW;?YN9]+#;.#
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MS%12Q&H-;&(R9C,)VH3J9F9Z>DS,]3,^)F(J<
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MG\JW_'Y3_LX?WW1L\CIEQ?U3[MO\W,^EAMG!@
M
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M1'$MN=L4?4G'4I4M!$1'M(U?#H NXB@  @3/K"N^D[^S, I?JN-]'\)@)X
M -2Y+8^<%'-@QV;>C?<NK#W&JB^Y2$J)*M[NYQ9O&6C;2%*49%[1EH1<1427
M;'S3QV]Q].3VE1(Q^TG)@2784)Y#R'74J-E&BWCT)Q1;=_':>FI:'P#:(B@
M                          /E3^90B//8!F1'_P#%-?MWAV6Y? GM<T.8
MWK'_ +8[/.T[M3\!?<&\:G"#:GX"^X!A!M3\!?< P@VI^ ON 80;4_ 7W ,(
M3*NR53S43FVDNG_=+;/AJEPR(]#]!D-)OS=M.?RE=JJ9IP_%$QKIX8Y8?3EJ
M^A=IP_JJII_55%./W8XK9MQ[-8I.(,VYR$]/!$IK7T&7Y2?ND/P.F;V6GAT3
MLE^GS.?W%=Z,\-N9Y;=7)U:MD\JG7%!8TBC5(3VL/71$QLCV?(LNE)_+P^,;
MBSF*+NC3J^VEWF[=\9?/1A1/1KXZ)T_=UHY-C%CZ&Z 0  'T)_*M_P ?E/\
MLX?WW1L\CIEQ?U3[MO\ -S/I8;9P8
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M<HN4171,54SHF-#H*]@#Z$_E6_X_*?\ 9P_ONC9Y'3+B_JGW;?YN9]+#;.#
M
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MH62I$6P2^;9I+V$I92RC@9\.G@ N0B@  @3/K"N^D[^S, I?JN-]'\)@)X
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MCZ#+XR'5[NJBK&:9QA]WU%?MW[5JNW5%5,]+AC[MD^B7TB-PXH
M
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MLMQ?ET-G-G9%# 6:E5BJZ,CM6U*4M2#=(S66JE:ZD&(V((H
M              #Y4_F4_P"O8'_*F_V[P[+<O@3VN:',[T\6.SSM/#>-2
M  .CG0GZ:/ZQ##?\*OLU?#+)9\:W^Y;^.E#1\Q/R$/PRG1#^K+GO3RN1Z8P
M  $ZKN+"F=-R"YHVH]78Z^+2_E+T'_XB&&[9HNQA5MXVNS^[;&=IPNQPQHJC
MWH^_5Z)X&V\&S&U6F3=8^3T9Z 3:;-&WM&4I=,]A.>A2%&1Z'PT^(:N*+^4J
MZ=N>#CGB_-#\LWGNJ]N^N,9BJFK1,<?+'%+?&)>9=5D'9PK#;7VZN"6U*_4N
MG_Z:S])_FJX_*.GR6]K=_"FK\-7JGDGF:ZBY$KR-XR@
M
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MM*:8S/KGRU9E1EI=:41'H>BDF9<#Z1%30
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M_$3-JI*9#)\%$7!:%?FK2?%)_*.OL9BW>IZ5$XP^F)B=#(#Z%
M
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MX:O5/L9:+L3I;#Z1T+,
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M?XP^BFJ)T,L/J>@
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M@/E[^8M]4C.8*U,K9,JQLMCA$1_W[O'@9CL=R^!/:YH<SO3Q8[/.U(-XU(
M   Z.="?IH_K$,-_PJ^S5\,LEGQK?[EOXZ4-'S$_(0_#*=$/ZLN>]/*Y'IC
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M#-@           ^5/YE/^O8'_*F_V[P[+<O@3VN:',[T\6.SSM/#>-2
M.CG0GZ:/ZQ##?\*OLU?#+)9\:W^Y;^.E#1\Q/R$/PRG1#^K+GO3RN1Z8P
M !]"?RK?\?E/^SA_?=&SR.F7%_5/NV_S<SZ6&V<&      "BY;Y9U5_VDVNV
MUULKBI:4_J'3_P#407I/\Y/'Y1H\[NFW?QJI_#5ZIY8YV*NW$J!79!E_EO-3
M663"G*_7A#=5JTI/I..[QT^3H^$AH+69S.0JZ%<?AU<7Y988JJHX);=QS+*7
M*(_:UKW^\(+5^(Y[+S?RI])?&7 =;E<[:S$8T3P\<<</IIJBK0S@^YZ
M
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M):;NMM-IUI]M+S"TNLK+<AQ!DI*B/TD9<#'4Q,3&,:'T.XH
M
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ML\CIEQ?U3[MO\W,^EAMG!@          I^6>7E/DI+E-%[C;F6I2VB+:L_\
MU4]"OEZ1I\[NNWF/Q1^&K7[=;'5;BIK2/.S+RPG%%D(W5JU'M969KAO?";2_
MR%?%]TC'-TW,SNZK"?=_MGDU2P8U4-L8QFM+E+>V(YV%@DM78+QD3J?A-/H4
MGXTCJ\GO"UF8_#.%6J=+Z*:XJ6,;%[
M                                      <&9)(S,]"+B9GT: "5)6DE
MH,E(46J5%Q(R/H,C <@    (EE:5M/$7/MIC,&"W\^1)<2RV6O1JI9D7$!S&
MLZZ8B,N++9>1,;[>(;;B5=JT6FJT:'[22W%Q+X0$H   $"9]85WTG?V9@%+]
M5QOH_A,!/   !1\B\QL5BR9>-M19.37"-69E+61535)-1$>Q\S(FD$9&7]XL
MA<$53!6L@L,BDNT.-4F$U%7,3&NHZ6D2+21JTEXVB6P2&VR,EH/750#<8B@
M                          /E3^93_KV!_P J;_;O#LMR^!/:YH<SO3Q8
M[/.T\-XU(     Z.="?IH_K$,-_PJ^S5\,LEGQK?[EOXZ4-'S$_(0_#*=$/Z
MLN>]/*Y'IC     'T)_*M_Q^4_[.']]T;/(Z9<7]4^[;_-S/I8;9P8
M     "/-@P[*,Y#GL(D172T6TXDE),OZ?OC'<MTW*9IJC&)28Q:DR?RLG5KO
M-<2<<=0T?:)B$HRDM&7'5E? U:? ?'Y1R><W-7;GIV)G@XN..27SU6L.&'KB
MOFN_%45;EJ%*)!]G[^2#2X@RX:/MZ:\/2I)?*0]9/?4T_@O_ *O_ -0M-WBE
MMB+*C38[<J&ZA^,Z6YMULR4E1?$9#JZ*Z:XQIG&)?0]A[
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MG0".:7%+B;B5U@UE0+IXMK$DG(O9%@S82I5A*+13SQ-H29K,SW:]!$1)+0M
M'K&J,[R-[%J[):N/55^-R6;"?.:E)D^^R832FV4L(2DE(0I:NT4;FAEH1?&
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M"CQPN!F%><U.23H5G$ENKFQ)<0WB6A4A9K4R273679((R)HTJZ.D@1;!%
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M42M)$/70]?\ Z3@VN1_J^[G<)]51,56N2K^+Z*&T<0
M#5>0O9>[:8I73*?'9F72E6SK$F6E]V+&CQ5-F@VE;363BT*1OX=)"HL-/.\P
MFKN'$RMS'F8,I+NQF"[*]]<6VC=^J2\1)42>E?P$ N8B@  @3/K"N^D[^S,
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MO;[+,4/ROC,N9#%GH=GS:F*J,TS4DA12425DA"#2LC2E*%:GOTTZ &[A%
M       !T=:;>;6RZDEM.)-"T*XD:5%H9'\I .L:-'AQV8D1M+,6.A+3#+9$
ME"&T$24I21=!$1:$ ]0
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M@/%[,W+TQ-<XX/HM6+=K'H1ABS@^=G
M                          57,<JE4JH5)20EV.5729!5,5*D--I]V;)3
MCSJW#))(1N3PXFHS(B(4=JK(+>)BA665U<EBXA)2Q,BQT(E.R7R)*-\=,<U$
M:75*]DN&WTZ$6H#RQS.H]QC=IDEI"<I6*>1.CSX\A:'5M%7*43BE&UJGH2?
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MJ?'7]%Y!_>,98O6YT51M7%)0\TY_=N)7]$R/[PRQ,3H5W%
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MQR6G0SE]M?VK,GM:JOL9$U]CWM"3(E[%-(3N01F>JCT2 W8(H
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M#J[*)<0&+.":U1)"=S1NMN,+T(S+BAU*5IZ/RDB*E@
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MY2G+HU V=>5-$O'<G:M"E:628\A2W'(WNVW=[2W%-J<W;3;/HU!&VQ%
M
M                       #(CX'Q(!X+@PG?[R,TOZ2$G]\AXFW3.F($5R@
MHG?[VLB+U_.8;/\ \HQ3EK4Z::=D)A"$[A.)/<7*:(9_$T2?O:#!5N_+SIHI
MV)T(U(B_+G"7.FH:+Z*G$_>40Q3NK*S_ $1ZWGNZ=2&[Y588Y\V*ZW]!]POO
MF8PSN;+3_3,??*=W2BK\G\35\U<QOZ+Q'_628Q3N/+_\MIW5*&[Y,4JO[FQE
MM_2[-?\ Y2&*=PVN*JKU>Q.ZA$<\DXJO[NY<+XEQT*^\HAAGZ?IXJYV0\]SZ
M4)SR2E%_<6S)_3CF7WEC#/T_5Q5QL_FG<^E'5Y-9"W_<643_ /?-_>(QC^0W
MHT5QZSN9UO(_+'.XQ_[M,;5]"6\C[Y#S\HS=.BK^Z4[NK6[%B/FM%_N)+_#\
MR?\ VE$$9'>%.B9_6="MU.'YPQ3^?/7I\#K3OWS,.AO*GK;8DPK<E;><$7I9
MFKT_.BMNEZDAW^\J>*K],28UN#SGS/BG_O$5P]/SX"B_JD0?,<_3IIG]!TZW
M)>:^9QO^(@L*T_Q([S?WE!\ZS5.FF-DG>U:FWJ&PD6M-!LI48XDB4REUR,K7
M5!J+X]#X]):CKLM=FY;IKJCHS,:'TTSC&+(CZ%
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MD@]?:-1<2)/2 ]ZRTK;F$U95,MF= ?+5J3'6EUM6AZ'HI)F7 ^!@)8
M
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M[)FA6I?!H"(E56UMIY6^84RW8;<F3I>0.V;SA$:R=B+=;:U5TEV26T;/S=.
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M6@.0:[M7%2'G)<V7)<-Z3)DN_/==</YRCT(O@(B(B(B$&9
M
M                                         !4\WQ.?D4=B126LNGO(
MZD-M2HLEQA!QW'6S?2XA)*2L]B5;-R>"O3TBC)XYC%5BT-V)6)<4N2\J5-ER
M7%/R9$AS0E..N+,S4HR(B^ B+0N @S(    "DXG(9\P*AZ[R.M@RHO,)K-.P
MZPEY3,6,^J-JLW=WZQ:FC4K;H6FA>@5!UYC%<VHJ6KK8,6GR)B8VOW6.EB0B
M7"03Z5&I&A*;4WN29&G4E$7'B NPB@  @3/K"N^D[^S, I?JN-]'\)@)X
M*;YFR,59QQ#>5-27VWI3**MBN)Q5BJPU,V3B=D9*)U.AJ)1&6A:Z\-18&O<+
MB8E5Y35-WM=E$*S=>?5CQY2M+L(IKY*6Z;78J-M,A9&L_P!9[1\=.((WH(H
M
M
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M6^P224>PR6XE!F9ET\!%94
M
M                                                0)GUA7?2=_9F
M 4OU7&^C^$P$\   &N?.9QIC'8$FSG.P\7:L6/WA;BO*CR7X:R4@FVU(,EGH
MX:%+0CVE)(]!825:QMOR!+(JL\?EK7>^\)Y:@W[-1&_H>A:.GL/AK\[@'"-U
MB*
M
M                            "!,^L*[Z3O[,P"E^JXWT?PF G@   HWF
M;475C#I9^.5:;>YI[-J='B//-,QS2EMQM9N=KP,MJS).WVDJT4708L(]*W)O
M,&58Q8UA@IP(#KA(DSN;1'NQ;,CU7V:$[E:? 0"ZB*
M
M
M        "!,^L*[Z3O[,P"E^JXWT?PF G@   U]YLRE-5M+!E6+M/CEG:,PK
MZTCN''<;BN-N&E!O%H;27720TIS4M"5IJ6HL(K4BIQ7!\EQ4\#M'465M8-0I
MM,B<[/9EP%MK4\\MIQQS:;1$2R=+33H/74!N810
M
M
M     0)GUA7?2=_9F 4OU7&^C^$P$\   %0Q^T?R^;ED.UC1G<=KYYTT:$XW
MVBG389;6^M_?JDR4IPB0G;T%KQU%&&G4N/\ EM<X].Q:AK($6YL4T]H;,=+<
MHREH6;*FG"Z"2XCVT::&D_B!&R!%
M
M                                                      ! F?6%
M=])W]F8!2_5<;Z/X3 3P   4*[P&Z3>3,FP7(%8_:61(YK$>CHFU\IQI)(0\
MII1I-#I)+::T*]HB+4A1YU'E_D$F\@9%GV1\^EU)J<JJ^-&3"@,/K2:#?-!*
M6IQPDJ,DFI7LZGH"-@B*
M                                  #J;C:5&DUI)1)WF1F6I)^'Y '*
M5)6DE),E)46J5%Q(R/TD Y     <*6A&F]1)W&22U/34SZ"(!R
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MR)7:R6FU.;VBE-[$DDW4GJ79J5M/V5 -TB*
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M:VM*"+^[U)2N)Z%P ;3$4
M                      0)GUA7?2=_9F 4OU7&^C^$P$\
M                             8:VR[%J&2F'=7,*OEK03J&)4AME9MF9
MD2B2M1'IJ1EJ,=5RFF<)G!]5K*7KL8T4551Z(F4'^(_E_P#ZGJ_\XS_:'GO[
M?6AF^79K_'5^F3^(_E__ *GJ_P#.,_V@[^WUH/EV:_QU?ID_B/Y?_P"IZO\
MSC/]H._M]:#Y=FO\=7Z9/XC^7_\ J>K_ ,XS_:#O[?6@^79K_'5^F67J+VEO
MV%R:.PCV,=I?9N.Q74/(2LB(]IF@S(CT/H'NFNFK1.+Y;MBY:G"NF:9],8(5
MAF./U>25>)S979WEPAQV"QL4:5):(]=RR+:DU:'M(S]K0]![86=
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M4G;[9)/V>&O2 CR\CB0\DK<9<:<5,M(\F4RZDB[)*(9MDHE'KKJ?:%IH0#,
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ME539NG F2ES%,GNCD;J5/*4XGM3UW:GM,T\/2 VR(H
M                   @3/K"N^D[^S, I?JN-]'\)@)X
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M6>IH-PM3(CT+4O@/TD(K.@
M                     @3/K"N^D[^S, I?JN-]'\)@)X
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M\DR$58
M      0)GUA7?2=_9F 4OU7&^C^$P$\
M                      &.E459-MZ^]E,]I95:'T0'34K:T4HDI=,D$>TU
M*2G;J9:D6NG2 R(                           /"9#BV$1^!-:2_#DMJ
M9D,KXI6VLMJDG\1D>A@/1IIIAI##"$M,M))#;:")*4I26A$1%P(B+H(!W
M
M       $"9]85WTG?V9@(E7:0(\!AEY]*'4)T4D]=2/4_B%$OG57XE/KZA Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
MU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H YU5^)3Z^H Y
AU5^)3Z^H!$DVD!R;"=0^DVVE.&XHM?9)2#(M>'PBC__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>px_24cyclacelpxy1pg01-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 px_24cyclacelpxy1pg01-bw.jpg
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M_\0 K  !  (# 0$! 0            4& P0' @@!"0$! 0$!
M      $" Q    8! P(# @@)"00## ,1  $" P0%!A$2!R$3,2(40151,B/3
ME!8(&&%"4M)TE597.'&2,[.T586U-X$DU!=B=3:1H;%RLD-SDS14)371@E/D
MI29G&>&$978)\,%C1$6&*!$! 0$! 0$              !$!03$A_]H # ,!
M  (1 Q$ /P#[^
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M           &O/GPJN%(LK*0W$KXC:GY4I]1-M---EN4M:E:$1$1:F9@.6']
MI_@0C,CSB%J1Z=$2#+_NDT _/O0<"?MO"_\ 5R?F@#[T' G[;PO_ %<GYH ^
M]!P)^V\+_P!7)^: /O0<"?MO"_\ 5R?F@%KPKE7COD9V4QA60Q;B1"2E<IAD
MU)=0A1Z$K8XE*C3KTW$6FH"X@
M
M
M                                                Y%]J$S+@/-]#
M,O\ <V_#I_\ W+(#^3X.B9IG\79KKEN^ARY-H]'2FB>BO(::8E$LC4M]*DJ-
M:#3TT29 CH-%>?9T8I8#.0XGDDJ]0PVFRDQK..VPY((O.IM!MZI29_%(_ OA
M\14^J1FTO"9EX;V 5TZKH.TV11;1]$J1WBUWJWH2DMI]-"$7%<!7TE]APS+G
M!)$9D1U$XC(C\2W-'U!G7]*P9
M
M
M                                               !R+[47^@>;_H;
M7]I9 4'[)>!X/?<%8_8W>-U=C8./V!.2Y<-A]Y1)FNI+<M:#4>A$1%U\ 7?7
M;?\ E5QC^QM)^KHOS8(?\JN,?V-I/U=%^; /^57&/[&TGZNB_-@'_*KC']C:
M3]71?FP'RSQI7U]5]N/+Z^JB,P8#$%\F8L9M++*".-$49)0@B(M3,SZ$*O'V
MH(@
M
M
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M!'VQ@N<8YR-B\#+L5E>JJ)Z3-&XMKK3B3T6TZC4]JT'T47^TC,C(P96(
M  ?)GVG\EY+H>7N.8G%MBY$R.VC2HK4-3B$Q):B>0I+3R'C[1D?@1J\/89>(
M-8L''GVM*>7:EA/,=6Y@.<M*)ETYB5MUSKA]"/>YYF25IT[AFCX'#!(^D6G6
MWFT/,K2XRXDEMN(,E)4E1:D9&70R,@1Z
M
M
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M*/P-?]&>GB2C+V@8X)_^[XMK%;.<T2C4JH857S6D]=C<E\GVEF7LU6EI&O\
MX@+K[;!D     ?+'/G\2W!WZ0[_7H!<\=UY$XKP7E.J.JS2I:G$DC*+-27;F
M1S/VLO)\R>O4T_%/\8C!'S<[@7/_ -F9Q5AQI.<Y"XQ;-2W\9EDI<R,UIJ9H
M;1YBT_*C]#/JIK0&O78N)/M(\=\M$FNAR#I<M3Y7\=LE);D&LNADPKHEXB/\
MGS_E)($CL((
M
M                                                .1?:B_T#S?\
M0VO[2R @OL:_P_8Y_P"GL?[<\"Z[T"    /C3 _X[\T_0G_[+$%7C[+$0
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M^PS(&5O
M
M                                          !R+[47^@>;_H;7]I9
M07V-?X?L<_\ 3V/]N>!==Z!    'QI@?\=^:?H3_ /98@J\?98B       _%
M)2HC2HB-)]#(^I& \,QV(Y&F.TAI)]3)"221_P#< 9 'EQMMU!MNH):#\4J(
MC(_]A@/QIEEA.QAM+2/':A))+7^0@'O0O@\?$   'YH7P>/4P'Z
M\.--O(-MU"7$'XI61*+_ +A@#;33*";90EM!>"4$22_[A /8       /ECGS
M^);@[](=_KT N>/J<$ &"9-AUT5Z=82&HD*.DW'Y+ZTM--H3XJ6M1D1$7PF8
M#YCSS[5*LALW^/N!,>7G>1R$*9>L%-*75MI61I4>T]O<26NAK<-#7_240+&M
MPC]DF5BF0-<C9]<*1EQO*F-T] OT,%A;B^X:'%L$C>G7H;+9):T\OG2!NOJP
M$
M
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M$<?X=QS3IHL,J6*J 6AN]HM77EI+3>\ZK5;BOPK48,K*
M
M
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M24GH?@8S4AR=PWB'*6*1<6MFW*]-6I#M%/@&34B ZTG8@VNFFW0B(T'T,M/
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MB0>A):2?Y+9%^'7Q!*ZF"
M
M
MY%]J+_0/-_T-K^TL@/YLXYS1RIB-.QC^,Y785E+%-9QX4=S:T@W5FXO0M/:I
M1J_V@W$K]XSG+]N[7_UW_P"8"8^EN",4^T!R_B"LTL^7+2CJY#CT>K9:24IY
MU3"MBG%ZK;)*"62DD74ST]G36LZXGR1RA]HCC+-K?![K/[%Z?5.I0;[+_P F
MZTZVEYIQ.I:EN0M*M#\/ 1<S%5^\9SE^W=K_ .N__,"S'5/L>9!=93]HA^_R
M*:[8W,VJF*E37SW..&@F4)-1_@2DB!-?T:!D
M              %-R7BO!LRR>JRS*:INVLJ1E;%:S+^5BMFXLG#<-D_*I>J2
MT-9'I\&O4!<2(DD24D1)(M"(NA$1 /T
M
M
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MUU+3J3=?60(
M
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MS-)2B-,1Q;K1H_%/5Q#9D?PEI_M!&Z
M
M
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M:&9_**\VAGY? $;P
M
M
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MI*>V^MI"W.XE*2)PFS61%\) BZ
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M4!^"U);?(U)<CJ>21.HT3U4C73I\((N
M
M              HI<90GT9 S;VDJS:R,EE.=?1'1*3YR6R3;S;:5$B/IHRW\
M5/B9&HU&97M7&["GRMO?$Q&4G(5)=O4$QWE;XY1#;)HVS:2V31>1)(\J_/U,
MU:D2+V"42L:K\8B$["B5"F'JN2PO_>8\B,>Y#Q+62B4LS,]^\CW[E;M=3 8'
M\,F/R8EN5])9R6*R[#.V:8C$;L1]:7#:<94VILR2I!*0K3<1Z^PS(PU5\68X
MY3VM,IZ9V[>"4"1,[Q'+0ONO2%2D.FDS*0I]XWC</4MZ4Z$1)(@"PXLQRRI'
MZ-]V4AI^1 E>J:<0B0A58TRPVA*MFA(6VSL<3M\R7%ETW= ]2>/$2JRUI7;B
M3[LLYJK(F>U&-33ZYQ3S+<;1]Q&\NWM<U^3\OX05O0<2F0[]60G>R7Y4F/'B
MSVG&HW;>;B*=4V2=K9*;ZO*-1(/J8(U;+CV-9VEQ-=M9K4'($L-V]<R;3:'F
MHS?:)HG2;[J&U)W;TH61GN/J6H#',XPQ^7&?C=Z4R<AZP>6ZTM"5DBU8.,\R
MG5!DEM+>U+9$7EV)^ !(*PBH/)"R=MQ]J6W!37QXS:TE&9-)+24A"-NO?)M9
MM$LS/1'0BZGJ&SBF/.XO41Z7WB[80X334:$;[;+:VV6$$A)&;*$$HS(M349>
M("<
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M%K6HR6R<1*G64&+,C]^')69H3I#[;BD)VIU0HS!&&1Q-G]-E/(5# J#EX4C
M\DI\%EM&GK[Z?:ELUBB4LSU8<-YIK7IVR3X JW\1T5U XVR#''Z?+XEP5&U$
M[.53&Y<5<I,1UHVJPBD.]MO=TV[4%IL^#H372.&:BTH.*,-I+J,N';5]3$C3
M(KNF]IUMLDJ2K0S+4@-7D$
M
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M,=PI<=+^S:Z:E$MO7KYNI&D^FN@(M0
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M(B(@$J
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MKCK+[CD^BS'$"B4KD4X;5OD:+"4W+D5K#RW'X#U>EE3#Z%D9=M:G$FD]?@2
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M=EUV0TV;:"(T-NOZ.*0D^B#7YMNFH(G0
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MO1!F9J2 Z("
M                                   'AT+P
M
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MM 2,;#*V)DTO*VI4T[.;VTR4+D*<8-MEO8AM*%$>QLM37L1H1K,U'J8"Q
M
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M&>TM?$]"/H ]@ #4D64&+M)YXM5/MQ=J"4X9//:;$J)!&:==Q'JKIIU\ &V
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M:(33O<?=8]6WL)2D*8-1))1.$6P]3/PW:^T!M@
M
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MK#FJ<<=3"23:VT$X[YW$)-:DH4HU>7IJ>@(N@
M
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M6M!'N3KU+0!-T.78UDZY#=#9,SEQ=O>)HS^*LS)*TZD6YM1I5M<3JE6AZ'T
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MD9?@,!BQ[*L=RR._,QNQ:LX<9TX[LF.9K:[I)2LR2O3:K0E%J:3,M>GB F
M
M
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MH7\7P^DQV3V?4UD-F,\<8C)DUMI(E&C4DGH9]>I BP
M
M                                                    "L97DUE2
M3J*IIZQ-E97TEZ*R;K_IF8Y,1G)"G75;'%&@NWMT2G=J9 *XWRC8NO0HWN)#
M3K96SF2NN3/DJYJAD,LR30:65*?-Q+R5L$24ZE\;8"O3?(N3&U7+<Q='J,A@
MOV&-PT3DFZZN.VE_TL@U-)0TZXT>Y!I4MLE$:5*+0E&&&LYIJ+&%!R+T+K>%
MV\:RET]R:M5OHJ64OKWLFDC;[B4R#;)2M?D3U(MQ 18I^76,/':*P*F6>19
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M[]K)K6'[N&U LW"-3\-A\Y3;6JCVI[IH;W'MTW:)TUUTU+J"-X
M
M
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M"=89+IH1$VA*%+W+2E)$2M 5?00
M
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M6&6CC-:&M"F5Z[5)(BZ[M0C96;SEYVCW782&HC]C95$BODSF77#*!72W36B
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MX_9X BZ
M
M                                               _#2DS(S(C-/5)
MG[#\.@#"4*&F4J<F.T4U:2;5))">Z:"\$FO373\&H#%[JJ^U(9]#'[,Q1N2V
M^TC:\L^IJ<+311_A4 V4---DDD(2DD)V())$6B2]A:>! ,/NZO-$ALXC/;EF
M:I2.VG:ZI1:&:RT\QF73J S,LLQVD,1VTM,-I)#;39$E"4ET(B(NA$0#PQ#B
M1641XK#;,=OJVTVA*$)/4SZ)(B(NI@#\2)*;-F2PV\RI1+4VXA*TFM)D9*,C
M(RU(R(R,!E(B(M"+0OP?A :Q5E:26$E#8),51N12[2-&EF>IJ1T\IF9^) -A
MQMMUM;3J"6TLC2M"B)25)46AD9'T,C(!XCQ8T-I#$1EMAAM)(;;:22$)274B
M(DD1$74!@*IJR8>BE!CE&D*[DAGM([;B]2/<M.FBCU+74P&=R-'=[?=:0OLK
M)QK<DE;%D1D2DZET,B,RU(!Y9A0XSKS\>.TR](5OD.-H2E3BOA69$1J/^4!^
MIB14/NR4,-IDODDGGB0DEK)!:))2M-3T]FH#(2$%IHDBVEM3H7@7P%_W &)V
M%#??9E/1VG)4?7L/+0E3C>[QV*,M2U]N@#\?@0926DR8S3R65DZR3C:5DAPO
M!2=2/0R^$@'ZJ%#7*1.7':5-;2;;<DT)-U*#ZFDEZ:D1_!J ],1HT5!-QF4,
MMIUT0VDD)+<9J/H1%XF9F \LPH<=+B(\=II#RS=>2A"4DMQ7BM1$751Z>)@,
MIMMFK<:"W:D>[0M=2Z$8#$U"AL/O2F([34F1H<AY"$I<<V]"WJ(M5:>S4!F)
M""4I1)(E*TW*(NIZ>&H# U @,15068K+<)9*2N,AM*6C)>NXC01:'KKUZ=0&
M5++2-I(;2G;T3H1%ITTZ?["T 061XLC(V2B+LYE?"4AQJ1'@FP@G$.D9*,EK
M:6MM>AF6]I25$1GUUZD$Q$@Q($.-7Q&4M0HC;;,9DNJ4-LD24)+77XI$6@#*
M;+*D=M3:3;ZEM,B,M%:D?3\.H#"BNKVXJ(+<1E$)LR4W&2V@FDFE6\C)!%H1
MDKS>'CU >Y$2++87%E,-OQG/CLNH2MM77=U2HC(^O4!^28,*:UV)D9J0P2B6
M33R$N(W)\#T41EJ7L >BC1B>7()E!2'"2EQTDEO43>II(U::GMU/3X 'E$.&
MTX^\U';0])T]2XE"24[M+0MYD6JM"Z=0&;:DE;B26[3373KI\ #RMEIQ#C;C
M:5MND:74J(C)1&6ADHC\>G0!Y9C1H[3;,=E#3+);66VTDE*"\-$D1:%_L >R
M;06FB2+:9FGH70S\=/Y=0'XEEE"B6EM*5D6TE$DB/:9ZF6OP:]0'L
M
M
M
M
M
M
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M?2/CU+P!
M
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MO4!6J+AK*\=)=17SC=X[<;E,JP&;9^JJ^Q-:<:<8)Y=;ZGLEW#4AON=%:=3
MK1_Y&YZC'IF&Q\MLF<-D155\.F][)6<.*I23[3<DZLGEH2A/92E:M"09D!66
M/P?ES.,0L8=ME2$4DJ%88I8'-:9>II-<E2&CCMLU:&W$*2M27$/)42R/KUZ@
M5I3OL\Y#*3CZHEJ[7S,>ER[9J8U8MO+E7%@X;K]A(0]5J;4_J9D@]GD+HG0"
MMS)/L^Q<MB1_K%C5+89 V[$D3LD=EJ396"X1HU*2M%>E)I>2C8[M27E/IIT
MKO<-KL1([':0SVFT([+1ZMHVI(MJ3,B\I>!="!&8
M
M
M
M
M
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M:VHUW'O(]-"T/7J RM.M/M(>96EQEQ)+;<09*2I*BU(R,NAD9 /8
M
M
M  KV=4ZK_#KNJ::6[,>B.J@$TKMO)FM)[D9QI>I;'$.I0MM>OE41'[ %%EXN
M5-%PAVPQMV\H:BND,3ZEE#<MUFTEI85ZM;+BB2\HS*0A:^JB4X:OQE&14$Q1
M99C]/8PDXQ-DKO,<DU=3"BOLO)@N>JL'HT*0ZMPB0EMF4TV3OF06U2=>B=0M
MLW"G+.SXX;M:Q$^LHX4MNQ0_M<8:?7":81O;49DLS/>1>4]/$!4J_!;_ !K%
MZ%REQYOWTU0V,*Z:=0U*4ZY(E0E$E]*W"]4M+9/K:;6YM,RV[DDH!$3:;*\6
MKIF55,%V/9HNH[&/,R41:]V0SD$&-6/;8T71MO9)[4@VU)W*[.I_& 7[*<:F
M5-)B6)5%;Z[&H"/2S9+<"+9RT+9:0VR:6I:B;23NKANO&E>T^FFBS405&LP*
M[35-UUOC7?N;+!O<WJGD19!-6<4GR)E]_4]IFE;24+^(>WQ+:0#%]3+BRNX4
MB576-93SHM*BI])70UR*U=>YN?:4I2]T,^[\J:FB-*B4>AF9: +"OCVP160Y
M=75-U^6OW>1/R;-!I)]IBS1:I86IXC-9M&IV,9((SV^4]I;>@>^/<=<AYE56
M$/#7L:A5V-.4]C*>-IM+LY,F*M+24-K4;NTFW%>H,O/KXF U:_ E/7!5LW&D
MHK(V92[F0HVF41'X3\&449WR'\J2%N)2:%)\JCZE[0$'?8#?$\4=ZMDIQ9)W
M\"'$@0HEDJ)Z^P-]EUIAY9$TEQD]$+;_ */;M/:1D Z-<X6BUR+""LH1W-13
M0;!F6]8;'B[SK,=IM;S:CVK6LDN==ID1Z^ "@*XROXF%5M=05'HKQW%9$&V6
ME;?>?EG*@.]A]Q:_E5K;1(0A3BC26XR-1)4 P2,+N?30;2%!L'*4[-^3:U#U
M/!2;3BH+<9EYFMW=I:-24E:BU7N/<1::F V+/C^RB0GH%93S+&1/Q%FMAVLE
MJ,B64F,^M:F)"TJ(VU=IQ"$%J:3).W7R@)IK IS$U=RU3;;M><JM3GDI'J?=
MCA]HW"<-6XFC;\IM$?A^* AL3IFZC-^.*US&O=-[6P+AJXM-[*CFN=B.3CZ5
MM+4M]MYQ1.]UTBVJ,D_'49 -O(,!R>1)RJGCP7)&-PXUK:8R?=;)+MGD+9H6
MRAO4MOIE')4DU:%\NG3XI@-Y-+E,[DFON'Z=<5<&[D.2I,>)#CQO=2H4EAEP
MYA*5(DK=,V3<1Y4I4>BD^1)F'G*,)D6-]FD1./&\QD#N/26YS2&FVWXT.:P<
MQIQY*DK)9$@UJ0KXR2Z:^ #1RO"+IB\FNU50I&(-7$>>N!#B19C;A.51Q5/M
MPGE)0OMO$G>6F[KO(C,@%G8Q2?$Q7 :NO;ERD5-M%ER3G):9DLQ21(,]Z$*V
MI)ON)0E"3/:G0O8 K+'&$N+C6-U]?0-,37,5LZR^)7:,W9K\>.IE$I:C/NGW
MTJ4E2C5M/4]2U 1*<(N)\VM5.K+&NJI==31JTHE=#=D5K]>XKU*#4M>Z(9NZ
M/=QK5*R/774M %JB\;M+=JW)M TI4G+K:XO37M7WHZ_>7I''C-6KC9=UKMMG
MJ2=2\I: *Q>X!>I>*,[6RD8LD[^#"B0(42R7$]?8F^RZRP\LB:2XR>B%M_T>
MW:>TM %_PS'7\=S3)C55N*]=#K7(=XZVUK*]/&2P\EYYOS=Y3B=ZR477XQ:@
M.;RL+S&_BVBY./.1I=A32H5O&CQH=9&.:_8PGNPP;#ANOH2VA_:^XL]2ZIT4
MM1 +3?X2<#))LZ-B_KL-;L*JPETT)#7;E&U#FQUNHBFI*%J9<7&<4DR\VTC+
M<I) ,U#A%I*X_P KJTUCF/39=[.N\;B*6V;C"VY*)<-PMBE);W.-DHVR/R$9
MI]@".AX[:QYD/+,VQ%Z[;O(TZ58T;:6+)V!9SWFU(;6TZI+:ML1IJ+W4_%[9
MET2O4!%2^/,Q9JEUS58:LEL,3:KFK9OLO&U(BR7''(;LI:B5N5&6B.A:O(YH
M>JB(@%IH,1LEX5FS%,4Z!9W[#C4.%-B1Z=IE],/LI-EJ*9DC?T2MWX2U+PU
M5R3BUA*LIUMBV"R:*LCU%0T4 _31')$BJN437&&VD.F@UH:0K8ZHR)PU$6[0
MM0$XC%9N7Y?[[N\<>1CK]]$L&XMD36Y3$2ADQDO/,$M6A%(<2@FUZGJ1*,O#
M0-:OXYF3I\I>1429<8JB^C14R^V\V3\^ZD26R2DU&1+6T;:B7IJDNFI=2 53
M,\=E5V&6WUDQA=A=V$;'4PKMUYIQ45<5$%A<=;JG.ZVXW()QU*6B/O*<Z:F:
MM ZCR#129>25%M!ICGR#JKFL1.9:96Y&E2FV5Q36M9DI"-6W4DM.NU2M#Z*
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MI*3,D(,U*42>FFO@0(N
M
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M?VUG65T24IFID.PI5BM+:8WJX^SN,E\IW-Q;RZJ;)*O%)F0(L
M
M
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MC))$H]5$74_#4P'Z
M
M
M
M
M
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M\7<Z0$7T$
M
M
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ME8^J%W,)GKCK8?>3/F$DB-#)(-&I/$6Y"?*?B ^O 9
M
M
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M:&T)J;9VNC&T2B-3+;##I&O4S\VKJO#0@%A
M
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MF:^=6'83+>)*=]45@P_.-Q9I)'<4P>U3JR2X24GL/33751A%<;8EEZZC%DY
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M--#,M=058L;H'J-^^>=?2\5O9NV39)2:>VAQEEHD'J9ZF1M&>OX01.@
M
M
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M*.+'82;VXRU4IO3RZ&HU&6AF5AK^5,FFOP<G?9C1\4;Q>RO+2IVNG-]36O\
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M',E?NGV64)IH$Y5?6RTJ-1RNPVCON^&W:3REM)VF>NPS!%A
M
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MKT,S,MRC-6FI^("P
M
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MI;6]M#JU_&7H1[O,9ZEUZ@BP
M
M
M                    BK3'JZXL*RPL.XZJH=5)B1^XI,?U!EM2ZMLNBU-E
MKV]WQ3/4NNAD$J
M
M
M
M
M
M
M #E_,^39#A#6)YC6338QN!>1(>7Q5);-I=59K**;RE*2:B-EU;:D[3+77J"X
MYM>\J<@27\@FX[:HA5^19S7\<X>_(CM/,UW8;6B=8H(R(I!N/)6EM*U&G5)>
MSQ"P&7(&/Y_'XFE9U/LJ_*ZB195>0+C0??%7+K7VC>+RL$RMAY"S2GN-&:3Z
M)/H YRO,N4ZK@K,>25Y[8S[J#9KHX#3D.N)#*6+MB'WD(;CI-3JVMR=%&:=5
M>'@8*[]Q!*MIN-RI-Q-R*8^J8M#9Y;7QZJ>A"6V^B&8[;:3:,S,TK,M3/=\
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M,_QM0'TX"
M
M
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M&IPE),EF?M!&],G0Z]#;LU]$=MUUJ.VIQ1))3SZR;;06OXRE*)*2^$!L
M             ,$V;$KH;\^>\B/"BMJ>D2'3)*&VT%N4I1GX$1%J8#,1DHB4
MD]4F6I&7P& _0 !K0[&#8>H]#(;D>E>7%D]M1*[;[6F]M6G@I.I:D V0
M !@CS(DM3Z8KZ'E1G#8D$VHE&VZDB4:%:>"B)1'H?P@$R9$KXSLV<^B-$9+<
M\^ZHD-H3\*E'H1$ S@ #7;G0W9C]>T^A<Z,AMV1')1&XVV^:R;4HO82C;7I_
M(8#8           !@=FPV)$>(\^VW*EFLHK*E$2W3;3N7L2?4]I=3T ?BIT-
M,YNL4^@K!UI<AN,:B[BF6E(0M9)\=J5.((S_  D V    :UA8P:F&Y864AN+
M"9V]V0\HD(3O422U,_A,R(!L@
M
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M3N-G[E^@>5;SVK%*9;J:]]J6U8.IB$E&UM^0RAM"W$KWEJ2==NW=JK4P1<0
M
M
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M64DVA.O7HE)$1 ,P
M
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MU]#,>8GMOFTR\MI#JD>*2=2@G$D?7:HM>H(EP
M
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MDW94B8DW6WV%*)>J6DI46OE-/AUU,,?)>5Y'B[V/.X\PB8EV5(=M:\T&M^3
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MXFHB 6_&$7K>.U2,H>;?R,HK/O5UA!-M'+-!&[L2DS(DDK4BZ@B5
M              &"9"A6#"HL^.U*C*,C4R^A+K9F1ZEJE1&70!E;;;9;0RRA
M+;3:20VV@B2E*4EH1$1="(B >@           8WX[$IE<>2TAZ.Z1I<:<22T
M*2?B1I/4C(!YBQ8L)A$6&RW'C-EHVRRDFVTD9Z]$I(B+J8#,
M      ,3<:,T\](:90A^0:3?=2DDK<-!;4[S(M3T+H6H#*
M
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M(+V= $\4>7[R.7ZQ1P38)HJ_8WL)TEFHW=^F_4R/;MUV_@U ;0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M)WJU4G4KH\:W@29[].F0W[YB,,29L%*R4XRW)-9-J5X>51M+))^W:8(W@
M
M
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M:(,J:XA27TL$2MY;%H-1DIM)$2TZ:]=")X
M
M
M?BDI46BB(RU(]#Z]2/4C_P!A@/T
M
M
M
M
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M!&4)<V-OQ4P&ZQVOEHW&ZRXP1F\VKJ1=I_SIT\3U 7\$
M
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MV)T[5'4]ST+3LE]'>6;B]\R0Y)<U4?LWNJT^ N@"7
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MB6"4(=E5KYQ9:"0XEPC;=21FG4TZ'TZEJ0(Y']U7#_VOS+]>.?-@M/NJX?\
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MKA_[7YE^O'/FP*Z)QUQK5<:09L"JM+:T;G/)D..74Q4YQ"DH)&B%&E.U.A>
M(TN1N(Z7DR17R;6YNZI=<AQMI-)/5!0LG329FX1)5N,MO0P52/NJX?\ M?F7
MZ\<^; H?V5,/,M/K?F7Z\7\V!7:::K9I*>OI8[KS\>NC,PVGY3AO2'$1VR;2
MIUQ75:S).JE'XGU!'*+_ .S;BN17EC?2<HRN+(LY#DMZ/#N'&8S:WE&HTM(V
M'M06OE3KT+H"U&_=5P_]K\R_7CGS8%2^+_9UQC%,@K\CAY-E$R57.]YJ-/MU
MR(JU;33HXV:"W%U\-0*Z9D=''R:BL,?ER)$6-9,+C.R83IL26TN%H:FG"(]J
MB]A@CCGW5,/_ &OS+]>.?-@M/NJX?^U^9?KQSYL"K[QQQ73\9)LDU-O<VOO0
MV3>.[G*G]OTY+)/:W)22->X>[X="^ !^\C\6T_)K5<U;6UQ5%6*=6RJDG*@&
MX;Y)(R=VI42M-A;?@Z_""*#]U7#_ -K\R_7CGS8+3[JF'_M?F7Z\<^; KL.,
MT$;%J"OQV'(DRXM<RF.U)G.G(E+2GVN.&1;E?AT!'-\K^SQC.7Y%/R2;DN40
MI5@M+CL6OMEQHJ#2A*-&VR0>TM$ZZ:^(+4-]U7#_ -K\R_7CGS8%25!]FW%<
M=O*Z^C91E<J162&Y;,>9<./1G%LJ)1)=1L+<@]/,G7J70"NKW-6S=T]A2R'7
MF(]C&>ANOQ7#9D-HD-FVI33B>J%D2M4J+P/J".+%]E3#R+3ZWYE^O%_-@M/N
MJX?^U^9?KQSYL"KOQSQ'2\9R+"357-W:KL4-MNINYZIR$$T:C(VR-*=IGNZF
M W>1>-:KDN#"@6MI;5;<%Y4AMREF*@N+4I!HT6HDJW)T/P!'._NJX?\ M?F7
MZ\<^;!:?=5P_]K\R_7CGS8%=<Q#&(>&8Y QF!*F38E>E:&I5D^<J6LEN*<,W
M'5$1JT-6A=.A:$"*%FG &-YQDDS)Y^1Y+7RYI-$Y$J[5<6(CLM):+MM$A1)U
M).JM#ZJU/V@M0'W5</\ VOS+]>.?-@5M5GV8\3J[*'9M97ESSL)]J2VT_=+<
M96IE9+)*T]LM4F9:*+X *[/,C(FQ'X;BUH;D-K94MI1H<23B329I47@9:]#!
M'#B^RIAY%H67YET__7B_FP6GW5</_:_,OUXY\V!5OX\X8H>-K:5<5=Y?6C\N
M.<1;-U8KG,)0:TN;DH-*2)>J=-WP:_"!4YR#@%;R/2,T5I8V=9'9DHF)D4TM
M4&0:VT+025+22M4&3AF:3+Q(C]@(YI]U7#_VOS+]>.?-@M/NJX?^U^9?KQSY
ML"NK83B$+!<<BXS7S9UA$B*=4B5:2#ERU&\XIP][ID6I$:M$].A BFYSP/CN
M?9"[DECD&1UTMUIME4:IM%PXI$R6A&39(5H9^WJ"U6_NJX?^U^9?KQSYL"LL
M?[+6(1Y#,A.6Y@M3+B'$H7=N&DS0HE$1EVRZ= *[BHMQ&GX2TZ CA1_95P_J
M?UOS+X?_ )XY\V"U^?=5P_\ :_,OUXY\V!5JP#A"@X[O'+ZLO\ALY+D=<0X]
MQ9*FQB2XI"C439H3YRV=#_E JS9Y@]?R#0*QZSGV%=&4\W(]3423ARB4T9F1
M=PB5Y3UZEH".7_=5P_\ :_,OUXY\V"T^ZKA_[7YE^O'/FP*Z?@."UW'E">/U
MEA8V48WW))R;>4J;)W.DDC3W%$G1);>A:?""*YR#PI0<CW3%[:7V05DAB,B&
MEBFLE0HZD(6MPE*;)"B-9FLR-7P$7P M5/[JN'_M?F7Z\<^; I]U3#_VOS+]
M>+^; KNC39--(:29J2A)))2CU,R(M-3/VF".(R_LNXC,ER)B\LR]M<AU;RFV
M[MQ*$FXHU&22[9Z$1GT!:P_=5P_]K\R_7CGS8%6#"N L;P;)(N3U^19+82XB
M74-Q;2U7*B*)YLVSWM&A)*T)6J=3Z'H?L KJX(
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MXE)>U26EJ,BZ^(#6R3DOCS#YK5;E64U=/8/$2D19LQEAW:KP4:%J(R2?Y1]
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MDZI69&6H#9EY+CD"C+)YUO"C8V;3;Y7#TAIN$;+VTFU]]2B1M7N3M/=H>I:
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M?0@'Y3\F\<9!-364.7TMG9+Z(AP[&+(?5K\"&W#4?_< 6H
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M1>*-?B]?8 D^&)<R=19!*L&78TMS)KTW(<ATGW(Y^M7\D:T*6@R3X%L4:?@
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MJ\I>*C,!^.9'E$O".+XDS&["MA*L\42JY<G1'$N)[C'QTLOJ>43G@9*3[?,
M*Q^ZOJL[5%:O*Z&FRO*CN,27*4RN8AVS=0R\T;BTM.+BDE?;CO*2VHEGH:5)
M0 ZQCUGC]IQZS/Q'<Q0G!>1!;6EQIQCL$MI32T.>="VEI4A:5=4J29 CYYH6
M[_&..X'(.'4T_&&*_#7%7MG->;=;LY\F,P4:4F,;[^XHZS<EJ?=2@]ODZDI6
MTTZ'G>!X_P :8:C-L25)8RZ@>AOIMWI3S\JU4_*9:>8G*4H_4%*WFG11>5:B
M4C:9$"*3:13?S:[=9KY,&ZEYW&KJWD+U1DQ7J*/#<**IE#IN*)Y)+C(0IKLK
M<=(E*Z@+N]QSA*N<V8JJALXSF//VRV>X]VSGE9M:/FC?MWEJ?73\ ",H(OUN
ML:'#;Z<^K')EGF]Q80.^MOWB]6WQQX\5Q:5$LV6BDJ>4T1[5&E&I&E)D TN2
MJV'@R<SQ7&GW(F-7&)2;>12-/.;(<N-,8C=V-JHS8*0V^I*DHT3N:W$6N[4)
M:1;V\2?B& WLI][(,8RN"T<U2UDNRI9$&=Z*6LRTWFHDFP_XEWVE'X&D!;N1
M8Z<BS'#,%LI+C.,VR;.PLXC3JV%3UUC;'9BJ6VI*NV9OJ><01^?MZ'Y=Q&%(
MY$J(.!(RVCQ5U<*@O<'R&RFT+3JR8C3*LF&VY4=)J,V.\F4IIPF]J5&A"M-Q
M&9AAL;*VJRQ+CNUF29%EC65T!PK)Q:DNV-!+)Y,5YU1&6]:#0J-(U^,M&\_Z
M0@%@Q/&[#+N'H3==8N0<HK[6TL:"T<<<434^);3.T3VAF;C"TF;+K9ZZM*,B
MZZ:!*\9.V'(,T^6+YER"E;;E7C5$;QN(A,,+-J8\YL/8MZ0^VHB5IT90WIH:
ME@.I@@
M                *IR#C&-9'C<]614T&W.#$ENPCL(S,KLN*9/53?=2K:9Z
M%U2 ^7^.L:QR/]BFTR>/3PF<ED4%\Q(N6XS29SK1S)*=BWR3W%)VH2G0U::$
M7P UU4N1;?EA[[*%/76^+U43 T5M&4:Z8L3=F*:2;'86<?;H2G/+O3N\NI_
M!UU1JD=R/[1V?X]'E*@2+;C=NO:GMEJMA<HV&B=3H9'J@U$HNOL!&OQ%+?X;
MR?$N).2L"JZZXEE)BXIGM0EEY,YQ)&;G<4I!/(6M*B2I1F1GN+5!)/4%3GVS
M"(\*PG6"5I_^&-9I6'M_WKY"5\CYR-/RGQ/-TZ]03',\IX[R6HPSFGD*=B<?
MC[&KVGB0Z_$([[#VYV/(:-4IQ$7Y)L^A[4I+\=7\JBOSBJK1;\S<7Q;3%(/&
MME1XZ=M7JKS:>>R9E^,3)+6[&2VA!DDEN*0LE.:;R,^I&07S[,&(8EG&*Y=E
M>:U,.^S.XO[&/D+MHPW*>:)!IVQB)U*MB")6[:6GC_T4Z$U!<7U>'V/$W-6$
MY3+,^(<=OK6-36"U&]Z2,S\JDXRE&>Y32R;<;(M=ZU>![M#*U/LNSIV8Y_%L
MN4W7E9KCN,P6L"AS63:)RC?)1*L4&HU;WG$J0A;FNXTJ/Q_%&G)N'91AG)<K
MBG IC-;AW.[O<E%JI*ZQZ*HE6BHZ"/;H^PK30_C;MA;=J3 ?6N/8_58G05^-
MT$9,6HJHZ(L*.GV-M)T+4_:H_%2CZF9F9]09?./V5L5Q'-\6R'/<PK(=]R!;
MW4]K(7[-EN8]&-*D[8R4O$HD())DK1)%KKIX)21%UI?::RKCZ/E/'O#F53&Z
M7CUE1W.2ML-NDAN%$:<9@Q4(BI4HDK6E:=I)\NB3 Q4<.SJ)D?V1>1L-3/*R
MD80T_6QYFBDG(JW'M\)[:LB4DC(EH2DRU(D$"]8.*ZM%QRUQ'!M<4@\<6%/C
MY7%;,@&R_(R=M45*-RW8R6TH,T)6ZM#NYS::R,^I +EPWQYQ]F]CSB6<45?8
M1TYC;-'83&6R?CL[UJ4;<DR);6W4U;D++3Q 7;[']C/G<1*BR);L^KJKBPKJ
M":^9FMVL84@VC(S_ !24I:4E^*1;2Z%H":YS68%9<F/_ &E\*IIJ:ZSM+R#Z
M>0YN)HUL../]MPT$:B0YLV*,B/3770_ RK[PEEK-3F*N*LPX]K\'Y&AU"'XT
MRI1'5$LJQE>S<VZT6\BWD:B0I:^I*U,E%H":_?M,QU8I9<?\VPTFEW"[EJ-<
MN(+J=-:F3#^X_P &NQ/_ *0P,5VIS.N^NW,WVB9JFY=%AT1.)XNX2B4VZJ&D
MG7T(673Y62MHD*3[' '&N%L_PK">1..\@KLB*SR'-6IM=R8A2)#?;GVDHI$5
MU1O(2V9I<<0VM39F6B%'^,"Z^B<#3_\ ]9\KJ(O_ /#TNI_RQV/_ * 3BGY*
ME)\T?:!U(NO'_7Z D!6+3C[CE'V/*?-Y5;#I\PKZQB=5Y#$;1$L%6)2/DDF\
MV25N&X?E\QGI\8M#+4B]?2\:^R9S@UK)G4J+,58H5BI.WS^\CKN]\73Q[OLT
M!'*N!.,N*\B^SU7SK^J@6:[^++EY)=S$-N3#D]UTG5JDK(UH4SM\IDHMNF[Q
M,S,:X@U"?Y$X1X0QG*'WWJVPRY^ABS=='SKU+<CM*2:M?Z+4T)+X$$D%7.@R
MFQN>8N$L6RA[?GV#2\DQ[)$*(R-PXT))199&KS*3)9(EDO\ &42C =!^S%50
M+J@Y=J+:,B756&:7<29&=+5MUEUMI"T*_ :5:&":Y_AW'N2VG)*?LWY)/;G\
M6<<S%Y0A"S-3\^%)V.5\)_7H:&UO*-Q)IVGYB_(T*^G^6<23G/&>4XFELG'K
M*M?;AHTU+U3:>Y'/3\#J$&#+XNM'&^?,1QVM<6Y*>P'C2PN3-E1D974=]$-#
M:]/QUHA[]/;J#3J&'7R>7^1Y>>&X4B)B?'41E6TR435Q?1UR'NOY1-]QM7\@
M#G6*V_+#?V0Y-;!Q>K>X^.MM"7=N6)MS2:5-?4ZOTVW3<E>XDIW>;0C]H'4K
MD,&PL+[[-D.GQ^NRF>O#E=FBN30F!()%8A1]TUH6GR)(W$ZI/S)(!:.=L3.=
MQSQ=BN3XY78>5QG$.'9U&/&WZ5EJ9ZAE3C9MH;2:U(42S\OB!B$@9#8R.2>&
M./<H?)W-N.;^WH+-:_*Y)AE%957S4I,S5L?82GS*/4U),S\0'T)]H+C:[Y3X
MY?QK'I3+%HU+C6#,>8:BB2_2J-7IWS1J9(5KKX?&(O#Q(F.*7.<PK#C+EO +
MG 8F \C4V/E(M8E<W']),AI\K3K;K"2U2CN%M2HU;27T4?FT*T*:KI\VY%X+
MP7-DIE8=#X[K[FLII)ZQ)ELJ.:%$M'@O:VV2]A_D]?*HR,+>SF1-Y1FG'MMQ
M56X-?_4ZULF;6#)AR7)-:VHV&TGZ6.WHE:M5;5.>7;X CA^/O_\ +?A"?42Y
M*V\-Y2Q*595CD@]R6,HK3-J1'1M+1)26$MK2:SZJ222\ 5<\P@V-AE7V<H=1
MCU=E$]>(*[-%<FA,!\D5B%'W#6A:?(DC<3JD_,D@%BYOHWX^ \45-]B=1C;\
MG/(*9V.4Z6G:XTO&^D^B&T)5W4:&LMOMT Q*\AXOBW''/_$]AQQ$8H[_ "*7
M(@7]-5I3'CR:K:G<Z[':T06W5:MVWS&G7Q1T(['S?GZ.,N+LBRU*R181XQL5
M1'U,Y\KY%CI[22M1+47Y*3 Q\H_9YS/CW ^5\3H,.O"L8&;8_&K\LU3)03>4
ML*<>2YK);1J2S6;*-FI:JU!=;T$Y.$\P\B\TUZW?3XSEZ*K+XZ>K2\<MR)#S
MNQ)&I2X[R6WB(O'34^B0%=O'(LC[+7)#\-U$F(]R+)<8D-]6W6U/1MJTG[24
MG0R_ !UUCG[$,/XYON,LPX]KHF.<@/Y)"K6(50TB&4^$_JF0VXRR2266O;;-
M6G@O:?B6@QTO[4Y$? .;:_\ NK']L8!,<6YPP["\+X9P;D/$ZZ)CO)D!5*NC
MEU;*(DF9)=:0;K2TM$GNZIW+/<1GTTUT49&7&W]I7-,!R'D[%N,>1[9-3AE1
M!DW61&E+[VMG+C+8@M$49*UDMK?WO#0TJTUZ@8R<:6^+\I_9;NEY'6U]UD^!
MTUM3-3I<9J0\TF-#6N*\PIY!K1JT3?F+0S4@S\2 :$C&,:KOL1/W]?308E[/
MH8R9UFQ&9:EOI.P:49.O)22UD9D1^90'5WXUQ_(8&$V4ZXXYQG%X*\3=3$OJ
M93*[&4:XR#)+VQE"B2XDNXO59^8B\?$B.;T?'7&L_P"Q@QEUW5P:_)(%983H
M&1---Q[#W@Q,D%%2;Z"2M?<6E#6U2CZ'TZD6A>OJ/AVUN;SBK#;C(5+<N9M/
M"?F/._TCJULI,G5?])PM%G_*#.KN             \K0EQ"FUEJE1&E1?@/H
M Y_C_#>+4*JDG9=I<Q,?-I5# MYSDN)"7'1VV5M,>5!K;3T;6LE*1XI,CZ@K
M<3QI7L9-+R:!>74!R?-;LIU9%F[*]Z0VVTT9K9-"NBT,H2LB46H(W;_C^@R-
M^YDV!R4NWU8S261L/K9WP&'77>VG;\7?WW$K,NII/0!OY'BU1E%(=!8H6U!2
MY&?85$6<=UAZ$\A]A;*T:&A2%MI,M/Y/ !!6O%]1-MYUW56MMCDZT,E6ON28
M<9F6ZE"6R=<:4EQ!.DE))[J$I69$6IGH6@6"'C=="O9>1M&ZJUG0HE=)<<<-
M:5,0%ON->4^F[60YN5[?]@#S38S6T$2RB5AO-(M)LRRDK-PUK*38.*==4@U:
M[2W*\I>! ,,+#,>@X<G VHN[&2@JJW(KBC4IR,ZV;;G<7\92EDI1K4?4S,S\
M0&M18!CM"BS0PAZ8FYC1(5F4]U4OOLP(A0D;^YKJ:FBT</\ '/4S 5Z+PGC%
M954%31V=S3M8XS/BUTB#8+1).-:2$27VG7%$HUI[C:#3KU3M+J"U<,9Q:DQ"
MN5644<V6'7G)<IUQQ;\B1*?/5Q]]YU2G'7%F75:U&>A$7@1$"(ZQX\QFUKLI
MJYS+CL3,'2D6Z3<5N[R8S,9"V3_\VI"8[:D&GP66[Q :+G&4#ZQRLFAWUY E
M3GHTJPB1)W;AR'HC+4=*G&C0HO,VRA*]NFX!8D8Y6HR9[+4DY[X?@-53BMY]
MKTS#SCZ2)'@2MSJM5?  JC_#>)R)+J7'['ZNR)AV<C%2F+*E<EJ=.0I2H^FN
MU3Q]Y31+[2E]30>I@J9F\?8S8EEB9S#C[6:,MQKUI;BC0MMJ-Z1/;+_S9]OV
MI_&Z^((R56#4-4Y</;7ISE^S%C7!SW3E%(1#BE$3O)?0S6V7RGY1ZF8#+A6'
MTV XU"Q/'R>*HK^[Z8I+JI#I$^\MXR-Q>JC(E+,DZ^!:$ \.851N(RA"DO;<
MP(RN='5==8:(/R7_ -G\DVGXOMZ@$C":*3246/NI>]W8Z]7R:TB=42R<J30J
M/O5XK(C06XC^-[0$;*XVKUQ#AU5U<4;;DVPLGU5DSLJ=?M7E/O[]Z'"-)+49
MMZ%Y/Q3 3E-B]+C^.LXK41SC4L=E<=MDEK6O:YN-:E.+-2E+6I2E*6HS4I1F
M9GJ ]5F-4]5C,3$&F._0PX+=4B-*^7)R(TT3!(=WZ[]4%HK=X@*I6\.XQ72:
MLW)MK8U%$ZB114-A/=DUT)UC3L*0VKS+[!%\CWEK[?0TZ&1&1:E)W&^,6%-D
M=%);?.#E$T[2R-+ZTNHF;620ZPLCU:4V<=I:-OQ5)U!$K]6:SZT-Y>9.'=-U
MZJA*S</M>E6\E\]4>&[>DO, @9G%>*RZMBM3ZN(]"L9EU6VD62MFPB3K)YYZ
M0MEY/4DK-]Q)MJ(T&D]ID9 ,*.(\674W];9/3[23DS2(]S;SI:W9[K#)F;32
M7"))--M[E;4-)2G4S/34S,%3%[@N.9%D%!E%E'4=WC3KCM9):6ILR)Y&U2'"
M+HM'@HDJ\%%J7M!&7+,.I\RA1XMIWV9$%\IE;8PGEQ9L24E*D$ZP\@R-)[5*
M2HCU2I)FE1&1Z (-GB;&/09!%LGY]O.R>$JJM[BPE*>GJ@F2R)AI9$E++:>X
MM1):0DMQ[CU,%2N08%C>36..VUK'6JQQ>4F;4R&UFA:5DG::%Z?&0>B5&D_:
MDC!$?C/&==B5BF94W=SZ!#LI]%(_-[M<E<U:W7-&C1KH2W%*26[H8"?Q?&JO
M$*2/C],3B:Z,IY;1/.&ZO=)>6^O52NI^=Q6GP$ EP
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M.*KD U2FKFG@KJX49E]3<$H[F_7<P7E-1;ST/^3X"!%K
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M)\%?MU6?SU_F 0^\GP5^W59_/7^8!#[R?!7[=5G\]?Y@$/O)\%?MU6?SU_F
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M7^8!$M0<W<1Y1.16T69U4JP<,DM1?4H:=<4?@2$N[34?X$Z@1?@0
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MM]9[T]5DI2MQ&8"X
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M]GW%YU9B[+%S=5N28A#364N6P)2(]N4)'1+#RTM=MULB\NU3?AK^4K45BM^
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M-<?>0,@          XA]K[^';,O\,_S6("XE?LQ_Z"X/^@J_KW0-=:!
M
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M:<3G:6V^VE!Z[F74+0MM*B-.O5*DF9%U
M               !\&\=?QWWWZ;<_P!D<!KC[R!D          '$/M??P[9E
M_AG^:Q 7$K]F/_07!_T%7]>Z!KK0(  #G')G-..<4N)5DU3=NUG81)?N*^N<
MDUS!.NFRA#T@C2A"S41%M,]?,GX2!8T:_G*LLLEP[&TXY=5K^8O6K$8[J(JL
M>8]S16Y:UJ9>\RFW$N;4+3TU(_@ CJ?<;[?=WEVM-V_4MNW3777PTT!#>@T=
MPCW(TW$HNI&6FNI ./XC]I;CO,+"GA1(]Q71\A>5$H;6SKG8U=-E(-2399DZ
MJ0I>Y)ITU^-T\>@+'8.XC?VMQ=S3=LU+=MUTUT^ $#<;)9-&LB<,M21J6XR+
MVZ !K01D1J(C4>TBU\5::Z%^'0M0%.M.185;R)CO'GHG7Y.11)LUBQ;6CL-%
M7D1K0HM=3,]=.G@ N*W$-[=ZB3N,DIW&1:J/P(M?: H/(_)_U%L<;QZLHY&1
MY7E<A]BIJ8SS$4E(AM$\^XMZ0I*$DA)D9$?Q@5DY#Y9Q[C:71UUO M+*TR)4
ME-5 I8:Y\EQ4)*%NEVT&1]$N$?3V$?P -2HYHQG*L8NK["HLZ_MJ$TMV.+-,
M'&N6GUJVDVN/)[9I/HH]==#VJT,S+0"+_&E$]%8D/(.,MY#:E,/&1.-J<(C)
M"M#,MQ&>G0_$$9DN-J4I"5$I:-"6DC(S29EJ6I>P!&WN14F-5,^\O)S<*JJV
MC?GR%F9DTVDM=32DC5X>!$6I^P!L0+6OLJR-<0WTKK9C+<F/(/R)4T\DE(5Y
MM#+4C+H8#;U(C(C/J?@0#P3[*C0E+B3-PMS9$HM5)^$OA+J ]+<;;(U.*)*4
MEN4:C(B(B]IZ@'<;[G:W%W=-VS4MVW7373X #N-]SM;T]TRW$C4MVWPUT\=
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MR68O=][;MG><)&[3T9:Z:ZZ:@1]H@R    ^#>.OX[[[]-N?[(X#7'WD#(
M       .(?:^_AVS+_#/\UB N)7[,?\ H+@_Z"K^O= UUH$  !Q3[6L.;8<
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M:@([)N.(=+BG+%K14DYBUQ3+H;>#=@IBC@15RV%O*@-ZF1$O56]2"/4B+X"
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MVUG6?4S5ETVUT=TZM++TA'<W&XTU%E.N&DR3T2 [2"
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M JZ.1(DO**^+53J2;ADNMEV#MTW:L*D$N$ZIISM,),][*#29..DK:E1&1Z:
M)>HY P7(+(J:AR:JL[8V4RB@PIL>0^;"B)1.;&UJ/:9&1Z_ 9'[0'C_F-Q][
MT?I/K54>^(S[<-^!Z^.4A$EY6QMDV]^[>I7E).FNO0!+UUW37#LUBIL8TYZM
M?5#L6XSR'E1Y*"(U-.D@S-"RUZI5H8#?                      %0S_CJ
MGY(@Q:F_G63%.TX:YE=73%PV)[2B(C9EDWU<:/3XI*+^4!;&66H[3;#"$M,-
M))#3:")*4H26A)(BZ$1%X$ ]@
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M8W(D2T16R;3)FO+DR5D7XSCKAFI:OPF W0
M              'PU]K_ /B"XP_]' _S18-8^Y09    ?!O'7\=]]^FW/]D<
M!KC[R!D          '$/M??P[9E_AG^:Q 7$K]F/_07!_P!!5_7N@:ZT"
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M9/VL05BRDVSQ.RE-QV_>ZBT+UY&QU5W"+XSGF^$&5N
M
M
M                               ?#7VO_P"(+C#_ -' _P T6#6/N4&0
M   'P;QU_'???IMS_9' :X^\@9          !Q#[7W\.V9?X9_FL0%Q*_9C_
M -!<'_05?U[H&NM @                 H5+PKQ9CN3+S&GQB)&R13CCR9V
MKCAMNO:]Q;2'%J0VI6X]3;2GQ!:OH(
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M0(]
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MWDQN+N&GX=NNN@#\C2XLULWH;[<ADEK:-QI:7$DXTLVUIU29EJE232HO89:
M,P  Q.28[*VVWG4-N/'M:0M1)4M7P)(SZG_( RF9$6I^ #PVZTZ1J:6E:2/0
MS29*+4O9T ?C$B/*;)Z,ZAYDS4DG&U$M.Y"C2HM2U+4E$9'^$!D
M                              !PKBW^(SGC_P#U7_+' 5D^UM_HQ._Z
MSJ/[>R!CN((     .'8)_$URW_U9CO\ 9E@K\^V#_#QEW_C5G^:10,=O:_HD
M?^*7_@!'L    !Q#%_XIL]__ &:J/ZQ0+QN_:I_T S;]&C_VQ@#'4Z/_ .25
MOZ*Q_5I!&^
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M"&Q3D'/^0+:C*K=@5$'W$5Q;QNT<A4FP8GOP5QV75*^3C.&RI7=VJ61;=/:
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MF?(C.WDJI=F2)[D:*^B1VF2>+:E2E-I\Q^'_ 'C#Z+(B(B(NA%T(@1^@
M.+YM@G)U3R0[R?Q,Y3RYMM6M5%]37YOMM**,X:V7V'6.I*(CVJ2KII\)GY2J
MWEF(?:1Y6I7<#S-K%<?Q*U<9*ZL:IV9)GE%9=2ZI#"'BV;U&@BU5TT ?1$=A
MN,PU&9+:RRA+;:?'1*"T(O\ N$",@
M
M   ^&OM?_P 07&'_ *.!_FBP:Q]R@R    ^#>.OX[[[]-N?[(X#7'WD#(
M       .(?:^_AVS+_#/\UB N)7[,?\ H+@_Z"K^O= UUH$  !'WE+79'36&
M/V[1OU5I'=AS624I!K8?0:%IW(,E%J1GU(]0'Z_41)$RMFK4\AVK-PXR&WW6
MVE=UHVC)UM*B2X1)/RDX1[3ZEU ;X   *BSQS11<@DY'!E6<*5-F)LIL2-8R
MFH+\HD(;-;D9+G;5N2VDE%MT/3J \R^,\5D1H#$=N372:MV8]6V$"2]'F,*L
MG3?E)2ZE6IH=6K53:]4]$]-4IT#U:<;X]:*K92G9\2XJHZH,6[B3I#5D<5U2
M5N,NR-YK=0M2$J,G=VBO,6A]0'[/XVQ:SEVDN8U(7[[ALU]NQZEXF93<;3M.
M.))75U!%M)PO-IT/4!BNN+L/OK*78V$=_;9FTJ[KV9+S,&Q5'2E+1RXZ%DAT
MTDE*>I>=)$E>Y)$0"5EX=C\Z)D$&3%-<;*-??:.XX7>UC-Q.ADK5'R32$^33
MPU\0&W>4%/DE/)H+R*F942T$V_&6:BU))DI)DI)DI*DJ22DJ29*2HB,C(R 0
M,7C+%6(-U#E(DV3N0QB@W$^PE/29C\1*5I0SWEJW(;02U;4HVEJ9J^,9F86\
MDI))(T\I%IH?P *;3<8XWCL]F50O6-=7QW%/,44:PE(J4..&:CVQ-_;2G51F
M3:2)LO8D!DD<:8LZN&]&1*KY4)R:MJ5 EOQGU-VDGUDME:T+(U-.O><T'\4R
M+;M :Z^)\-5!K*9+$EO&:EIEF/CB);Y5:TQGC?:[T<UF3FQSS>;XVA$K<1$0
M"2K<&I:Z_7DJW9EA;DE]J&[8RWI:8;,I2%O-QD.J,FTK-M&[0M=$DG7:6@#6
MR;CJBRV4Z[<2K,X4IHHT^JCV,N/7RF2(RV/,-N)29&1F2]NF\NBM2 3MC0U-
MK0RL9EQD^XYD1RN>AM?(H]*ZV;2FT]O;M+8>A;=-/8 @Z'C?%<?L6+EAJ3/N
MHK*HT.QM9DFQ?CL+(B4ADY+BR:(R(B5VR2:B\=0&_689CU/(@RJ^*;3U:F>B
M&HW'%;$VTA,J46BE'KO<0E77P\"T(!ITO'U!CUBN;3KF18:EOO(I43'_ '4V
M[+4I;RD1-W;3O4M2MI%M(SU2DC 8*OC'%JB%/IXB99XU817H"L>=EON5C,:3
MKW4,,*69-D>ID1)/1!=$;2Z ,<OBW&YK<(WI%FFPA155IVS-A)9L'X"UFX<:
M1(;6E;B-QZIW'N3^*:3,]0EJ["\:IWVI%3!3!4Q6M4<=,=2VT-5["E+;:0E)
MD2=IJ/11>;\(#'CF$T^-3)=G'<ESKB:VW&?L[.4[-E>F84M;3"7'5&:6T*<6
MHDI\3,S/4^H"Q@
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M_AG^:Q 7$K]F/_07!_T%7]>Z!KK0(
M
M
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MJ;-PCBO*\KQ(TT<V_%/0C\0$T
M
M
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MDY J*2'/Q&=(OCBWUQ<V,:826R3;2FIK""BOM.*)+J4+2>BSVET(P$MQC:X
M>*9#CV7SWX$*DMZ%F3FN/75K:5EU:/DI31QW7NXM"C6?^\MMEL(S+4R(B ?8
M(,@
M
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M6A=>GP@/QN%#:83&:CM(C(/5#*4))"3(]=221:%U 9P
M
M
M                                    !\&\=?QWWWZ;<_V1P&N/O(&0
M          <0^U]_#MF7^&?YK$!<2OV8_P#07!_T%7]>Z!KK0(
M
M
M
M      ^#>.OX[[[]-N?[(X#7'WD#(          .(?:^_AVS+_#/\UB N)7[
M,?\ H+@_Z"K^O= UUH$         'YJ6NFO4^I%[=" ?H#&R^Q(2:X[B74)4
MIM2D*)1$MM1I4D]/:DR,C+V& R      #$]*C1VC?D/(:8)24&XM1)1N6HD)
M+4STU-1DDOP@,H#R3C9N&T2TFZDB4I&I;B2HS(C,O'0]# >@   8V9#$E)KC
MNH>0E2FU*;42B);:C2I)F6O5*B,C+V& R
M
M
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MR/@/0PZL"
M
M                                            ^#>.OX[[[]-N?[(X
M#7'WD#(          .(?:^_AVS+_  S_ #6("XE?LQ_Z"X/^@J_KW0-=:!
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ME3>6IW(=G 1";KZHJ"H,W4O.2DN/G(=E*2G4F]")+3>OGT->NA: KH((
M
M
M                              #X-XZ_COOOTVY_LC@-<?>0,@
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M[@[J"
M
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M4Y4_215WZ7$2/5FCXTAE.UMY2-=BG4%H27%)-9:%H?0@&2)18Q95]G!]SDW
MEV#TBPC28ZF4R)K3Z5*D;5D6\E+;2M#A=%:$9 +"  (QF]@/Y!+QI&_WE"B1
MK!_5)DWV9CCS3>BO:K<PO4O9T^$!)@
M
M
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MEN/4]"!'600
M
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MSAN)T-Q:UJ6HR(NIGIH0"=:C1H^WL,H:VH2RG8DDZ-MZ[4%H7Q4ZGH7L 90
M
M
M                                       'P;QU_'???IMS_9' :X^\
M@9          !Q#[7W\.V9?X9_FL0%Q*_9C_ -!<'_05?U[H&NM @
M
M
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M,.,N?,6Y&H[S(Y#"\7IJ28U"<DW;S,9*_4)2ME9FI1$C>2T;24?74M-06.L
M@
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M]!<'_05?U[H&NM @  .0_:@QR]RS@_)J#&H#UG=2U0/308R=[J^U81W5[2_
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M2"
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M' :X^\@9          !Q#[7W\.V9?X9_FL0%Q*_9C_T%P?\ 05?U[H&NM @
M                                          "L9CQYAO("*]K,:I%M
M'K'O4Q([SCJ6.Z>G](VA:4.IZ%Y74J3^ !9R(B+0NA%X$              (
M7),3QW+X\*+DD!$^/73&+.$AQ2T]N9%,S:=+8I)ZIU/H?3X0$T  (:ZQ/'LA
ML*>TN8*)<^@D'-IWU*6DX\A2=AK(DJ(CZ>Q1&0"9       !C)A@GCDDVDI"
MDDA3NTMYH(S,DFKQT(S\ &0
M
M                       !\&\=?QWWWZ;<_P!D<!KC[R!D          '$
M/M??P[9E_AG^:Q 7$K]F/_07!_T%7]>Z!KK0(
M
M
M                                                     ^#>.OX[
M[[]-N?[(X#7'WD#(          .(?:^_AVS+_#/\UB N)7[,?^@N#_H*OZ]T
M#76@0
M
M
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M9)+<M9D1:F>GB 5]E76T1$^JELSH+FI-R8KB'FE;3-)Z+09D>AEH?4!M
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M9'15TB9%GV#$9^OAE934.K)'9A*4M!/+,^A(U;66OX# 2A&1D1EU(^I&
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M25J2B2GH0#1A<>8; K)=.Q5I76SW&'I;$AUZ23BXAH-DS-Y:S\AMIVD1Z%H
MFO=%9[S=N?2M^]'XZ(+THRU6J,TM;B&S_P"B2G%GI^$!@Q_'*7%:U%/C\0H5
M8TI2FHJ%+4A&[V():E;4E[$EY2+H1 -7),*Q?+O3GD-<B8[$)Q,9\E.,OMH?
M3L<0EUE2%DA9?'1NVJT+4NA -IO&Z!EJH88K8[+%">ZF9:;)MN(9,KC_ "24
MZ$GY)Q2.GL,!* (/ZG8O[J;I/=;'NIF85HS%).B43BE'-)]/74E]\S<U+V@-
M%'&^$(R,\L]T-N7W?5,3)=6ZZE$I:20;S;2UJ;0YM+3>A!*_" VI^#8A:5=O
M2V--%E5-])*=<PW4$IJ5*+M:..)/Q5\BW_-(!))IZM-PYD"8K973L9$!R;I\
MJJ*TXMU#1G^22UJ47X3 9IT&%9PWZZQCM3($IM3,F+(0EUEUIPMJD+0HC)23
M(]#(R 0.,\>X;ATAZ7CE2W#F/M)CN236X^]V&SU2TEQY:U);(^NQ)DG\ #'0
M\;X3C-HNZI:AMBU4AQI,M:W7UMMO+WN(:-Y:^TE:NJDM[2/IKX$ L4Z%$LX4
MFMGLID09C2X\J.X6J'&74FA:%%[241F1@*=#X=XU@5EA2QJ!KW1:1T0YT)QU
M]YER.THE(1L<<42229$9;=- *WJSC7"*>(N#!J4%$7+C6*FGG7I!>K@K)QAT
MN\XLR4A2246GM 6L!"9#B&-Y4J(N^@(EO0%.*AO[EM/-=Y.QPDN-*0LDK3T6
MG7:KIJ70@$=.XSP2PK85-(I&2IZY#K42N9-R/%2U(62W6U-,J0A:%J(C4A:3
M2?P +4VVVRVAEE"6VFTDAMM!$E*4I+0B(BZ$1$ @I6%8M-LK.WE5C3D^YA'5
MVSAFLDRH9I-/;=02B2KRJ-)*-.[;TUT 2!4M4F;"L2B-E.KH[D."_IYVH[YM
MFXVD_8E1LMZ_^*0")I>/\/QRR7:T=6W!EJ[Q$3*W4L(]2LEN]MC?VD;U%J>Q
M! +* J-3QA@E#;HO*6F;@3VEN.M)CN/-QFW'DFA:D1DK)E)F2C^*V SO<=83
M(O\ ZSOTL==UWVYBGSW;%2V4[&Y"VMW;4\A/1+JD&LM"T/H0#>F8EC=A'M8D
MVL8?C7CK<BV:6G5,EUE#;:%N?":4LMD7_BD CLSPV/DE%DD6 AB+?W]4NG58
MNH-1=HDN]I+A%XH0IY9Z?](P&2BX^PW'%2G*BFC1W9K!1)1Z*=(XJ=3)A).F
MO8R1J/1I.B/P /%+QO@^.K-VGI6(SQL+A)=\[BT1'"22HZ%.*4:&O(GY-.B"
MTZ$ DVL9H8Y4Y,5[*/J\V;-)HG_V5LV?3[6_@+M^3^0!"8/B,NBG9)D=TF(6
M2Y3.1,L"K^X<=MF(PW%C-$MPDJ6:6V]RUFA.JUJZ:: )/)<,QK+TLMY'!]<T
MPEQ"&E.NMH4V]M[B%I;6DEI5M+5*R,OP )MEEJ.TW'CMI:8:22&FD$24)0DM
M"2DBZ$1%X$ B5XICCBG%.5K"E.V#=TX9I^-9,DA+<@_^FDFT$1_@ 9',9Q]]
MVW>?K8[R[YI#%UW&R6F6TTV;2$.I5J2DDA1IT,O P$;1\=X5C;[TJGIV694B
M,4"1(<-<AUR(1ZDRM;REJ4V7L29Z%[ $:OB[&JS'[VKQ&$W4S+:LD53#F]YQ
MAA#K;A-I0TI:DH;0I>NQLB(!N8;QUB^&-1WZRMCL6Z(34!Z6T2S(FF]%*;9)
M:E$TTI?GV-[4F>FI=" ;%/Q]AV/VB[FEJFX,Y1O*^16ZEE)RE$MXT,;^T@UJ
M+51H06I@-Z/BV.Q(E1!C5S+42A63M,RE.B8JR:6R2F_@/MNK3_(HP$5)XQP&
M9<JOY5#&=M52F[ W5$K9ZYDTFB236[MD\6Q/RI)W]/$!L3< Q"PO2R:35H]^
M;V'7);:W63=<B'JRIY+:TI=4CP2;B5&1$1>!$ VY&*8Y+A6M;)K6'8-V\<FV
M84G5$EXTMH-;A>T]K2"_^J0#W*QBBFWT+)Y,)*K^N:<CQ)R5+0XEET]5-JVJ
M(EIU+4DK(R(^I=0&Y95T&XKI=3:,(E5LYER-+C.%JAQEU)H6A1? HC,C 1U]
MB&-Y/'B1KRO;E(KW"?@.:K:>CNDDT;FG6U)6@S29I/:HM2Z'T 5[*\!C3<>J
ML<I:2KG55:YN:B6C\IA3))0I*5QY+"774KU49*/\9)F6O4%9L*X[K\<Q^!6V
M;,6781;"1>).,R;$2//E*=,_2M&I1H0VAU32-3,S3U5YC,!*T^#8I0VK]Y5U
MR6K:0E;:Y:W'7W$MO.&\XALW5K[:5+/<I+>TC/37P($:Q<:X,5&YC94K/N-R
M5[P3#U<V-2]V\G6#W:LF1]4]HT[>NFFI@-Z#AV-5L:OBQ8"29JI+D^O-Q;CR
MVI3R'&UNDMU2E&I27G$ZF?@HP&M=<?8=D-HFZMJM#UJ3;;*I;:W6''&F5]QM
M#ILK1W$H5U2ES<1==/$P'F_X[PG*9IV.04K$Z6MCT;ZW-Q$]&(S433Z4J)+J
M$FHS2EPE$G4]--3 6&+%CP8K$*(V346,VEEAI/Q4-MI)*4E^ B+0!12XGQNQ
MR7(,BR:OBVCMK.C2XA*2LC)B+$C-(:D)W$AXDNL*<0E:5)+<"IW(<!P_*Y;<
M[(:AF?*;9.(;CFXNY&4LG#9=)*B)UO<6[MN$I.NO3J8(Q6W'6$W;<%%E3,.'
M61_15SS9K8>CQ="(VFG6E(6A!DDB,DJZD74!(1<4QN$=.<.KCQ_J^TXQ2):;
M)"8C3R";6EHDZ$DE)21& T9?'N%S:.%CC],Q[GK7?4UT=O<T<9_<I7<8<;4E
M;:]5J\R%$>BC+P,P$W65L*G@1ZRN;-J%%03;#9K6X9)+X5+-2C_E,P$#;<<8
M/>6;]Q;TD>7/E$T4M3I*-M\XY&32G6M>VXMLCT0M:34GIH?0@&:XP/$KZW8O
MK.L0Y<QT(91.;6['>4TVONH;<4RM!N(2OS)0YN21F>A=3 ?KV"8F]D7UL56(
M1D!J:<=F,K=9-U;"32VMY#:TH=4E)[4J<2HR+0O B 8D<=82W?\ UH12QRN_
M4*FD_P";84QQ&Q<A+6[MD\I/0W21O/KUZF \6?&V"W-H_<VE)'E6$E33DE;F
M\VW'8Y$33JVMW;4X@DI)+AIWEH6A]" 2CN,T#R[AQVO96O(&DQ[I1IZRFD-&
MPE+GPD39FG^0!CD8ECLF73SW8"/64"3;J'D&MM3#:B2DVR-"BU0>Q&J%:I\I
M'IT >HV+8[#]W^EKF6O=3\F77;4Z=B1.[O?6CX#<[SF[_P 8P$;D6(0I5!;U
M=145LE5S)*98P[(G$Q9+RS;)QQ:FDK4ES:VG8M*3-*DI/V (SC7C]6%JNY\A
M,5B;>/LN+@5W<5$CLQ&B9:23CWRCSBBU6Z\LB-1GIH1)(%7&QJJZV;8:LHR)
M+<:0S-82X6I(D15DZTX7_20I)*($:5ABF.6OO/WC6L2??+3$:U[B=?4,Q36I
ME"_A)!K5I_* W)%36R[&%;R8R'+.N2\B#*46JVDR223I)/V;R0G7^0!IMXIC
MC46#";K6$Q:V8NS@-$GRLS7%N.*>3\"C4\X>O_2,!,@(%S"\4=QM6(.5$=6-
M*)7_ ,--'R)&IPWMR2\4J)P]Z5)/5*NI&1@,,3 ,.@U$JBCU#/NN=(3,G-.;
MG52)+:T.)=><<4I;BTJ;1H:U'IM(O B 60!$RL8HIM]"R>1"2J_KFG(T2>E2
MT.)8>/53:MJB):=2U)*R,B/J74!XCXICD2%55L:M8:@TCQ2:EA*=$1GB2X@E
MME[#VNK+_P"L8#3;X_P]B_5D\>K;9NG'SF./M+=;0N2I!MF\ME"R:4X:3T-9
MHW'\("R@(1G#\88KZZJ9JV$5U1**?61B3Y&)25K63J"]BB4XL_\ : PUN#8I
M4W;V1P:Y*;M[O:S'%NO+04E?<=)HG5J)HEJZJ)LDD?M :D+C/!*YNQCPJ1AJ
M%:LO1IT#5Q4);,E6]U"8RE&TA*CZF2$$ ]PN.,(@19T./3,FU9Q%5UBIXUON
MR(:]=67775*6I'F/1*E=-3T 6="$MH2V@MJ$$24I+P(BZ$0"G5F'R3Y%L^0K
ME,4IIUS=!3)BFM3B:Y,A4IQ3ZUI3YW'#1Y$EM02/C'N/0-]C ,0BWZ\FBU:&
M+EQ]<MQYI;K;:I+B#;6\IE*R:-Q23\RS1N/Q,]0&*#QO@U;:%<PJ2.U8H?7,
M8<(E&EF0\:C<<80I1H:4LUJWFVE.[4]==0$[6U==3QE0ZN,B+%4\])4TV6B3
M>E.J?=7_ "K<6I9_A,!@O\=I,IK5U&006I]<M2'.R\7Q7&E$M#B%%HI"TJ+5
M*TF2B/P,!IPL)Q:OAQ(,>N2<:!-.UB$\MQ]:)QDHC>);JEJ->BU=3/V@,\O%
M<<GM7$>;61Y#&0;2NFG4$M,K8TEA/<(]2/1"$I+^0@$7!XSP2MC6<2+2,$U=
M1_16ZG36\[+C$2B)MYQU2EK21*42=RNA'H70!.>Y*GU<R?Z1OUEA':A37M/,
M[&8-PVVU'[4I[SFG_C& J&:8&FUJZ:HI:&FF5].VIF$Q9N28IQ4I;2TT3#D5
M"U;-I;7&^A*(B+4%3>!8J6$XC68R3Z9*X27#=>::3':4[(=6^YVVDZDVV2W#
M)M&I[4Z%J8(L@   .7YYPG69CD:,RJ<BN</RLXR8$RSH))1E2XB%&I#;Z%)4
M2MIGY5=#^'70M"U7V?LW1ITR$O-<^RG,*:%(;F%0V\U"X#S["MS9O(2V1K2D
M^NW7_O 5W $     ',^0.%ZO-[^+E]=?6^)9=&C'7N7%!)*,[(A&LUDR^E25
M$M*5'N3X'K\.A:%JKJ^S5'M78S.;<@Y5EN/LO-R7\?M9R%09*V5$M"7T(;(U
MH)1:[=2 KNA$1%H70B\"!     !S;D3AJISV[@97$N[7%,PKXZH+=[0R"C2'
M82U&LX[VY*B6V2C-22Z:&"U4W?LTHM^W#S+D;+<GQWN(=ET-A/3Z.5VE$M*'
MB0@E*1J1&9$9?RD!7<T(0TA+;:20V@B2A"2T222Z$1$7@1 CT   #X-XZ_CO
MOOTVY_LC@-<?>0,@          XA]K[^';,O\,_S6("XE?LQ_P"@N#_H*OZ]
MT#76@0         </QK+\%HH/*$7+["&<5S)K1N33NJ0_(DM/1HR#91%U-;I
MNZ[4MI09KUTT!52C%E$9&.X5D<I=>[6X572(4>5>.T"V9RU/HDO]QIEWU#T)
M#<=!DM9I;U-1I5W-0%NQM\KK*I]5RADA^_*2OI55T.+.>K8$DGHK:W[*/V5L
M>H[LONM:GJ2"02=J=Q[@AL-G9CD%W#N%6D6%D;62S(]VU+O'365>Q)?976)J
M.SVT&3"4.,GNW&9$[O,E'J'C$ZZ3:UG&,N;DEO(DY8_8-7[QV#R?71F8TN4V
MQM2O1M*%-((E,[5["41J/<HP&F4F%)RK"Z'(+N0U3PLCR^EC/NRW$/.1HS7R
M,-V7O)S0B\NJE[E$A*349^(84Y'<//4V.MVKMG@CF17\&LF3;1ZM1/9@M,'$
MBKM$(=<=0AQR4EOS:O=@B-2MIDH+90UEU:WV%T&29'(E1&85_9]JKM7GFIC$
M6R@IKT2I39,KD*C-NFAQ6A;U?'W:JU#J66SO35GI8^0Q,;M)9[8,Z:EITMS?
MG626G7&R6>TC_&Z>((YSQ8Q!L>.\G<G-,6L@KFV?EW^PEQ+>;'46EE'0LC0A
M.J$H2ELU)0ILR2I1%N,JU\76,&)Q3@3LR6TPB535+$=;SB4$Z\]%;)"$&HRW
M*6?Q2+J8&I//,YI^/Z+WQ:J);\AYN#55Y.-M.S9\@]K,=M3JDI(U'XJ49)0D
MC4HR2DS!')(L.NQN'AF27MM73VY^9R+G,9\%Q+U9%N+2NDL1D)<(S)#3"U1X
MZ%N&1F>U:M%*!4E$Y"H,3O>2\T=F-2\?FVM554C<9UHBL;U%>VRY'CK4HFU.
M&?:;6O=M1L5O,B;5H&"/#R&'@<E%*M5]>9I=/3LZL,6?BO'7(EM)[K,,W'6R
M-2&&F8;;AGN(S[YEKT ;_"=]6Q&,Y8D5[F.54/*'HT8IWI8T=M3K46.S%3VW
MED3A&2$[?::TZ&HS UV@$
M
M
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M.-K:<AL+:==3)=0IM!I4^A25)<41EH:R-*3)7CJ1 -H
M
M
M                           !\&\=?QWWWZ;<_P!D<!KC[R!D
M  '$/M??P[9E_AG^:Q 7$K]F/_07!_T%7]>Z!KK0(
M
M
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MR. UQ]Y R          #B'VOOX=LR_PS_-8@+B5^S'_H+@_Z"K^O= UUH$
M!2N2ID2KJ&;6SR:TQNLCK4EYRFBIEOO.*0:D$I/I):]$[%'HA!:^!_  S<77
M%WD&!4MUD#S<BRFM+=*4VEMOOQS=649Y:&5+0AQQDFUNMH49(6:DEX +>
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M-W[51$?V?\V(R(R]-&/0RUZE-8,@,=4I#-5-7*49J4<5DS,^IF9MI\01O
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M"MIEKH9*"X8_CB86.N4MM"JT)ED\4Z'4Q?205(?+:I/;4I1JU1Y5*/XWP%X
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MRB0VZXZXLEJ,]J4?%+J?LU\##Z7A1BA0X\-*C6F.TAHE'XF3:23K_P!X$9P
M   '!<Z9R_C[FG_FM4XI/S#';?'T4$V+2[')\24Q*[Z%FRHRWMK3TU+P/773
MIN*K_(W(.?<K87;<=4'$^2UMED3:8*;&[9:AU\9M;B36ZZ[O5T2DC/0BZ_\
M> ?1E+7^Z*:NJ=_=]!&9B]S33=V6THW:?AT!&\   #X-XZ_COOOTVY_LC@-<
M?>0,@          XA]K[^';,O\,_S6("XE?LQ_Z"X/\ H*OZ]T#76@0
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M".C<>9+)RS'BN),^KL.XZI"'J4W^RC8E.YMU$@B<0ZA6I+0LB,NFI$?0$6L
M
M
M                                  'P;QU_'???IMS_ &1P&N/O(&0
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MM&VE.XT$3AF6IK!5V!
M
M                                                     ?!O'7\=
M]]^FW/\ 9' :X^\@9          !Q#[7W\.V9?X9_FL0%Q*_9C_T%P?]!5_7
MN@:ZT"
M
M
M                      /@WCK^.^^_3;G^R. UQ]Y R          #B'VO
MOX=LR_PS_-8@+B5^S'_H+@_Z"K^O= UUH$
M                                  ?F]&_M[BWZ;MNO73PUT ?H
M                               /S<G<:-Q;R(C-.O70_ ]/]@ E25I)
M:%$I"BU2HCU(R/X# ?H
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M8WD$.P>MJN0IQV1WH9MH>2EQ"22KMF9]I7EW=347@0#L@(
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M2:S))&M;B$I26OM,ST(@,7W#D+;Q&@;<2:'$5T-*T*+0R43"",C+X2!$T
M#X-XZ_COOOTVY_LC@-<?>0,@          XA]K[^';,O\,_S6("XE?LQ_P"@
MN#_H*OZ]T#76@0  $/;XGBV0/(DWU'7VDAI';;>G1&9*THUW;4J=0HR+4]=
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M.J5*9==-"]/@41E\) M=G!    'P;QU_'???IMS_ &1P&N/O(&0
M <0^U]_#MF7^&?YK$!<2OV8_]!<'_05?U[H&NM @
M
M
M                                                       #X-XZ
M_COOOTVY_LC@-<?>0,@          XA]K[^';,O\,_S6("XE?LQ_Z"X/^@J_
MKW0-=:!
M
M
M                       'P;QU_'???IMS_9' :X^\@9          !Q#[
M7W\.V9?X9_FL0%Q*_9C_ -!<'_05?U[H&NM @
M
M
M                                                    #X-XZ_CO
MOOTVY_LC@-<?>0,@          XA]K[^';,O\,_S6("XE?LQ_P"@N#_H*OZ]
MT#76@0  ')^7^=:CAVZQ*NNJQZ77Y,](1)L67"24!B(I@G'EM[%&M*2?W*T,
MM"28+&S:<V4%#E.745U'5&J<0I8U_+N4N)=2\U*,R2VVT1$>XST)/F\QGIT
MBLQOM"W4%%-?9OQ[/QCC[(7V(]9DKTV-*4V<S^@7-B-D2XZ%ZEYC4K3V@1^7
MO.7)%+FS&"(XG>E7-D4Q^CVWU>VF9#@JT6]J:3)K5.U6QPR5UT C=?YJSB;F
MV087A_&SN0/XN=>BZEE<PH*67+*,F0223(26_9JM!F@SUVZ^T@(ZK$R&HM)%
MI7TTZ-/M:=1,V$)IY)N,/K2:T-O$G<;9J+X2!%!B<E9K(N,AI9.(18CF-1F9
M5E**V]0DDRH[KS7;;3$0I?\ 1;5$9H\>FH*LF$<@4.80("&+"(O(7:^-/GUL
M=TEFT;S:%.$C7JI*%KV*,M=IZ$K0P1)4F98IDLJ5"H+F)92X762U&>2XI*=Q
MIW=#ZIW$:=R=2U(RUU(!!S\YNIF06.-X10%=2*4VV[JRFR_=U>Q)>;2\B,AP
MF7UNO=I:7%DAO:@E)W*U5H14K99I1XS6U\O-)L6@ESD%K$>D)<T=2DC=2A1$
MDUI;W>9S:1$74] 1ZML[PRB:8?M[Z#$:DM(DQE./H^4CN'H3R"(SW-^TUEY2
M+J9Z /<3-\0G2YT"'=PWY=:RJ3-;;>0KML(^.YJ1Z&E&NBU)U))]#T, J,VQ
M"_F2(%)>0K"9&:*0ZU'?0X?85I\JDR/13>ID1K3JDCZ:Z@,5?G^%6L>;*@7T
M)V-6DE4]WO)0EEMP]$.*-1EHVHR/:Y\4]#T/H8#U!SK#;)$AR#>0WT19#,.0
MI+R=$/RU]IA)ZF7]*ORM*\%GT29@)"3?4D,[!,JPCLJJ8Z9EH2W$D<:,LEJ2
MZ[U\B3)M9D:O8DP'M5U4)GPZM4^.5C8,N28,3NH[K[#.SN.-IUU4E/<1J9=.
MI *AEO(*J6NL[*D=K;)N"4-!,%)4J03SUGZ!_N-H3H2$&2DI5N_I$J29%M!6
M[CF;IL(&3V=X3-?!QZWGUJGTJ4:?3033HZO4NBCW=2($8:KEG ;3&:G*UW,>
M#6W*4G"1,<2T\IU6PC9)!GJIQ)N)2I*->I@)EC-,3E7SN,1[B*Y?LDLW*\G"
M[NK1:K(B_&4@NJTIZI]H#'69WAEU8KJ:F]A3;%#1OFPP^A9FTG3<I)D>BB1N
M3OVF>W4MVFH#S&S[#)E?/MHMW$=K*Q2439:'"-I!K/:C17@HEGT0:=24?AJ
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MVK0]KGQ%:'H9Z -J/EN,2Z5S(X]O$7C[*UMNVG>041)MN=I6KIF2="5TW:Z
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MOJ>2EIG3:V@FDM$MQ2MVI+21$74P%[
M !\&\=?QWWWZ;<_V1P&N/O(&0          <0^U]_#MF7^&?YK$!<2OV8_\
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MX'8<3&)$R2\2S4T<8VC4A)IW*V)V=3Z!FC87:)R"WQO)&<@*!9Y2>0PY=0S
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MX#7'WD#(          .(?:^_AVS+_#/\UB N)7[,?^@N#_H*OZ]T#76@0
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M*6M2C,U*49F8"3  &D=36G;)O3C(.X1'5"1,T^4*,M:75-Z_DFI)*_V -T
M                                5R_P/$\HEHG7]:F<\AM+!I<<=)EQ
MI"^X2'6DK)MQ.[KM<2H@%B2E*4DE)$22+0B+H1$0#]      $6O'*1V_9RAV
M&AR^CQU0X\U9J4IIAQ1*6EM)F:4FHR+<I)$HRZ&>@"4  $8WCU,U?/9.B(GW
M\_&3!7.4:E+*,A6\FTDHS)"35YE;2+<9%KKH0"3           !HW%/5W]<_
M47,5N;62=I/Q7BW(7L42TZE^!22,!O    TZRJKJ6&5?51D1(27'7DL-%HDG
M)#JGG%:?"I:U*/\ "8#<
M         ?!O'7\=]]^FW/\ 9' :X^\@9          !Q#[7W\.V9?X9_FL0
M%Q*_9C_T%P?]!5_7N@:ZT"
M
M
M                                      /@WCK^.^^_3;G^R. UQ]Y
MR          #B'VOOX=LR_PS_-8@+B5^S'_H+@_Z"K^O= UUH$
M
M
M
M      ?!O'7\=]]^FW/]D<!KC[R!D          '$/M??P[9E_AG^:Q 7$K]
MF/\ T%P?]!5_7N@:ZT"
M
M
M                                   /@WCK^.^^_3;G^R. UQ]Y R
M        #B'VOOX=LR_PS_-8@+B5^S'_ *"X/^@J_KW0-=:!
M
M
M
M    'P;QU_'???IMS_9' :X^\@9          !Q#[7W\.V9?X9_FL0%Q*_9C
M_P!!<'_05?U[H&NM @
M
M
M                                 #X-XZ_COOOTVY_LC@-<?>0,@
M       XA]K[^';,O\,_S6("XE?LQ_Z"X/\ H*OZ]T#76@0
M
M
M
M  !\&\=?QWWWZ;<_V1P&N/O(&0          <0^U]_#MF7^&?YK$!<2OV8_]
M!<'_ $%7]>Z!KK0(
M
M
M                                ^#>.OX[[[]-N?[(X#7'WD#(
M     .(?:^_AVS+_  S_ #6("XE?LQ_Z"X/^@J_KW0-=:!
M
M
M
M  'P;QU_'???IMS_ &1P&N/O(&0          <0^U]_#MF7^&?YK$!<2OV8_
M]!<'_05?U[H&NM @
M
M
M                               #X-XZ_COOOTVY_LC@-<?>0,@
M     XA]K[^';,O\,_S6("XE?LQ_Z"X/^@J_KW0-=:!
M
M
M                                                           '
MP;QU_'???IMS_9' :X^\@9          !Q#[7W\.V9?X9_FL0%Q*_9C_ -!<
M'_05?U[H&NM @
M
M
M                            #X-XZ_COOOTVY_LC@-<?>0,@
M  XA]K[^';,O\,_S6("XE?LQ_P"@N#_H*OZ]T#76@0
M
M
M                                                         !\&
M\=?QWWWZ;<_V1P&N/O(&0          <0^U]_#MF7^&?YK$!<2OV8_\ 07!_
MT%7]>Z!KK0(
M
M
M                           ^#>.OX[[[]-N?[(X#7'WD#(
M.(?:^_AVS+_#/\UB N)7[,?^@N#_ *"K^O= UUH$
M
M
M                                                        ?!O'
M7\=]]^FW/]D<!KC[R!D          '$/M??P[9E_AG^:Q 7$K]F/_07!_P!!
M5_7N@:ZT"
M
M
M                         /@WCK^.^^_3;G^R. UQ]Y R          #B
M'VOOX=LR_P ,_P UB N)7[,?^@N#_H*OZ]T#76@0
M
M
M                                                       !\&\=
M?QWWWZ;<_P!D<!KC[R!D          '$/M??P[9E_AG^:Q 7$K]F/_07!_T%
M7]>Z!KK0(
M
M
M                         ^#>.OX[[[]-N?[(X#7'WD#(          .(
M?:^_AVS+_#/\UB N)7[,?^@N#_H*OZ]T#76@0
M
M
M                                                    !\&\=?QW
MWWZ;<_V1P&N/O(&0          <0^U]_#MF7^&?YK$!<2OV8_P#07!_T%7]>
MZ!KK0(
M
M
M                      ^#>.OX[[[]-N?[(X#7'WD#(          .(?:^
M_AVS+_#/\UB N)7[,?\ H+@_Z"K^O= UUH$
M
M
M                                                   ?!O'7\=]]
M^FW/]D<!KC[R!D          '$/M??P[9E_AG^:Q 7$K]F/_ $%P?]!5_7N@
M:ZT"
M
M
M                    /@WCK^.^^_3;G^R. UQ]Y R          #B'VOOX
M=LR_PS_-8@+B5^S'_H+@_P"@J_KW0-=:!
M
M
M                                                 'P;QU_'???I
MMS_9' :X^\@9          !Q#[7W\.V9?X9_FL0%Q*_9C_T%P?\ 05?U[H&N
MM @
M
M
M                  #X-XZ_COOOTVY_LC@-<?>0,@          XA]K[^';
M,O\ #/\ -8@+B5^S'_H+@_Z"K^O= UUH$
M
M
M                                                 ?!O'7\=]]^F
MW/\ 9' :X^\@9          !Q#[7W\.V9?X9_FL0%Q*_9C_T%P?]!5_7N@:Z
MT"
M
M
M                  /@WCK^.^^_3;G^R. UQ]Y R          #B'VOOX=L
MR_PS_-8@+B5^S'_H+@_Z"K^O= UUH$
M
M
M                                              ?!O'7\=]]^FW/]
MD<!KC[R!D          '$/M??P[9E_AG^:Q 7$K]F/\ T%P?]!5_7N@:ZT"
M
M
M
M               /@WCK^.^^_3;G^R. UQ]Y R          #B'VOOX=LR_P
MS_-8@+B5^S'_ *"X/^@J_KW0-=:!
M
M
M                                            'P;QU_'???IMS_9'
M :X^\@9          !Q#[7W\.V9?X9_FL0%Q*_9C_P!!<'_05?U[H&NM @
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M55$D6T'W98N-D<B!WD2>ROPV]U!$E7\I$"-\
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M1Y.O0]JM G<KS5K&+"DIFZR5:V^0KDL5<:)VTI-V*P;ZNZMU:";1M2?GZZ?
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MO$Y8AVDJEK:6BL9UK<>M[L4BCM>A.IF(A3BEK6Z24&RXO3R&K?\ B:ZD"NA
M@                              /@WCK^.^^_3;G^R. UQ]Y R
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MR"1>O.]I6CK+[\QTFDENZ*(I1%N/\GPZ@(CC[B=_!YU?#.!CTRGITN-5UT4
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MO0!<ZXK!-?$3;*97:DRV4Y<5*D1U2-I=PVDK4I1(-6NTE*,]/$P1L@
M                       #X-XZ_COOOTVY_LC@-<?>0,@          XA]
MK[^';,O\,_S6("XE?LQ_Z"X/^@J_KW0-=:!
M
M
M                                                   'P;QU_'??
M?IMS_9' :X^\@9          !Q#[7W\.V9?X9_FL0%Q*_9C_ -!<'_05?U[H
M&NM @
M
M
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M1P&N/O(&0          <0^U]_#MF7^&?YK$!<2OV8_\ 07!_T%7]>Z!KK0(
M "LU/_;7)?T>L_\ !( 68
M         !6;_P#[48E^D3/[$Z LP          ALN_[)WW_ %=+_J%@-VH_
M^4P/T=G_ ,@@&X                               "LN_P"H,7_J:3_:
MF %F                                                 5G-/_9J
M?_KFM_M"0%F           !6>/?^Q5+^CE_X3 68
M          ?!O'7\=]]^FW/]D<!KC[R!D          '$/M??P[9E_AG^:Q
M7$K]F/\ T%P?]!5_7N@:ZT"   K-3_VUR7]'K/\ P2 %F
M                                  5F_P#^U&)?I$S^Q.@+,
M   (;+O^R=]_U=+_ *A8#=J/_E,#]'9_\@@&X
M        "LN_Z@Q?^II/]J8 68
M              !6<T_]FI_^N:W^T) 68           %9X]_P"Q5+^CE_X3
M 68                              ?!O'7\=]]^FW/\ 9' :X^\@9
M       !Q#[7W\.V9?X9_FL0%Q*_9C_T%P?]!5_7N@:ZT"   K-3_P!M<E_1
MZS_P2 %F                                                 5F_
M_P"U&)?I$S^Q.@+,          (;+O\ LG??]72_ZA8#=J/_ )3 _1V?_((!
MN                                K+O^H,7_J:3_:F %F
M                                       5G-/_ &:G_P"N:W^T) 68
M           %9X]_[%4OZ.7_ (3 68
M?!O'7\=]]^FW/]D<!KC[R!D          '$/M??P[9E_AG^:Q 7$K]F/_07!
M_P!!5_7N@:ZT"   K-3_ -M<E_1ZS_P2 %F
M                        5F__ .U&)?I$S^Q.@+,          (;+O^R=
M]_U=+_J%@-VH_P#E,#]'9_\ ((!N
MK+O^H,7_ *FD_P!J8 68
M        !6<T_P#9J?\ ZYK?[0D!9@           5GCW_L52_HY?^$P%F
M                            'P;QU_'???IMS_9' :X^\@9
M !Q#[7W\.V9?X9_FL0%Q*_9C_P!!<'_05?U[H&NM @  *U4_]M,E_1ZS_P $
M@!90                                                %:OB,\GQ
M,R+H4F9J?_Z$Z LH          ALNZXI>D7]W2_ZA8#<J/\ Y3 _1V?_ ""
M;H                               *T[_J#%_P"II']J8 64
M                                        !6LT(SC4^A:Z7-:9_P G
MJ$@+*           "M<>_P#8NE_1R_\ "8"R@
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M6#[X^7\@UT9LDTS-I%DLFD]4E-F0&'I:"^#51H=47Y3AG[01?
M             4WEPB/BK-R41&DZ&S(R/PT.(X"XIN9UU)66'&,RHBL1,\>M
M8$:)Z-MMN8[5FRH[)#A((E*CH8W+7N\J5D@^BMH#1A9G8W.6X]:4%A<JP_++
M*?4MRIZX#<)YIF',=0Y7QTI]2G8N/JVZM/F3J:R/5*@%=QRSR*AP[!L9IIUO
M,3E5O>)F2V'(:IZ&:]<M[L1G)1--(4\:-ZE&9K))+V%KH:0[-QTYF*J.0UFD
M=UF9'G26JUV4N.N8_6$O6,Y)](I31/;3V+V>.W=H6N@(MP
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MS0C,BWF?0P&&AX]PG&'3?HJ2+#?-M;!.I1N6EAS;N90I9J-+7E3\DG1!:="
M:J^+./W*>)0JHF"JZ]QQZO92IQ"HRWOC]EQ*R6VE1=#2A1)TZ:: +/ @0ZN#
M'K:]E,>#$;2S'91\5#:"T21:]>A$ V
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M-MDE*7U6HUJ,U+-2C,S,S,S,!(
M   (++LRQG!*.3D6663-94Q4FI;KRB)2S(M20VGXRUJ\$H21F8#XJ^RS$M>4
M?M#Y7S-Z946CC.S7R)7L>L][;#!&712D-;C7I\!?E$#6OO(&0
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MU:=5'_(6A$1 RL0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
(       #_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>px_24cyclacelpxy1pg02-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 px_24cyclacelpxy1pg02-bw.jpg
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M_\0 K  !  (# 0$! 0            8'! 4( P(!"0$! 0$
M      $"$   !@$# @,""08, P,' 1D  0(#! 4&$1('(1,Q% A!(E%A,E(C
MTY05&$*2TA96.'&!LC-SLW2%M1<W5V(DE9%#-*&QT7*"M#5UP5-CDU1E-G9$
M)2;P@X1F***CPZ3$1;8G=Q$! 0$! 0$              !$!03$A_]H # ,!
M  (1 Q$ /P#OX
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MHTT21$9%XECKOD*TGTF Y5=5;O8LZZGL)D)_:E?;?CQ7'&U;5$:3T4DCT,M
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M-Q\E.I-)MDV:T$1LKZJ21= (LD$
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M')<9J55RI,B+ 2]#3/)$PYDQ25DE25;3)*5>^".J 0
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M#]9C1X\=$2.RAJ*VDFVV&TDEM*"+0DDDBT(B+V ,"KQG&Z1]Z534\&NDR/\
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M<=P_"*+!41V[*MHF4MLN3&D.&M\M5+>VJ)1)4M:UJZ>&N@(EX
M
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M[$C^:=2HC-)(<\&UF9)4?1)F EX
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M/;[##TGR[C:-NFB5MJ4A1>TCZ@8SJ9ILO41E?T:2TQ:D4D]I$>OG;#4RZ?\
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M&Z#CJ$=O63W[F._/G3CK$+C2'7VVG8[;*%;#2@G-Z]I$9EX$"M)05\2\M?3
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M8(E(
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MI;/5P]=/8")<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M/4_$"MCR)QEB_*%;$JLJ*4<2$_YI@H<EV(KN;#1[RFC(S+11]#!%<_A%X?\
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MU:7^F!6XQ;TT\8X?D$#)J9-H5I6N=Z,;]E)>:W[33[R%*,E%H?@8%6^"
M
M
M
M
M
M
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ML?R2/"BM4IU[E:S"-QQ:6)S;JM'W5[26Y]&2CV()*==OO:;C">@@
M
M
M
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M69UEV32'&55]\U5MPVT&HWD'7M.H<[A&DB+4W"VZ&?Q@B6
M      T&49OA^%1DS,NO8-*PYKVE3I#;!N&7B2$J,E+/XDD8"%?B3X*_;JL_
M/7^@"P_$GP5^W59^>O\ 0 A^)/@K]NJS\]?Z $/Q)\%?MU6?GK_0 A^)/@K]
MNJS\]?Z $/Q)\%?MU6?GK_0 A^)/@K]NJS\]?Z $/Q)\%?MU6?GK_0 A^)/@
MK]NJS\]?Z $/Q)\%?MU6?GK_ $ (?B3X*_;JL_/7^@!#\2?!7[=5GYZ_T (?
MB3X*_;JL_/7^@!#\2?!7[=5GYZ_T (?B3X*_;JL_/7^@!#\2?!7[=5GYZ_T
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MP.\'?,M_MQ?5 4_ [P=\RW^W%]4!3\#O!WS+?[<7U0%/P.\'?,M_MQ?5 4_
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MP.\'?,M_MQ?5 4_ [P=\RW^W%]4!3\#O!WS+?[<7U0%/P.\'?,M_MQ?5 4_
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MP.\'?,M_MQ?5 4_ [P=\RW^W%]4!3\#O!WS+?[<7U0%/P.\'?,M_MQ?5 4_
M[P=\RW^W%]4!3\#O!WS+?[<7U0%/P.\'?,M_MQ?5 4_ [P=\RW^W%]4!3\#O
M!WS+?[<7U0%/P.\'?,M_MQ?5 4_ [P=\RW^W%]4!3\#O!WS+?[<7U0%/P.\'
M?,M_MQ?5 4_ [P=\RW^W%]4!3\#O!WS+?[<7U0%/P.\'?,M_MQ?5 4_ [P=\
MRW^W%]4!3\#O!WS+?[<7U0%/P.\'?,M_MQ?5 4_ [P=\RW^W%]4!3\#O!WS+
M?[<7U0%/P.\'?,M_MQ?5 4_ [P=\RW^W%]4!3\#O!WS+?[<7U0%/P.\'?,M_
MMQ?5 5%L[]!V$2Z5]SCZTG5N0M(4J,S8NIDPWUD6I(69-I6C7PWI,]/FF"UZ
M>CKF#)[B3<\.9\XZ[D6,H6NO>EF:I*6(SI1Y$5U1]5*96:=FIF>TS+P20&NM
M@9          !2'J^_=VS+^[/\5B N-IZ84I1P+@Y(222\BL]"+3JJ0Z9G_&
M9Z@:ML$
M
M
M                       <,\5$2/7)F*4%M2;MN9DGH1F9)4>O\)]0:X[F
M!D          %(>K[]W;,O[L_P 5B N-KZ8_]!<'_L*OZ]T#5M @
M
M
M
M       #AKBS]^;,/Z2W_DI!KCN4&0          4AZOOW=LR_NS_%8@+C:^
MF/\ T%P?^PJ_KW0-6T"
M
M
M                                   .&N+/WYLP_I+?^2D&N.Y09
M       !2'J^_=VS+^[/\5B N-KZ8_\ 07!_["K^O= U;0(
M
M
M
M   X:XL_?FS#^DM_Y*0:X[E!D          %(>K[]W;,O[L_Q6("XVOIC_T%
MP?\ L*OZ]T#5M @
M
M
M                              #AKBS]^;,/Z2W_ )*0:X[E!D
M    %(>K[]W;,O[L_P 5B N-KZ8_]!<'_L*OZ]T#5M @
M
M
M                                                           #
MAKBS]^;,/Z2W_DI!KCN4&0          4AZOOW=LR_NS_%8@+C:^F/\ T%P?
M^PJ_KW0-6T"
M
M
M                           .&N+/WYLP_I+?^2D&N.Y09          !
M2'J^_=VS+^[/\5B N-KZ8_\ 07!_["K^O= U;0(
M
M
M                                                       X:XL_
M?FS#^DM_Y*0:X[E!D          %(>K[]W;,O[L_Q6("XVOIC_T%P?\ L*OZ
M]T#5M @
M
M
M                      #AKBS]^;,/Z2W_ )*0:X[E!D          %(>K
M[]W;,O[L_P 5B N-KZ8_]!<'_L*OZ]T#5M @
M
M
M                                                   #AKBS]^;,
M/Z2W_DI!KCN4&0          4AZOOW=LR_NS_%8@+C:^F/\ T%P?^PJ_KW0-
M6T"
M
M
M                   .&N+/WYLP_I+?^2D&N.Y09          !2'J^_=VS
M+^[/\5B N-KZ8_\ 07!_["K^O= U;0(
M
M
M                                               X:XL_?FS#^DM_
MY*0:X[E!D          %(>K[]W;,O[L_Q6("XVOIC_T%P?\ L*OZ]T#5M @
M
M
M
M              #AKBS]^;,/Z2W_ )*0:X[E!D          %(>K[]W;,O[L
M_P 5B N-KZ8_]!<'_L*OZ]T#5M @
M
M
M                                           #AKBS]^;,/Z2W_DI!
MKCN4&0          4AZOOW=LR_NS_%8@+C:^F/\ T%P?^PJ_KW0-6T"
M
M
M
M           .&N+/WYLP_I+?^2D&N.Y09          !2'J^_=VS+^[/\5B
MN-KZ8_\ 07!_["K^O= U;0(
M
M
M                                       X:XL_?FS#^DM_Y*0:X[E!
MD          %(>K[]W;,O[L_Q6("XVOIC_T%P?\ L*OZ]T#5M @
M                                                         -3E
M%_$Q3&KC)YY&J%30I%A(2DR)2FXK2G5)+7VF2=" <N<7X+GGJ-I7.4.2LWNZ
M>EM7WRQ[&\;E?=\9F.PXIK>K5*R/1:5)3JG<>W<:SW: UXVO-&#<@<6X1C6>
M8)E=W=6''[JG+MFQF/.G95"Y"WO^:0A1(<[!+[2CV%]#J>I;"!&'+Y#G^I;D
MG%<4X[M)]7QW2Q&,@S:PA/.PWUNOI(T5ZG&C2>I?S:B)7B:U=>V0+XR<NOL]
MYIYRM.&\2R.5B&"8C%0]D=I5J-N?*?62-6T.D9*3U<)M*==/=6I6[W4@B0W_
M !0[Q#QSR+?8_FN2V!+QJ>EF+;6!R2CRFVE.%)86A+9H<+335/7XP$P]--E9
M7'!V'65O,?L+&1&>4_,EN+??<,I3R2-2UF:CT(B+J8&H!ZEKW*\HRW"^#./;
MIZDR6^5(M[*PBNNL+9AQ&73:2M;*DJV.*0Z9EKXH2!B4^F7DM[-N((LS(I"U
M9#C"GJG('))F;^^$6Y+CF[51J4R:#6I7BLE>T#56<<UN<^JF3=YYE&77&,<<
ML3G(&/XW02/)+<0T1*-;[A$HE;26DE*4E1J7NTV)21 OCT]1U%?<-\#Q*V@S
M2_ENKR=A;-K-GN?>#45Z*_\ \MWVNV9MI-O>1?"!B8\-X[QS'S1J9BG,]UG%
MG&BO+713KI%A'4TLB;4ZIE*2/W#66A^P] 37CZ6+Z]NK[EMJYM)=BU R5UB"
MB8^Y(2PT3L@B0T3BE;$Z$7NIZ= -=( C^?V.%>7U5RQFEARW>XS<8E:3RI(I
MVRRA.I:-UQ#*H[B]RMZB2V@D'_ E7@#3<Y=RWG%OQ!PEF=[<R:B?.OUL74^,
M\N"W+B1)':[SR6C21I4A&JRTVF>ID6AZ )EZK.<,4L.,&V.-<\85D16D92DT
ME@:)7ER;>)?5A9*V:FG7KIX 9BU_4!R*]QOPM9WD1]35_/CM55,XDS)WSTY&
MTEH/Y[:"6\7QH!,5QZ:KW-,+Y!RCA'DJYDW%RF)#OZ:;.>=?4I#S#9R64+?4
MI1DDUH+:1Z;D.&!J+<H2V[GU/V^*Y3R3:X)B#-)'F,/P[?[K8*8EMK:@NZKM
MZJW*49$6X] 7C;<*9?R!883S'$F9#.R;#:"+.;P[,I?<1)?4VQ))2FGE>^O0
MD-+UW'L,^A]0-1STD9MF=?F=;2YE?3[JIY HW;.A<L9+TK9+JY;[+K39O+7H
M>QIY2]OCHD#4;Y@SO/K[ENPRBAR*RK\%ILIK,,BQ84Q]F,]*:2IR29H;6E"O
M>;7J>AZDI)> #I7U29_88-Q=(B8^\XUEN42&J*C.,HT2$NRC^D6@TF2B,FR4
ME*B^2M203$6],F1930Y+G'!_(%P_=9/C$A%A7V$MUUYU^!)0WNVJ>-2MB34V
MM.I_]Z!K49!<Y[SSS=D'%V.Y+,Q#CK"FTHO9E2OLSYDI1DDT$Z75/O[T)+Y.
MU!J,E&9$02/)^+GN'^+N1[?'LTR2P2]0R#C,6U@J0<20RA2N_'<0ELT+/7J9
M=?C 5=PG6X1DU=AMM=\YY"6=37F'7\75?D;:Y:7_ '(QL.)4LR7M2DTFKKK\
M8+JR:&_O7?6=E&/.VDM= SC33[-4I]PX:'33"]]+)JV$KWE>\2=>I@G#D:_O
M8GJTXOH8EI+8HY]5,.96M/N(BO+[4[1;C25$A2BVI,C41^!? !Q5_+?&=YQ_
MGW&&)U7)N:2(6;V;E?9/2;=PW66T/16R4R:"01*T?5\M*O @5(.>*&]X;P/#
MJ>BS7(K%RRS!EZ19V5BXY--IR-VSC]QOMZL_1[]A]-QF8&)%RCE6?\E\W,\!
MX'>O8K35<%-GEMY",TSC;<0A?;:61D:2VO-)+:HO>69JU).@(LKCOA"/QO?J
MNJ_,LEN(ST5<:35WD_SL5;JU(43Y))"-%EM,O;\HP*YOYRSODC(^0LTRGCN]
MEPL9X;36MS8$9YY$>;,7+_YCN(;425[%$M+A+U+8T?P@N.@.5LU*^]-UYG>+
M3'H96%&W80)49U34ADWMBM"6@R-*TZFE6G@>H(W_  )/G6?#6%6%G*=FSY-6
MPY(E27%//.+,CU4M:S-2C^,S URUB,Z/R]R-F5=R_P FW>&Y7!LW8..XW!G_
M '3'9;;6I*>V;B3;6M.A)VEHM7RC-6[H5V[35ZZFHKZIV6]/<@QF8RYTI6^0
M^IELD&ZZKVK7IN4?PF#+UGJ4F#)4DS2HFG#)1=#(R2?4@'!M/FN9N>BW(,B<
MR*T7D#61-LM6JIL@YB&C=B$:$O;]Y)]X^F[VF#75@X5R+ES/!W)O'N86;Q<F
M8-22I3%FF2M<I^NF0SDQ)*']26I2-Y)W%U26S4]3 8EAS'F^*^F_C"#C4MR9
MR/GB_NN#:35G(>09OJ0MW<[NW.:N--I->I%KK[" 6+CWIHL*]ZMOKGE#+9^8
M1GV)<Z4BQ4F"\IM:5K9["DJ5VE:&G0W/#XN@)5_@@
M                                                  X:XL_?FS#^
MDM_Y*0:X[E!D          %(>K[]W;,O[L_Q6("XVOIC_P!!<'_L*OZ]T#5M
M @
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MEY9F>5X@K'K"K3B[J62M):-L:;N6I.Y@]"U+W=WCX& G@(
M                                                      X:XL_?
MFS#^DM_Y*0:X[E!D          %(>K[]W;,O[L_Q6("XVOIC_P!!<'_L*OZ]
MT#5M @
M
M   T,["\6LLGK<SGUC4C)Z=IQBLLE[C<8;>)25D@M=O4EJ+737J WP
M
M          #AKBS]^;,/Z2W_ )*0:X[E!D          %(>K[]W;,O[L_P 5
MB N-KZ8_]!<'_L*OZ]T#5M @
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M!R-2N7V.E*3#:D+AO-SHSL-]#[24J4DVW2(^A+3U+H")0
M                                            #AKBS]^;,/Z2W_DI
M!KCN4&0          4AZOOW=LR_NS_%8@+C:^F/_ $%P?^PJ_KW0-6T"
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MD8'&\]-*TJY9]0!)41F62HU(C\/IYY?_ # 34U]4YD7 &;&9Z%Y6.7\9S&"
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MMV!8NP*^^:8.*BQCM)2?>)O:@M249D:DI27LTW$H#5X @
M                                           .&N+/WYLP_I+?^2D&
MN.Y09          !2'J^_=VS+^[/\5B N-KZ8_\ 07!_["K^O= U;0(
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MXZA*U-+Z>\@U$9I/IXD Q5X[C[EB5PNIAJMDGN3/5':.21E[2<-.[7I\(#9
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MMAAB,RB/&;0S':22&VFTDA"4EX$E):$1$ ]
M                                   <-<6?OS9A_26_\E(-<=R@R
M       "D/5]^[MF7]V?XK$!<;7TQ_Z"X/\ V%7]>Z!JV@0
M                                                         '/O
MJ1YQRWC.70XSQS7QK7+K-F9:3(\II;Y,UE>RIQ;FQMQH^NQQ6[7P;5TUT!<Q
M:7&N>0>0N/*/.V30RS90TR)B$G[C,AK5$EO4_8VXA:=3]A C7R><^'HD:#,D
M9O3HBV2E)A.^;;,E]M9MJ,]#/:DE%H:E:%\8+$DN<SQ/'BK%7EU#KT7+J8]4
MN0\AM$EUPB-*6U&>BM2,M- 1K\:Y/X[S*SE4V*Y/77%I#(U/Q8<A#JR0D]IK
M223]])'T-2-2^,!LZ;+,9R&?:U=':QK"QHWBBW$:.XEQR*^9J3L=(ODJU0HM
M#^ P&'7\A8-:T$S*J_(J]_&JYQ;,ZV3);*(PXV234EQTS)*3+>GQ/VE\(#"Q
M7EGC7.+!RJQ/*:ZVLVTFM4..^DWC0GY2DH/0U)+VFG4@%;\19SEF0<X\N8O<
MVCDNAQ]^(BGA+2V2(Z73<W$DTI)1Z[2^49@K?>H[DO).*>.BRG%6HCULJPBP
MDHGH6XSLD;]>B%MGK[I==P&/+T_\N6?)6"V=MF;4:MR?'9\NNOV&$J99:\N1
M.)7M6M9I+8>T_>/JE0&JKX4]3'(G)?+4/&K6NKXF%W#5E-J%M,NHF*B15.):
M,UJ>4DSU;-*CV%J9'IH"[CH&_P"7N+\6NDX[D66U=;=JVDJ%(DMH6WOZI[O7
M1O4CU+>9= 9C?7N48YC%.O(,AM8M92())G/E/(:8/N?))*E'H9J_)(NI^P!I
MZ;E/CG(:2PR.ER>NFTE4DW+28W(1LBH(C/<\1F1H(R(]#41:@(+Q5ZC<0Y3R
M*]QR(]%KIT.<Y"H&%RTNR+1EAM;BY+39)3[FB#46AJ]WJ8+&3Q?G)57'$K)N
M2.1J7)XS%@XRK)X/9C06T*)I+<=1MH;3O)2M?#\H@$NB<L<:3\E3A\+*ZR1D
MJ^C=<U*;6XM6F[8G0]#7IUV$>[X@1D9=R3@6!+BM9ED4&E>FZ^5:F/);<<(C
MT-1)\=I'XJTT+X0&71YMB&33YE9CMY!M9]>AIR:S"?;D&TB0G<TI1MF9:*+J
M1@-I96=;30'[2WF,P*R*@W),R4XEEEI!?E+6LR2DOX3 1K%.5..,YEO0,1R>
MOMY[!&IR)&?2I[:7BHFST4I)?.21D YSY7YI?O\ FFOX^Q[D^)A&$U\!U^VO
MHW8>-5HA;B#C.+=T21IVH+9N+\K74]"(U'5ME8,4E/,M9RE+C5T9R5)4DM5F
MB.V:UF1>TS))@RYHP'DSU,<P5KF>X1&Q2LQ#SBXT*GLE2G9CK;*B)>]UK4B4
M6OC]'KX[=--2I_REZC<.XSRW'\-?<C3+*TG-1;MQ4MMA-/&<[*N_)3M4KWFW
MMZ$^Z1D1GN+VB)_8<C8'4XW&R^RR.OBXS-22H5H[(0EA\E>!-&9^^9Z>"=3!
M'OB><8?G4)RPP^[AW41E1(?7">2Z;2U=22XDCW(,R+H2B(!JIO+W&%=DJ,/F
M976M9.X\B(FL\PE3Q2'%$E+2B3J25F9D6U1D8"LN*.2+Z?ROS579=>:XIB,E
MA5>F5VF6(4;62;AFLDI]TDMEJ:U'X K"]0?+\V+A.&Y-Q5DB#A6V3QZM^Q@]
MMYI]CMO=QLE.)41EN06II]I::@8N*CY0X[R6^DXO09/76.01-W>KXTA#COT?
MR]I$?O[?RMFNWV@C]R[D[CW WF(^8Y) II4DM[$:4^E+RD:Z;R;+56W4M-VF
M@"+<RYTN)P;DN<X#=-+=:A)?J[F MJ2WKWT(-2%>^@_$TG\'\(*R,+Y&JJOA
MK#\VY%OH\)=A4P'YME/<;8[TJ0PE:M"+;N6H]3VH3_$ K]WEZ3D7J3P*BPO)
MVK+CJYHYDF;&A*9>CNRV$33]]1)-:5IV-ZIU+33P\0%LY#R[QAB=PG'\DRRL
MK+E6W=#DR4(<;WD1I[G71O4CU+?IT!&[L\MQFF75-VMM%B*O'4QZ?NNI24IU
M9$I*6CUT49D9'T :0^7.,2Q^1E1Y96%CD64NN=L_,H[!S&R)2F4*U]]>ADHB
M1KJ74N@#;8GFF*9U6KM\/MXUS6MNG'=D1%DM*'DI2LT*]I*)*DGH?L,@&^
M
M         !PUQ9^_-F']);_R4@UQW*#(          *0]7W[NV9?W9_BL0%Q
MM?3'_H+@_P#85?U[H&K:!
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M*:R:]L)/?:-&I&K1&AGN5JG:9*T/0AJ\P0
M                                            '#7%G[\V8?TEO_)2
M#7'<H,@          I#U??N[9E_=G^*Q 7&U],?^@N#_ -A5_7N@:MH$
M
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MS+0O@(!DQ>-./X6.V&)1L<@(QFT>7*L*KL)5&>?=V[G%(/4MWN)T/V:%IIH
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MMVQ.[KUT(!M,;Q?'</JFJ/%JN-45#)FI$2&VEIO>KY2C)/BH_:H^I@-L
M
M       #AKBS]^;,/Z2W_DI!KCN4&0          4AZOOW=LR_NS_%8@+C:^
MF/\ T%P?^PJ_KW0-6T"
M                                            # N[$ZBEL;9+?>5
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M=KLC5(,SE-0CV]U#)M$6Q:B/;])KIX]=2(L=# @
M
M     .&N+/WYLP_I+?\ DI!KCN4&0          4AZOOW=LR_NS_ !6("XVO
MIC_T%P?^PJ_KW0-6T"
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M@O'Z"]BXW58PSC<*!(K3;L=ZG'"[[C*3(S0I3F]QWX=3T =Z@R
M
M                #AKBS]^;,/Z2W_DI!KCN4&0          4AZOOW=LR_N
MS_%8@+C:^F/_ $%P?^PJ_KW0-6T"
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M
M                            X:XL_?FS#^DM_P"2D&N.Y09
M !2'J^_=VS+^[/\ %8@+C:^F/_07!_["K^O= U;0(
M
M
M                                                         X:X
ML_?FS#^DM_Y*0:X[E!D          %(>K[]W;,O[L_Q6("XVOIC_ -!<'_L*
MOZ]T#5M @
M
M
M                        #AKBS]^;,/Z2W_DI!KCN4&0          4AZ
MOOW=LR_NS_%8@+C:^F/_ $%P?^PJ_KW0-6T"
M
M
M                                                    .&N+/WYL
MP_I+?^2D&N.Y09          !2'J^_=VS+^[/\5B N-KZ8_]!<'_ +"K^O=
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M?:8;U+>XO3:A.I:GT 9$21YN*Q*[3C'?;0[V7D['4;TDK:M/711:Z&7P@/8
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MP(%BP@0               !B6D]NKK9EFZA2VH3#LE:$:;E)90:S(M="U,B
M0ZEY3J;N3@L5B%);7GE0_>UZE]O1AB.U&>4A[11^\924D6W4NA@J> @
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MD&N.Y09          !2'J^_=VS+^[/\ %8@+C:^F/_07!_["K^O= U;0(
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M<F4+"Y+A8RC',@N+2"A*3[JZPXBD*U,MVJ4K61:'[0$:H:'DO,,"A\HHSJ?
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M5.&Y9C_)M_DM9,KWL/RQR-,MXLEMY-C'E0H28:2CJ09MJ0OM-J5W-#3[Q%J
MT62JK+GG_$ZGN,S29QK(46L-*TN*;9D/0&R[R",S2E?5);O$!C1>-^6Z7'?\
MMJ#*JQ&!H957P;J5&D+R&%6*(T)CHV.)CN.--GVVWSVZ$1&:#,@&_K.)8U%E
ME3;4DE$>@IL0=PZ%7K2I;Q$J0P\AY3FI$K1+.BNFIF>NH#S9XMFM<$'Q"=BT
M<\Z%=%]Y]M79WK9-KN;-=VG7734 S# ,JE6.$9/ATZO3DF',3()1[9MXX,F/
M9,,LO&:F#[B%H-A"D:=#ZD8#-B8C68W9\A9#E=A#_5[,G8SLIF49,,,L,5K4
M%Y#KCBB2:5]M2O9[I@*?XM@Y=AW$=-98DU(L,JY OH,:+:S8IOKB8ZQI&B2)
M*$FG1INMB)6G<HO><+\HP%Y\GX,UR3@=SA3LQ4#[T;;)J8E!/$V]'>1(:-;:
MM"6C>VDEH,_>3J6I:@B'2,$Y6RR\Q*YS>ZI(S&*6R+1-52QI1LRS*.\P;BW)
M+AJ0M)._1H21I3JK<I730K]ML"Y,S:\H4YO8T+.,XU=,9!$=IXLHK*2] 6I4
M=I1R7%H829*^F4V:U++5);248#P]0$"79N\90:^P756#F91%0[%#:7C9?:KY
M[C:E-J-)+0:DDE:#46Y)F6H&-M2X/G%SF51FG)EA5N/8RU*1CU50MR6XQ2)S
M9,O2GUR5FI2^UN;0V1;4$HSU,P'E4<,QD\./<39!/4^V^Y.?.SA$;#C3TFS=
MLH[K1&9F2V5K09:GH9I^ "L*?Q]REF[$/&.2KVE?PJ+(CR;,JB&^S.NBA.)=
M::D$\XIJ.VMQ"5O$SN-6FU)H28#*M.&4Y8O,;+,+$GLAR!3<;'[&"A;2Z2!7
M.=^O*,HU[^\A\O,O+)22<<Z:$E) 5]_Y4V-]>SKG.9\>>F[PQK#KV/";6QW7
M?,2'7I#2C,]B5D^>U.FJ3]H#VQ2BYIH':NAL;NAM,4K#;87;.QIB;J5#93M2
MEQ!.]A+QD1$IW<HC\=FH#!R?!.3,\GQJ?*;&ACX3!MHUNQ)K8THKE::^24B.
MT1O.*;87[I)<>;49F6XDI22M $EP6[RR_O<TDW4<X6-P;7[JQF,]'6P^XS!:
M2F3*-:C^D;>?4HFC(B+:CVZZ@B;@                .&N+/WYLP_I+?^2D
M&N.Y09          !2'J^_=VS+^[/\5B N-KZ8_]!<'_ +"K^O= U;0(
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M4CU(^I& Q:>EI\>KVJF@KXU75L:]B%"9;C,(W&:E;6VR2DM3,S/0O$!G
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MTE[%[C,!KI%7G"O5"TIK)(B(_P"JZY263K349516[6Z)KYDOI3/_ .Z-.GS
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M!KCN4&0          4AZOOW=LR_NS_%8@+C:^F/_ $%P?^PJ_KW0-6T"
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M/XY$E-S'9\YM\WOO&4J.E#*5I09LHV[EJ(S-2BZ$ MX$
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M2DC,S 8D;)*&9/C546QCO64R%]ZQ8J'"4X[ W)1YA*2ZFWN6DMWAU(!M
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MI-#'E,_?,=E$V5 0HN\AF0I:4.J2771:D*(C]ID8#8
M   .&N+/WYLP_I+?^2D&N.Y09          !2'J^_=VS+^[/\5B N-KZ8_\
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M*0:X[E!D          %(>K[]W;,O[L_Q6("XVOIC_P!!<'_L*OZ]T#5M @
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M\?:P^96KL/=[93';.*\EKQW;C0A2O#3H KC,,,SYPN17JRNFN5%KEM186<&
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MH*YBHI(3-=5QB44>'%;2TR@EJ-:MJ4D1%JI1J/X3/4!F@
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M+5E/P_+FJW&K"'GV.1U)ML><>B-R8:)$=QQJ:V^;O9>8]TU)4VLU'M,MNI:
MK]]-T5F/Q1CKJ,51C;LBMKG792?*&NU4N&VLYRCC*4HS=4I2OI]'.O4@-0_%
MZ?&\_P LR"FY5N+5CE2-8S%P*)-K.J&HU4EU10W:IJ(\PAYI3*4J6]HM>_=O
MT 2'.N0\_P ?Y=PW$Z3')LV@EQK5;C;<FN3]Z''8BJ2XE3[I+;**IQ6\EFC>
M:NF[0!(;+E:P?O+6DP/$)^8?J\\46_GQ9$2%$8E;"<5%9<E.([\A"5)-Q""V
MHW))2B4>@#T<YHQ16(5>55T>=/DW4HZNKQQF/MN'+1M2T.Q%L.*233C)MK[R
MG%$A"4FK=IIJ(A?)EYE>08A7(R;$G\8D,Y7BWE&W)D2P3))VU9(R0<5:C2I&
MA$HE)+Q+:9@)VYGL'*9&3X_CT-^?6TT.4Q:9$C8FN18$A1'":69[GG4%J;W;
M(T-]$J5O/:05=Q?R\[BW#>&6LG$[1WC^JJ8$.XRM)QT)8<0E##KR(:G/,.QV
MG.BW4I\"-24J26H$6GE/)3U7D*<-Q+'Y>6Y:45-A,AQ'6(D6'$<6:&UR94A2
M4(4Z:5=IM.Y:B29Z$GJ K?ES/(&;\,95&\E)I\AH[>A@W]!8$A,N&^JX@.(U
M-M2T+:=0HELNMJ-*T]2]I$,6#?\ )\V/E4O#L-Q>9EMS4-,2,A.-(BPF(*):
M36RVIR4X@EON(+>EI/Y)D9J+4!7?%_(M%CV/\E9A*8EK;LL^F1:RG2SMLY%C
M)BP&$0D,+4GZ?NI4@TFHB+::C/:6H"PJGE22JPFT.88O-QC)6*U^[@P7GHTQ
MF="BF27?+R8ZU-FZVI22<:5H:24E1;DGJ T$'U!1K#'8N6LXE:IQZX.#"QA]
MU<1MZUM[%9-(ALM+=)2"2K=J^]L;,DJ-)F6FHBQ<3NLBNH;[N2XT]C,YES8B
M,[*C3D.H-)&2T.1E*Z>PR4E)Z_%U!%<4_(F?S.;[?$96,3F\<CUT%:&U2:TV
MXR7I4M!V"C2YW%(>2VE*6R-2T[.J"U!66?-\F9#E91C>%6E[QS!6\E_*(CL1
M/>;BJ-+S\.(XZEZ0R@TG[Z2(U:'L)0$2_);.OR'C*YMZ9]$RKLZ.5)@R6]=C
MK+\1:T*+70]#(R\014G'?,4C&>(\+MI^'VJN/JNDJX-GE:#8,F5,1VH[KY0M
M_F5QD++WGB1KM(UDDT>\95DY)R5(@WQ8IAF.RLPR-J*W96#,-^/%B0X<A2DL
MJ?E2%I03CQH5V6DZJ4E)J/:GJ WN$YE5YU1)NZQMZ,:'GX4^OF))N7#G1'#:
M?C/H(U$EQM:3(]#,C\2,R,C!%(<8\@W&.8WE#5#AMGDT2FR;(WKZ5$<C1B92
M=B^\;<9,AQ"I3I-&2S0V1%U).[<>@*L^WY:JT0,;7B-;*RNZR^+]Y4%5"V,*
M5 )M#BY4EV0:$1VD$XA)FY[QK42$I-7@%?\ *6=1\RXLO8$FO?I<GH;['(E]
M0S%-N/1G'K>"ZTHELJ4AQIU"MS;B3T47P&1D GM[RA-8RF=B.&XK-RVTI$,/
M9$Y%?BPF(12D&XTT3DIQ!.OJ06\FT]-IEJHM0$>].MA'MZ_D*XB-NLQ[#-K>
M0AJ2VIA]!J:C$I#K:NJ%H41I4D_:0&I%EW(V3XO(L93. V=IBU.@WK*Y8E0&
MUFPVV3KKD6*X\3KQ(3KT/8:C(R21@(=F?+.8,Y_QU&PNCE6^(Y&S,FLKC/U[
M:+EA5:4EKM*DN(6SV=W<5OV;_ MW@ NJ>5D[622JU-1[=;"RAKE(-UAN0:#V
M&ZAM234DE:;B2HM2\#!%1\*MY%7YKRAC^19%-R615V%5I/G:(+N2ZMJ2\3+"
M/HV6NXL]C:/DIT(S,^IEUA\S(S.NS# KM&2/1<;?RVDJHM! )49#J)7=5)<G
M.DHU/Z["2VV6U"2ZJ)2CU(8MN[NIE3+J(T6GEVC=G+*)(D1.WLA-FE2N^_O4
MD^V1EI[NI]? $5+34?\ G/D.:V^0W%O$I\>NI.,XW75%C)JT1UUC;:7YIJB.
M-FZ^I]:R3W=R4)21:'J8*CD3.<OR:FQSBIZ]?C9/,RRXQ&]R:(11YKM;C;;T
MEUYA2?YI^0PEA/<+Y)J4HB(]- ET2 YQ1REB>-4EA82\.SAFRBO5MI-?L2AV
M=:P4QM]AV6MUU)/-D\EQ&_;N))D6H"?\C9>C \(NLK-KS,BOCGY&(1*,Y$YY
M1,Q6"))&?TKRVV^GP@BON''<IP[)[GBO.;A^\MG(,3*JJSENJ?<=;EI3'LF4
MJ,B(FV)B#-M'B2'D@NIURO-E5O%N;V,%Y<>;#H+61&?:4:'&W6H3JT*2I.AD
MHC(C(R\ 1"?3Q?VR\>D83DEA(M;JB9@SX=I,-:GYE-=QBEQ75K69FM3:S?BJ
M,O\ YT7P@NHO?93>7_/V)R:RWD1\/J+R7BGW;'=6B//G-5#\V<\Z@M$K)APV
M8Z25KHM"] '1H(YSR=>&V?-^6UG(N7R*&JA5%*[2QCR&10L&X^<KS"D(:D,$
MX?N-[CZZ?Q@JU&K)K&,,JBX]KI><1'3[5:J/9-2M[:][AO.SYKYDILC+;NWK
M5J9$1? &E1S9!A4V1R,FQ^PI\FQ=V!'L<<(V9;[SERX34 XKS2^RZB0L]A*W
M)VJ2HEDG:!&#FW(?)-5QAEN0?J/+I+ZM@2G8BRGUDQ+"$Q'G?.F?=VJ*.I"3
M6UL-2M?=)9:@,JKY6L:_ <;M,BQVP<S"^./!I*!A<21.M)"HJ7U2$FR[VFF=
MI+==6ZI!-(29J(O=(P]D\S,U]7E2\KQZ919/B-:=Y/H''8\A<BN,EFB1%?:7
MVW4&;:D*/W30LM%$7341X2.<8M?A\[D.YQBTKL);>KD5$][L*DV$6R>2QYE$
M1#BG6T)-:5DETB6M)EHG7H!&?4<IV#F456-Y9B%CBR<C[Y8U.EO19+4ER,V;
MZF'RC..'&?-HC<2AS4E:*(E;BT ;;.\!I,N:3.M)5I'>@,.DP57:3JQ)ZENU
M6F(\V2S(RZ&HCT!%5\.8M1HX=JN2L@F7=Q92L?D2;AJ7<6$EF0AQESO$3#L@
MVB4I)&23(BV^PR/J"I'!Y9HZ"GX_QG$<6LIR\GQQBPQ*HCK;/MQ8[$?ML2'W
MW=&^VTX1K=6HR]T^JE&DE!ZP^;+6VE3L=H\#M9V=T2B_6?'S?AQT5Z'$DMDS
MF.N$RZ<A![V$M&9J(E&K9H!&V>YGQQ_$L=R7'X<RZGY<ZJ)CF/,(;:L'Y;6_
MOM.$ZM*&BC=ISS#BU[&]I]3Z:B-IAF?KR2SLL9O*63C68U#;,J93RW&GTN0Y
M1K)F3&?84I#S1J0M"C+0T+2:5$734B:                 .&N+/WYLP_I+
M?^2D&N.Y09          !2'J^_=VS+^[/\5B N-KZ8_]!<'_ +"K^O= U;0(
M                Y&3)2[Z<[KC5,>2O-\?O$+MZ0HL@WFFWLP3)0LM6]KB%
M,J)PE-FHMO7V&#2YN9X<N7/XO5%CNR$QLWKGY!M(4YVV4PIR3<7M(]J2-1$:
MCZ=03%05=?BN"R+_ !?DG)<OQJS3;V<JM16R[,JZS@6$ER4T]$1":<0:S2[L
M=:(S63A'KX@J_&*K"<.XN13R(CSF U]7V'H4F._.>.O6C12'6"0MU?NJT4C8
M9_$#*N>(K-@\VL,=XVM+*\X>;J3=)5FB2N/56J7D-M0X,N6E+KC:F34I;*C<
M)K:6BBW;05"L3DOJXNXT.M@3)]_Q)9Q7\UQDHKZ)K#*V9<-Y3;2VR[SK._NH
M0V9FI)'IXEJ5.\@RFIYGR;!*? 2DV$#'[Z/DU]>'$D1H<)FN9>2B.I<E#1F^
M^MTD$V@C4E.XU$1 C#XMSJ@X<Q2/Q=R*<JFOZ"3+C1'U093\>UC/2G7F9<1R
M.TZESN)<+>G7>E9*W)(!IZC%,HHN0,^Y=Q^K=M+2LR*9#E8\^V1+FTKL& XM
MZL4LBV2B4D_DGM?2GMJZDDR"=,6#63\S83E=2Q(<HI6*7!HDO1W6>VMR9!T;
M<)Q*3;<]U1&A6A]# 1#E##\CRW(^5ZVC@')FR*+%95:AY)H8EO5%E)G+C)<5
MH@U.$WL\="-1:] &5R9R!2\PX),XSPF)82<RR8XT*36S*V5%53MF^VN0_8J>
M;0ADHZ4JT]\S6YM)O=KJ U688OD=ID',,^HJY,Z379!A^00H*$&G[Q9IX<-Y
M]EE2B)+BMK:R)*==5D2?$P&PY"Y&HN1[#CJNPJ+86R(.94T^ZF%73&FJUMI:
MTDB0IYI&QU2E[=O7:DE&K:6FH1N!"QC!;?**+DC)LNQ>>Y>6=E4'5S+,JZR@
M6,A<IIV,F$TM!O$3FQUHO?WD9]=05.\.Q2OQCF#%8&-PY;6)0./Y4:"]*0\9
MH[MM$=0VXMU)&3FW4]BM%$7LZ C)Q5RDQ&RY=Q'+6#?J5V#V6+97'7+*52Y
MPDGMK#27%NI0^S):<2E!^SIU(!IN+L@J*K,)T'C^YL++A*#3O3+%VV1).#23
M8SB.VQ#ES$)<4V;/<4MA1K)K:1DHM=H";<#U\EG CR";'5$EYA:6>5+B+^4T
MU<RW)+"3^ ^PIHU%[#U(#58TC?'M=Q+0P>4W9U!-.ZR.50VT9J='GPGRMY9]
MQF3%;4IA2T.IVI7HETO8H@&3QW+R[DC+<4@Y:B9(J,$.ROF[*PBE$<LCE/.0
M:)^0RI".V_Y;S,A1$DNNQ1D1F Q["[A6&89C Y4LLG+(V+*1&P[":1VS@Q)=
M0A"#AO1CKMB7W7SW&ZXZ\9-JU2HD)3U#]XGJ;2-(X"\U D-?=^,9 S,-UAQO
MR[R_(DE+FY);%'M41;M->H#QM*VAPKD'-BY#O\HQBMO[--W06U-+GL54QN1%
M89<944)#B4R65LFDR<T4M!HV]" 7#AF*8['XS71X>[.137,>8_&E6GF#F&Y9
MFXXMYTI))=)2EN&O1:2/J H'%*CC[]4ZOC7DB\S2KRIJ,Q0VN&G+MG8SRFB3
M&UCHCM+97$=(B6A2%;$H/0SZ JY..JZ1!Y=Y94J,\U"<5CB(DEU"R0\EFK)"
MMCBBT7M/HK0ST/QZ@BL[FDNY/"_,\6/62W):\WL;!F,EA9//1(]G#D+=:09$
M;B>VVM233KNTZ + >NJ_,^6.,<LQE3EACBJO)VOO%##S;25ZP$D2^XA)I,S0
MHD[B+70] %>S)B"XJYLXY[$G]=2FY3:HJ/*O]QR#-F&ZP^TK9M<2XEY!IVJU
M/KTZ& R,FIZS%>4;G),ZMLBQS%\JJZA5=>4#\R-"1+K6%L/1)IPTJ4EPR-+C
M)N)))D:R(]W0!DJH<;Q9G".5\(1=W>(UV16=ODTB6W-E6;B;:O75NV)M24)D
M+;9-MM2B0V9FWJM)&0#<_KG6\A<[<?66*Q9LS&JBNOT.9$<20S =DRVHOT"'
M'4(U-LFR-2ODZJVD9J)1$$AYZ6<&)@61OM.JIL=R^OL[J2RTM[RT),:6PI]:
M6R4K8E;R"49$>FNH&-!49I1\?Y]E^4Y(I]G">02J[K&\H3%DO1EFS!;BN1)!
MH:-3*R[:7&2<21*0H]#W%H D'$L6;<YAR!R><*37466OUD:BCSV5Q9+\6FBJ
M9.:IES1:$OJ</MDXE*S;0DS26I (;R/C%TKD&TP*O@S'\8Y==J95G.8U3%A%
M2JVW"7%)+W#E0V8[2#/Y:S,O$!OD9! XDY0SFQS=#T+&<R<KK&ER%$=^3&[L
M2$B$]"D+8;7VG$]HG&27[JTJ/0]Q: (W*HKS,L6YWSJLJIC$/.*MN#C%;)CN
M1YTQFHK76"E%'67<3YE;ADRE:4K4A*3-):D PLLGTF5.\>\DP+"\_4:EASJ#
M([*@\]"GUK\AF(ZAQQIIKO*:)31MO[4^Z9IU\# 6)Q'6\=SK>VR[#;NZR.?Y
M=FJE6]V]/D(..E:I"&F')C:"625*4H^WN))J^$P$0R.Y@R>1\CK.5+C(Z]EA
M]EG!\:HE646)80G([:N\ARL)"Y$A;YN(4A;FC>A%IIU 1FK@65)Z?N-)]K63
M(3.,YJU;7T=QIUV3!@,7DTW''4$DW%]LG$FM9$9J+WNOB"NFXME"R;'BLJ1W
MS,&RC*7">-*VR6EQ)DD]'"2HB/XR!ES716#-QPIQQBD!B4YD6)9#B<3):QR)
M(:>A/,6*"<)U+C9=$]M1F9:EIU/H9 JW.08TMWDWB60Q'=>CQK2V5*=0A2FV
MDN4LMM*EJ(M$D:E$1:^T!0^'T6"XMB*>,N4<AR^GR*#YFIF8]#D6RJZQBNNN
M(0Y!:BLK0ZQ(;66J4]4F:B41>)E="YW+G8#Q>JLPB&])NFXT7'\6BIW.K3*D
M;(<9;BSU]UG4G7%K/Y*#Z@B")]/F8)P4^-BY,>_4TX1UAUOW%5[384DR,]^W
MN;S,]_<W[]_O:[NH%:W&;')\BRWA.7DM=*;R&B:RFGR9U;+JFT3X,9F*;JG3
M02=LC9W6U:Z*W:$9]0&ZS>#/=Y<RJ2U#D.1G.,I,9M]#+BFU/G.?,FDK(C(W
M#(R/81[OB :S,*RS<]&T>I:A2%VQ8?3L' 0TM4GNICQ24CMD6[<1D>I:= .M
MW99+5<8<R9/?YF;\''LKJ*=NIMFXS\F,<JK7,0]&6IA#AI=,GT+01E[Q>'7H
M K_[ZS")C&:W<2)=8M5W?(J',@F-0W/O>%B[]=$)4QEHT*6A2]C9*4EM:FDJ
M4>W<D] S,9CXU,Y;I;3!?O\ N,?+&[QA_);=ZSG1I,M2HFC3#E@I6BDDG59M
MDE*C/0M329$%M<"Q9,+AG!XDUAR-+9J(J'F'D*;<0HD=24E1$9'_  @:J'#J
M"YK/3[@.;PJR465\?SIMR5=V#1.?K7)\IJQB)0Z1*(WHCBEH+3WEH0 S+S'+
MQSB*+D5C!D*RO,LPILHMHFQ;K\9J191O+1U)).Y)18;;+2B/Y)I4 Q[2MH<*
MY!S8N0[_ "C&*V_LTW=!;4TN>Q53&Y$5AEQE10D.)3)96R:3)S12T&C;T(!Y
MWV(8[C,G!<MK9641.+CK;:'-N:YZP8MH;]M-;L4RII$CS1L/K2X2]S?NJ-"E
M: )!#QK#<AX\Y/M>-[&\RJ\N\?F4ASK=V=(5)<3"D''9CKFH;)9$I\RU1J6J
MM-==0'Q'NX.85?"4K'2?F,T=[&A7.L9]I420Q124N(>2XA)IVJ425'\G7IJ
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M>8X=>7>2V[$)NHDV]T_/D-E%<=.0EEER8VA*]%I-2NWNVZ]=-P(N$$
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MS)+I>29G;,LPW[-<=N&RQ!C*6MJ-&CMFOMMDMQ:U:K4I2CU,_ !-@
M
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M("Z 1J<EK[JUI9$#'K@Z"U>V$S;)C-3%LI):37M:>]PU*21I(UD9),]=#TT
M5=#EYG@/*^*85*RF9F-#E\2T>DM6K,1,RL=K&T.E(2[#98(V7C63.QQ'NJTV
MGXD"O&J/D+EB1DF24F:2<1I:NTFTV*08$2'*9?55K..Y,G');6MY+KR5DEE"
MFR2A)==QF8#;XS:9;R]QY07$2]=PJT-V3%R9%;'CR7U28#SD-]IA<M+R64FZ
MTI:5&A:MID7CU ?''=SE-;R-E7&5U>.976TL"OM(5U):8:G13GJ=1Y.8J.AM
MMQ9DUWFU$VD]I]=>@"-<J\FY6>1P(.!V*(&/XYD5)4Y78=E+YSIMK*:;56,J
M6E2$]EASNR5I/<2EMH+0]P"_@1II64TT+)Z[$93JFKJWC29M<VI"NV\W!4V3
MR4KTV[T=U"C3X[>H"*YIFF'*E2,;G7T^LGTL^A<GKJ5+;=2]:S-L*,ZM*%$:
M)"FS2ZC_ .=GUT(]05EY5RE38G8.U\BGO;)41M#UA)J:F5-C16EEN)3CJ$;3
MT26XTMFI1%XD E=1;5M]5P[NGDHF55@RW*A2FCU0XR\DE(46OPD8(HWB"[BO
M<>\8/9%?VR;J;:7:*]II]QQ-B\P[8J-B8:B6:VT-(-3:5*+WTHT\- 5:;?)6
M&N\?GR>BP+]32AJL3G&A1*)E&I*+MF6[>2BV;--=W3Q!&JR'F/$\>LETZHUK
M:642.U-N8U1729ZZR-(2:VUS>RD^T:DD:B;ZN;2UVZ=05-:FUKKVLB7-/);F
MU<]E$F'+9/<VZRZDE)4D_@,C!$&5S1BK-LS7SH%U KI$I-?'R&;52XU0N6MS
MLH;\PZA.A+7[B%J22%'X*!8E=;E=+;9%>8M">4NYQU,-5JR;:TI;*P;4ZQM6
M9$E6Y*#UVGT]H(T[W*>#Q:/(\CF67EJ?%)[U1=2'6G4]N;'-LE-(3M-3AF;J
M$H[9'N4>A:F KC)>3XF2YCQE55Z+?'[-[(3<E4MO%DU4F37_ ';,^E)MPB2Z
MR3A))1:F:%;=R2/0%3.ISG",:Q>]R&3D,Z941+VQAR7[,W9,E-CYQ3:H,1M+
M>]:$.?11VFTJ]W334!GXORGCN3W'ZNJB6=#D*V52HU5?07JV1)C(,B4ZP3I;
M7"29^\25;D_E$0(WKF4T[.5Q\+=<6B]EP';6*VIM9-.1H[J&7=KNFPUI4XC5
M&N[0]=- &+69YBUQE]U@D"<3N38^U'?LX>Q2=C<I)+0:5&6U6A&G=M,]NXM0
M&IL.7<(KH5E-5*?DG76R\;*)$C/2)4JX;0EQ46*RVDU/+(E:*V%M(R5J9;3T
M"$<G\E5V3\*\B/XT_/J,DHH!IL*Z6T]6VT!UTDN-*6VK:I).(]YMQ!FE1:Z*
MZ'H5*:[FW")=I5U9G8,0KEU$*BR*5 DLTUC+67N-1IBT$A2G-#[9GHES3W#5
MTU$;'*>4\=QBW_5U$6ROLC2RF5(J*""]928\=9F277R:+:TE1E[N]1&K\DC!
M'S<<HU53$K9#='D%E)LXI3FZ^OIY;TIE@]"UD(-"2:41].VM1+U_)!7Q(Y@P
MEK&:S*(C\JQ8NGUPJFL@Q'W[.1,9W]Z.F(22<2XUVU]TEDDD;3W&0",<D<W.
M8O@47**BBMVK"=,CQ&X]C3S"\NGST>.^4A*=O;4IMU7E]5:.+T).[P BTZ6W
M9O*F/;LQY4-F2DUICV$=R'*025&GZ1ETDK0?3711> (A4/FC%)-Q7U4J#=5,
M>WD)@T]Q:U4N!73);A&;;+;SZ$Z+<T/MDXE._P $ZGH"QIZKF9RQY>LL 53V
MC=7&AQ#C/*J)B%E,>D26G77G5%M3&-+2.TZ:22H]WO'H!%AJRJF1EK>$K<6F
M_>KUW##2FEDTY$:>3'6:7=-AJ2M:=R-=VBB/30$8E1GV*WN6WV$5DXGLDQI,
M9=O$VJ23:9B.XC:HR)*]"TW[3/:9D1]0&)1\FXED64SL/JY#R[B!YLEFY'=;
MCNJK7FX\M++RDDAPV774(<))]#,!EU&?8K>Y;?8163B>R3&DQEV\3:I)-IF(
M[B-JC(DKT+3?M,]IF1'U 8=#R=B.2Y79X952'G+JK*0;W<CO-1W/(OIC229>
M6DD.=EU:6W-I^ZHP&92Y]BN093D.&5,XG\@Q?RWWQ&)*B)OSB#6WM69;5Z$6
MB]IGM/H>A@,BDRZFR*-;RZ=3TEFDG2ZJ89,N)-4N 9)?0T2B+N$E6J-R>AJ(
MR+P 8"N2L.3Q^7)ZK BPTX16)3MBMW95H1)[>F[>:CV;--=W3Q :4LXPO%%Y
MO?6=]8*AU=E :OFYYN.Q:QZ:Q%;:;CI)!;&3)YMQW0U$E2EJ,_$%1;-_4%&J
MJ"%;XW2W+K<RX@U[4V523O*OPWY3+;KT=6C>[N-N'Y;7^<5T))@18]1GU#<7
M,#'FDRXMY8U:[UFOG17HKZ8+3Z(RC<2ZE)H62W$EL5[WMT!'NG-L>7;9'2I?
M<.PQ6-&FW32675FVQ-;==:-&Q)FX9I97[K9&?LTU,!HL?Y=QR^OXF-O0+BCL
M[)#KE,F\K9%:B>F.GN.%'4\DB4I"/?4VK:O;UV^(+$-P'D.#BV+Y%/R63-L9
M<G-LBK*>OC-O6,^2MN>^;<>,RC<HR0V@STZ(0DNID0#XY0Y"974<=91K9XU5
MHS6&Q<-6;$BMD%';A336VZT9:N(6HD;2+<E9Z::F G^*\GX_E=R_CJ(EG3WS
M3!S6JZ[@O5S\B$2R;.0P3Q%O02E$E6A[DF9;B($:Z;S1BE;:>3LX-U!J2E%7
MJR6552V*9,I3O82E4I:"(DJ<,D)=,NV9F7O: L9-_P O8AC^1NX>Z4^PREDH
MRSJ*R#(FR39E[M'B2T@_HD;?I'-=J-2(^ID0##M><<%J+2=!?5/?KJB1Y&\R
M&+ D/TU=+U(C9DS$)-"5(-22<TU2V9^^:>H$1J[SV/BW.UFQ-=GV#$G$ZURK
MH*QMZ<_)D'83C<<8C-:EJ2$I[CAZ$2=-5> "?4_)V&W&+6&8%..OJ*9;S-X5
MDTN%(KY$8B-UF2RZ1+0XDE)]W3KJ6W74@1K*+F7%+NV@T[T2VI'K<S312+NM
MDUL:Q,DFO;'=>21&HTEN2A>U:B\$F"Q'\(S&!CB>7<AS"W.-04>5R$JE2W%N
M-QXY5\ TMMI]X]#6O1#:"ZJ5H1&9@-!FW*L/)+SC2IJF[K'[23ET%UROM8DF
MI>FU91)9.+0EPDDZR2U-[T:ZI,T[DEJD!/+[FO"L?M9];(38S(U,LF\AN*ZO
MD3*RK7M)9IER&DJ2@TI42EDG<:"ZKV@1E95R]A>(SXM3.>DSK>QA%95-?517
MK"1.8-PF_P#EDL)5W%==VB?!&JOD]0&+:<U8A6V4VC9BV]ID=:EAVQI*RLE2
MYL=B3';DI><;0C1*"2ZE)]==^J2(U$9 1A.>H/C78S.B2ID_&U$QYW)X<&2]
M3P52DI4TF7*)!):5HM&\E?S>I=S8!$CS#D>@PV5#JY+,ZUO[!"WX='2Q'+">
MN.T9)<>-IHO<:2:B(UK-):]"U/H"/-/*N#'AQYT=D::)+IQ%I4R\4Q,XG.R<
M,XNSO>8[GN=G9OU]F@##JN7\:M8]II7W,2[IV&IDO&Y=9):N51'U]MM]F)M-
M;S9J(R-36[:9:*T,%0#&N8(7('#DC)<U>N,4-F5'3.MJB++@)U7<^7C-Q'G$
MN=PE&AMJ22#5H2E$K;KT$3_(>8<2Q^_FXF3-E;99!0P\[25$!^;+4Q(2:R=2
M2$[>VDB]]9J(B,R3\HR(!G-<IX*YA$GD-VU*+BT'N)GR)+;K+T9]ESLKCNL*
M23J7B<^C[6S<:C(B(]2U(TM;SEATVZJL<L(5S0WMZ_V*6#=54J"Y++8I9N-F
MM!IV))/O[E$:3-.XBU(%BPY\^%509-G92&XE=#:7(ERGU$VTTRTDU+6M2M")
M*2(S,S!$*QCEJ@RZ>U'JJN\152FER(.0S*J5$J9#+:-^]$AY*2)*D]4&LDDK
M\G4%:UGGS 7GF7S^\F<8DOE$BY@]726J!U];G9229JD$@D*7[B75:-&?@L"-
MOD_*^*8M>JQ644Z?E9Q&K"-1UD)^;,D1GG'6][26TFDR0;*^X:E$2>FI^\6I
M&C=]0?'GD_/02M+-B,TI^\*OJY<A=.TVM;;AV2$M[HZD*:<W-J+?HDU;=O4%
MC-Y7S=^KXX^\<,F-/7^5JAT^&RFUI4VY-NE);COMJT4DR;0M4C4R,MJ/@ 1Z
MNDYIR3;6V/8_E,J@PC#7RQZPOHK4=V[N+:(RCS9DY(:<;8;:4I*5*0R:EN;M
M#)): ),>"9E6XI=T])GUK*NY*4.4-K<HA2'8<AD]Y)6;<5!.-.*(DN$M"E$G
M7:9& T1\UN/<:M7L2KUY(D3?U71B2C(UHRHCV+BK42M"9;ZR%.&HO^7+?KU(
M"/BSN,^@/XOP]1WR)?(4ZM=MLFS*9&:<*'"9<2TY(9B))MM2W7W.U';5[J4I
M,UDK3J$GQOC^^Q^X9M9.?W]XSHOSM;:_=[D1Y2T&1&@F(C*VMJC)1$A>G30P
M$88GYGRY?W[-%D,C$>/,=GO492JQEE5O:6$/1,M9/2FGFV([3GT3?;;4MQ25
M&:DEH0"94^(9)1T5K4L9I8V<Z6E15-K=,Q);\%9HVD>C#49+Q$KWM'/X-017
MURO/.+\JP;?FD[,8>67**.VI+2-!0LB>CNNJFQ%0V&%-(C]K<XV>])I5XD>A
M@K8R9.8\E9YE%#29/*Q+$\,5%KS?JF8KLR?;2(Z9;AK=EM/)0RPAQM':2C5:
MC49JT(B >N(6N=YUBMUC$G(2H\WQ2[=H;?(8<)APYC,9+;R)#,9\UMLJD,/-
MF>I+)"]VTM-- \<<L,LQ#EV-QM/R63E]);4<B[2Y9-QDV=<Y%D-LDI;D5IA*
MV'S<-*-S>XE)Z'H U7J"Y)RBGIKVCXXL$5]]CU6>09'=&T4DH,4E&46*E*DJ
M;\Q,6E6W?\AI"UZ=4 8NZ"XMZ%&=</5QQI"UG\)J21F"($GFC%2MXU;,@75?
M FRDU\*_GU4N+5.RW%]IMHI#J$Z;U^ZA2TDE1^!^ +'K>\Q8G27EEB[,>SN<
MIJC9.92TU?(G2TM2&4OI>T0G;VMJR(U[M-WNE[W0",\N4L'_ %'5R(NT)&+(
M(TKD+:=2\EY+O8-@V-O=[W=^C[6S=NZ: BN+WDV+DW('&%57HMZ"Q<N93DVC
MMXLBKDR()U<LTN]IPB2ZT3B4Z]3V*TW$1Z JWLGR:#BE85G.CS9A+=1'8B5D
M1^?*=><UVI2TPE1^P]5*T27M,@1'ZCEK%;:IR&S=;GU;^*1U3;^IM(3T2QC1
MB:6\EPV%$9K2M#:S0ILU$K33Q 8$+G/!9]A71V"LDTUP\W#J<G=KY+5)*EO'
MHVRW+6@DFI2O<29Z)4HM"49@L2['\LI,F^^"JGEJ50V$BGM$/-K94U+BDE2R
MT<(M4FE:5I67NJ29&1@AC&5TV78W#RRD<<<HY[:WXK[K3C*ELH4I.\FW$DK:
MK;N3TZIT/V@(O5\RXM8W,"FDP+FF*W=\O26-S52JZ%.D&DW$M,NOH3HXI*5*
M0APD&K3W=3!8]+SF#$Z._EXZ;%G9RJI*%WTFIKI,^+6(=3W$G+=90HD&:/?V
MIW*)/4RT B <79'66&*XE.M\ELC>LLPO6J)R'(<<8L=)-@;+,A6U>^,3*36@
MC-):I1\&@"=7G,^(TMK/JFHMM<G3*V7TREK9-C$KEDDEJ3(=829$M*3W+0C<
MI)?*(@(WY9]BCCF,(C6"92,Q-Q.//QR4ZS([,9<M1[TD9)+MH4?O:=>GB",F
M7EM)"R1O%)#RRNW:Y^Y0R3:S2<*(ZVRXK>1;=24ZDMNNI@(C4\[8#>5=E?U2
M["3C536*N)UZFODE7I;;2E;D=+ZD$E<A"5$:V4:J3U(^J3(BQ]P.;\'L+>MK
MF_O%FNNWTPJ+(Y%?)8I9\MPC-#,>6M!(4I>BB;,]$N&7N&KH!'O>\Q8G27=G
MC#4>TN<FJ.RJ?3TU=(GRD,/LI>2_M;3H;>U:2W;OE>Z6JN@$:USU!\;=IFPA
M29MCCIH97/R.% DOU5?YDDJ;3-D$C1E6BD[TJ+<WK](2 (DF7\C4&'/0H$EJ
M;:WEDE;L"DIHKEA/=9:,B<>)IHO=;3N+5Q9I3[-=>@(P'N9N/(V)Q\UE6AQZ
M!Z<50^Z\P\V[$G[S;4Q*94@G&5H4DR63B2TZ>PRU+#'^7<9O[)RF\E;U5L<9
MV? A6];)@/3XD?3>Y$2ZDC=V[DZHZ.%J6J0&CXLYA=Y R#**:346,--9:/1J
MQUZKEQ&40V8L9PDRG7B-*))K=6?;5M/9M/:!%L@@               #AKBS
M]^;,/Z2W_DI!KCN4&0          4AZOOW=LR_NS_%8@+C:^F/\ T%P?^PJ_
MKW0-6T"               AW+-1;W_&&8TE 2EW-A33HT)I&A*<==CK239&9
MD1&O781_& J[)>2N-;/T^RZ6KF17I]E0GC]7B+)I7:)M'HOE&8)0T:NI=;=-
M*3+9[FW=X%J"MCQQ6S*SF"7 NU)D7]=@.-PILLS):U/H?F$^9*\=%K01G\.A
M -YQ8K_\/^7D$>B2R&&K:7@1JIX6IZ?">G4!I\LNZ;)N=^+(..6$:VEX^O(I
M=ZU!>;D'!957G#2<CMJ5VS-]:6R)6A[M?@,!A<<YWB6#U'(=9E-JQ6W-9E=_
M)?J7UI1.<:GRE28BF(YGW'2D(<1V=B3WF>TNH"&<8DRH_3$A9I4I-/D2VB/K
MHM,%I)F7QD2E)/\ A,%2;DZML;OE/.*.C(UWECQ1+C0F6S(EN/.SY*&TEJ9:
M&:E;2/V:@C18]7U&?8+C>/3N9D-5<@ZN.SB_E*>!81YU>XRZU")"4$^V\TZR
ME.TNO3VI 7KR5R+0\7XN]DU^O5)N(B5\0EI;7+G/$?:80I9DE)JVF9J4>U*2
M-1]"!$&XCL\.D74R_N,UH<AY;RLDE+BUEE%E%$AQDJ<:KH#:'%*[+"=RW%$6
MKB]SB_9H5D\\*),OBC4]-<_J"+^$XLT#%FVV04M$NO:N)S4-RVEMUU:AU6AO
MRWB4I#2"]JC))G_$"-/R+R!C_&6*R\LR-TTQ(YI:CQT:=V3*=Z-,-[C(MRS]
MJC)*2U4HR21F KOBBXPZ=D,G*\BS/'[?EG*&TQ4UE=:1)A5]>R:GFZR&E#AJ
M6E'5QY:2^D<U5X$0*PN-<\PWBNIRK"<^NHF.V6-W5M,:9L7DLNRZNPE.3HTJ
M,@SW/$M+NS:T2E$M.TRUTU#3X[R ?$/#]&JW9CP,]SJPM+*CI[A],*,RJRF.
MRR<FNN&DFF8[+S2WRUW:GL+WC 2S DTD7$,AJ.-LXI,KY=M69%M:7BIL>4;]
MJ^DFTR'6HQNFW&:4:&V6DHVH024]3,S,*PSBBY5PKCS$\9DTF.E B9+1+3.3
M;SY,N9:.6*'3?DJ=A-ZG(?,UO+W&:24>TCT(@5TO"R-J.]34.32(</-+6,X^
M55%>6\A9QDI-\V5+0VI2$;B]Y2$_P RAO-K!U=9C_)#.J7\"MX]K-=;;[KOW
M-(UA6:4D770HSRGC_HR!<5=8QESN,F.0)FXIN?9]1WS2GDDEQ-6JUC1ZQ&OC
MM*&RRLM?:HP&_D9[/R#)<V;R3D3_ "]JL4L7*N'C<)NO*UE,---NMSE+G-2'
M'"DFL^PVPT1&1::J5KH$L],_^A&#ETZ5^AZ'KU)YPC_C^$#53<<.(7BGI]4A
M1*2>39#H9'KKHBW(%;)5<Z>9N^G<R<.K>RPLU-DV".-^J1__ 'U4SK\DD?>I
M>6T^ P1^4"[2BSWDNEM.3TX'8O7[]XS7SHM<M$NLF,,E'E-/V"-5H2EOLK2V
MHR;-&AZ:@+=X^I:_CSB:+"Q:8YEE?70YEC5R&>UNGE(<>FI0SV")O:M3FQO8
M6W330!SKR#EK^6<+M9-?\F-V%W?+JI2<%JT5[,*,I<Z.XY&>03;LPBBZ'W'7
M'TZ+1UTU))E7%3W]'AW.7)1Y99Q:-N[@4$^I>L7VXK4F/#8D1WU-K=4E)]I?
M19:ZEJ1@BJ6+"/98K;YS&-;F)TW,A9#<N[%ZHIV291YE;9)W[$&XU)TVZ["W
M&0*L3D/-\)R/D_B"MQ^TAW%JU=ORU2J]UN6VQ%=K9*=JW6C4E)OJVFA)G[VP
MS_)!$)@.M5*:;,;@C7AF.<I94]?JV[VHIRW9D6),>]B6V'G$[EG\G=J"K&S7
M(*#..1>,ZG"+&-;WE-;.WMG/K76Y;<*F3!D,/)>=:-1(*2MUIM"3/W_X@1L^
M;UHQD\1Y7-.C>$VR3N'2W*--'<(\C-,D)U-6PULO:?\ T,#%;'*?XPQK#>><
MB;4R].?NIF9-,-FXLXN5I.;#;4?51$R]'@QR+\G4_C 8-MB]Y@S7"]G>9 YB
MRFV;M61Y2]&BR6X60Y(34QSS!RB4A!.N&^PEU1>[T3J1*!61R+C]>O ^4\Q+
MD9O-[W]6$4TY$<J]IJ.PE]<ECN(@$1=PS6YM-?4TJ^#0$2'E7-L,SGB2LQ/!
MK**_DV1RZ:'C='&6GST:1&FQWU]QA&KC!1&V5F\:TI)O;HHRU ;C LBHL'Y
MY+HLXL8U1D-Q=E>UDRR<;BHG4ST..S')AUTTDX4=3+C:TI/W#_A 8UWR')R/
MD.UQPL_B8'AE36U]E7V+)UZY%ZS9(6M4F-*G$ZR4=@T$V9M-J,U'U41:$80S
MC>NPJ^PF7-MLT50WT7-\CG8AES\B+"LEOJ=42W%-R$(:<[S*]9#'9)*DJ^2G
MIH5GY)G=KF? >165[(BS4X]E%=6JR6N2IJNLX5;<P%G8-$9J)+>AJ)S8M;9*
M0HTJV^!%ZY)ES<'!+S,<72UD*JZOF38#,-PGVY3T1M:B;2MHU:ZK1M/;J?\
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MX$@-9R0AE_%^>V'R)<=W+,8;>0KY*FUJI4J(_B,M2,%6UZA7FXF#5UA)<2Q
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MH(<Z49[U*?;G2TOF2O$R4M&I_#T ?7%AM?<_,ZT;=WZX9 3BBT\4Q(Q=?X"
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M(5HHBT]T_@ 6^"                .&N+/WYLP_I+?^2D&N.Y09
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MR2DGV]-"^3H ^K+&L<N8RH=O40K"(MPWU1Y<9I]LWE>*S2XDRW'\[Q 9::^
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MZDEIW(,E)/11&6I&1&7Q@/Q46*N0W+6PVJ6RE2&GS21N(2O3<25&6I$>A:Z
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M)>FXDJ/J6NA:Z ->WC..,S)EBU3P6["Q2;=A+3&:2](0H]32ZLD[ED>G@HS
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M
M
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MYLI:D&ZF/N3W#;2>AJ).NNTC/34&7L
M
M                                                    .&N+/WYL
MP_I+?^2D&N.Y09          !2'J^_=VS+^[/\5B N-KZ8_]!<'_ +"K^O=
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M:-S(&LK7 95D;,55<U9&GZ=,1;A.FT2OFFLMVGP@-F
M
M
M    .&N+/WYLP_I+?^2D&N.Y09          !2'J^_=VS+^[/\5B N-KZ8_]
M!<'_ +"K^O= U;0(
M
M
M                                X:XL_?FS#^DM_P"2D&N.Y09
M     !2'J^_=VS+^[/\ %8@+C:^F/_07!_["K^O= U;0(
M
M
M
M X:XL_?FS#^DM_Y*0:X[E!D          %(>K[]W;,O[L_Q6("XVOIC_ -!<
M'_L*OZ]T#5M @
M
M
M                            #AKBS]^;,/Z2W_DI!KCN4&0
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M!:GKJD_8",/ESEVCX;IZV_R.!-EU5A.17+?@I;7V''$*<2IPG%H]W1"ODZ^
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M          %(>K[]W;,O[L_Q6("XVOIC_P!!<'_L*OZ]T#5M @
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MB!5[\2DUG7J-Y5Y(;6F15TL:)C=,^D]S9D;:5/*0?\+&O_Y0$49B7[B_(/\
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MB;F2NA66,W"VJ7&LIK%:+^C-N.T3B=$[B1O;2K<VA9$K=JO0!>_,W^D.>_\
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M6GEZF:V]#^29: 5)\LXAJ\MY*Q+DJ592(\_$DN)BP6DMFR]W=VN\U%N+Y7L
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M,@          I#U??N[9E_=G^*Q 7&U],?\ H+@_]A5_7N@:MH$
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M-72TI4FJBM.RY9)7U2:D,I5LW%\G>:=?8!$<<]6'!K-+$OG\@>;@3)#\-O=
MFFXF1$2TMU"TI9,R,DO-GKX'KT\# C]I?5AP9D-S74%3D+KUI:RF8,%DZ^<@
MER)+B6FTFI;))+52B+4ST(")_A_(^(YY+O8.,352Y.-3%5MPA3+K/:DH4M)I
M(W$I)1:H5[R=2!$ O?5AP706SU/)R0Y3T99MRY$"+(EQ6E$>WJ\TVI*NOM;-
M0+%A-<BX7*PJ3R'!MV9N'Q(STU^RB;GTI9C)-3ON((U[DZ'JC;N(^FFH(\L
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MB3J6ID!&1QORSA'+$*;.PR8[)16NH8G-/QWHSC3CB34DC)U*==2(_DF8(FX
M               #AKBS]^;,/Z2W_DI!KCN4&0          4AZOOW=LR_NS
M_%8@+C:^F/\ T%P?^PJ_KW0-6T"               U.4?\ V,W/]AE?U*@'
M!/ KB^)*;C_F:(;B<7R.=-Q3/S<5JPRER5_R4O3KM)O3WU? C:75P&M;>IM+
M*DX>]2TRG=,I1Y&[&-]A6O\ R\N;Y=Y25%XD;3BNI>P!TUZ>\/Q6KX/Q2#7P
M8ST.YJ8TVWWM(64J1-:)Q_O;B/?HI1HT5KHDB3X$":J_TGMIH.1>:,$I5*5A
MM+=)76M:FIN.XIZ2RI"3]IFAE"#/_P"AD!K<>H7C;D21R'B',_'=9%R6=BC"
MH\G&IAI]])+<63K25FDE*T=5X*WI4E"DDKV#'Q'YOIN6^(>5X2Z1_&<VI*"R
M1D%+++Z5*CAO()1+-*%*)*DF@R6A*DGXEU+41+/2F9'Z=\.,C+3R\[KKTZ3Y
M(&N5\6N[2E]$F8JJG%-*GY,NOEO-GH:8LE$,G2U+V+(NVKX25H"]=H\-8;BN
M+<78Y5X]$C_=TRLBR)3Z4),YKDEA+CCSJM/?-PU&?7H1="Z$1 CG[F6QRB@]
M7&$S,$Q]O(;^/C"T0J0Y#<!M:#.Q0O1US1"20@S41?%H"\:;,\DY+R+U!<,K
MY'PMO#GX]@ZFO0U8,V7F4+<:-PS-DS)&PR3T/QU ='>HG_0[//\ Y(D?^8@3
M$&XZPC#\U]+&/5F70HSD Z%Q:IKJ$$Y%4CN*)]MPRU0I!ENW:_PZEJ!US1(N
M+2U]#[;-DXMUNLRE,&O4X9F914H[I)(S]B5NK27P$6GL!>K/Y;MKZC]2G%=I
MC6.GE=TQBI^6H2?1%.1N;GI69.N)6E.Q)J<ZI_)T ;OTLQF,TY/Y$Y>E,Q\>
MOE**BFX1#;6UY'JT9NO[DH(UK5%/J22U7W#,B\ -5_Z9LFY<I\+NXF!\:1<Q
MIUWTMQZTD642"I$@V8Y*9V/F2C)*20K<73W@-3[F^)&S7U.<3\>Y<@OU-\BN
MS77.&1QGII^95VE%X*)1Q6F]#\2,R_* SQU8FNKTM1V$Q&29B%I%;)M!):+:
M:-$%IHGW3V]/8#+F7/8L9'K3XO92PV32J"8:FR0G:9]JSZF6FGL!>'/;;;7J
M(X(;:02&RFR=$)(DI+5U@^A$!C!X7KX66>J/E[),G;3+O<=D(A429!$OL1B=
M<8)QI*ODF3;+9$HOGG\XP7?#U/U\/&.6N'<ZQQI,3,IMT4"0I@B0Y,C$['0:
M7-O57NO*:,_$TN:? !BNL[PJSRKGWF*ZQ?N)SO#6:G(\:<:,]3?@LQ%.-;"U
MWFMO7:GVJ(B]I@)GCF<5_)7J?XLSBL-),VV%O*D,H/=V);9V"9#!GXZMKU+K
MXEH?@8'&*F/R3Z6,RS;+'\11F?&^3SG+&9>0UD5A%86XXYH]T49$GN^_O1L4
M9:DM.I@>NK,%RW'\ZQ&IRO%E&=#9,$Y#2I!-*;)!FVIM2",R2IM25(41&9:E
MT,R!ERUS'E&!Y[ZD:G!\^MH,+CW"*V4]:IL'DL,R+.>R1$VA1GH:VR<841>S
M8L&L2CT79HW-Q"]XS?GM6$O"+!UF#,87O9D5LEUQ3;C2O%2>XES0_8E2 37-
M>'YWDF-\!YK1IP1FVQ"WN9<27F4I:76:^1-888T.,EM2][1;7&W-Y$2U%[>A
MFEH\]XE%P3TJ\:X[56*;Z-'NH<J/8IU2U)\\Q.ED;9*ZDV9NZ(U_)TU!,]=%
M<:9+RW=7[\;/>-(N'5#<5;C%HQ91)ZUR2<;2EGML&:B)236K=X>[I[01 _6^
MHD<.0UJ22R3?0#-"NI&1-O\ 0_B,#$(QW+T^GV'SS@*7.RU0&5_AY&>A;;M"
M&64H^$FG'(Y'M]NX%:#@7"F,"Y[P&G)"D6$O!OO:V)9:+\]8J=>6E7MU0DT-
M_P#L@:V7*U]@'*?J*GXOGM] JL&PBEF5["[!]#33MU.;)MQ3>XRU6RIQ!G\"
MF %B^C;._P!8^+I>&S)3<FWPF2Y7&ZVON)<@.FM<9Q*O:GHXVC_A00)K2^BZ
M@H\AX/N:V]KHUE DWTYI^/+:0\A:#C12T,ED?P@:@G%J4X_COJ?X_I)"Y.%4
M,6S.I)2S<0RI3$YDR)1^)J0RA*E>W9J"I/Z:,FY>9P#"*>NXQBV&#F\;2\L7
M9Q&W2BN3G.^_Y91]S5K5>B?%6WIX@:[ !EI<KCL.XY;N.M(<6B!*VJ6DE&7T
M*OA(!17HFCL+X.A.K:0IU-G/VN&DC47OI]NFH+JI/3YEG+F/.\@1^.N/VLOK
MWLCE.3)CEI'KC9>(S(F]CYD:O=T5J0+K9\'S+JPR'U)SLBK2I[V1%6Y8U:74
MR$QWU(L#6V3J-4KVG^470P-:[#^*,@Y=]'F.4N+NM%=U=U+M8T22KMLRNT_)
M:4TI1]"/1W<DU=-2T/374AU</%'/LNUS*%Q3R=ABL*Y"1&4FL)""\C(;:;-2
MDL:EJVDTMJ-!)6M![=-^NA D8OKB_P!#E_\ RO!_\SH&(2FCS;FGECC/)X''
MDW!Z+"W&9EK?6S:(LB:VPMEU+))2E)K29-;&]-?YQ1GM(%5S29_DN$2^?)-7
M@+664$F^FE;6$EU'EH&Z5*;1W8_;4MU![S,]JDD6G4R\0&YS.D<X]]$]7$QZ
MZ.VA95:QI=C-8)3;1,2R6Z;*4J]Y))7';0LCTU5NU+KH!UU]CW'F$,\:P<#8
MJXTC$'J]MA<8VTFA]#C1;G5&1=7%F>\W/E;NNNH,J%]';,7(.(LTPN^,K/"H
MEO.KHYR#^B5"D,(4Z@C+0DI]XW.G@:S,&M4%QPNMR/D'%>'\DOI$[@FOR.P>
MQ5Z2PIN/:26U?0L*6HB3M6I9:I+P-Y1=.X6A79OJ-XF_S2X_<;J?^7S+'E':
M8S+0?;<3(9(E*9)9:&DG4I(BZEHLD*/Y(,XJ7TW1\BYSS-?/W(1-.)Q^.W08
MO";_ )I,MIDCE2MGL,S<-1?\3AZ:=M(+J[/4/B/Z[<,9?2H;[DM$%<^&DOE'
M(KS*4@D_&KM[/XP3'-4>PC<X0O3G@-FGS=<]"L)60(,^IIIF50DJ5\!J..YX
M^U1 J+HN;:V]--#PJE9ED$C.SPYYK751--/^<,S+QVI=>;(M?@^(!<F70(M5
MZQ^(ZN$CMPX6-2(T=OYK3,>R0DOXB($XR?33_K/Z@O\ Y?:_]YL -?',W[U7
M"W]'*_\ X@&>.H01QMG-CE]7ZQ)DG",:8RJ[/&FT?=<J4U";[*D)WN=UWW=4
M]"V^W4&N/+AR+"8J^?95RC[EY*G09SM]AC4?RT6N8)B4IHV5$M:7DK-S7>D^
MA&7SM3#\],.3<NQ>-\5J*'C&)<X:<M]"LH<LHC#G9=GN&^X<=P^X9M&:DD7Y
M6WH!KK^^I8.1T=EC]HCNUMK%>@RV_G,R&S;67_8H&7%G'/)-GQ=Z?.6,%M'3
M3DW'TV13UZBU3I]\O+CM*;(_'8\3[W_JZ TPN6\4F<=>ESC/!7EK@1KZVBR,
MK>+W3[LMMR6;;OL/MF:?_I1? !UUUD7'F$/<:S\#?JXT?$&J]QA$8FTDAA#;
M1[74F9='$&6\G/E;NNNH,JE]%,Z9=<'QF;=/F&JJSFPJU3Q$LTQM&WM$FK7H
M2W%D7_8"ZU7HC8CN85F2W&6U+1E4LT*-"346D>/IH>FO3V :@?'=_P E4G,O
M-Q<>X''S8G\@/[Q5(G1X'E-DF;VB+S!EO[FJ]=OAM!4L]6+]I+X]XKDWE8BG
MN'\@@.6%2VXA]N-(7'6;C)+1[JR2HS+<70P3&]]9^&8F[Q/+S1<9B#EM)*AK
MJ+)A*69*UO2$-+9WI(E*+8I3A%[#1J7M Q>7'-G8W?'V*7-OJ=K84]?+G&KQ
M-]^,VMPS_A49@CC7T\9)RM30,TC8#QQ&S.M<R*4Y*GR+&+ 4T_M07:V/F1J(
MDD2M2^<#6I\Q7P\R];MG#RUE$F+BV/L2,=@R")QE+QLQ5F:4J]TS0N4\LNGR
MDD?Y) <9'K@JZVLP_&N0H!(A9M37D5NKLFB),A23;=>V;BZJ)"V4N)U^3H>G
MB8)B,\DY!E%+ZLZ:YQ[$U97>_JHV:\?2^B*HR<3([IDXXA9>YJ?3;J?@"\2/
MTB0HF3Y#G_+VZ/5V=U,.OE8C":6RBM-M7=,W-Y)W*7[IDI*2+7?[=2235X\T
M1XZ^)<\>6RA3J<=M=JU)(U%I#=,M#,O8!B#^E^/'_#EBLCM([_D[#Z7:6_\
M\9)+QTU\ -4/Z6<SYJH>,EP< XW9RJA.SDN*M'+:+7J[ZD-$MOM/*)7ND2?>
M\.H+K*X1>F2.'/49(L8Q0K!U5PY+ADLG"9>5"D&MLEEJ2MJM4Z^T#4B]-&3<
MO,X!A%/7<8Q;#!S>-I>6+LXC;I17)SG??\LH^YJUJO1/BK;T\0-=(\K?Z79O
M_P#(%K_[DZ#+F?TRY-R]'XZPVHI^,(MKA)R76U94Y9Q&7?+NV+O?>\NL^X9L
MF:R(O%6SH#6I-:?ORTO_ -JR_P"3)!./7UUZEPW7&1:G^L,+0OA_Y:4!BP>-
MLFY>N+Y<;.N,(N(TZ(CCC5HQ91)JU2$J026>VR9J(E)-1Z^!;0%2^B^KK,G3
MF_*5^VB9R#.O'X\B3((G'XS!MH>T;W:F@EK<6D]OL01>! NNK3KX!J6LXK)K
M=5W'%=M.JEZ$G<9Z=3T(BU!ES+Z'(\=SC/(G'&4*<1E$S8LTI-1:18AEH>FO
M0%U5F,VMG3<6>IN?4+6W.*[<8)QL]%I:E2W&'C(RZEHVM?4%=)^F_$<7JN#,
M6CU\&.ZQ=UK4VX-3:%^:DRT;GB>U(]^TS-LB5X)+0$USIAS*,<K_ %3X'1*/
M]3JJ)/=@QB,S:C/&B4T;:?CVH)L]>IDV7P K)X%>/AN;QYD&Y4?C[EFL36V[
MKJS4U%R*(XZEAPS,M$I>(R21:_E+/P0!JT/0\E2.&I:%D:5IOIY*2?B1DVQJ
M0)K1-P(>9>N"VAY8TF7$Q6A9D8Y#DD3C/=[49>XD*Z&:527G"Z=%$1^*2!>/
M?UP5=;68?C7(4 D0LVIKR*W5V31$F0I)MNO;-Q=5$A;*7$Z_)T/3Q,$Q'.4[
M;+X'JSQ6SQ3&6\ER8\40::%Z0U#0KN>=[NKKWNEL(S/KXZ O'3_'%GF%MCOF
M\XQAG$;LY#B?NF/*:FH[)$G8X;C/NZJZ]/B!E1'K CQVI?%':9;1ORIC?HA)
M:ZJ;UUZ==07&V]:[#+'!4WLMI;W6< U;$DG4]ZNIZ 8KOEO..=K#@RVJLBXM
M8I\3<KHC<B\3<Q9"FF4.,FAPF$*-9[C));?$M>H*T_,#LQCA+TY/U\5,Z>TY
M5+BPEJ)"7WDQ6#0T:E="):M$ZF Z=XQR'E*[LIZ.0..XV&0VF4JARV+&+/6^
MZI?O-F3!F:2(NNI@BJ_6= A6D/C.LLD*=KIN4QXTQM![5*8>3L61&7@9I,^H
M&*DY!L9^)\*\E< Y ]K.PBR@2\8=?47=F8]-GH6RI/SC:-9;]/D[R3^08*F6
M<PXV7<^<$83E"2?Q!O'V+)$)[14=Z83#[FU:3Z*)2HK"5)/Q+I[0%F>L'%\<
MLN#+NTL(S+=A0>5?II9(2EQEQ4EIDVT&1$9)6E9I-/AX'["!,5'R8VKD%'I@
MCYBV<I6217&+4W.JW3FQX"%.GK^4K=W/X05JRSB]K?2]9\/J,UYU&R9?'+3)
M'](M+SYO:D7CL-!.1R_B ZWW$F.U6)9GZA\8I6^W65-*S#83X&?9AOI4H_C4
MHC4?\(&H%8J)/H3HU&DE$61*,TGX'I+D]# ZEEWWN+<1Y<X$DN+/')-,YE6
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M%0BK].O-6%T5A@/'_)[$3 )RW>RW-@DNPBM2?YU+3B==#5J>IH4CKJI)),S
MJS<2X"PS&N(G^'I?<M:2>AU5K+=(FGGY+RB6;Z2+<3:D*2CM>.W8G7<>IF*@
M5#PES[Q[7GBW'O*47]3V]Q5S5Q6HD2X;:S,]K:C)PCT,^A&9)^!)> %2]WAN
M^E\TX;RS/O6)*L<H?N:RCG'4AV7*-J4A;Z32K:@E*D;MNAZ::>T"LOD?B&PS
MCDWCW/8MHS#BX6^X_(AN-*6Y()Q;:M$*)1$GY&G4!+N3,2D9Y@&0X=%DHA2+
MJ&Y#;E.I-:&S<_*-*3(S($4+#]-'+LS$87&]_P K]GCV(T45=555C;+ST8CU
M[2WS4E9I/7KO-1'[2,%J:<C>G6MR#AFOX>P>4W15U=)8DM2)2%2#7VC<4XIP
MTFDS<<4X:S5X:^!$6F@K86?#-E/YIPCE--LPB#B=0NI?KC96;KZU-2F]Z5[M
M$E_S!'H9?D_&!7YC?#%GB7.61<H4=LPUC.51]MO0*:7W#E[4J[R%DK;J;B37
MU+\M9? !5=X+Z>^>N-*N92X3R=6UU7-F.V+K"JAN1K(>2A"E;GR<46J6TEIK
MIT JQ.4N"6^5J#'';2\=J^2,90TY RVO;[9E,2E!NJ-E*D^XIU!.()*R4@_D
MGXD8KXPS#O4/77]6YFG(=;;8O 4HYD6-6-LRYJ>VI"$N.;$[-%&E6J#ZZ=0&
M;D?$5A><\8ER^W:,LU^-UKU>[5J:4IYY;R):=R7"5M(B\R70R_)^/H'YR/Q#
M89QR;Q[GL6T9AQ<+?<?D0W&E+<D$XMM6B%$HB3\C3J TN?<"WDOD ^6>)\H_
M5#.9+*8UNAY@I5?/:224_2MGX&9(1N]U1&:4J(DJ+<8KQQ3@/)9O($'E'F3*
MTY9DE,G;0UL.,42MA*ZF3A)Z;E$9FHO=3[VAF:M"T%2/$^))^.<U9KRH[9LO
MP<JBQHS-<EM27651T,H,U+,]#(^U["]H"$87Z72P7G5[E&DMV48PM<UZ/C_9
M43C)SV5)6A"R5L)"7%F:?=^3H7Q@5DYGQ/Z@\K+(,<3R;!8P6^?E)4TJL2<]
MBNEK5K$2M.FY)-J[>IN$HR]I$8"VN/,%K.-,(J<(HEJ=A5#*FVWW_ENO.+4Z
MXXO;X;W%J5H7AKH"*RXR]-=!0'D=QR?&J<XRW)+-RRDSY=>VZTRESWNVTB23
MAIU6I:CVZ=-I?D@M9-+P"C#>;T\G8))@T>+S*\Z^ZQB/%[+;A[--S/:-+:/?
M;9<,MGB2OG 5@\>^G)6,</9AQ3D5JQ9HRF5,E)FL,*;2PJ0PRVTK8M1ZJ:<9
M)TNOP 5HKSTU9ED'!V-\33LKB'98U:IG0[?RSJD*AM-OI;9-!KUW(-_1)^&U
M)%H!5@8+B?/-3DC$W.^0H.0XVAMU,BKCU+$-Q;BDZ-J)UM*3+:KKX]? ![<_
M\3S^9,&9Q*NLV:I]NPCSSDR&E/(-+"'$FG:A23U/?K_$!B(\T>F:-RUGF-9?
M]YMP(M>VQ#R&$II2SG0XT@GTH2:5$1*,E+1JHC_)^ #-26PXCMW><VN88-I&
M;9CT2Z9BL=96:N^9.;%J4E1%L(UEJ1==" :7BKTSXKB=39JY%@U6<9;<6+]E
M.N)\!I\R[VGN(*0E9D6[<M6FFJE'\! 5DXGP*K N9K7D##9D.JPN]@E#L<58
MC&TA#B4)T6QVS)"?I&R7\G\I9%X@57^&>FCFS"L<DX9C_+#%+C,Z0Y*EE!JT
MJE]QY*$+-MY:TN(,TH3\EPM/8!5F8QZ?L=P;B;)>-L6DK\_DT&9'L+V:7<>=
ME2XZF$N+2G31#>[W6T^'7J:C-1BH9@_"OJ%P&DJL7H>4*UG&JM6C4(Z9EU7:
M6\;SB>XX2EGN-:O%7M J78PSR=<\_97;6[EC6\84L-B%0U[I]N).EN(23CZ4
M]=Z4F3O7XT?P +:MX2K*JG5R%DVN7'=CI<,M22;J#01F73734$5[P+Q;.X?X
M^9PRPL6K20U+D2O-,-J:1M?41DG11F>I: NL/@SB&PXE9RIJPM&;,\BMW+5H
MV&E-=I#A:;%;C/4_X -UK,5X,L\>R+ER\=N&'T<DDZ4-I+*TG#[A22+N&:O?
MT[Y?)T\ *Q<5X9Y'P/ANHX_PK,HU7E-78N3E7'DR?C/QW7'5JCJ:=W:$9N)U
M5I^2!7EAO!.9/<FPN6>7LM9R/(:=A<:CKZ^*42%&):5I-1^!JT)Q9D6S7<>X
MU'IH!4KY]XJG<QX">'5]DU5OG-CS#E/MJ=1M8)9&G1)D>I[@,63 C*AP(L1:
MMZX[+;2EET)1H223/^/0$5!QOP4>(O\ )[603V;:HY%G/R7(C32FE-1I1R>X
MVLU&HE&:7]-2+V M:W ?3LNHX?N.&,^MF[_')<AQVKD16U1GXB'%)=+;O-9$
MI#Q=U/B6JC(]2Z 5H(_!?/\  QT^.H'++"<#)KR34E=<1VS5?IL["'-VI$2/
M=2?>(R+H1D70A4IM>!IM/PM_D[Q=<-T3$TU(NKF:VIZ3)9?(SDF7:-!$M[1+
M9^PFM4E[#(5Y9GZ9L9ON'*?BZC?*MGXWVI%'>J09NHG$>K[SA(,C^G-2S625
M:$HTF7R$D!5JXU79'&Q&%4Y78,661M1?+3K..VIIM]Q)&@G30HS,E*+12R+I
MNUTT($0KT_<33^&<$<Q"PLV;5]<]^<F2PVIE!(>0VDDF2S4>I=O77XP75IK0
MEQ*D+22D*(TJ2HM2,CZ&1D".<N$?2_)XDY"L,OE7S=I5E%E0J*N2TXA41N5(
M2[J:E+46I(2:3VEU-1F"[K\J?2Z_7<\N\KKO6G,;^\Y5XSCQ-+)29TME236:
MMVS4G5=S4DZ]"("IOD?$5A><\8ER^W:,LU^-UKU>[5J:4IYY;R):=R7"5M(B
M\R70R_)^/H$!C<"<R8QG&:Y9Q]R% I&,RLG+&5%>JT3%$GNO.,I,WMY:H)Y1
M&:=-0*RLUX'Y5RRYP3,6\Z@Q\[Q&(\R_;JKB4V_(==4HG$L%]&1$A6TR-/CU
M JS>-*#E:C.S_P S,OBY43_8^ZRB0&J_R^SN=W=VDIW[]4::^&WXP%>9YP9R
M/:\O2.6./\RAXY8.US=8A$B"4U1-I3HO4G-R.ID1E[H%9F#>GB9C-=G=ED.4
M.9)R'GD!^!/O7V"9992ZTMM)(:2HS,B-235[Q%HE))).G45&<'X,]0O'F.PL
M4Q7E&LAT,%3BV(JZ9I_;WW5/.>^Z2EGJI2C^5_V 5TX".:.1_2BG.^7F^06;
MQN%CDY^ODY%0FTL_-K@&E*B(TK)'TB$)+52>BC4?4%JYN4.-L>Y8PZ;AN2$M
M,22:78\IG0GHTEK4VWFS41EJ6ID9'XI,R]H(IA[@OG^?CA<=6/++"L#-KR+T
MENN(K9VOV[#86X:M=#1[IF;IF9=#-1=#+5Z8%@]#QQB59AN-M*;JJQLT(4X9
M*==<6HUN.N*(BU6M:C4K0B+KH1$6A B%<!<0V'#E!>4]C:,VKMO;/6J'6&E,
MI0EUIMO89*4K4_H]07=0*-P)S)C&<9KEG'W(4"D8S*R<L945ZK1,42>Z\XRD
MS>WEJ@GE$9ITU K=\G\(9]RAQ]B>/W.6Q#S+'[#[SFWODMC,AQ!.DWM8;-*4
MFDEH(^FAZ>'4"M7+]->8\@V]=-YSY$>RNEK'2?CXY7PVZR&MPBTU<-HRUU+W
M3/9OVF9$LM0*Z,:::8:0RRA+;+:20VV@B2E*4EH1$1="(B!%4\$<0V'$-9D<
M"PM&;1=Y;NVK:V&E-$VEU"4[#)2E:G[H+K"Y8X*D9KE%3R3@^0N8CR72M]B/
M:H:*1'D,>]HV^T9EKH2U)W==4GM4E1::"H\QZ?LYS;*Z7)N=,R9R2%CCI2*G
M':N(42 ;Y&2M[Q^Z:]32G<G;U\-VW4C%2Z7Q#82>?X',J;1E-?#J%52JHVE&
M\I1I=+>3F[;I])\'L 8V!\,V> <O9EG-1;,?J?F7_,2Z VEI>;G;B<[I.$K:
M9;UOGIM+HYI[ *L/.<>=RW"\BQ5A],5^[K)E:W)6DUH:5+86R2S21D9DDU:Z
M:@C0<3<>S..>+:CC^9.;GRZUF2RN:TA3;:SDR'7B,DJ,S]TG"+QZZ K4^G[B
M:?PS@CF(6%FS:OKGOSDR6&U,H)#R&TDDR6:CU+MZZ_&!J-87P!;8MB/*F-/W
M<>0]R$Y/<B2$,K2F+YYEUHNXDU:JVFYJ>GP 5I,'X5]0N TE5B]#RA6LXU5J
MT:A'3,NJ[2WC><3W'"4L]QK5XJ]H%7UF-&[DV(W^-L/)C/W%;,KFI"TFM+:Y
M;"V26:2,C,DFK4RU!% X/PCZAN/J"NQ3&^4:V-CM:I1L0U4S3QDEYY3[A=QP
ME+/52U?E>WV M;KD;@_D&_Y<C\L8#E\3'+.-6(JVTR8)35$G5S>>B]4&2B<^
M;T K#SO@KE7DWC0\,S?.H-C>-W3-K%M45R8S:(K,9QKL&VQLU5O<->X_X *E
M^#8CSW4Y+$FYSR' R#&6T.IE5;%2Q$=<4ILR;,G4)(RVKT4?7KX>T!$[7T[Y
M9C&;VV=\'9D6*2+]PW[JAG1BF5KSRE*6:DEUVEN4I1%L,T;CVJ2GW0*M/C>F
MY%IZR:GDK(XV1W$F3W8SD**F&Q'C]M*29222(U>\2E;E%KU!$;]/W$5APSB=
MICEE:,VS]A;/VJ9$=I3*4I>99:)!I6I1ZD;1G_&"ZUW&G R,19Y(KLGF1[NF
MY GORGH;;:VNW&D]XEMJ4:C/=H[T4G3334@*B5-P/S?Q] D8EQER@S%P9Q;B
MH+%K 1)FP$/*-2TLKT4DSU,SZ;$[C-1)29F!4KQOT[5.'\399Q[3V;DJ_P O
MBRF[?)9R-SK\J4TIHG%()1F2$;C,D[S/J9ZF9F!1_@!BT]/T/A>ZGMNSZ^,1
M0KEIHR2S.:=6ZR\E"CW:%NV+ZZFDU%TU K;^G_B>PX:P5W$;*S:MI#E@_/\
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MF<;660Y?E.0+R?/LJ6A=M9FT4=E*&S-1(:01GXF?4^A:$DDI21=1NKA!
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MCN4&0          4AZOOW=LR_NS_ !6("XVOIC_T%P?^PJ_KW0-6T"
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M5'#:Q'.Z3B>@X3QB6QRU5KKE7V20H2X;#2V64D\Y(=3T</ND3O>5^2D^OO:
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M(Q<AD.S,QN\9EY!E,E\R4K[TL5RC=06W4M$$E*3,O%6I^ +KN$&0
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M.-8/._J<MI5]9Y6\9MORG9JV(Y/J<[+2&X'OZFEM2_ D(+W4I+;J8=#\ /\
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MO.9JOE3*I?"'(-;A,RQO,;=<M,CHVW&F%LRD+A+4T:U*41$M33FQ1$?3Q+V
MF+EXWS_/<PL)T3+^.IF%Q(S*78TN5-:F)?<4O:;9);;09&1>]KU 0?TB81E6
M!\?7E7E]0[36$F_E3&(S_;W*CN1HR$K+MJ46FY"B+K[ -=  CF[EOC3DC'N6
MJ_GGB*&S=V912K\DQIYU+"Y;"4[-S:UFDCU02.FNJ5(2HB7J:05+L9SC->3Y
M$[#\NXOLL5QFQKI<>TLY\MI1;GD$UV6D$VDU;DK5[_LT\ %8\<KYQ].U9+XY
M?P&1GV+QY+[^-W5/(;:/MOK-9MO-J):D$:C-9[B]TS5H:RT,%]2WA+C'.RSO
M+.;N4X[-?E^3LE"KJ)AQ+WD8!$WHE:TF:=^UEI!:'K[JC5U5H1-59C/"/(?X
M8IE([2OUW(]#DOZRXY"<-KO*=8[*2-)DHT]4&[M(SZJ(@6_7[<\*\CO^F2SA
MR*5^=REE^1_K%?PD]OS!+<?47O'N).FTB<,B/H:S OU,^=<5Y"5G7$>8XIB4
MG)F\1:<>LH3#K3.BR[&C9K69Z&>U77:?@"8MSC3.\YRZ981LMXZE83'C--N1
MI,F8S+3(6I1DI!$VVC0TD6OM 6.".%^/*GG7">,,JXM:XA>MG<GFS7T6,Z7%
M;BLIG1VH_OLJ,R5L[>\C[J2Z_$#3=\@<'<E5/IVX[P6N@.9+E%#=E9V,2(XD
MT,M.%*=[25N&G5*#=2WJ7MZET J],!Y*Y(R;)&JG)>*9N)5+C3KB[E^>Q);0
MMLB-*#0VT@_?/IX@B*^EO!LJPV-GJ,LIW:Q5GD+\VO*02#-V.LM"6G::N@&L
M7EWCKD/'^5ZCGKBFO;OK*/$^[<CQEQU,=R5&(E)WM+49$9[3(M/%*D(,DK]X
M@$;SRKYC]2[U-AMEA<CC[CN),:GY!86<AMR8^;1*23;#:22?0E*V^Z:35H:C
M3IH9?$HR7CF^E^JC",HC4*G\"J\<=K94XR;7%9<)N>E#2DK5K_WC9%[I_*+X
MP3CQX<P3,.*.;,\Q^)3/%Q-DJBM::P:V>4BR^CG9)!*U06CCC/R?^[1[.H&J
M_P"#IG-G#&+VN-.\.6%X<VVD6J):9T:+M2\TRT39I-#NNG:UUW>T%UV'42Y4
M^I@3IT-5=.E1V7Y->XI+BX[KB"4ME2D]%&@S-)F70] 9:7D:OFVW'N6U=8PJ
M58SJ:QC0XR-"4Z^]%<0V@MQD6JE&1%J8"%^F?&;_  _A3&<=R> Y67</SOF8
M3VWN([LY]U&NTS+JA25>/M!=1CTC8/E.#\?WE7F5.[4V,F_E3(\>3VS6J.Y'
MC(2LC0I1:&I"B\?8!J/<7<=9Q20_4&W:4;\5>4R[)W'4J[9><2^F=V^WHK0M
M>XCY6GR@&EX7R/FOBGCZHP5_A:QM5USDA2K!-A%C[RE27'_YM3:]#23FWJOV
M>P%UUX#*@N5,*RN[]0'$^4U-4]*Q^C\W][6#>WMQ^Z7N[]5$?7XB!5;T' ^<
MPO4-Y!^"XGA:JOY.:UKWT?ESGR&&U-H06[=JVZ2$;3+Y+9G[=06IAQU@.9U-
MOZAW[*E?C,Y5+E.8XM9MZ34.)GDDV]%'X]QOY6GROX01%.%<@YLXEX^KL(>X
M6L;9R$[(=.>FPC1MQ27E.Z=LVW#+;NT^4"ZWW+M+R14^H[%^4L4PB5EM14T!
MPGV8[[,8C??5-0:-[F[0T$\E7R.H(N?C/,<PR^-8NY=@TG"'8CC:(K,J4U+\
MRE:3-2DFVA&W:9$1ZE[0%<<'X1EF.<Q\R9!>U3T&FR"Q9>IICIHV26T/2E&I
M&U1GIHM)]2+Q TQ#",M@>JKD3-9E2\SB=M21XM=:J-'9>?0U 2:$Z*W:ZM.>
M*?R?X .(?Q/P1?7/IJR'C/-ZM=)D$RRESJGS6S>Q*0VRJ,^1MFK1.]!I5IU-
M.XO:"WZ\?3SQ-G]E0<M4_,=9*K)6<(C,NSGNRIQYQ3<I#KR.VI1&M"EH7J?0
MS/V@:]L"D\Z<(T:>-<DXX7R!C%:XY^K]S4/LJ^A6XI9(<;<2M1$2E&9&LDFD
MNGO$1 -=@%OF'ILX'S;,LMQ]%=>V60G,HZ28\V9.E.*.V1*["C,MA)=5M]T]
M$>! >NK,6EW<_&ZF=DD9J'?R8C+]E#C[NTS(<02EMIWF9^X9[>H,O7(6'I5!
M:QHR#<D/0Y#;+9::J6MI1)(M?A,P%0^D[$,FP?B&-0Y;6NU5NB?,=5$?V[^V
MXI)I5[IJ+0P76L],>#95A\GD=>55#M:FVR%V;6JD$@^]'6;ADM.TU=.I :Q.
M+\#S"EY9YMO+.G>BU&1*+[CE+V;)1$;_ ,C11_.3XZ>("!\&6O-O#>"%A[W#
M-C=.)EOS/.IGQHW1_;HG8;;I]-OCN!==APWGI$2/(D,'&?=;0X[&49*4VM22
M,T&9=#-)]-09<^\_<=7^;<K\0V$2A.ZQ>HG/GD1K0T[&:CNO13^F0Z>BDFE"
MM2T/P!<7;^KM134$^KQNJBUS#K#Q(B0&&HS:G%-FDO=;)*=3\ 1RCP9:\V\-
MX(6'O<,V-TXF6_,\ZF?&C=']NB=AMNGTV^.X&M6!EF$Y7D/J>XXSA>/.+Q.%
M0O,7$EWM.L1I+S,_Z%PC/JHE.MEJ2?:"<>'%."9CQ1SIG556TCRN*,J3]Z5<
MUGME%BSB+N]HD;BV)U6ZSH2?R6_9X!">77.6^<\8:PF3PBY594MYDOUEG2H[
MD>"AMPEK4P_M0>BR(TJ+<?NF?11Z J8<G<)Y[#B\9YQQV\U;\A\:PHM?)BRE
M]M-I&CM)0LB6M22(U'W",E*3N2X?O$HBU)6IY!M.>>><=3QK7\=OX-66;C/Z
MRWMQ*;<:0PRXEPT,)2E"UD:DI/5)&:B+;H1&9@-UR-Q1>0\PX @X?5OS\9P6
M4;%E-2:/^7CM'"2EUW51'JHFEJ/:7B1@*]]37!7(4S-7;OC*K>L\<RYR+-R:
MLBFT1-VE89I0^:5J1IW&W5>\G\K?N^40+FK\Y2SO-\;MTTM9Q?)SO$IT!*WY
M45YK0I:G'$JCNL.(7JC:E"MY]/>\#T!$,]*_%N78,YFN4Y14M8NUETUJ168D
MPXEU$&.RI]9$>PS2GH\2$I\2)/4BZ$0U>N51I$W%[N'$;-Z5(@2F6&DZ;EN.
M,K2E):Z%J9GH".:,,X.RBV]+$7"+>"[2<AT\N5<X]W5)0_'LF)+CT=1+2HR3
MW$F;>[7W25K[ 6_49X\Q;G'$N#^3V)&,3U\B9?9&45HNR3JBL6B1)E:I7HG:
M1N&1E^7H"I3C?HPJDX'#I+;-,G@SI<)"K6IB3VDU*9KR"4ZDH_9,E(2Y\*M5
M:>()433@7,=AZ4[KBBYQ>8K)Z2SCM4S1*:7YJN\VE_5M6_WNVKN%U_(VZ O6
MPYXX>Y0L9&*7'&]>Z=A?8TWA^9MMFV7:C)-E9&]N470SU2I2==";(#$XL.+K
MVG]0?$D^@J7G<%Q''GJB1:)V$TR;<66RVE9;MVY6Y'@7BK^$$12M8Y:XTYPY
M+RZJXRG9739-(;3"?:E,1$[&3W;R-:7#,E;O@(%;KU"4_)','!5,F#A$NMRM
M5XU)E8UWV9#S$>.B4T3BG/HTF2M4'T+4MP)C!Y :]1?/E.C &\';X\Q":XR=
MY:V4]J8^XRRLE[$-M$A>FY)*VDCWC21&M*3/4KI;%,<@8?C-/BM7N^[Z:&Q
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M(>K[]W;,O[L_Q6("XVOIC_T%P?\ L*OZ]T#5M @
M
M                                          #$L*NLMF41[6$Q.8;6
MEYMJ2TAY"7$:[5D2R,B46O0P&6
M                                    .&N+/WYLP_I+?^2D&N.Y09
M        !2'J^_=VS+^[/\5B N-KZ8_]!<'_ +"K^O= U;0(
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M#KGF6Z]1TC >-N,["712K9E%SR#9UKCC#U;'C'VW8Z'4GKU7J:?G&IG7HI1
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MY.?;GY?A3R4MV[223YN(I1HW+(DI(S+W%)7M(U)66XMQ&9DUT*"
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M,O[L_P 5B N-KZ8_]!<'_L*OZ]T#5M @
M
M                 T-!A6+8O87-K05;,&RR&1YVZE-[C<E2-5JWK-1GX&M9
MD1="U,!O@       :&9A>+6&55^;3:ME_*JIA<6NLU[C=89=)9+2@M=I:DXL
MM=->I@-\
M                           #AKBS]^;,/Z2W_DI!KCN4&0
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M #R]*/-V:9A(DX?RC+.3?3HB;_%[!UMEDY=<:U,/(23*4)/MN-F9=-WR]>B
M-PXIY\OJ[@[.^3.0IJ[V7C]Y+@US1H:CJ<+MQ41HY&TA)$1NO=5[3,DF9]=
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M#!X>3SOR3B%!F\GFQJO39NN&Y1N5->XZ28\I;!H-9&V>KA-ZE[GY0+KKH&0
M
M                                  '#7%G[\V8?TEO_ "4@UQW*#(
M        *0]7W[NV9?W9_BL0%QM?3'_H+@_]A5_7N@:MH$
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M1&9$?@!JJ^0RN^.LMY*]/5%&<./R7<5,G'%(/8RPU-D=Q:$EXF2C4F.?Q-F
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M0
M                                    '#7%G[\V8?TEO_)2#7'<H,@
M         I#U??N[9E_=G^*Q 7&U],?^@N#_ -A5_7N@:MH$
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MGW? *8=B45G[P-/;.7VT][9\W?INT^+4!D@
M
M          X:XL_?FS#^DM_Y*0:X[E!D          %(>K[]W;,O[L_Q6("X
MVOIC_P!!<'_L*OZ]T#5M @
M
M
M                                     #AKBS]^;,/Z2W_DI!KCN4&0
M          4AZOOW=LR_NS_%8@+C:^F/_07!_P"PJ_KW0-6T"
M
M
M
M     .&N+/WYLP_I+?\ DI!KCN4&0          4AZOOW=LR_NS_ !6("XVO
MIC_T%P?^PJ_KW0-6T"
M
M
M                                  .&N+/WYLP_I+?^2D&N.Y09
M      !2'J^_=VS+^[/\5B N-KZ8_P#07!_["K^O= U;0(
M
M
M
M  X:XL_?FS#^DM_Y*0:X[E!D          %(>K[]W;,O[L_Q6("XVOIC_P!!
M<'_L*OZ]T#5M @
M
M
M                             #AKBS]^;,/Z2W_DI!KCN4&0
M  4AZOOW=LR_NS_%8@+C:^F/_07!_P"PJ_KW0-6T"
M
M
M                                                         .&N
M+/WYLP_I+?\ DI!KCN4&0          4AZOOW=LR_NS_ !6("XVOIC_T%P?^
MPJ_KW0-6T"
M
M
M                          .&N+/WYLP_I+?^2D&N.Y09          !2
M'J^_=VS+^[/\5B N-KZ8_P#07!_["K^O= U;0(
M
M
M                                                      X:XL_?
MFS#^DM_Y*0:X[E!D          %(>K[]W;,O[L_Q6("XVOIC_P!!<'_L*OZ]
MT#5M @
M
M
M                     #AKBS]^;,/Z2W_DI!KCN4&0          4AZOOW
M=LR_NS_%8@+C:^F/_07!_P"PJ_KW0-6T"
M
M
M                                                 .&N+/WYLP_I
M+?\ DI!KCN4&0          4AZOOW=LR_NS_ !6("XVOIC_T%P?^PJ_KW0-6
MT"
M
M
M                  .&N+/WYLP_I+?^2D&N.Y09          !2'J^_=VS+
M^[/\5B N-KZ8_P#07!_["K^O= U;0(
M
M
M                                              X:XL_?FS#^DM_Y
M*0:X[E!D          %(>K[]W;,O[L_Q6("XVOIC_P!!<'_L*OZ]T#5M @
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MEJ):4&V6A-+Z*41] 0BY]B,W-9O'<:S2YF5=%383*LFW24W%7V]%]PT$V?\
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M+H9&0(J_+/4=PSA%^[C.19.VQ<QE$B8PQ'E2TQU'IT=7':<2@]3(C(SU+VZ
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M]I1+;6VLMR5)4G4C(R/4C($>@
M                           X:XL_?FS#^DM_Y*0:X[E!D          %
M(>K[]W;,O[L_Q6("XVOIC_T%P?\ L*OZ]T#5M @
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MM#?(4FRG-VD"5'4]+LR>:)IMAK1*C6HWB<T3[#62]=#U(NH?(]WT-1DGT/\
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M&&Q!2<*X0RY&1(B.+4XP:6W3-:2)I2$D1_ ":L $
M                                         '#7%G[\V8?TEO\ R4@U
MQW*#(          *0]7W[NV9?W9_BL0%QM?3'_H+@_\ 85?U[H&K:!
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MBTT^$!OFFFF&D,,(2TPTDD-MH(DH2E):$1$70B(O @'V
M                                              .&N+/WYLP_I+?^
M2D&N.Y09          !2'J^_=VS+^[/\5B N-KZ8_P#07!_["K^O= U;0(
M
M
M
M              X:XL_?FS#^DM_Y*0:X[E!D          %(>K[]W;,O[L_Q
M6("XVOIC_P!!<'_L*OZ]T#5M @
M
M
M                                         #AKBS]^;,/Z2W_DI!KC
MN4&0          4AZOOW=LR_NS_%8@+C:^F/_07!_P"PJ_KW0-6T"
M
M
M
M         .&N+/WYLP_I+?\ DI!KCN4&0          4AZOOW=LR_NS_ !6(
M"XVOIC_T%P?^PJ_KW0-6T"
M
M
M                                      .&N+/WYLP_I+?^2D&N.Y09
M          !4?J?Q^TR?@C,JFF8.38>7CRT,((S6IN!,8ENDDBU,U=MI6A%X
MGT!<5YZ-.7<;R'CFNX[ES&HN78]W6$075$A<J(MU3K;K)'IOVDO8LDZF1IU/
MHH@-=/@@
M
M
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MZL"GX*>;?]P(7VJQ^K I^"GFW_<"%]JL?JP*?@IYM_W A?:K'ZL"GX*>;?\
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MZL"GX*>;?]P(7VJQ^K I^"GFW_<"%]JL?JP*?@IYM_W A?:K'ZL"GX*>;?\
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MZL"GX*>;?]P(7VJQ^K I^"GFW_<"%]JL?JP*?@IYM_W A?:K'ZL"GX*>;?\
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MZL"GX*>;?]P(7VJQ^K I^"GFW_<"%]JL?JP*?@IYM_W A?:K'ZL"GX*>;?\
M<"%]JL?JP*?@IYM_W A?:K'ZL"GX*>;?]P(7VJQ^K I^"GFW_<"%]JL?JP*?
M@IYM_P!P(7VJQ^K I^"GFW_<"%]JL?JP*?@IYM_W A?:K'ZL"GX*>;?]P(7V
MJQ^K K-I_0AEEG:,N\@YPW(JVNBB@=^1*-/M2A<I))1J?MVJ_@ KL/!\%QCC
MG'(N*XC!3 J(NJMI>\XZZK3>ZZL^JUJTZJ/^ M"(B!E(@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
?                                     '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
